Science.gov

Sample records for magnesium alloy-zr

  1. Devitrification of Mechanically Alloyed Zr-Ti-Nb-Cu-Ni-Al Glassy Powders Studied by Time-Resolved X-ray Diffraction

    SciTech Connect

    Scudino, S.; Sordelet, D.J.; Eckert, J.

    2009-04-13

    The crystallization of mechanically alloyed Zr{sub 67}Ti{sub 6.14}Nb{sub 1.92}Cu{sub 10.67}Ni{sub 8.52}Al{sub 5.75} glassy powder is investigated by time-resolved X-ray diffraction. The powder displays a multi-step crystallization behavior characterized by the formation of a metastable nanoscale quasicrystalline phase during the first stage of the crystallization process. At higher temperatures, coinciding with the second crystallization event, the amorphous-to-quasicrystalline transformation is followed by the precipitation of the tetragonal Zr{sub 2}Cu phase (space group I4/mmm) and the tetragonal Zr{sub 2}Ni phase (space group I4/mcm). The transformations are gradual and the quasicrystals and the subsequent phases coexist over a temperature interval of about 25K.

  2. Electronic structures, magnetic properties and half-metallicity in Heusler alloys Zr2CoZ (Z=Al, Ga, In, Sn)

    NASA Astrophysics Data System (ADS)

    Yan, Peng-Li; Zhang, Jian-Min; Xu, Ke-Wei

    2015-10-01

    The electronic structures, magnetic properties, and half-metallicity of full-Heusler alloys Zr2 CoZ (Z=Al, Ga, In, Sn) with the Hg2 CuTi -type structure have been studied by using the first-principles projector augmented wave (PAW) potential within the generalized gradient approximation (GGA). The Zr2 CoZ (Z=Al, Ga, In, Sn) are found to be half-metallic ferrimagnets within a certain range of the lattice constant. The total magnetic moments (μt) of the Zr2 CoZ alloys are calculated to be 2 for Z=Al, Ga, In and 3 for Z=Sn, linearly scaled with the total number of valence electrons (Zt) by μt =Zt - 18 . The origin of the band gap for these half-metallic alloys is well understood. These new Zr-based Heusler alloys are the ideal candidates for spintronic devices.

  3. Magnesium basics

    PubMed Central

    Ketteler, Markus

    2012-01-01

    As a cofactor in numerous enzymatic reactions, magnesium fulfils various intracellular physiological functions. Thus, imbalance in magnesium status—primarily hypomagnesaemia as it is seen more often than hypermagnesaemia—might result in unwanted neuromuscular, cardiac or nervous disorders. Measuring total serum magnesium is a feasible and affordable way to monitor changes in magnesium status, although it does not necessarily reflect total body magnesium content. The following review focuses on the natural occurrence of magnesium and its physiological function. The absorption and excretion of magnesium as well as hypo- and hypermagnesaemia will be addressed. PMID:26069819

  4. Magnesium and magnesium alloys

    SciTech Connect

    Avedesian, M.; Baker, H.

    1998-12-31

    This new handbook is the most comprehensive publication of engineering information on commercial magnesium alloys under one cover in the last sixty years. Prepared with the cooperation of the International Magnesium Association, it presents the industrial practices currently used throughout the world, as well as the properties of the products critical to their proper application. Contents include: general characteristics; physical metallurgy; melting, refining, alloying, recycling, and powder production; casting; heat treatment; forging, rolling, and extrusion; semisolid processing; forming; joining; cleaning and finishing; selection, application, and properties of grades and alloys; design considerations; mechanical behavior and wear resistance; fatigue and fracture-mechanics; high-temperature strength and creep; corrosion and stress-corrosion cracking; specification.

  5. Accuracy of orientation distribution function determination based on EBSD data-A case study of a recrystallized low alloyed Zr sheet.

    PubMed

    Bozzolo, N; Gerspach, F; Sawina, G; Wagner, F

    2007-09-01

    The question of the statistical accuracy of EBSD data for global texture calculation was re-explored on the basis of a very large grain population (83 000 grains measured on a recrystallized low-alloyed Zr sheet). Previous works aimed mainly at identifying and quantifying the main texture components and were based on much smaller data sets. The present work attempts to quantify the accuracy of the complete texture, including low-density regions of the orientation space. For that purpose, a new statistical parameter, V(Delta), based on the calculation of texture difference functions is proposed. This parameter has two main advantages: it is equally sensitive to both high and low peaks of the orientation density function (ODF), and it has a physical interpretation because it is the material volume fraction corresponding to the difference between a given ODF and a reference ODF (considered, or known to be close to the truth). Two main variables were studied: the number of grains taken into account and the peak width phi(0) of Bunge's 'Gaussian' model density used as kernel for the actual analysis. The orientation distribution functions were computed by nonparametric kernel density estimation with harmonics up to the order of 34. Minimizing the value of V(Delta) serves as the objective function for optimizing the peak width phi(0) as a function of the number of grains. The properties of the V(Delta) parameter also allows for the definition of a method for estimating the accuracy of a given texture that has been obtained from a limited number of grains, without knowing the true texture of the investigated material.

  6. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2011-01-01

    Seawater and natural brines accounted for about 54 percent of U.S. magnesium compounds production in 2010. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties from well brines in Michigan. Caustic-calcined magnesia was recovered from seawater by Premier Magnesia in Florida, from well brines in Michigan by Martin Marietta and from magnesite in Nevada by Premier Magnesia. Intrepid Potash-Wendover and Great Salt Lake Minerals Corp. recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from seawater by SPI Pharma in Delaware and Premier Magnesia in Florida, and by Martin Marietta from its operation mentioned above.

  7. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2010-01-01

    Seawater and natural brines accounted for about 40 percent of U.S. magnesium compounds production in 2009. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties from well brines in Michigan. Caustic-calcined magnesia was recovered from seawater by Premier Chemicals in Florida, from well brines in Michigan by Martin Marietta and from magnesite in Nevada by Premier Chemicals. Intrepid Potash-Wendover, and Great Salt Lake Minerals Corp. recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from seawater by SPI Pharma in Delaware and Premier Chemicals in Florida, and by Martin Marietta from its operation mentioned above.

  8. Magnesium Test

    MedlinePlus

    ... Mag Formal name: Magnesium Related tests: Calcium , Potassium , Phosphorus , PTH , Vitamin D At a Glance Test Sample ... checked to help diagnose problems with calcium, potassium, phosphorus , and/or parathyroid hormone – another component of calcium ...

  9. Production of magnesium metal

    DOEpatents

    Blencoe, James G [Harriman, TN; Anovitz, Lawrence M [Knoxville, TN; Palmer, Donald A [Oliver Springs, TN; Beard, James S [Martinsville, VA

    2010-02-23

    A process of producing magnesium metal includes providing magnesium carbonate, and reacting the magnesium carbonate to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The carbon dioxide is used as a reactant in a second process. In another embodiment of the process, a magnesium silicate is reacted with a caustic material to produce magnesium hydroxide. The magnesium hydroxide is reacted with a source of carbon dioxide to produce magnesium carbonate. The magnesium carbonate is reacted to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The invention further relates to a process for production of magnesium metal or a magnesium compound where an external source of carbon dioxide is not used in any of the reactions of the process. The invention also relates to the magnesium metal produced by the processes described herein.

  10. Production of magnesium metal

    DOEpatents

    Blencoe, James G [Harriman, TN; Anovitz, Lawrence M [Knoxville, TN; Palmer, Donald A [Oliver Springs, TN; Beard, James S [Martinsville, VA

    2012-04-10

    A process of producing magnesium metal includes providing magnesium carbonate, and reacting the magnesium carbonate to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The carbon dioxide is used as a reactant in a second process. In another embodiment of the process, a magnesium silicate is reacted with a caustic material to produce magnesium hydroxide. The magnesium hydroxide is reacted with a source of carbon dioxide to produce magnesium carbonate. The magnesium carbonate is reacted to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The invention also relates to the magnesium metal produced by the processes described herein.

  11. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2012-01-01

    Seawater and natural brines accounted for about 57 percent of magnesium compounds produced in the United States in 2011. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties LLC from well brines in Michigan. Caustic-calcined magnesia was recovered from seawater by Premier Magnesia LLC in Florida, from well brines in Michigan by Martin Marietta and from magnesite in Nevada by Premier Magnesia. Intrepid Potash Wendover LLC and Great Salt Lake Minerals Corp. recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from seawater by SPI Pharma Inc. in Delaware and Premier Magnesia in Florida, and by Martin Marietta from its brine operation in Michigan.

  12. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2002-01-01

    Seawater and natural brines accounted for about 60% of US magnesium compounds production in 2001. Dead-burned and caustic-calcined magnesias were recovered from seawater in Florida by Premier Chemicals. They were also recovered from Michigan well brines by Dow Chemical, Martin Marietta Magnesia Specialties and Rohm & Haas. And Premier Chemicals recovered dead-burned and caustic-calcined magnesias from magnesite in Nevada. Reilly Industries and Great Salt Lake Minerals recovered magnesium chloride brines from the Great Salt Lake in Utah.

  13. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2007-01-01

    Seawater and natural brines accounted for about 52 percent of U.S. magnesium compounds production in 2006. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties from well brines in Michigan. Caustic-calcined magnesia was recovered from sea-water by Premier Chemicals in Florida; from well brines in Michigan by Martin Marietta and Rohm and Haas; and from magnesite in Nevada by Premier Chemicals. Intrepid Potash-Wendover and Great Salt Lake Minerals recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from brucite by Applied Chemical Magnesias in Texas, from seawater by SPI Pharma in Delaware and Premier Chemicals in Florida, and by Martin Marietta and Rohm and Haas from their operations mentioned above. About 59 percent of the magnesium compounds consumed in the United States was used for refractories that are used mainly to line steelmaking furnaces. The remaining 41 percent was consumed in agricultural, chemical, construction, environmental and industrial applications.

  14. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2004-01-01

    Dead-burned and caustic-calcined magnesias were recovered from seawater by Premier Chemicals in Florida; from well brines in Michigan by Dow Chemical, Martin Marietta Magnesia Specialties, and Rohm & Haas; and from magnesite in Nevada by Premier Chemicals. Reilly Industries and Great Salt Lake Minerals recovered magnesium chloride brines from the Great Salt Lake in Utah.

  15. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2003-01-01

    Seawater and natural brines accounted for about 60 percent of U.S. magnesium compounds production during 2002. Dead-burned and caustic-calcined magnesias were recovered from seawater by Premier Chemicals in Florida. They were also recovered from well brines in Michigan by Dow Chemical, Martin Marietta Magnesia Specialties and Rohm & Haas. And they were recovered from magnesite in Nevada by Premier Chemicals.

  16. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2006-01-01

    In 2005, seawater and natural brines accounted for 51% of US magnesium compounds production. World magnesia production was estimated to be 14.5 Mt. Most of the production came from China, North Korea, Russia and Turkey. Although no specific production figures are available, Japan and the United States are estimated to account for almost one-half of the world's capacity from seawater and brines.

  17. Low magnesium level

    MedlinePlus

    Low magnesium level is a condition in which the amount of magnesium in the blood is lower than normal. The medical ... that convert or use energy ( metabolism ). When the level of magnesium in the body drops below normal, ...

  18. Half-metallic and magnetic properties of full-Heusler alloys Zr2CrZ (Z=Ga, In) with Hg2CuTi-type structure: A first-principles study

    NASA Astrophysics Data System (ADS)

    Deng, Zun-Yi; Zhang, Jian-Min

    2016-01-01

    The half-metallic and magnetic properties of Heusler alloys Zr2 CrZ (Z=Ga, In) with Hg2 CuTi -type structure have been investigated by using the first-principles projector augmented wave (PAW) potential within the generalized gradient approximation (GGA). The equilibrium lattice constants are 6.635 and 6.875 Å for Zr2 CrGa and Zr2 CrIn, respectively. Under compression and expansion deformations within lattice constant ranges of 6.515-7.100 and 6.371-7.126 Å for Zr2 CrGa and Zr2 CrIn, respectively, the Zr2 CrZ (Z=Ga, In) maintain a half-metallic nature with a fixed total magnetic moment of -1 μB / f.u ., following the Slater-Pauling rule μt = Zt - 18, but the absolute values of the local magnetic moments on Zr and Cr atoms increase with increasing lattice constant.

  19. The structural, electronic, magnetic and mechanical properties of quaternary Heusler alloys ZrTiCrZ (Z  =  Al, Ga, In, Si, Ge, Sn): a first-principles study

    NASA Astrophysics Data System (ADS)

    Yan, Peng-Li; Zhang, Jian-Min; Zhou, Bo; Xu, Ke-Wei

    2016-06-01

    The structural, electronic, magnetic and mechanical properties of the quaternary Heusler alloys ZrTiCrZ (Z  =  Al, Ga, In, Si, Ge, Sn) have been investigated firstly by using the first-principles calculations. The preferred configurations of the ZrTiCrZ alloys are all Y-type (I). At their equilibrium lattice constants, the ZrTiCrZ alloys are half-metallic (HM) ferrimagnets for Z  =  Al, Ga and In, while spin-gapless semiconductor (SGS) antiferromagnets (AFM) for Z  =  Si, Ge and Sn. The total magnetic moments {μt} of the ZrTiCrZ alloys are  -1 {μ\\text{B}}/\\text{f}\\text{.u}\\text{.} for Z  =  Al, Ga and In, while 0 {μ\\text{B}}/\\text{f}\\text{.u}\\text{.} for Z  =  Si, Ge and Sn, both linearly scaled with the total number of valence electrons {{Z}\\text{t}} by Slater-Pauling rule {μ\\text{t}}={{Z}\\text{t}}-18 . The elastic constants {{C}11} , {{C}12} and {{C}44} of the single crystal and the related elastic moduli G , B , E , \\upsilon and A of the polycrystalline aggregates are also calculated and used to study the mechanical stability of these alloys. Although the Curie temperatures {{T}\\text{C}} of the ZrTiCrZ alloys are overestimated by using the mean field approximation (MFA), they can be better estimated by including the exchange interactions. Finally, the HM stabilities as well as the total and atomic magnetic moments of the ZrTiCrZ alloys (Z  =  Al, Ga, In) under either hydrostatic strain or tetragonal strain are also discussed.

  20. Choline Magnesium Trisalicylate

    MedlinePlus

    Choline magnesium trisalicylate is used to relieve the pain, tenderness, inflammation (swelling), and stiffness caused by arthritis ... painful shoulder. It is also used to relieve pain and lower fever. Choline magnesium trisalicylate is in ...

  1. Magnesium and Space Flight.

    PubMed

    Smith, Scott M; Zwart, Sara R

    2015-12-08

    Magnesium is an essential nutrient for muscle, cardiovascular, and bone health on Earth, and during space flight. We sought to evaluate magnesium status in 43 astronauts (34 male, 9 female; 47 ± 5 years old, mean ± SD) before, during, and after 4-6-month space missions. We also studied individuals participating in a ground analog of space flight (head-down-tilt bed rest; n = 27 (17 male, 10 female), 35 ± 7 years old). We evaluated serum concentration and 24-h urinary excretion of magnesium, along with estimates of tissue magnesium status from sublingual cells. Serum magnesium increased late in flight, while urinary magnesium excretion was higher over the course of 180-day space missions. Urinary magnesium increased during flight but decreased significantly at landing. Neither serum nor urinary magnesium changed during bed rest. For flight and bed rest, significant correlations existed between the area under the curve of serum and urinary magnesium and the change in total body bone mineral content. Tissue magnesium concentration was unchanged after flight and bed rest. Increased excretion of magnesium is likely partially from bone and partially from diet, but importantly, it does not come at the expense of muscle tissue stores. While further study is needed to better understand the implications of these findings for longer space exploration missions, magnesium homeostasis and tissue status seem well maintained during 4-6-month space missions.

  2. Magnesium and Space Flight

    PubMed Central

    Smith, Scott M.; Zwart, Sara R.

    2015-01-01

    Magnesium is an essential nutrient for muscle, cardiovascular, and bone health on Earth, and during space flight. We sought to evaluate magnesium status in 43 astronauts (34 male, 9 female; 47 ± 5 years old, mean ± SD) before, during, and after 4–6-month space missions. We also studied individuals participating in a ground analog of space flight (head-down-tilt bed rest; n = 27 (17 male, 10 female), 35 ± 7 years old). We evaluated serum concentration and 24-h urinary excretion of magnesium, along with estimates of tissue magnesium status from sublingual cells. Serum magnesium increased late in flight, while urinary magnesium excretion was higher over the course of 180-day space missions. Urinary magnesium increased during flight but decreased significantly at landing. Neither serum nor urinary magnesium changed during bed rest. For flight and bed rest, significant correlations existed between the area under the curve of serum and urinary magnesium and the change in total body bone mineral content. Tissue magnesium concentration was unchanged after flight and bed rest. Increased excretion of magnesium is likely partially from bone and partially from diet, but importantly, it does not come at the expense of muscle tissue stores. While further study is needed to better understand the implications of these findings for longer space exploration missions, magnesium homeostasis and tissue status seem well maintained during 4–6-month space missions. PMID:26670248

  3. Magnesium industry overview

    SciTech Connect

    Clow, B.B.

    1996-10-01

    Magnesium products provide an excellent strength-to-weight ratio, good fatigue strength, high impact strength, good corrosion resistance, high-speed machinability, and good thermal and electrical conductivities. As a result, applications are expanding in almost every industry. Dozens of automotive components are now made of magnesium, including steering wheels, valve covers, and seat frames. Magnesium alloys are also used in computer housings, in-line roller skates, golf clubs, tennis racquets, and baseball bats. Good strength and stiffness at both room and elevated temperatures make magnesium alloys especially valuable for aerospace applications. This article presents an overview of magnesium technology, world production, increasing demand, and recycling.

  4. An x-ray photoemission spectroscopy investigation of thermal activation induced changes in surface composition and chemical bonds of two gettering alloys: Zr sub 2 Fe versus Zr sub 57 V sub 36 Fe sub 7

    SciTech Connect

    Sancrotti, M.; Trezzi, G. ); Manini, P. )

    1991-03-01

    We report comparative XPS ({ital h}{nu}=1253.6 eV) core level (Zr 3{ital d}; C 1{ital s}; O 1{ital s}; Fe 2{ital p}; V 2{ital p}) results from two relevant gettering alloys: Zr{sub 2}Fe and Zr{sub 57}V{sub 36}Fe{sub 7}. The samples were studied as-received (after in-air fracturing of bulk ingots) and after different annealing treatments (up to 700 {degree}C) performed in ultrahigh vacuum. With increasing temperature both alloys show a progressive dissolution of Zr oxides, an increase in the metallic character of the surface, the gradual loss of C based adsorbates, and a progressive increase in the surface Zr content and at the expense of the C concentration. At temperatures in the range 300--550 {degree}C a fraction of the C atoms form metallic carbides. OH-based groups are depleted from the surface at low temperatures (200 {degree}C), resulting in a sizable decrease of the near surface O content, while a nearly constant O concentration is found at intermediate and high temperatures. Only minor changes are observed for the near surface concentrations of Fe in Zr{sub 2}Fe and Fe and V in Zr{sub 57}V{sub 36}Fe{sub 7} as a function of temperature. The two alloys show strong differences in the activation kinetics of these changes, with surface metallization being initiated at lower temperatures and proceeding faster in Zr{sub 57}V{sub 36}Fe{sub 7}. Metallic carbides are found to almost completely dissolve in Zr{sub 57}V{sub 36}Fe{sub 7} at 600--700 {degree}C, while they are retained even at high temperatures in Zr{sub 2}Fe. The kinetic differences determined via XPS are consistent with the differences in gettering behavior of Zr{sub 2}Fe and Zr{sub 57}V{sub 36}Fe{sub 7}.

  5. Magnesium in disease

    PubMed Central

    Wanner, Christoph

    2012-01-01

    Although the following text will focus on magnesium in disease, its role in healthy subjects during physical exercise when used as a supplement to enhance performance is also noteworthy. Low serum magnesium levels are associated with metabolic syndrome, Type 2 diabetes mellitus (T2DM) and hypertension; consequently, some individuals benefit from magnesium supplementation: increasing magnesium consumption appears to prevent high blood pressure, and higher serum magnesium levels are associated with a lower risk of developing a metabolic syndrome. There are, however, conflicting study results regarding magnesium administration with myocardial infarction with and without reperfusion therapy. There was a long controversy as to whether or not magnesium should be given as a first-line medication. As the most recent trials have not shown any difference in outcome, intravenous magnesium cannot be recommended in patients with myocardial infarction today. However, magnesium has its indication in patients with torsade de pointes and has been given successfully to patients with digoxin-induced arrhythmia or life-threatening ventricular arrhythmias. Magnesium sulphate as an intravenous infusion also has an important established therapeutic role in pregnant women with pre-eclampsia as it decreases the risk of eclamptic seizures by half compared with placebo. PMID:26069818

  6. Superplasticity in Thermomechanically Processed High Magnesium Aluminum-Magnesium Alloys.

    DTIC Science & Technology

    1984-03-01

    California DTIC EECTE JL I 1984 THESIS SUPERPLASTICITY IN THERMOMECHANICALLY PROCESSED HIGH MAGNESIUM ALUMINUM-MAGNESIUM ALLOYS C:L by CD) John J. Becker...High Magnesium Aluminum- March 1984 Magnesium Alloys S. PERFORMING ORG. REPORT NUMBER 7. AUTHOR(@) S. CONTRACT OR GRANT NUMBER(&) John J. Becker 9...magnesium, aluminum-magnesium alloys were investigated. The thermomechanical processing itself included warm rolling at 300°C to 94% reduction

  7. Magnesium in pregnancy.

    PubMed

    Dalton, Lynne M; Ní Fhloinn, Deirdre M; Gaydadzhieva, Gergana T; Mazurkiewicz, Ola M; Leeson, Heather; Wright, Ciara P

    2016-09-01

    Magnesium deficiency is prevalent in women of childbearing age in both developing and developed countries. The need for magnesium increases during pregnancy, and the majority of pregnant women likely do not meet this increased need. Magnesium deficiency or insufficiency during pregnancy may pose a health risk for both the mother and the newborn, with implications that may extend into adulthood of the offspring. The measurement of serum magnesium is the most widely used method for determining magnesium levels, but it has significant limitations that have both hindered the assessment of deficiency and affected the reliability of studies in pregnant women. Thus far, limited studies have suggested links between magnesium inadequacy and certain conditions in pregnancy associated with high mortality and morbidity, such as gestational diabetes, preterm labor, preeclampsia, and small for gestational age or intrauterine growth restriction. This review provides recommendations for further study and improved testing using measurement of red cell magnesium. Pregnant women should be counseled to increase their intake of magnesium-rich foods such as nuts, seeds, beans, and leafy greens and/or to supplement with magnesium at a safe level. © The Author(s) 2016. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

  8. Magnesium in obstetrics.

    PubMed

    James, M F M

    2010-06-01

    Magnesium is a critical physiological ion, and magnesium deficiency might contribute to the development of pre-eclampsia, to impaired neonatal development and to metabolic problems extending into adult life. Pharmacologically, magnesium is a calcium antagonist with substantial vasodilator properties but without myocardial depression. Cardiac output usually increases following magnesium administration, compensating for the vasodilatation and minimising hypotension. Neurologically, the inhibition of calcium channels and antagonism of the N-methyl-d-aspartic acid (NMDA) receptor raises the possibility of neuronal protection, and magnesium administration to women with premature labour may decrease the incidence of cerebral palsy. It is the first-line anticonvulsant for the management of pre-eclampsia and eclampsia, and it should be administered to all patients with severe pre-eclampsia or eclampsia. Magnesium is a moderate tocolytic but the evidence for its effectiveness remains disputed. The side effects of magnesium therapy are generally mild but the major hazard of magnesium therapy is neuromuscular weakness. 2009 Elsevier Ltd. All rights reserved.

  9. Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency.

    PubMed

    Ryzen, E; Elbaum, N; Singer, F R; Rude, R K

    1985-01-01

    Magnesium deficiency is a common clinical condition, frequently present even with normal serum magnesium (S-Mg) concentrations. We have studied retention of a low-dose (0.2 mEq/kg lean body weight), intravenously administered magnesium load in 6 hypomagnesemic patients and 18 normomagnesemic alcoholics as compared with 16 normal subjects. Both normomagnesemic and hypomagnesemic subjects retained significantly greater amounts of the administered magnesium than did the normal subjects. In patients who were restudied following parenteral magnesium repletion, retention of the magnesium load normalized. We conclude that increased retention of a magnesium load is a more sensitive index of magnesium deficiency than is the S-Mg concentration, and suggest that low-dose magnesium tolerance testing be used more frequently as a clinical tool in the evaluation of states of normomagnesemic magnesium deficiency.

  10. Magnesium and depression.

    PubMed

    Serefko, Anna; Szopa, Aleksandra; Poleszak, Ewa

    2016-03-01

    Magnesium is one of the most important elements in the human body and is involved in a number of biochemical processes crucial for the proper functioning of the cardiovascular, alimentary, endocrine, and osteoarticular systems. It also plays a vital modulatory role in brain biochemistry, influencing several neurotransmission pathways associated with the development of depression. Personality changes, including apathy, depression, agitation, confusion, anxiety, and delirium are observed when there is a deficiency of this element. Rodents receiving a diet deficient in magnesium displayed depressive behaviour that was reversed by antidepressant drugs. Poor nutrition, gastrointestinal and renal diseases, insulin resistance and/or type 2 diabetes, alcoholism, stress, and certain medications may lead to magnesium deficiency. Since the extracellular concentration of magnesium ions may not reflect their intracellular level, none of the current methods of evaluating magnesium status is regarded as satisfactory. The mood-improving potential of magnesium compounds have been confirmed by the results of numerous pre-clinical and clinical studies. It seems that magnesium supplementation is well-tolerated and enhances the efficacy of conventional antidepressant treatments, and as such could be a valuable addition to the standard treatments for depression, although differences in bioavailability between inorganic and organic compounds should be taken into consideration.

  11. Method for production of magnesium

    DOEpatents

    Diaz, A.F.; Howard, J.B.; Modestino, A.J.; Peters, W.A.

    1998-07-21

    A continuous process for the production of elemental magnesium is described. Magnesium is made from magnesium oxide and a light hydrocarbon gas. In the process, a feed stream of the magnesium oxide and gas is continuously fed into a reaction zone. There the magnesium oxide and gas are reacted at a temperature of about 1400 C or greater in the reaction zone to provide a continuous product stream of reaction products, which include elemental magnesium. The product stream is continuously quenched after leaving the reaction zone, and the elemental magnesium is separated from other reaction products. 12 figs.

  12. Method for production of magnesium

    DOEpatents

    Diaz, Alexander F.; Howard, Jack B.; Modestino, Anthony J.; Peters, William A.

    1998-01-01

    A continuous process for the production of elemental magnesium is described. Magnesium is made from magnesium oxide and a light hydrocarbon gas. In the process, a feed stream of the magnesium oxide and gas is continuously fed into a reaction zone. There the magnesium oxide and gas are reacted at a temperature of about 1400.degree. C. or greater in the reaction zone to provide a continuous product stream of reaction products, which include elemental magnesium. The product stream is continuously quenched after leaving the reaction zone, and the elemental magnesium is separated from other reaction products.

  13. Magnesium battery disposal characteristics

    NASA Astrophysics Data System (ADS)

    Soffer, Louis; Atwater, Terrill

    1994-12-01

    This study assesses the disposal characteristics of U.S. Army procured military magnesium batteries under current Resource Conservation and Recovery Act (RCRA) hazardous waste identification regulations administered by the U.S. Environmental Protection Agency. Magnesium batteries were tested at 100, 50, 10 and 0 percent remaining state of charge. Present findings indicate that magnesium batteries with less than 50 percent remaining charge do not exceed the federal regulatory limit of 5.0 mg/L for chromium. All other RCRA contaminates were below regulatory limits at all levels of remaining charge. Assay methods, findings, disposal requirements and design implications are discussed.

  14. Castability of Magnesium Alloys

    NASA Astrophysics Data System (ADS)

    Bowles, A. L.; Han, Q.; Horton, J. A.

    There is intense research effort into the development of high pressure die cast-able creep resistant magnesium alloys. One of the difficulties encountered in magnesium alloy development for creep resistance is that many additions made to improve the creep properties have reportedly resulted in alloys that are difficult to cast. It is therefore important to have an understanding of the effect of alloying elements on the castability. This paper gives a review of the state of the knowledge of the castability of magnesium alloys.

  15. Magnesium toxicosis in two horses.

    PubMed

    Henninger, R W; Horst, J

    1997-07-01

    Magnesium sulfate, a saline laxative, is often used for treatment of intestinal impactions in horses. Clinical signs of hypermagnesemia are an uncommon complication following oral administration of magnesium sulfate. Overdose of magnesium sulfate in combination with renal insufficiency, hypocalcemia, or compromise of intestinal integrity may predispose horses to magnesium toxicosis. Establishment of diuresis with fluids and IV administration of calcium may provide successful treatment of magnesium toxicosis in horses.

  16. Magnesium for automotive applications

    SciTech Connect

    VanFleteren, R.

    1996-05-01

    Die cast magnesium parts are rapidly replacing steel and aluminum structural components in automotive applications, as design engineers seek to reduce assembly costs, raise fuel efficiency, and improve safety. Dozens of automotive components are now die cast from magnesium alloys, including seat stanchions, valve covers, steering wheels, and a variety of steering column components. Because of their excellent castability, complex magnesium die castings can sometimes consolidate several components and eliminate assembly steps. Highly ductile magnesium alloys such as AM60B (6% aluminum) and AM50A (5% aluminum) are important in helping to meet automotive industry crash-energy requirements for car seating and steering components. AZ91D (9% aluminum, 1% zinc) alloys are making removable rear seats in new minivans much easier to handle.

  17. Magnesium blood test

    MedlinePlus

    Magnesium - blood ... A blood sample is needed. ... When the needle is inserted to draw blood, some people feel slight pain. Others feel a prick or stinging. Afterward, there may be some throbbing or a slight bruise. This soon ...

  18. Rechargeable Magnesium Power Cells

    NASA Technical Reports Server (NTRS)

    Koch, Victor R.; Nanjundiah, Chenniah; Orsini, Michael

    1995-01-01

    Rechargeable power cells based on magnesium anodes developed as safer alternatives to high-energy-density cells like those based on lithium and sodium anodes. At cost of some reduction in energy density, magnesium-based cells safer because less susceptible to catastrophic meltdown followed by flames and venting of toxic fumes. Other advantages include ease of handling, machining, and disposal, and relatively low cost.

  19. Interstellar magnesium abundances

    NASA Technical Reports Server (NTRS)

    Murray, M. J.; Dufton, P. L.; Hibbert, A.; York, D. G.

    1984-01-01

    An improved evaluation of the Mg II 1240 A doublet oscillator strength is used in conjunction with recently published Copernicus observations to derive accurate Mg II column densities toward 74 stars. These imply an average of 40 percent of interstellar magnesium is in the gaseous phase. Magnesium depletion is examined as a function of various interstellar extinction and density parameters, and the results are briefly discussed in terms of current depletion theories.

  20. Magnesium and cardiovascular system.

    PubMed

    Shechter, Michael

    2010-06-01

    Hypomagnesemia is common in hospitalized patients, especially in the elderly with coronary artery disease (CAD) and/or those with chronic heart failure. Hypomagnesemia is associated with an increased incidence of diabetes mellitus, metabolic syndrome, mortality rate from CAD and all causes. Magnesium supplementation improves myocardial metabolism, inhibits calcium accumulation and myocardial cell death; it improves vascular tone, peripheral vascular resistance, afterload and cardiac output, reduces cardiac arrhythmias and improves lipid metabolism. Magnesium also reduces vulnerability to oxygen-derived free radicals, improves human endothelial function and inhibits platelet function, including platelet aggregation and adhesion, which potentially gives magnesium physiologic and natural effects similar to adenosine-diphosphate inhibitors such as clopidogrel. The data regarding its use in patients with acute myocardial infarction (AMI) is conflicting. Although some previous, relatively small randomized clinical trials demonstrated a remarkable reduction in mortality when administered to relatively high risk AMI patients, two recently published large-scale randomized clinical trials (the Fourth International Study of Infarct Survival and Magnesium in Coronaries) failed to show any advantage of intravenous magnesium over placebo. Nevertheless, there are theoretical potential benefits of magnesium supplementation as a cardioprotective agent in CAD patients, as well as promising results from previous work in animal and humans. These studies are cost effective, easy to handle and are relatively free of adverse effects, which gives magnesium a role in treating CAD patients, especially high-risk groups such as CAD patients with heart failure, the elderly and hospitalized patients with hypomagnesemia. Furthermore, magnesium therapy is indicated in life-threatening ventricular arrhythmias such as Torsades de Pointes and intractable ventricular tachycardia.

  1. Magnesium for Future Autos

    SciTech Connect

    Nyberg, Eric A.; Luo, Alan A.; Sadayappan, Kumar; Shi, Wenfang

    2008-10-01

    In the quest for better fuel economy and improved environmental performance, magnesium may well become a metal of choice for constructing lighter, more efficient vehicles. Magnesium is the lightest structural metal, yet it has a high strength-to-weight ratio makes it comparable to steel in many applications. The world’s automakers already use magnesium for individual components. But new alloys and processing methods are needed before the metal can become economically and technologically feasible as a major automotive structural material. This article will explore the formation, challenges and initial results of an international collaboration—the Magnesium Front End Research and Development (MFERD) project—that is leveraging the expertise and resources of Canada, China and the United States to advance the creation of magnesium-intensive vehicles. The MFERD project aims to develop the enabling technologies and knowledge base that will lead to a vehicles that are 50-60 percent lighter, equally affordable, more recyclable and of equal or better quality when compared to today’s vehicles. Databases of information also will be captured in models to enable further alloy and manufacturing process optimization. Finally, a life-cycle analysis of the magnesium used will be conducted.

  2. Electrodeposition of magnesium and magnesium/aluminum alloys

    DOEpatents

    Mayer, A.

    1988-01-21

    Electrolytes and plating solutions for use in processes for electroplating and electroforming pure magnesium and alloys of aluminum and magnesium and also electrodeposition processes. An electrolyte of this invention is comprised of an alkali metal fluoride or a quaternary ammonium halide, dimethyl magnesium and/or diethyl magnesium, and triethyl aluminum and/or triisobutyl aluminum. An electrolyte may be dissolved in an aromatic hydrocarbon solvent to form a plating solution. The proportions of the component compounds in the electrolyte are varied to produce essentially pure magnesium or magnesium/aluminum alloys having varying selected compositions.

  3. Electrodeposition of magnesium and magnesium/aluminum alloys

    DOEpatents

    Mayer, Anton

    1988-01-01

    Electrolytes and plating solutions for use in processes for electroplating and electroforming pure magnesium and alloys of aluminum and magnesium and also electrodeposition processes. An electrolyte of this invention is comprised of an alkali metal fluoride or a quaternary ammonium halide, dimethyl magnesium and/or diethyl magnesium, and triethyl aluminum and/or triisobutyl aluminum. An electrolyte may be dissolved in an aromatic hydrocarbon solvent to form a plating solution. The proportions of the component compounds in the electrolyte are varied to produce essentially pure magnesium or magnesium/aluminum alloys having varying selected compositions.

  4. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium phosphate. 184.1434 Section 184.1434 Food... Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic (MgHPO4·3H2O...

  5. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic (MgHPO4·3H2O, CAS Reg. No. 7782-0975...

  6. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... Listing of Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic...

  7. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... Listing of Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic...

  8. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... Listing of Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic...

  9. Corrosion in Magnesium and a Magnesium Alloy

    NASA Astrophysics Data System (ADS)

    Akavipat, Sanay

    Magnesium and a magnesium alloy (AZ91C) have been ion implanted over a range of ions energies (50 to 150 keV) and doses (1 x 10('16) to 2 x 10('17) ions/cm('2)) to modify the corrosion properties of the metals. The corrosion tests were done by anodic polarization in chloride -free and chloride-containing aqueous solutions of a borated -boric acid with a pH of 9.3. Anodic polarization measurements showed that some implantations could greatly reduce the corrosion current densities at all impressed voltages and also increased slightly the pitting potential, which indicated the onset of the chloride attack. These improvements in corrosion resistance were caused by boron implantations into both types of samples. However, iron implantations were found to improve only the magnesium alloy. To study the corrosion in more detail, Scanning Auger Microprobe Spectrometer (SAM), Scanning Electron Microscope (SEM) with an X-ray Energy Spectrometry (XES) attachment, and Transmission Electron Microscope (TEM) measurements were used to analyze samples before, after, and at various corrosion stages. In both the unimplanted pure magnesium and AZ91C samples, anodic polarization results revealed that there were three active corrosion stages (Stages A, C, and E) and two passivating stages (Stages B and D). Examination of Stages A and B in both types of samples showed that only a mild, generalized corrosion had occurred. In Stage C of the TD samples, a pitting breakdown in the initial oxide film was observed. In Stage C of the AZ91C samples, galvanic and intergranular attack around the Mg(,17)Al(,12) intermetallic islands and along the matrix grain boundaries was observed. Stage D of both samples showed the formation of a thick, passivating oxygen containing, probably Mg(OH)(,2) film. In Stage E, this film was broken down by pits, which formed due to the presence of the chloride ions in both types of samples. Stages A through D of the unimplanted samples were not seen in the boron or iron

  10. A Quick Reference on Magnesium.

    PubMed

    Bateman, Shane W

    2017-03-01

    This article serves as a quick reference on the distribution, handling, and supplementation of magnesium. It also lists the manifestations and causes of magnesium deficit and provides criteria for the diagnosis of a magnesium deficit. Copyright © 2016 Elsevier Inc. All rights reserved.

  11. Magnesium Metabolism and its Disorders

    PubMed Central

    Swaminathan, R

    2003-01-01

    Magnesium is the fourth most abundant cation in the body and plays an important physiological role in many of its functions. Magnesium balance is maintained by renal regulation of magnesium reabsorption. The exact mechanism of the renal regulation is not fully understood. Magnesium deficiency is a common problem in hospital patients, with a prevalence of about 10%. There are no readily available and easy methods to assess magnesium status. Serum magnesium and the magnesium tolerance test are the most widely used. Measurement of ionised magnesium may become more widely available with the availability of ion selective electrodes. Magnesium deficiency and hypomagnesaemia can result from a variety of causes including gastrointestinal and renal losses. Magnesium deficiency can cause a wide variety of features including hypocalcaemia, hypokalaemia and cardiac and neurological manifestations. Chronic low magnesium state has been associated with a number of chronic diseases including diabetes, hypertension, coronary heart disease, and osteoporosis. The use of magnesium as a therapeutic agent in asthma, myocardial infarction, and pre-eclampsia is also discussed. Hypermagnesaemia is less frequent than hypomagnesaemia and results from failure of excretion or increased intake. Hypermagnesaemia can lead to hypotension and other cardiovascular effects as well as neuromuscular manifestations. Causes and management of hypermagnesaemia are discussed. PMID:18568054

  12. Magnesium Research and Technology Development

    SciTech Connect

    Nyberg, Eric A.; Joost, William; Smith, Mark T.

    2009-12-30

    The Magnesium Research and Technical Development (MR&TD) project supports efforts to increase using magnesium in automotive applications, including improving technology, lowering costs and increasing the knowledge needed to enable alloy and manufacturing process optimization. MR&TD supports the U.S. Department of Energy (DOE)/United States Automotive Materials Partnership (USAMP) Magnesium Front End Research and Development (MFERD) project in collaboration with China and Canada. The MR&TD projects also maintains the magnesium bibliographic database at magnesium.pnl.gov.

  13. Grain Refinement of Magnesium

    NASA Astrophysics Data System (ADS)

    Lee, Y. C.; Dahle, A. K.; StJohn, D. H.

    Grain formation during solidification of magnesium and Mg-Al alloys has been studied with a focus on grain refinement mechanisms, solute and particle effects. The variation in grain size with increased aluminium content in hypoeutectic Mg-Al alloys showed a continuous decrease in grain size up to 5 wt% Al, and a stabilisation at higher Al contents (above 5 wt%). Strontium additions to both low- and high-aluminium content magnesium alloys showed that Sr had a significant grain refining effect in low-aluminium containing alloys. However, strontium had a negligible effect on grain size in the Mg-9Al alloy. Additions of Zr, Si, or Ca to pure magnesium produced significant grain refinement, probably because these elements have high growth restriction effects during solidification. An attempt was made to identify the grain refinement effect of particles added directly to the melt that are considered to be powerful nucleants in Al based alloys (TiC) and in Mg based alloys (AlN, Al4C3). Most of these particles produced grain refinement, probably because of enhanced nucleation due to the small lattice disregistry between their crystal structures and that of magnesium. However, it is not clear whether the grain refining mechanism of the effective particles was catalysis of primary crystal nucleation or simply restriction of crystal growth during solidification.

  14. Magnesium fluoride recovery method

    SciTech Connect

    Gay, R.L.; McKenzie, D.E.

    1989-10-17

    A method of obtaining magnesium fluoride substantially free from radioactive uranium from a slag formed in the production of metallic uranium by the reduction of depleted uranium tetrafluoride with metallic magnesium in a retort wherein the slag contains the free metals magnesium and uranium and also oxides and fluorides of the metals. The slag having a radioactivity level of at least about 7,000 rhoCi/gm. The method comprises the steps of: grinding the slag to a median particle size of about 200 microns; contacting the ground slag in a reaction zone with an acid having a strength of from about 0.5 to 1.5 N for a time of from about 4 to about 20 hours in the presence of a catalytic amount of iron; removing the liquid product; treating the particulate solid product; repeating the last two steps at least one more time to produce a solid residue consisting essentially of magnesium fluoride substantially free of uranium and having a residual radioactivity level of less than about 1000 rhoCi/gm.

  15. Magnesium fluoride recovery method

    SciTech Connect

    Gay, R.L.; McKenzie, D.E.

    1989-10-17

    This patent describes a method of obtaining magnesium fluoride substantially free from radioactive uranium from a slag formed in the production of metallic uranium by the reduction of depleted uranium tetrafluoride with metallic magnesium in a retort wherein the slag contains the free metals magnesium and uranium and also oxides and fluorides of the metals, the slag having a radioactivity level of at least about 7,000 pCi/gm. The method comprises: grinding the slag to a median particle size of about 200 microns; contacting the ground slag in a reaction zone with an acid having a strength of from about 0.5 to 1.5 N for a time of from about 4 to about 20 hours in the presence of a catalytic amount of iron, the reaction zone being maintained at a temperature within the range of from about 60{degrees} to 90{degrees} C. and the weight of ratio of slag to acid being within the range of from about 1:2 to 1:6 to produce a liquid product and a particulate solid product; removing the liquid product; treating the particulate solid product; and repeating steps at least one more time to produce a solid residue consisting essentially of magnesium fluoride substantially free of uranium and having a residual radioactivity level of less than about 1000 pCi/gm.

  16. Do diuretics cause magnesium deficiency?

    PubMed Central

    Davies, D L; Fraser, R

    1993-01-01

    1. Controlled trials, of which there are few, do not substantiate claims that diuretics play a role in causing magnesium deficiency. Consequently, the vast majority of patients taking conventional doses of thiazide diuretics (i.e. bendrofluazide 2.5 mg day-1 or equivalent) do not need magnesium supplements. On balance, potassium-sparing diuretics tend to increase serum and intracellular magnesium content; this should not be taken as evidence of prior magnesium deficiency. It remains theoretically possible that large doses of loop diuretics given more than once daily for long periods could induce negative magnesium balance and magnesium deficiency. However, it has been difficult to run appropriately controlled trials in conditions where such therapy is needed (i.e. heart failure) and until more reliable information becomes available no absolute recommendation can be made. 2. Methods for the measurement of intracellular free magnesium levels are now available and are more relevant to the assessment of magnesium deficiency than total intracellular magnesium content; the complex relationship between intracellular free and total magnesium content remains to be defined. Future work involving the effect of diuretics on intracellular free magnesium measurements should make every attempt to avoid the errors of trial design and multiple publication that litter current and past literature. PMID:8373706

  17. Nondestructive spot test method for magnesium and magnesium alloys

    NASA Technical Reports Server (NTRS)

    Wilson, M. L. (Inventor)

    1973-01-01

    A method for spot test identification of magnesium and various magnesium alloys commonly used in aerospace applications is described. The spot test identification involves color codes obtained when several drops of 3 M hydrochloric acid are placed on the surface to be tested. After approximately thirty seconds, two drops of this reacted acid is transferred to each of two depressions in a spot plate for additions of other chemicals with subsequent color changes indicating magnesium or its alloy.

  18. Highly Soluble Alkoxide Magnesium Salts for Rechargeable Magnesium Batteries

    SciTech Connect

    Liao, Chen; Guo, Bingkun; Jiang, Deen; Custelcean, Radu; Mahurin, Shannon Mark; Sun, Xiao-Guang; Dai, Sheng

    2014-01-01

    A unique class of air-stable and non-pyrophoric magnesium electrolytes has been developed based on alkoxide magnesium compounds. The crystals obtained from this class of electrolytes exhibit a unique structure of tri-magnesium cluster, [Mg3Cl3(OR)2(THF)6]+ [(THF)MgCl3] . High reversible capacities and good rate capabilities were obtained in Mg-Mo6S8 batteries using these new electrolytes at both 20 and 50 oC.

  19. Magnesium borohydride: from hydrogen storage to magnesium battery.

    PubMed

    Mohtadi, Rana; Matsui, Masaki; Arthur, Timothy S; Hwang, Son-Jong

    2012-09-24

    Beyond hydrogen storage: The first example of reversible magnesium deposition/stripping onto/from an inorganic salt was seen for a magnesium borohydride electrolyte. High coulombic efficiency of up to 94 % was achieved in dimethoxyethane solvent. This Mg(BH(4))(2) electrolyte was utilized in a rechargeable magnesium battery. Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  20. Magnesium fluoride recovery method

    DOEpatents

    Gay, Richard L.; McKenzie, Donald E.

    1989-01-01

    A method of obtaining magnesium fluoride substantially free from radioactive uranium from a slag containing the same and having a radioactivity level of at least about 7000 pCi/gm. The slag is ground to a particle size of about 200 microns or less. The ground slag is contacted with an acid under certain prescribed conditions to produce a liquid product and a particulate solid product. The particulate solid product is separated from the liquid and treated at least two more times with acid to produce a solid residue consisting essentially of magnesium fluoride substantially free of uranium and having a residual radioactivity level of less than about 1000 pCi/gm. In accordance with a particularly preferred embodiment of the invention a catalyst and an oxidizing agent are used during the acid treatment and preferably the acid is sulfuric acid having a strength of about 1.0 Normal.

  1. Constraining magnesium cycling in marine sediments using magnesium isotopes

    NASA Astrophysics Data System (ADS)

    Higgins, J. A.; Schrag, D. P.

    2010-09-01

    Magnesium concentrations in deep-sea sediment pore-fluids typically decrease down core due to net precipitation of dolomite or clay minerals in the sediments or underlying crust. To better characterize and differentiate these processes, we have measured magnesium isotopes in pore-fluids and sediment samples from Ocean Drilling Program sites (1082, 1086, 1012, 984, 1219, and 925) that span a range of oceanographic settings. At all sites, magnesium concentrations decrease with depth. At sites where diagenetic reactions are dominated by the respiration of organic carbon, pore-fluid δ 26Mg values increase with depth by as much as 2‰. Because carbonates preferentially incorporate 24Mg (low δ 26Mg), the increase in pore-fluid δ 26Mg values at these sites is consistent with the removal of magnesium in Mg-carbonate (dolomite). In contrast, at sites where the respiration of organic carbon is not important and/or weatherable minerals are abundant, pore-fluid δ 26Mg values decrease with depth by up to 2‰. The decline in pore-fluid δ 26Mg at these sites is consistent with a magnesium sink that is isotopically enriched relative to the pore-fluid. The identity of this enriched magnesium sink is likely clay minerals. Using a simple 1D diffusion-advection-reaction model of pore-fluid magnesium, we estimate rates of net magnesium uptake/removal and associated net magnesium isotope fractionation factors for sources and sinks at all sites. Independent estimates of magnesium isotope fractionation during dolomite precipitation from measured δ 26Mg values of dolomite samples from sites 1082 and 1012 are very similar to modeled net fractionation factors at these sites, suggesting that local exchange of magnesium between sediment and pore-fluid at these sites can be neglected. Our results indicate that the magnesium incorporated in dolomite is 2.0-2.7‰ depleted in δ 26Mg relative to the precipitating fluid. Assuming local exchange of magnesium is minor at the rest of the

  2. Magnesium in Prevention and Therapy.

    PubMed

    Gröber, Uwe; Schmidt, Joachim; Kisters, Klaus

    2015-09-23

    Magnesium is the fourth most abundant mineral in the body. It has been recognized as a cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine triphosphate (ATP) metabolism. Magnesium is required for DNA and RNA synthesis, reproduction, and protein synthesis. Moreover, magnesium is essential for the regulation of muscular contraction, blood pressure, insulin metabolism, cardiac excitability, vasomotor tone, nerve transmission and neuromuscular conduction. Imbalances in magnesium status-primarily hypomagnesemia as it is seen more common than hypermagnesemia-might result in unwanted neuromuscular, cardiac or nervous disorders. Based on magnesium's many functions within the human body, it plays an important role in prevention and treatment of many diseases. Low levels of magnesium have been associated with a number of chronic diseases, such as Alzheimer's disease, insulin resistance and type-2 diabetes mellitus, hypertension, cardiovascular disease (e.g., stroke), migraine headaches, and attention deficit hyperactivity disorder (ADHD).

  3. Low brain magnesium in migraine

    SciTech Connect

    Ramadan, N.M.; Halvorson, H.; Vande-Linde, A.; Levine, S.R.; Helpern, J.A.; Welch, K.M.

    1989-10-01

    Brain magnesium was measured in migraine patients and control subjects using in vivo 31-Phosphorus Nuclear Magnetic Resonance Spectroscopy. pMg and pH were calculated from the chemical shifts between Pi, PCr and ATP signals. Magnesium levels were low during a migraine attack without changes in pH. We hypothesize that low brain magnesium is an important factor in the mechanism of the migraine attack.

  4. [Magnesium disorder in metabolic bone diseases].

    PubMed

    Ishii, Akira; Imanishi, Yasuo

    2012-08-01

    Magnesium is abundantly distributed among the body. The half of the magnesium exists in the bone. In addition, magnesium is the second most abundant intracellular cation in vertebrates and essential for maintaining physiological function of the cells. Epidemiologic studies have demonstrated that magnesium deficiency is a risk factor for osteoporosis. The mechanism of bone fragility caused by magnesium deficiency has been intensely studied using animal models of magnesium deficiency. Magnesium deficiency causes decreased osteoblastic function and increased number of osteoclasts. Magnesium deficiency also accelerates mineralization in bone. These observations suggest that disturbed bone metabolic turnover and mineralization causes bone fragility.

  5. Magnesium Hall Thruster

    NASA Technical Reports Server (NTRS)

    Szabo, James J.

    2015-01-01

    This Phase II project is developing a magnesium (Mg) Hall effect thruster system that would open the door for in situ resource utilization (ISRU)-based solar system exploration. Magnesium is light and easy to ionize. For a Mars- Earth transfer, the propellant mass savings with respect to a xenon Hall effect thruster (HET) system are enormous. Magnesium also can be combusted in a rocket with carbon dioxide (CO2) or water (H2O), enabling a multimode propulsion system with propellant sharing and ISRU. In the near term, CO2 and H2O would be collected in situ on Mars or the moon. In the far term, Mg itself would be collected from Martian and lunar regolith. In Phase I, an integrated, medium-power (1- to 3-kW) Mg HET system was developed and tested. Controlled, steady operation at constant voltage and power was demonstrated. Preliminary measurements indicate a specific impulse (Isp) greater than 4,000 s was achieved at a discharge potential of 400 V. The feasibility of delivering fluidized Mg powder to a medium- or high-power thruster also was demonstrated. Phase II of the project evaluated the performance of an integrated, highpower Mg Hall thruster system in a relevant space environment. Researchers improved the medium power thruster system and characterized it in detail. Researchers also designed and built a high-power (8- to 20-kW) Mg HET. A fluidized powder feed system supporting the high-power thruster was built and delivered to Busek Company, Inc.

  6. Magnesium reduction of uranium oxide

    SciTech Connect

    Elliott, G.R.B.

    1985-08-13

    A method and apparatus are provided for reducing uranium oxide with magnesium to form uranium metal. The reduction is carried out in a molten-salt solution of density greater than 3.4 grams per cubic centimeter, thereby allowing the uranium product to sink and the magnesium oxide byproduct to float, consequently allowing separation of product and byproduct.

  7. Electrolytes for magnesium electrochemical cells

    DOEpatents

    Burrell, Anthony K.; Sa, Niya; Proffit, Danielle Lee; Lipson, Albert; Liao, Chen; Vaughey, John T.; Ingram, Brian J.

    2017-07-04

    An electrochemical cell includes a high voltage cathode configured to operate at 1.5 volts or greater; an anode including Mg.sup.0; and an electrolyte including an ether solvent and a magnesium salt; wherein: a concentration of the magnesium salt in the ether is 1 M or greater.

  8. Innovative Vacuum Distillation for Magnesium Recycling

    NASA Astrophysics Data System (ADS)

    Zhu, Tianbai; Li, Naiyi; Mei, Xiaoming; Yu, Alfred; Shang, Shixiang

    Magnesium recycling now becomes a very important subject as magnesium consumption increases fast around the world. All commonly used magnesium die-casting alloys can be recycled and recovered to the primary metal quality. The recycled materials may be comprised of biscuits, sprues, runners, flash, overflows, dross, sludge, scrap parts, and old parts that are returned from service, An innovative magnesium recycle method, vacuum distillation, is developed and proved out to be able to recycle magnesium scraps, especially machining chips, oily magnesium, smelting sludge, dross or the mixture. With this process at a specific temperature and environment condition, magnesium in scraps can be gasified and then solidified to become crystal magnesium crown. This `recycled' magnesium crown is collected and used as the raw material of magnesium alloys. The experimental results show the vacuum distillation is a feasible and plausible method to recycle magnesium. Further, the cost analysis will be addressed in this paper.

  9. Magnesium substitution in brushite cements.

    PubMed

    Alkhraisat, Mohammad Hamdan; Cabrejos-Azama, Jatsue; Rodríguez, Carmen Rueda; Jerez, Luis Blanco; Cabarcos, Enrique López

    2013-01-01

    The use of magnesium-doped ceramics has been described to modify brushite cements and improve their biological behavior. However, few studies have analyzed the efficiency of this approach to induce magnesium substitution in brushite crystals. Mg-doped ceramics composed of Mg-substituted β-TCP, stanfieldite and/or farringtonite were reacted with primary monocalcium phosphate (MCP) in the presence of water. The cement setting reaction has resulted in the formation of brushite and newberyite within the cement matrix. Interestingly, the combination of SAED and EDX analyses of single crystal has indicated the occurrence of magnesium substitution within brushite crystals. Moreover, the effect of magnesium ions on the structure, and mechanical and setting properties of the new cements was characterized as well as the release of Ca(2+) and Mg(2+) ions. Further research would enhance the efficiency of the system to incorporate larger amounts of magnesium ions within brushite crystals.

  10. Magnesium in Prevention and Therapy

    PubMed Central

    Gröber, Uwe; Schmidt, Joachim; Kisters, Klaus

    2015-01-01

    Magnesium is the fourth most abundant mineral in the body. It has been recognized as a cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine triphosphate (ATP) metabolism. Magnesium is required for DNA and RNA synthesis, reproduction, and protein synthesis. Moreover, magnesium is essential for the regulation of muscular contraction, blood pressure, insulin metabolism, cardiac excitability, vasomotor tone, nerve transmission and neuromuscular conduction. Imbalances in magnesium status—primarily hypomagnesemia as it is seen more common than hypermagnesemia—might result in unwanted neuromuscular, cardiac or nervous disorders. Based on magnesium’s many functions within the human body, it plays an important role in prevention and treatment of many diseases. Low levels of magnesium have been associated with a number of chronic diseases, such as Alzheimer’s disease, insulin resistance and type-2 diabetes mellitus, hypertension, cardiovascular disease (e.g., stroke), migraine headaches, and attention deficit hyperactivity disorder (ADHD). PMID:26404370

  11. Synthesis of magnesium diboride by magnesium vapor infiltration process (MVIP)

    DOEpatents

    Serquis, Adriana C.; Zhu, Yuntian T.; Mueller, Frederick M.; Peterson, Dean E.; Liao, Xiao Zhou

    2003-01-01

    A process of preparing superconducting magnesium diboride powder by heating an admixture of solid magnesium and amorphous boron powder or pellet under an inert atmosphere in a Mg:B ratio of greater than about 0.6:1 at temperatures and for time sufficient to form said superconducting magnesium diboride. The process can further include exposure to residual oxygen at high synthesis temperatures followed by slow cooling. In the cooling process oxygen atoms dissolved into MgB.sub.2 segregated to form nanometer-sized coherent Mg(B,O) precipitates in the MgB.sub.2 matrix, which can act as flux pinning centers.

  12. Magnesium deficiency: What is our status

    USDA-ARS?s Scientific Manuscript database

    Low magnesium intake has been implicated in a broad range of cardiometabolic conditions, including diabetes, hypertension, and cardiovascular disease. Dietary magnesium and total body magnesium status have a widely-used but imperfect biomarker in serum magnesium. Despite serum magnesium’s limitation...

  13. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium oxide. 184.1431 Section 184.1431 Food and... Substances Affirmed as GRAS § 184.1431 Magnesium oxide. (a) Magnesium oxide (MgO, CAS Reg. No. 1309-48-4... powder (light) or a relatively dense white powder (heavy) by heating magnesium hydroxide or carbonate...

  14. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to crystallization...

  15. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to crystallization...

  16. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in aqueous...

  17. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food... GRAS § 184.1431 Magnesium oxide. (a) Magnesium oxide (MgO, CAS Reg. No. 1309-48-4) occurs naturally as... a relatively dense white powder (heavy) by heating magnesium hydroxide or carbonate. Heating these...

  18. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium hydroxide. 184.1428 Section 184.1428... Listing of Specific Substances Affirmed as GRAS § 184.1428 Magnesium hydroxide. (a) Magnesium hydroxide... is prepared as a white precipitate by the addition of sodium hydroxide to a water soluble magnesium...

  19. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food... Specific Substances Affirmed as GRAS § 184.1431 Magnesium oxide. (a) Magnesium oxide (MgO, CAS Reg. No... bulky white powder (light) or a relatively dense white powder (heavy) by heating magnesium hydroxide or...

  20. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food... Specific Substances Affirmed as GRAS § 184.1431 Magnesium oxide. (a) Magnesium oxide (MgO, CAS Reg. No... bulky white powder (light) or a relatively dense white powder (heavy) by heating magnesium hydroxide or...

  1. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to crystallization...

  2. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in aqueous...

  3. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in aqueous...

  4. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in aqueous...

  5. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food... Specific Substances Affirmed as GRAS § 184.1431 Magnesium oxide. (a) Magnesium oxide (MgO, CAS Reg. No... bulky white powder (light) or a relatively dense white powder (heavy) by heating magnesium hydroxide or...

  6. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium hydroxide. 184.1428 Section 184.1428... Listing of Specific Substances Affirmed as GRAS § 184.1428 Magnesium hydroxide. (a) Magnesium hydroxide... is prepared as a white precipitate by the addition of sodium hydroxide to a water soluble magnesium...

  7. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to crystallization...

  8. Mineral resource of the month: magnesium

    USGS Publications Warehouse

    Kramer, Deborah A.

    2012-01-01

    Magnesium is the eighthmost abundant element in Earth’s crust, and the second-most abundant metal ion in seawater. Although magnesium is found in more than 60 minerals, only brucite, dolomite, magnesite and carnallite are commercially important for their magnesium content. Magnesium and its compounds also are recovered from seawater, brines found in lakes and wells, and bitterns (salts).

  9. Dietary magnesium and urolithiasis in growing calves.

    PubMed

    Kallfelz, F A; Ahmed, A S; Wallace, R J; Sasangka, B H; Warner, R G

    1987-01-01

    The effect of high levels of dietary magnesium (1.4%) alone or in combination with elevated calcium (1.8%) or phosphorus (1.6%) on growth and health of male calves was evaluated during a nine week feeding trial after weaning. Twenty calves were randomly divided into 4 feeding groups consisting of controls, high magnesium, high magnesium and calcium or high magnesium and phosphorus. Elevated dietary minerals caused decreased feed intake and growth rate. Blood urea nitrogen and serum creatinine levels were greatly elevated in calves fed high magnesium or magnesium and phosphorus and serum urea nitrogen was moderately elevated in calves fed high magnesium and calcium. These elevations suggested the occurrence of renal damage as a result of microcrystalline obstruction of renal tubules. Serum magnesium levels were three times normal in calves fed high magnesium or magnesium and phosphorus, but only twice normal in calves fed high magnesium and calcium. High dietary magnesium resulted in a significant depression in blood calcium level. This effect was somewhat overcome by additional dietary calcium Three calves fed the high magnesium diet and two calves fed the high magnesium and phosphorus diet developed urinary tract obstruction. The chemical composition of uroliths recovered from these calves was calcium apatite. Elevated dietary magnesium has been shown to be a cause of urolithiasis in growing male calves. Additional dietary calcium, but not phosphorus, appears to protect calves against urolithiasis induced by elevated dietary magnesium.

  10. Magnesium Research and Technology Development

    SciTech Connect

    Nyberg, Eric A.; Carpenter, Joseph A.; Sklad, Philip S.

    2007-05-17

    The primary objective of this project is to provide DOE with high quality and state of the art information on magnesium R&D within the U.S. and around the world. The purpose of this information enables DOE to make informed decisions on direction for future funding related to magnesium applications within the U.S. and international cooperative programs. A second key objective is to serve as the Projecct Technical Committee representative for the 3-country Magnesium Front End R&D Project.

  11. Confession of a Magnesium Battery.

    PubMed

    Bucur, Claudiu B; Gregory, Thomas; Oliver, Allen G; Muldoon, John

    2015-09-17

    Magnesium is an ideal metal anode that has nearly double the volumetric capacity of lithium metal with a very negative reduction potential of -2.37 vs SHE. A significant advantage of magnesium is the apparent lack of dendrite formation during charging, which overcomes major safety and performance challenges encountered with using lithium metal anodes. Here, we highlight major recent advances in nonaqueous Mg electrochemistry, notably the development of electrolytes and cathodes, and discuss some of the challenges that must be overcome to realize a practical magnesium battery.

  12. Nonlinear anelasticity of magnesium

    NASA Astrophysics Data System (ADS)

    Aning, Alexander; Suzuki, Tetsuro; Wuttig, Manfred

    1982-10-01

    An approximate solution of the equation of motion of a nonlinear anelastic reed at or near resonance is presented. The steady state solution reproduces the well-known nonlinear resonances. The solution also predicts the existence of automodulations, i.e., self-excited modulations of the amplitude and phase at constant power of excitation of the reed. Numerical examples of such automodulations are presented for an antisymmetric deformation potential. Experimental studies of finite amplitude oscillations of a magnesium reed vibrating at 72 and 431 Hz at room temperature confirm the existence of automodulations. The experimental results can be semiquantitatively described in terms of the solution given. The assumption that finite deformation by twinning represents the essential nonlinearity leads to a self-consistent interpretation. The relaxation time of twinning is obtained from the analysis of the automodulation and is 22 msec in the sample investigated. It is proposed that point defects control the relaxation process.

  13. Magnesium: Engineering the Surface

    NASA Astrophysics Data System (ADS)

    Chen, X. B.; Yang, H. Y.; Abbott, T. B.; Easton, M. A.; Birbilis, N.

    2012-06-01

    Magnesium (Mg) and its alloys provide numerous benefits as lightweight materials; however, industrial deployment of Mg in most instances requires anticorrosion coatings. Engineering the Mg surface is an area that has been undergoing intense research recently. Surface engineering commences with the "pretreatment" step, which can be used to modify the surface composition and morphology, resulting in surface enrichment or depletion of alloying elements. Following this, electrochemical plating (including electro- and electroless plating) and conversion coatings have emerged as common means of coating Mg. In this study, we present the key aspects relating to the science and technology associated with pretreatment, electrochemical plating, and conversion coatings. This is followed by experimental examples of engineered surfaces of industrial relevance.

  14. In defense of magnesium sulfate.

    PubMed

    Elliott, John P; Lewis, David F; Morrison, John C; Garite, Thomas J

    2009-06-01

    Magnesium sulfate has been used by obstetricians for more than 25 years to treat preterm labor. Magnesium sulfate is effective in delaying delivery for at least 48 hours in patients with preterm labor when used in higher dosages. There do not seem to be any harmful effects of the drug on the fetus, and indeed there is a neuroprotective effect in reducing the incidence of cerebral palsy in premature newborns weighing less than 1,500 g.

  15. Cement from magnesium substituted hydroxyapatite.

    PubMed

    Lilley, K J; Gbureck, U; Knowles, J C; Farrar, D F; Barralet, J E

    2005-05-01

    Brushite cement may be used as a bone graft material and is more soluble than apatite in physiological conditions. Consequently it is considerably more resorbable in vivo than apatite forming cements. Brushite cement formation has previously been reported by our group following the mixture of nanocrystalline hydroxyapatite and phosphoric acid. In this study, brushite cement was formed from the reaction of nanocrystalline magnesium-substituted hydroxyapatite with phosphoric acid in an attempt to produce a magnesium substituted brushite cement. The presence of magnesium was shown to have a strong effect on cement composition and strength. Additionally the presence of magnesium in brushite cement was found to reduce the extent of brushite hydrolysis resulting in the formation of HA. By incorporating magnesium ions in the apatite reactant structure the concentration of magnesium ions in the liquid phase of the cement was controlled by the dissolution rate of the apatite. This approach may be used to supply other ions to cement systems during setting as a means to manipulate the clinical performance and characteristics of brushite cements.

  16. Magnesium and Dialysis: The Neglected Cation.

    PubMed

    Alhosaini, Mohamad; Leehey, David J

    2015-09-01

    Disorders of magnesium homeostasis are very common in dialysis patients but have received scant attention. In this review, we address measurement of plasma magnesium, magnesium balance and the factors that affect magnesium flux during dialysis, the prevalence of hypo- and hypermagnesemia in dialysis patients, and the potential clinical significance of hypo- and hypermagnesemia in dialysis patients. Many factors can affect plasma magnesium concentration, including diet, nutritional status (including plasma albumin level), medications (such as proton pump inhibitors), and dialysis prescription. Further interventional studies to determine the effect of normalization of plasma magnesium concentration on clinical outcomes are needed. At the present time, we recommend that predialysis plasma magnesium be measured on a regular basis, with the dialysate magnesium concentration adjusted to maintain plasma magnesium concentration within the normal range.

  17. Magnesium Uptake by Soybeans

    PubMed Central

    Leggett, J. E.; Gilbert, W. A.

    1969-01-01

    Magnesium contents of soybean (Glycine max) roots increase and the K and Ca contents decrease with increased MgCl2 concentrations in ambient solutions. The Mg uptake is inhibited when both Ca and K are present in the solution, but not by K or Ca alone. Chloride uptake, which is very low from the MgCl2 solution, is greatly enhanced by the presence of K. The selectivity against Mg imparted by K + Ca appears to be at an external barrier for cation uptake as shown by its dependence on the presence of Ca in the external solution. The Ca content of roots is influenced only slightly by changes in external Ca concentrations from 10−4 to 10−2m, but that of shoots is greatly enhanced as the Ca concentration is increased or the K concentration is decreased. These effects on Ca contents are explained as arising from transport to the shoot without involvement of vacuoles of root cells. PMID:16657186

  18. Myth or Reality-Transdermal Magnesium?

    PubMed

    Gröber, Uwe; Werner, Tanja; Vormann, Jürgen; Kisters, Klaus

    2017-07-28

    In the following review, we evaluated the current literature and evidence-based data on transdermal magnesium application and show that the propagation of transdermal magnesium is scientifically unsupported. The importance of magnesium and the positive effects of magnesium supplementation are extensively documented in magnesium deficiency, e.g., cardiovascular disease and diabetes mellitus. The effectiveness of oral magnesium supplementation for the treatment of magnesium deficiency has been studied in detail. However, the proven and well-documented oral magnesium supplementation has become questioned in the recent years through intensive marketing for its transdermal application (e.g., magnesium-containing sprays, magnesium flakes, and magnesium salt baths). In both, specialist and lay press as well as on the internet, there are increasing numbers of articles claiming the effectiveness and superiority of transdermal magnesium over an oral application. It is claimed that the transdermal absorption of magnesium in comparison to oral application is more effective due to better absorption and fewer side effects as it bypasses the gastrointestinal tract.

  19. System and process for production of magnesium metal and magnesium hydride from magnesium-containing salts and brines

    DOEpatents

    McGrail, Peter B.; Nune, Satish K.; Motkuri, Radha K.; Glezakou, Vassiliki-Alexandra; Koech, Phillip K.; Adint, Tyler T.; Fifield, Leonard S.; Fernandez, Carlos A.; Liu, Jian

    2016-11-22

    A system and process are disclosed for production of consolidated magnesium metal products and alloys with selected densities from magnesium-containing salts and feedstocks. The system and process employ a dialkyl magnesium compound that decomposes to produce the Mg metal product. Energy requirements and production costs are lower than for conventional processing.

  20. [Development of biodegradable magnesium-based biomaterials].

    PubMed

    Zhu, Shengfa; Xu, Li; Huang, Nan

    2009-04-01

    Magnesium is a macroelement which is indispensable to human bodies. As a lightweight metal with high specific strength and favorable biocompatibility, magnesium and its alloys have been introduced in the field of biomedical materials research and have a broad application prospect. It is possible to develop new type of biodegradable medical magnesium alloys by use of the poor corrosion resistance of magnesium. Bioabsorbable magnesium stents implanted in vivo could mechanically support the vessel in a short term, effectly prevent the acute coronary occlusion and in-stent restenosis, and then be gradully biodegraded and completely absorbed in a long term. Osteoconductive bioactivity in magnesium-based alloys could promote the apposition growth of bone tissue. This paper reviews the progress of magnesium and its alloys applied in bone tissue and cardiovascular stents, and the prospect of the future research of magnesium-based biomaterials is discussed.

  1. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... a white precipitate by the addition of sodium hydroxide to a water soluble magnesium salt or by hydration of reactive grades of magnesium oxide. (b) The ingredient meets the specifications of the Food...

  2. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... is prepared as a white precipitate by the addition of sodium hydroxide to a water soluble magnesium salt or by hydration of reactive grades of magnesium oxide. (b) The ingredient meets the specifications...

  3. Magnesium/Calcium Competition at Excitable Membranes.

    ERIC Educational Resources Information Center

    Belzer, Bill; Fry, Panni

    1998-01-01

    Considers some consequences of altering intracellular calcium supply by magnesium concentration changes. Focuses on using this procedure as an exercise with allied health students as they witness therapeutic uses of magnesium and other calcium entry inhibitors. (DDR)

  4. Magnesium/Calcium Competition at Excitable Membranes.

    ERIC Educational Resources Information Center

    Belzer, Bill; Fry, Panni

    1998-01-01

    Considers some consequences of altering intracellular calcium supply by magnesium concentration changes. Focuses on using this procedure as an exercise with allied health students as they witness therapeutic uses of magnesium and other calcium entry inhibitors. (DDR)

  5. Magnesium silicide intermetallic alloys

    NASA Astrophysics Data System (ADS)

    Li, Gh.; Gill, H. S.; Varin, R. A.

    1993-11-01

    Methods of induction melting an ultra-low-density magnesium silicide (Mg2Si) intermetallic and its alloys and the resulting microstructure and microhardness were studied. The highest quality ingots of Mg2Si alloys were obtained by triple melting in a graphite crucible coated with boron nitride to eliminate reactivity, under overpressure of high-purity argon (1.3 X 105 Pa), at a temperature close to but not exceeding 1105 °C ± 5 °C to avoid excessive evaporation of Mg. After establishing the proper induction-melting conditions, the Mg-Si binary alloys and several Mg2Si alloys macroalloyed with 1 at. pct of Al, Ni, Co, Cu, Ag, Zn, Mn, Cr, and Fe were induction melted and, after solidification, investigated by optical microscopy and quantitative X-ray energy dispersive spectroscopy (EDS). Both the Mg-rich and Si-rich eutectic in the binary alloys exhibited a small but systematic increase in the Si content as the overall composition of the binary alloy moved closer toward the Mg2Si line compound. The Vickers microhardness (VHN) of the as-solidified Mg-rich and Si-rich eutectics in the Mg-Si binary alloys decreased with increasing Mg (decreasing Si) content in the eutectic. This behavior persisted even after annealing for 75 hours at 0.89 pct of the respective eutectic temperature. The Mg-rich eutectic in the Mg2Si + Al, Ni, Co, Cu, Ag, and Zn alloys contained sections exhibiting a different optical contrast and chemical composition than the rest of the eutectic. Some particles dispersed in the Mg2Si matrix were found in the Mg2Si + Cr, Mn, and Fe alloys. The EDS results are presented and discussed and compared with the VHN data.

  6. Solid-state rechargeable magnesium battery

    DOEpatents

    Shao, Yuyan; Liu, Jun; Liu, Tianbiao; Li, Guosheng

    2016-09-06

    Embodiments of a solid-state electrolyte comprising magnesium borohydride, polyethylene oxide, and optionally a Group IIA or transition metal oxide are disclosed. The solid-state electrolyte may be a thin film comprising a dispersion of magnesium borohydride and magnesium oxide nanoparticles in polyethylene oxide. Rechargeable magnesium batteries including the disclosed solid-state electrolyte may have a coulombic efficiency .gtoreq.95% and exhibit cycling stability for at least 50 cycles.

  7. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium carbonate. 184.1425 Section 184.1425 Food... Specific Substances Affirmed as GRAS § 184.1425 Magnesium carbonate. (a) Magnesium carbonate (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium carbonate...

  8. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate by...

  9. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate by...

  10. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS Reg. No. 7786-30-3) is a... prepared by dissolving magnesium oxide, hydroxide, or carbonate in aqueous hydrochloric acid solution and...

  11. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium carbonate. 184.1425 Section 184.1425... Listing of Specific Substances Affirmed as GRAS § 184.1425 Magnesium carbonate. (a) Magnesium carbonate (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium...

  12. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate by...

  13. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate by...

  14. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium carbonate. 184.1425 Section 184.1425... GRAS § 184.1425 Magnesium carbonate. (a) Magnesium carbonate (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium carbonate hydroxide. It is a white...

  15. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium carbonate. 184.1425 Section 184.1425... Listing of Specific Substances Affirmed as GRAS § 184.1425 Magnesium carbonate. (a) Magnesium carbonate (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium...

  16. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium carbonate. 184.1425 Section 184.1425... Listing of Specific Substances Affirmed as GRAS § 184.1425 Magnesium carbonate. (a) Magnesium carbonate (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium...

  17. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate by the addition of an...

  18. Magnesium in sea water: an electrode measurement.

    PubMed

    Thompson, M E

    1966-08-19

    Magnesium ion in standard I.A.P.O. sea water was measured with a magnesium-sensitive electrode. The results, presented either as magnesiumion activity (0.017) or as the amount of ionized magnesium (0.048M or about 90 percent of the total magnesium), agree well with the data from the chemical model for sea water proprosed by Garrels and Thompson.

  19. Physicochemical properties of magnesium salicylate.

    PubMed

    Alam, A S; Gregoriades, D

    1981-08-01

    Magnesium salicylate tetrahydrate is a nonhygroscopic, crystalline powder, whereas anhydrous magnesium salicylate is amorphous and very hygroscopic. Magnesium salicylate tetrahydrate tablets formulated with gelatin as a binder showed a dissolution half-life (t1/2) of 12 min, whereas a formulation using pregelatinized starch as a binder showed a t1/2 of 33 min. The optimum level of calcium stearate in the formulation was determined by the oscilloscope tracings of compressional and ejectional forces from an instrumented rotary tableting machine. Increasing the level of calcium stearate from 1 to 1.5 and 2% resulted in dissolution t1/2 values of 12, 18, and 21 min, respectively, and a higher incidence of softer tablets and capping.

  20. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance is...

  1. 76 FR 69284 - Pure Magnesium From China

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-11-08

    ... COMMISSION Pure Magnesium From China Determination On the basis of the record \\1\\ developed in the subject... order on pure magnesium from China would be likely to lead to continuation or recurrence of material... USITC Publication 4274 (October 2011), entitled Pure Magnesium from China: Investigation No. 731-TA-696...

  2. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use. This...

  3. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance is...

  4. Synthesis of superconducting magnesium diboride objects

    DOEpatents

    Finnemore, Douglas K.; Canfield, Paul C.; Bud'ko, Sergey L.; Ostenson, Jerome E.; Petrovic, Cedomir; Cunningham, Charles E.; Lapertot, Gerard

    2003-08-15

    A process to produce magnesium diboride objects from boron objects with a similar form is presented. Boron objects are reacted with magnesium vapor at a predetermined time and temperature to form magnesium diboride objects having a morphology similar to the boron object's original morphology.

  5. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  6. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use. This...

  7. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance is...

  8. 21 CFR 201.71 - Magnesium labeling.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 4 2014-04-01 2014-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium content...

  9. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use. This...

  10. Synthesis Of Superconducting Magnesium Diboride Objects.

    DOEpatents

    Finnemore, Douglas K.; Canfield, Paul C.; Bud'ko, Sergey L.; Ostenson, Jerome E.; Petrovic, Cedomir; Cunningham, Charles E.; Lapertot, Gerard

    2003-07-08

    A process to produce magnesium diboride objects from boron objects with a similar form is presented. Boron objects are reacted with magnesium vapor at a predetermined time and temperature to form magnesium diboride objects having a morphology similar to the boron object's original morphology.

  11. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium sulfate. 582.5443 Section 582.5443 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use. This...

  12. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use. This...

  13. 21 CFR 201.71 - Magnesium labeling.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 4 2012-04-01 2012-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium content...

  14. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use. This...

  15. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium oxide. 582.5431 Section 582.5431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  16. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use. This...

  17. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  18. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  19. 21 CFR 201.71 - Magnesium labeling.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 4 2013-04-01 2013-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium content...

  20. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium sulfate. 582.5443 Section 582.5443 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use. This...

  1. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  2. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use. This...

  3. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use. This...

  4. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) SUBSTANCES GENERALLY RECOGNIZED AS SAFE Anticaking Agents § 182.2437 Magnesium silicate. (a) Product. Magnesium...

  5. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium sulfate. 582.5443 Section 582.5443 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use. This...

  6. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  7. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  8. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  9. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium oxide. 582.5431 Section 582.5431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  10. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  11. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use. This...

  12. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations, restrictions...

  13. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance is...

  14. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium oxide. 582.5431 Section 582.5431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  15. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance is...

  16. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use. This...

  17. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium sulfate. 582.5443 Section 582.5443 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use. This...

  18. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium oxide. 582.5431 Section 582.5431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  19. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium phosphate. 582.5434 Section 582.5434 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic). (b...

  20. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium oxide. 582.5431 Section 582.5431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  1. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium phosphate. 582.5434 Section 582.5434 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic). (b...

  2. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium sulfate. 582.5443 Section 582.5443 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use. This...

  3. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium phosphate. 582.5434 Section 582.5434 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic). (b...

  4. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium phosphate. 582.5434 Section 582.5434 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic). (b...

  5. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium phosphate. 582.5434 Section 582.5434 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic). (b...

  6. Neonatal serum magnesium concentrations are determined by total maternal dose of magnesium sulfate administered for neuroprotection.

    PubMed

    Borja-Del-Rosario, Pamela; Basu, Sudeepta Kumar; Haberman, Shoshana; Bhutada, Alok; Rastogi, Shantanu

    2014-03-01

    Antenatal magnesium in preterm labor for neuroprotection decreases the incidence of cerebral palsy. However, there are no guidelines on the dose and duration of magnesium infusion for neuroprotection. As increased neonatal serum magnesium concentrations may be related to higher risk of morbidity and mortality, the role of total amount of magnesium and maternal serum magnesium concentrations associated with safe neonatal serum magnesium concentrations is not known. A retrospective study was conducted on 289 mothers who received antenatal magnesium for neuroprotection as a loading dose of 4-6 g infused over 30 min, followed by a maintenance infusion of 1-2 g/h. Total magnesium dose infused to the mother and maternal serum magnesium concentrations were correlated with neonatal serum magnesium concentrations. Of the 289 mothers, 192 mother/baby dyads had all three measurements (maternal total magnesium dose, and maternal and neonatal serum magnesium concentrations). Magnesium infusion was continued beyond 24 h in 60 mothers. Total maternal magnesium dose at 24 and 48 h of infusion correlated with neonatal serum magnesium concentrations (r=0.55, P<0.0001 and r=0.35, P<0.0001, respectively), but not with maternal serum magnesium concentrations (r=0.004, P=0.98 and r=0.14, P=0.21). However, there was no correlation between the maternal and neonatal serum magnesium concentrations (r=0.10, P=0.15). Total dose of magnesium infused to the mother correlates with neonatal serum magnesium concentrations. To keep neonatal serum magnesium concentrations within a range that is effective for neuroprotection and safe for the neonates, the total dose received by the mother needs to be monitored and limited.

  7. Magnesium Diboride Current Leads

    NASA Technical Reports Server (NTRS)

    Panek, John

    2010-01-01

    A recently discovered superconductor, magnesium diboride (MgB2), can be used to fabricate conducting leads used in cryogenic applications. Dis covered to be superconducting in 2001, MgB2 has the advantage of remaining superconducting at higher temperatures than the previously used material, NbTi. The purpose of these leads is to provide 2 A of electricity to motors located in a 1.3 K environment. The providing environment is a relatively warm 17 K. Requirements for these leads are to survive temperature fluctuations in the 5 K and 11 K heat sinks, and not conduct excessive heat into the 1.3 K environment. Test data showed that each lead in the assembly could conduct 5 A at 4 K, which, when scaled to 17 K, still provided more than the required 2 A. The lead assembly consists of 12 steelclad MgB2 wires, a tensioned Kevlar support, a thermal heat sink interface at 4 K, and base plates. The wires are soldered to heavy copper leads at the 17 K end, and to thin copper-clad NbTi leads at the 1.3 K end. The leads were designed, fabricated, and tested at the Forschungszentrum Karlsruhe - Institut foer Technische Physik before inclusion in Goddard's XRS (X-Ray Spectrometer) instrument onboard the Astro-E2 spacecraft. A key factor is that MgB2 remains superconducting up to 30 K, which means that it does not introduce joule heating as a resistive wire would. Because the required temperature ranges are 1.3-17 K, this provides a large margin of safety. Previous designs lost superconductivity at around 8 K. The disadvantage to MgB2 is that it is a brittle ceramic, and making thin wires from it is challenging. The solution was to encase the leads in thin steel tubes for strength. Previous designs were so brittle as to risk instrument survival. MgB2 leads can be used in any cryogenic application where small currents need to be conducted at below 30 K. Because previous designs would superconduct only at up to 8 K, this new design would be ideal for the 8-30 K range.

  8. [Magnesium deficiency in an endocrinologist's practice].

    PubMed

    Tereshchenko, I V

    2008-01-01

    The review concerning a value of magnesium in an organism in healthy persons and cases with endocrine disorders is presented. The causes of magnesium-deficient conditions in cases with type 1 and type 2 diabetes, thyrotoxic goiter, hypothyroidism and obesity were analyzed. Participation of magnesium in secretion of parathormone and a control of calcium exchange is shown. The clinical semiology of hypomagnesemia seems to be nonspecific and manifold, and, therefore, as a rule, in most of endocrine patients magnesium deficiency remains to be undiagnosed. Questions on preventive measures and management of treatment magnesium-deficient conditions are considered.

  9. Major Minerals - Calcium, Magnesium, Phosphorus

    USDA-ARS?s Scientific Manuscript database

    Calcium, magnesium and phosphorus are essential elements critically important for the function of the musculoskeletal system, including the formation and transduction of energy and the maintenance of healthy bone. The major calcium concern for physically active healthy middle-aged adults is to consu...

  10. A SEARCH FOR MAGNESIUM IN EUROPA'S ATMOSPHERE

    SciTech Connect

    Hoerst, S. M.; Brown, M. E.

    2013-02-20

    Europa's tenuous atmosphere results from sputtering of the surface. The trace element composition of its atmosphere is therefore related to the composition of Europa's surface. Magnesium salts are often invoked to explain Galileo Near Infrared Mapping Spectrometer spectra of Europa's surface, thus magnesium may be present in Europa's atmosphere. We have searched for magnesium emission in the Hubble Space Telescope Faint Object Spectrograph archival spectra of Europa's atmosphere. Magnesium was not detected and we calculate an upper limit on the magnesium column abundance. This upper limit indicates that either Europa's surface is depleted in magnesium relative to sodium and potassium, or magnesium is not sputtered as efficiently resulting in a relative depletion in its atmosphere.

  11. Carbothermal Production of Magnesium in Vacuum

    NASA Astrophysics Data System (ADS)

    Qu, Tao; Yang, Bin; Tian, Yang; Dai, Yongnian

    Carbothermal production has been recognized as conceptually the cleanest and energy-efficient route to magnesium metal, but has suffered from technical challenges of development and scale-up. Work by National Engineering Laboratory for Vacuum Metallurgy of China has overcome some barriers of carbothermal production. By changing the condition of condensation, the magnesium vapor is condensed into bulk, so that the risk of magnesium powder explosion can be avoided, and it can reduce the oxygen content, enhance the recovered of magnesium. The mechanism of the carbothermic reduction process has be investigated, the reversion reactions are favored below 1373K at 30 100Pa, and reversion below 9% at bulk in condensation. Purification of magnesium by distillation is known technology, but difficulties with continuous operation are also known. In terms of process control, distillation temperature and pressure are controlled, the magnesium vapor is condensed into liquid, and then solidified into a solid, the solid magnesium is purified (>99.9%).

  12. [Magnesium: a kardio-renal viewpoint].

    PubMed

    Brandenburg, Vincent Matthias; Kaesler, Nadine; Kramann, Rafael; Floege, Jürgen; Marx, Nikolaus

    2016-10-01

    Disturbances in magnesium homeostasis are frequent clinical conditions, particularly the prevalence of hypomagnesaemia is high. However, it remains an open question which laboratory method is optimal to assess the magnesium level in the body. Most frequently physicians measure total magnesium in serum. Many associative data from observational studies point towards an association between low magnesium levels and increased cardiovascular risk as well as increased mortality. Vice versa, normal-to-high magnesium levels in patients with advanced renal failure translate to a better outcome. The present review summarizes our knowledge on protective effects of magnesium. Additionally, we address the limited evidence supporting targeted magnesium supplementation. © Georg Thieme Verlag KG Stuttgart · New York.

  13. Magnesium in chronic kidney disease: unanswered questions.

    PubMed

    Spiegel, David M

    2011-01-01

    Magnesium ion is critical for life and is integrally involved in cellular function and a key component of normal bone mineral. In health, the kidneys, gastrointestinal tract and bone are responsible for maintaining serum magnesium concentrations in the normal range and magnesium balance. Most clinical disorders involving magnesium, other than chronic kidney disease (CKD), result in hypomagnesemia, either from gastrointestinal or kidney losses. CKD and particularly end-stage kidney disease is the only clinical condition where sustained hypermagnesemia may occur and net magnesium balance may be positive. This review will focus on normal magnesium homeostasis and review the literature in CKD with a particular focus on end-stage kidney disease and the potential role of magnesium as a phosphate binder and in cardiovascular and bone health. A number of small to medium-size interventional trials have shown that magnesium-based compounds can serve as effective phosphate binders. Observational studies suggest that higher serum magnesium concentrations in dialysis patients may improve survival and may slow the progression of vascular calcification. While a few small prospective trials support these findings, no large or long-term studies are available. Magnesium balance remains poorly understood in patients with end-stage kidney disease. While observational and small randomized trials suggest that exogenous administration may be useful as a phosphate binder and may have protective cardiovascular effects in terms of both arrhythmias and vascular calcification, large randomized trials are needed to test these hypotheses. Copyright © 2011 S. Karger AG, Basel.

  14. Magnesium: its role in nutrition and carcinogenesis.

    PubMed

    Blaszczyk, Urszula; Duda-Chodak, Aleksandra

    2013-01-01

    Magnesium (Mg2+) plays a key role in many essential cellular processes such as intermediary metabolism, DNA replication and repair, transporting potassium and calcium ions, cell proliferation together with signalling transduction. Dietary sources rich in magnesium are whole and unrefined grains, seeds, cocoa, nuts, almonds and green leafy vegetables. Hard water is also considered to be an important source of magnesium beneficial to human health. The daily dietary intake of magnesium is however frequently found to be below that recommended in Western countries. Indeed, it is recognised that magnesium deficiency may lead to many disorders of the human body, where for instance magnesium depletion is believed to play an important role in the aetiology of the following; cardiovascular disease (including thrombosis, atherosclerosis, ishaemic heart disease, myocardial infarction, hypertension, arrhythmias and congestive heart failure in human), as well as diabetes mellitus, gastrointestinal (GI) tract disease, liver cirrhosis and diseases of the thyroid and parathyroid glands. Insufficient dietary intake of magnesium may also significantly affect the development and exacerbation ofADHD (Attention Deficit- Hyperactivity Disorder) symptoms in children. The known links between magnesium and carcinogenesis still remain unclear and complex, with conflicting results being reported from many experimental, epidemiological and clinical studies; further knowledge is thus required. Mg2+ ions are enzyme cofactors involved in DNA repair mechanisms that maintain genomic stability and fidelity. Any magnesium deficiencies could thereby cause a dysfunction of these systems to occur leading to DNA mutations. Magnesium deficiency may also be associated with inflammation and increased levels of free radicals where both inflammatory mediators and free radicals so arising could cause oxidative DNA damage and therefore tumour formation. The presented review article now provides a summary

  15. Magnesium in disease: a review with special emphasis on the serum ionized magnesium.

    PubMed

    Sanders, G T; Huijgen, H J; Sanders, R

    1999-01-01

    This review deals with the six main clinical situations related to magnesium or one of its fractions, including ionized magnesium: renal disease, hypertension, pre-eclampsia, diabetes mellitus, cardiac disease, and the administration of therapeutic drugs. Issues addressed are the physiological role of magnesium, eventual changes in its levels, and how these best can be monitored. In renal disease mostly moderate hypermagnesemia is seen; measuring ionized magnesium offers minimal advantage. In hypertension magnesium might be lowered but its measurement does not seem relevant. In the prediction of severe pre-eclampsia, elevated ionized magnesium concentration may play a role, but no unequivocal picture emerges. Low magnesium in blood may be cause for, or consequence of, diabetes mellitus. No special fraction clearly indicates magnesium deficiency leading to insulin resistance. Cardiac diseases are related to diminished magnesium levels. During myocardial infarction, serum magnesium drops. Total magnesium concentration in cardiac cells can be predicted from levels in sublingual or skeletal muscle cells. Most therapeutic drugs (diuretics, chemotherapeutics, immunosuppressive agents, antibiotics) cause hypomagnesemia due to increased urinary loss. It is concluded that most of the clinical situations studied show hypomagnesemia due to renal loss, with exception of renal disease. Keeping in mind that only 1% of the total body magnesium pool is extracellular, no simple measurement of the real intracellular situation has emerged; measuring ionized magnesium in serum has little added value at present.

  16. Magnesium-based implants: a mini-review.

    PubMed

    Luthringer, Bérengère J C; Feyerabend, Frank; Willumeit-Römer, Regine

    2014-01-01

    The goal of this review is to bring to the attention of the readership of Magnesium Research another facet of the importance of magnesium, i.e. magnesium-based biomaterials. A concise history of biomaterials and magnesium are thus presented. In addition, historical and current, clinical magnesium-based applications are presented.

  17. Method for magnesium sulfate recovery

    DOEpatents

    Gay, Richard L.; Grantham, LeRoy F.

    1987-01-01

    A method of obtaining magnesium sulfate substantially free from radioactive uranium from a slag containing the same and having a radioactivity level of at least about 7000 pCi/gm. The slag is ground to a particle size of about 200 microns or less. The ground slag is then contacted with a concentrated sulfuric acid under certain prescribed conditions to produce a liquid product and a solid product. The particulate solid product and a minor amount of the liquid is then treated to produce a solid residue consisting essentially of magnesium sulfate substantially free of uranium and having a residual radioactivity level of less than 1000 pCi/gm. In accordance with the preferred embodiment of the invention, a catalyst and an oxidizing agent are used during the initial acid treatment and a final solid residue has a radioactivity level of less than about 50 pCi/gm.

  18. Method for magnesium sulfate recovery

    DOEpatents

    Gay, R.L.; Grantham, L.F.

    1987-08-25

    A method is described for obtaining magnesium sulfate substantially free from radioactive uranium from a slag containing the same and having a radioactivity level of at least about 7,000 pCi/gm. The slag is ground to a particle size of about 200 microns or less. The ground slag is then contacted with a concentrated sulfuric acid under certain prescribed conditions to produce a liquid product and a solid product. The particulate solid product and a minor amount of the liquid is then treated to produce a solid residue consisting essentially of magnesium sulfate substantially free of uranium and having a residual radioactivity level of less than 1,000 pCi/gm. In accordance with the preferred embodiment of the invention, a catalyst and an oxidizing agent are used during the initial acid treatment and a final solid residue has a radioactivity level of less than about 50 pCi/gm.

  19. Substrate and method for the formation of continuous magnesium diboride and doped magnesium diboride wire

    DOEpatents

    Suplinskas, Raymond J.; Finnemore, Douglas; Bud'ko, Serquei; Canfield, Paul

    2007-11-13

    A chemically doped boron coating is applied by chemical vapor deposition to a silicon carbide fiber and the coated fiber then is exposed to magnesium vapor to convert the doped boron to doped magnesium diboride and a resultant superconductor.

  20. Microstructural Effects on the Spall Properties of ECAE Magnesium and Magnesium Alloys

    NASA Astrophysics Data System (ADS)

    Williams, Cyril

    2015-06-01

    Magnesium and magnesium alloys are light weight materials and hence, are being increasingly employed as light armor in military applications. However, because of its limited slip systems (HCP) magnesium and magnesium alloys are relatively brittle as compared to FCC and BCC lattice structures. For this study, the effects of microstructure on the spall properties of magnesium and magnesium alloys processed using Equi-Channel Angular Extrusion (ECAE) were investigated using a 51 mm and 105 mm bore gas guns. Symmetric spall and recovery plate impact experiments were performed at impact velocities ranging from approximately 100 m/s and 400 m/s. Free surface velocity profiles of the shocked samples were obtained using Photonic Doppler Velocimetry (PDV). The spall strength and Hugoniot Elastic Limit (HEL) were extracted from the free surface velocity profiles. In addition, the microstructures of the pre-shocked and post-shocked magnesium and magnesium alloys were acquired using Scanning Electron Microscope (SEM) and Transmission Electron Microscope (TEM).

  1. Catalysts comprising magnesium and a transition metal

    SciTech Connect

    Bujadoux, K.

    1984-10-09

    A catalyst comprising the product obtained by bringing into contact a compound of magnesium comprising at least one species selected from the group consisting of magnesium monohalides (MgX), halo-magnesium hydrides (HMgX) and magnesium hydride (MgH/sub 2/), X being a halogen and the said species MgX or HMgX being obtained by thermal decomposition of a powdery organo-magnesium halide R/sub 1/MgX wherein R/sub 1/ is an organic radical; and at least one halide of a transistion metal selected from the group consisting of titanium and vanadium, the valency of said metal in said halide being lower than or equal to 3, the quantities being such that the atomic ratio of magnesium to said transistion metal is between 1 and 25, and a catalyst system including the catalyst that is suitable for use in the polymerization of olefins and particularly ethylene.

  2. Lightweight Heat Pipes Made from Magnesium

    NASA Technical Reports Server (NTRS)

    Rosenfeld, John N.; Zarembo, Sergei N.; Eastman, G. Yale

    2010-01-01

    Magnesium has shown promise as a lighter-weight alternative to the aluminum alloys now used to make the main structural components of axially grooved heat pipes that contain ammonia as the working fluid. Magnesium heat-pipe structures can be fabricated by conventional processes that include extrusion, machining, welding, and bending. The thermal performances of magnesium heat pipes are the same as those of equal-sized aluminum heat pipes. However, by virtue of the lower mass density of magnesium, the magnesium heat pipes weigh 35 percent less. Conceived for use aboard spacecraft, magnesium heat pipes could also be attractive as heat-transfer devices in terrestrial applications in which minimization of weight is sought: examples include radio-communication equipment and laptop computers.

  3. Magnesium alloy applications in automotive structures

    NASA Astrophysics Data System (ADS)

    Easton, Mark; Beer, Aiden; Barnett, Matthew; Davies, Chris; Dunlop, Gordon; Durandet, Yvonne; Blacket, Stuart; Hilditch, Tim; Beggs, Peter

    2008-11-01

    The use of magnesium alloys in structural applications has great potential for the lightweighting of transportation vehicles. Research within the CAST Cooperative Research Centre has tackled some of the important issues related to the use of magnesium in structural applications. To this end, a new alloy with extrudability and properties similar to 6000 series aluminum alloys has been developed. Furthermore, a method of laser heating magnesium alloys before self-piercing riveting has enabled high-integrity joining between magnesium components or between magnesium and dissimilar metals. In this paper, new technologies and improved understanding of the deformation behavior of wrought magnesium alloys are discussed in light of key metallurgical features such as alloy composition, grain size, and work hardening rate.

  4. IMPROVED MAGNESIUM OXIDE SLIP CASTING METHOD

    DOEpatents

    Stoddard, S.D.; Nuckolls, D.E.

    1963-12-31

    A process for making an aqueous magnesium oxide slip casting slurry comprising the steps of mixing finely ground fused magnesium oxide with water, milling the slurry for at least 30 hours at a temperature of 2-10 deg C (the low temperature during milling inhibiting the formation of hydrated magnesium oxide), discharging the slurry from the mill, adding hydrochloric acid as a deflocculent, and adding a scum inhibitor is presented. (AEC)

  5. Nanotechnology Corrosion Pretreatment for Magnesium Alloys

    DTIC Science & Technology

    2012-08-29

    Pretreatment for Magnesium Alloys AMS-SAE-M-3171, Type IV Replacement on AZ91D Glycolic Nitrate Pickle (GNP) (1 min) PT-60 (3 min) 0 hr SST 1 4 3 2...Nanotechnology Corrosion Pretreatment for Magnesium Alloys Mr. Jules F. Senske and Mr. Daniel Schmidt Army Research Development and...SUBTITLE Nanotechnology Corrosion Pretreatment for Magnesium Alloys 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d

  6. Magnesium deficiency in a medical ICU population.

    PubMed

    Ryzen, E; Wagers, P W; Singer, F R; Rude, R K

    1985-01-01

    The serum magnesium level was measured in 94 consecutive patients admitted to the medical ICU of Los Angeles County/University of Southern California Medical Center over a 2-month period. Sixty-five percent of patients with serum creatinine concentrations of 1.1 mg/dl or less were hypomagnesemic. Of these, one third had hypocalcemia that was corrected with magnesium supplementation. Physicians should be alert to the high incidence of magnesium deficiency in critically ill patients.

  7. Lewis Acid-free and Phenolate-based Magnesium Electrolyte for Rechargeable Magnesium Batteries

    SciTech Connect

    Pan, Baofei; Zhang, Junjie; Huang, Jinhua; Vaughey, John T.; Zhang, Lu; Han, Sang Don; Zhang, Zhengcheng; Liao, Chen

    2015-03-02

    A novel Lewis acid-free and phenolate-based magnesium electrolyte has been established. The excellent reversibility and stability of this electrolyte in battery cycling render this novel Lewis acid-free synthetic approach as a highly promising alternative for the development of highly anodically stable magnesium electrolytes for rechargeable magnesium batteries.

  8. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of...

  9. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels...

  10. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of...

  11. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of...

  12. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of...

  13. Magnesium enrichment and distribution in plants.

    PubMed

    Courtois, D; Kastenmayer, P; Clough, J; Vigo, M; Sabatier, M; Arnaud, M J

    2003-12-01

    Food products enriched with stable isotopes are used in nutrition to study the metabolic fate of nutrients in humans. This study reports on the labeling of green beans, white beans, soybeans and wheat with a stable isotope of magnesium (25Mg) obtained in greenhouse conditions for further studies on magnesium bioavailability. Soybean and green bean are the most efficient plant species to obtain large amounts of edible parts rapidly with a minimum loss of labeled Mg in other parts of the plants. The results obtained showed that a relatively high percentage of the magnesium found in seeds (grains/beans) can come from the redistribution of magnesium previously accumulated in other organs.

  14. Wide Strip Casting Technology of Magnesium Alloys

    NASA Astrophysics Data System (ADS)

    Park, W.-J.; Kim, J. J.; Kim, I. J.; Choo, D.

    Extensive investigations relating to the production of high performance and low cost magnesium sheet by strip casting have been performed for the application to automotive parts and electronic devices. Research on magnesium sheet production technology started in 2004 by Research Institute of Industrial Science and Technology (RIST) with support of Pohang Iron and Steel Company (POSCO). POSCO has completed the world's first plant to manufacture magnesium coil. Another big project in order to develop wide strip casting technology for the automotive applications of magnesium sheets was started in succession.

  15. Evidence for bicarbonate-dependent magnesium reabsorption.

    PubMed

    Hartmann, A; Langberg, H; Dibona, G; Kiil, F

    1983-01-01

    During ethacrynic acid administration about 50% of the filtered load of magnesium is reabsorbed. To examine whether the remaining component of magnesium reabsorption is bicarbonate-dependent, i.e. varies with factors known to alter passive reabsorption, experiments were performed in anesthetized dogs. During ethacrynic acid administration MgCl2 infusion raised the plasma concentration of magnesium (PMg) from 0.64 +/- 0.05 to 3.06 +/- 0.27 mM and doubled magnesium reabsorption. The infusion of acetazolamide at high PMg reduced bicarbonate reabsorption by 41 +/- 3% and magnesium reabsorption by 31 +/- 16%. When plasma pH was reduced to 7.04 +/- 0.02 and increased to 7.83 +/- 0.02 by altering PCO2 at a constant plasma bicarbonate concentration of 31.2 +/- 0.8 mM, magnesium and bicarbonate reabsorption were correlated (r = 0.82). The infusion of mannitol, which acts by reducing passive solute transport without affecting bicarbonate reabsorption, halved magnesium reabsorption. By combining mannitol and acetazolamide infusions, only 6 +/- 4% of the filtered magnesium was still reabsorbed. These results indicate that the reabsorption of magnesium remaining after the infusion of ethacrynic acid and after raising PMg varies with changes in PCO2 and is inhibited by the infusion of acetazolamide and mannitol as expected for bicarbonate-dependent passive reabsorption.

  16. Laser-induced Magnesium Production from Magnesium Oxide for Renewable Magnesium Energy Cycle.

    NASA Astrophysics Data System (ADS)

    Liao, Shi-Hua; Yabe, Takashi; Baasandash, Choijil; Sato, Yuji; Ichikawa, Masashi; Nakatsuka, Masashi; Fukushima, Chika; Uchida, Shigeaki; Ohkubo, Tomomasa

    2010-10-01

    We succeeded in reducing magnesium [Mg] from magnesium oxide [MgO] by laser irradiation. The laser-induced vapor temperature was measured to be approximately 5000 K on the irradiating spot, where MgO separated into Mg and oxygen [O] atoms through thermal dissociation. The Mg vapor was intercepted a cooper plate, forming solid deposits on it. However, the presence of oxygen, resulting from MgO dissociation, leads to Mg oxidization in the course of vapor cooling. The deoxidization process results in lower Mg fraction in the deposits and degrades energy recovery efficiency from laser irradiation. To quench this recombination, we also employed silicon as reducing agents to capture oxygen in favor of Mg extraction. In these experiments, the molar ratio effect (MgO:Si = 1:0-1) on the magnesium fractions and energy efficiencies were measured by means of a chemical reaction. The maximal energy efficiency, %, was obtained at the ratio of MgO:Si = 1:0.5. This ratio is lower than that of the Pidgeon process with Mg:Si = 1:1 resulting in a lower energy efficiency of %. This implies laser-induced Mg production is a economical process of using reducing agents with large throughput. The usage of laser radiation generated from solar energy for Mg metallurgy will significantly reduce CO2 emission.

  17. Interdiffusion of magnesium and iron dopants in gallium nitride

    NASA Astrophysics Data System (ADS)

    Tsuchiya, Tomonobu; Kitatani, Takeshi; Terano, Akihisa; Mochizuki, Kazuhiro

    2015-03-01

    The interdiffusion of magnesium and iron in gallium nitride (GaN), i.e., magnesium-iron interdiffusion, was investigated using magnesium-doped GaN layers on iron-doped GaN substrates. The investigation confirms that the magnesium-iron interdiffusion strongly depends on the concentrations of magnesium and iron, that is, it occurs when the iron and magnesium concentrations are high (magnesium: 2 × 1020 cm-3 iron: 2 × 1019 cm-3). It also confirms that diffused iron in the magnesium-doped GaN layer acts as a nonradiative recombination center in GaN.

  18. The TMS Magnesium Committee: Committed to the Advancement of Global Magnesium Technology

    SciTech Connect

    Sillekens, Wim H.; Nyberg, Eric A.

    2011-04-21

    The TMS Magnesium Committee was established in the year 2000 as a spin-off of the Reactive Metals Committee, triggered by the strong global growth of magnesium being used in a variety of structural lightweight applications since the mid-1990’s. Since then the committee has seen a distinct development in terms of size, participation and focus. The article at hand outlines this development by recapitulating the output of its two main activities: the annual Magnesium Technology Symposia and the JOM Special Issues dedicated to magnesium research and development. Further records on the Magnesium Committee are available from the committee homepage (accessible through http://members.tms.org).

  19. Iatrogenic magnesium toxicity following intravenous infusion of magnesium sulfate: risks and strategies for prevention

    PubMed Central

    Cavell, Gillian F; Bryant, Catherine; Jheeta, Seetal

    2015-01-01

    A 65-year-old man being treated with radiotherapy and chemotherapy for recurrent colonic adenocarcinoma was admitted for management of hypokalaemia and hypomagnesaemia secondary to diarrhoea. He was treated with intravenous infusions of potassium chloride and magnesium sulfate. Following an infusion of magnesium sulfate, he experienced a sudden neurological deterioration. A CT of the head revealed no haemorrhage or evidence of acute ischaemic injury. Results of serum biochemistry later that day revealed an elevated magnesium level. Iatrogenic magnesium toxicity was suspected. Further discussions between the pharmacist and ward staff confirmed that a medication error had been made in the preparation of the infusion resulting in an overdose of intravenous magnesium. PMID:26231187

  20. Summary of "Magnesium Vision 2020: A North American Automotive Strategic Vision for Magnesium"

    NASA Astrophysics Data System (ADS)

    Cole, Gerald S.

    This paper summarizes the monograph, "Magnesium Vision 2020. A North American Automotive Strategic Vision for Magnesium"1 prepared under the auspices of the United States Automotive Materials Partnership The objective was to understand the infrastructural and technical challenge that can increase the use of magnesium in the automotive industry. One hundred sixty three (163) Research and Technology Development Themes (RTDTs), or RTD projects were developed that addressed issues of corrosion, fastening, and processing-other-than-high pressure die casting to produce automotive magnesium parts. A major problem identified in the study is the limited ability of the current magnesium industrial infrastructure to supply RTD and implementation-ready automotive magnesium components. One solution is to create a magnesium cyber center wrhere globally networked experts would be able to innovate in process and product development, model metalworking and non-HPDC foundry processes, and integrate theoretical predictions/models of metallurgical structure with component function.

  1. Magnesium: Is It a Viable Option?

    DTIC Science & Technology

    2012-08-01

    strike - High alkalinity • Magnesium strike – High alkalinity • Electroless Nickel - formulated to prevent attach of magnesium. Success Stories...ionic palladium, palladium reducer, electroless copper and electroless nickel. The initial results were encouraging: We were able to Get the parts

  2. An automated method for serum magnesium estimation

    PubMed Central

    Whitmore, D. N.; Evans, D. I. K.

    1964-01-01

    An automated method for magnesium determination in serum is described using conventional AutoAnalyser equipment. The method gives results comparable with those obtained by the flame photometer. The method may prove particularly useful with subnormal serum magnesium levels. PMID:14227433

  3. Nanostructured magnesium increases bone cell density

    NASA Astrophysics Data System (ADS)

    Weng, Lucy; Webster, Thomas J.

    2012-12-01

    Magnesium has attracted some attention in orthopedics due to its biodegradability and mechanical properties. Since magnesium is an essential natural mineral for bone growth, it can be expected that as a biomaterial, it would support bone formation. However, upon degradation in the body, magnesium releases OH- which results in an alkaline pH that can be detrimental to cell density (for example, osteoblasts or bone forming cells). For this reason, modification of magnesium may be necessary to compensate for such detrimental effects to cells. This study created biologically inspired nanoscale surface features on magnesium by soaking magnesium in various concentrations of NaOH (from 1 to 10 N) and for various periods of time (from 10 to 30 min). The results provided the first evidence of increased roughness, surface energy, and consequently greater osteoblast adhesion, after 4 h as well as density up to 7 days on magnesium treated with any concentration of NaOH for any length of time compared to untreated controls. For these reasons, this study suggests that soaking magnesium in NaOH could be an inexpensive, simple and effective manner to promote osteoblast functions for numerous orthopedic applications and, thus, should be further studied.

  4. Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy.

    PubMed

    Aali, Bibi Shahnaz; Khazaeli, Payam; Ghasemi, Fatemeh

    2007-04-01

    As ionized magnesium is the active form of magnesium and exerts a therapeutic effect, the present study was performed to determine the levels and correlations between ionized and total magnesium under baseline and therapeutic conditions in patients with severe preeclampsia and eclampsia receiving magnesium sulfate. Fifty singleton patients with severe preeclampsia received a loading dose of 4 g of magnesium sulfate, followed by 2 g per hour as maintenance dose until 24 h after delivery, or 24 h after the last seizure in case of postpartum convulsions. Serial blood samples were taken before magnesium sulfate infusion, 30 min and 240 min after the initiation of the infusion and 4 h after the discontinuation of the drug. Data were analyzed by repeated measure ANOVA and paired t-test. Baseline levels of total and ionized magnesium were 2.4+/-0.6 mEq/L and 1.3+/-0.5 mEq/L (mean+/-SD), respectively. Putative level of 4 mEq/L of total magnesium was not obtained in up to 42% of patients during the treatment. There was not any significant correlation between the two forms of magnesium under baseline and therapeutic conditions. Despite the effectiveness of the standard regimen of magnesium sulfate in the treatment and prevention of eclamptic seizures, it can not provide the proposed therapeutic level of magnesium in all patients. With respect to the lack of correlation between ionized and total magnesium, further studies are necessary to investigate the superiority of measurement of ionized, rather than total magnesium, for titration of therapeutic magnesium sulfate infusion.

  5. Magnesium in obstetric anesthesia and intensive care.

    PubMed

    Kutlesic, Marija S; Kutlesic, Ranko M; Mostic-Ilic, Tatjana

    2017-02-01

    Magnesium, one of the essential elements in the human body, has numerous favorable effects that offer a variety of possibilities for its use in obstetric anesthesia and intensive care. Administered as a single intravenous bolus dose or a bolus followed by continuous infusion during surgery, magnesium attenuates stress response to endotracheal intubation, and reduces intraoperative anesthetic and postoperative analgesic requirements, while at the same time preserving favorable hemodynamics. Applied as part of an intrathecal or epidural anesthetic mixture, magnesium prolongs the duration of anesthesia and diminishes total postoperative analgesic consumption with no adverse maternal or neonatal effects. In obstetric intensive care, magnesium represents a first-choice medication in the treatment and prevention of eclamptic seizures. If used in recommended doses with close monitoring, magnesium is a safe and effective medication.

  6. Lloyd M. Pidgeon — Magnesium Pioneer

    NASA Astrophysics Data System (ADS)

    Brown, Robert E.

    Lloyd Montgomery Pidgeon was an unusual man in an unusual time. His contributions to the development of the magnesium industry have never been appreciated (or even known) by many of today's magnesium followers. Dr. Pidgeon, working with one technical graduate, achieved commercial development of a process to produce magnesium by reducing calcined dolomite with ferrosilicon, i.e. the silicothermic process. He also received patents for electrolytic magnesium processes. He worked with engineers to design and build six magnesium production plants in a very short period of time. The original plant at Haley, Ontario is still operating. Dr. Pidgeon received many technical honors, but was always quick-witted, with a humorous approach to life.

  7. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects.

    PubMed

    Shechter, Michael; Saad, Tomer; Shechter, Alon; Koren-Morag, Nira; Silver, Burton B; Matetzky, Shlomi

    2012-03-01

    The magnesium content in food consumed in the Western world is steadily decreasing. Hypomagnesemia is associated with increased incidence of diabetes mellitus, metabolic syndrome, all-cause and coronary artery disease mortality. We investigated the impact of supplemental oral magnesium citrate versus magnesium oxide on intracellular magnesium levels ([Mg2+]i) and platelet function in healthy subjects with no apparent heart disease. In a randomized, prospective, double-blind, crossover study, 41 (20 women) healthy volunteers [mean age 53±8 (range 31-75) years] received either magnesium oxide monohydrate tablets (520 mg/day of elemental magnesium) or magnesium citrate tablets (295.8 mg/day of elemental magnesium) for one month (phase 1), followed by a four-week wash-out period, and then crossover treatment for one month (phase 2). [Mg2+]i was assessed from sublingual cells through x-ray dispersion (normal values 37.9±4.0 mEq/L), serum magnesium levels, platelet aggregation, and quality-of-life questionnaires were assessed before and after each phase. Oral magnesium oxide, rather than magnesium citrate, significantly increased [Mg2+]i (34.4±3 versus 36.3±2 mEq/L, p<0.001 and 34.7±2 versus 35.4±2 mEq/L, p=0.097; respectively), reduced total cholesterol (201±37 versus 186±27 mg/dL, p=0.016 and 187±28 versus 187±25 mg/dL, p=0.978; respectively) and low-density lipoprotein (LDL) cholesterol (128±22 versus 120±25 mg/dL, p=0.042 and 120±23 versus 121±22 mg/dL, p=0.622; respectively). Noteworthy is that both treatments significantly reduced epinephrine-induced platelet aggregation (78.9±16% versus 71.7±23%, p=0.013 and 81.3±15% versus 73.3±23%, p=0.036; respectively). Thus, oral magnesium oxide treatment significantly improved [Mg2+]i, total and LDL cholesterol compared with magnesium citrate, while both treatments similarly inhibited platelet aggregation in healthy subjects with no apparent heart disease.

  8. Interactions between magnesium and psychotropic drugs.

    PubMed

    Nechifor, Mihai

    2008-06-01

    Psychotropic drugs (antidepressants, antimanic drugs, antipsychotics, analgesic opioids, and others) are among the most frequently used medicines. Between these drugs and magnesium there are pharmacokinetic and pharmacodynamic interactions. Erythrocyte magnesium is decreased in patients with severe major depression (MD) vs normal subjects (44 +/- 2.7 mg/L in MD group vs 59.1 +/- 3.2 mg/L in control group, p < 0.01). Therapy with sertraline, 150 mg/day p.o. -21 days or with amitryptiline 3 x 25 mg/day p.o. 28 days increases significantly erythrocyte concentration of magnesium (56.9 +/- 5.22 mg/L after sertraline vs 44 +/- 2.7 mg/L before sertraline, p < 0.01). In patients with acute paranoid schizophrenia, erythrocyte magnesium concentration is decreased vs healthy subjects. Haloperidol, 8 mg/day, p.o. for 21 days or risperidone, 6 mg/day p.o. for 21 days have increased significantly erythrocyte magnesium concentration (46.21 +/- 3.1 mg/L before haloperidol and 54.6 +/- 2.7 mg/L after haloperidol, p < 0.05). Antimanic drugs (mood stabilizers) as carbamazepine, 600 mg/day, p.o., 4 weeks and sodium valproate, 900 mg/day p.o., 4 weeks, increased significantly magnesium in patients with bipolar disorder type I. Increased magnesium status positively correlated with enhancement of the clinical state. The existent data sustain the idea that an increase of erythrocyte magnesium is involved in the mechanism of action of some psychotropic drugs. Magnesium supply decreased the intensity of morphine-induced physical drug dependence. In heroin addicts, the plasma magnesium concentration is decreased.

  9. Tape casting of magnesium oxide.

    SciTech Connect

    Ayala, Alicia; Corral, Erica L.; Loehman, Ronald E.; Bencoe, Denise Nora; Reiterer, Markus; Shah, Raja A.

    2008-02-01

    A tape casting procedure for fabricating ceramic magnesium oxide tapes has been developed as a method to produce flat sheets of sintered MgO that are thin and porous. Thickness of single layer tapes is in the range of 200-400 {micro}m with corresponding surface roughness values in the range of 10-20 {micro}m as measured by laser profilometry. Development of the tape casting technique required optimization of pretreatment for the starting magnesium oxide (MgO) powder as well as a detailed study of the casting slurry preparation and subsequent heat treatments for sintering and final tape flattening. Milling time of the ceramic powder, plasticizer, and binder mixture was identified as a primary factor affecting surface morphology of the tapes. In general, longer milling times resulted in green tapes with a noticeably smoother surface. This work demonstrates that meticulous control of the entire tape casting operation is necessary to obtain high-quality MgO tapes.

  10. Identifying acid salts of magnesium

    SciTech Connect

    Plumb, R.; Thivierge, R.F. Jr.; Xu, W.W.

    1987-11-05

    In preliminary work they found that significant quantities of certain nitrogen oxides and of sulfuric acid were absorbed by lower hydrates of magnesium sulfate. It appeared that acid salts were being formed but the known chemistry of group IIA (group 2) sulfates and acid sulfates which was worked out many years ago did not provide an explanation of their observations. They developed a new technique for delineating the solidus boundary of ternary mixtures using friability tests and applied it to the systems of interest. Magnesium acid salt hydrates with compositions on the solidus boundary could be readily identified. X-ray powder patterns confirmed the existence of two previously unknown ternary compounds, Mg/sub 2/(HSO/sub 4/)/sub 2/SO/sub 4/ x 4H/sub 2/O and Mg(HSO/sub 4/)/sub 2/ x H/sub 2/SO/sub 4/ x 3H/sub 2/O. Mixed acid sulfate-nitrate-hydrates could be detected but fuming at room temperatures interfered with quantitative determinations of the solidus boundary and X-ray measurements.

  11. Analysis Methods of Magnesium Chips

    NASA Astrophysics Data System (ADS)

    Ohmann, Sven; Ditze, André; Scharf, Christiane

    2015-11-01

    The quality of recycled magnesium from chips depends strongly on their exposure to inorganic and organic impurities that are added during the production processes. Different kinds of magnesium chips from these processes were analyzed by several methods. In addition, the accuracy and effectiveness of the methods are discussed. The results show that the chips belong either to the AZ91, AZ31, AM50/60, or AJ62 alloy. Some kinds of chips show deviations from the above-mentioned normations. Different impurities result mainly from transition metals and lime. The water and oil content does not exceed 25%, and the chip size is not more than 4 mm in the diameter. The sieve analysis shows good results for oily and wet chips. The determination of oil and water shows better results for the application of a Soxhlet compared with the addition of lime and vacuum distillation. The most accurate values for the determination of water and oil are obtained by drying at 110°C (for water) and washing with acetone (for oil) by hand.

  12. Intracellular and extracellular blood magnesium fractions in hemodialysis patients; is the ionized fraction a measure of magnesium excess?

    PubMed

    Huijgen, H J; Sanders, R; van Olden, R W; Klous, M G; Gaffar, F R; Sanders, G T

    1998-03-01

    To establish the best measure for determining magnesium overload, we measured ionized and total magnesium in serum and mononuclear blood cells and total magnesium in erythrocytes in blood of 23 hemodialysis patients, known for their disturbed magnesium homeostasis. When comparing the mean magnesium values obtained in the patient population with those of a control population, all of these magnesium markers, including the biologically active fractions, were significantly (P < 0.05) increased. Because serum total magnesium was not increased in all dialysis patients studied, the population was divided into two groups, according to total serum magnesium > 1.0 mmol/L or less than that. Results in these two populations showed that ionized serum magnesium and ionized magnesium in mononuclear blood cells might give a better indication about the magnesium status of the tested patients than the currently used total serum magnesium data. However, neither of the two markers, especially ionized serum magnesium, was able to discriminate fully between normal magnesium homeostasis and magnesium excess. We therefore conclude that the two ionized magnesium markers offer minimal advantage for this discrimination, and that the total magnesium concentration in serum remains the measurement of choice.

  13. Magnesium status and the effect of magnesium supplementation in feline hypertrophic cardiomyopathy.

    PubMed Central

    Freeman, L M; Brown, D J; Smith, F W; Rush, J E

    1997-01-01

    Magnesium deficiency has been associated with the development of cardiovascular disease in several species. Cats may be predisposed to alterations in magnesium status because of recent changes in the composition of commercial feline diets. The purposes of this study were 1) to examine the dietary history of cats with hypertrophic cardiomyopathy (HCM), 2) to study magnesium status of cats with HCM compared to normal cats, and 3) to determine the effects of magnesium supplementation in cats with HCM. In part 1 of the study, diets of 65 cats with HCM were examined retrospectively. Forty of the 45 cats for which diets could be determined (89%) ate a diet designed to be magnesium-restricted and/or to produce an acidic urine. In part 2 of the study, 10 cats with HCM were compared to 10 healthy control cats for serum creatinine and magnesium; urine creatinine and magnesium, urine specific gravity and pH, and fractional excretion of magnesium. Urine creatinine and specific gravity were higher in control cats than in cats with HCM. No other differences were found between the 2 groups. In part 3, cats with HCM were supplemented with either 210 mg magnesium chloride (n = 15) or 210 mg lactose (n = 15) for 12 wk. No differences between the 2 groups were found for changes in either magnesium status or echocardiographic parameters. However, the 30 cats with HCM, as a group, did show significant improvements in measures of cardiac hypertrophy over the 12-week period. This was likely the result of treatment with other medications, rather than the magnesium supplementation. The results of this study suggest that cats with HCM are likely to be fed magnesium-restricted diets, but that they do not appear to have altered magnesium status compared to healthy controls. PMID:9243004

  14. [Diagnosis of magnesium deficiency in intensive care patients].

    PubMed

    Saur, P M; Zielmann, S; Roth, A T; Frank, L; Warneke, G; Radke, A; Ensink, F B; Kettler, D

    1996-02-01

    Magnesium deficiency was investigated in critically ill patients, comparing measurements of plasma concentrations with the results obtained by the magnesium tolerance test. 20 critically ill patients (5 females, 15 males) between the ages of 27 and 86 were investigated. Magnesium plasma concentrations were determined before the magnesium tolerance test according to Ryzen was performed. For this purpose, magnesium sulfate (0.1 mmol/kg) was infused intravenously over four hours. Renal magnesium excretion was measured in the 24 h urine beginning at the start of the infusion. Magnesium concentrations in plasma and urine were determined using atomic absorption spectrophotometry. In 12 patients magnesium plasma concentrations were decreased to 0.58-0.79 mmol/l. 6 patients showed values within the normal range of 0.80 to 1.0 mmol/l. In 2 patients the plasma concentration was increased to 1.07 and 1.27 mmol/l. Parenteral magnesium tolerance testing revealed a considerable magnesium deficiency by retention of 65-100% of the loading dose in 14 of the 20 patients. The remaining 6 patients retained 23-48% of the loading dose, thus demonstrating a moderate magnesium deficiency. Determination of magnesium plasma concentration appears suitable as an informative preliminary survey, since low values are reliable indicating a magnesium deficiency. However, this study confirms that normal magnesium plasma concentrations do not exclude a considerable magnesium deficiency, which is more sensitively determined by the magnesium tolerance test.

  15. The unexpected discovery of the Mg(HMDS) 2 /MgCl 2 complex as a magnesium electrolyte for rechargeable magnesium batteries

    DOE PAGES

    Liao, Chen; Sa, Niya; Key, Baris; ...

    2015-02-02

    We developed a unique class of non-Grignard, aluminum-free magnesium electrolytes based on a simple mixture of magnesium compounds: magnesium hexamethyldisilazide (Mg(HMDS)2) and magnesium chloride (MgCl2).

  16. Monitoring Biodegradation of Magnesium Implants with Sensors

    NASA Astrophysics Data System (ADS)

    Zhao, Daoli; Wang, Tingting; Guo, Xuefei; Kuhlmann, Julia; Doepke, Amos; Dong, Zhongyun; Shanov, Vesselin N.; Heineman, William R.

    2016-04-01

    Magnesium and its alloys exhibit properties such as high strength, light weight, and in vivo corrosion that make them promising candidates for the development of biodegradable metallic implant materials for bone repair, stents and other medical applications. Sensors have been used to monitor the corrosion of magnesium and its alloys by measuring the concentrations of the following corrosion products: magnesium ions, hydroxyl ions and hydrogen gas. The corrosion characterization system with home-made capillary pH and Mg2+ microsensors has been developed for real-time detection of magnesium corrosion in vitro. A hydrogen gas sensor was used to monitor the corrosion of magnesium by measuring the concentration of the hydrogen gas reaction product in vivo. The high permeability of hydrogen through skin allows transdermal monitoring of the biodegradation of a magnesium alloy implanted beneath the skin by detecting hydrogen gas at the skin surface. The sensor was used to map hydrogen concentration in the vicinity of an implanted magnesium alloy.

  17. Magnesium based degradable biomaterials: A review

    NASA Astrophysics Data System (ADS)

    Gu, Xue-Nan; Li, Shuang-Shuang; Li, Xiao-Ming; Fan, Yu-Bo

    2014-09-01

    Magnesium has been suggested as a revolutionary biodegradable metal for biomedical applications. The corrosion of magnesium, however, is too rapid to match the rates of tissue healing and, additionally, exhibits the localized corrosion mechanism. Thus it is necessary to control the corrosion behaviors of magnesium for their practical use. This paper comprehensively reviews the research progress on the development of representative magnesium based alloys, including Mg-Ca, Mg-Sr, Mg-Zn and Mg-REE alloy systems as well as the bulk metallic glass. The influence of alloying element on their microstructures, mechanical properties and corrosion behaviors is summarized. The mechanical and corrosion properties of wrought magnesium alloys are also discussed in comparison with those of cast alloys. Furthermore, this review also covers research carried out in the field of the degradable coatings on magnesium alloys for biomedical applications. Calcium phosphate and biodegradable polymer coatings are discussed based on different preparation techniques used. We also compare the effect of different coatings on the corrosion behaviors of magnesium alloys substrate.

  18. Magnesium in cardioplegia: Is it necessary?

    PubMed Central

    Shakerinia, Tooraj; Ali, Idris M.; Sullivan, John A.P.

    1996-01-01

    Objective To study the effectiveness of magnesium in cardioplegic solution in preventing postoperative arrhythmias and perioperative ischemia. Design Randomized, control study. Setting The cardiovascular surgery division of a major referral centre for the maritime provinces of Canada. Patients Fifty patients scheduled to undergo coronary artery bypass who had a normal ejection fraction, normal preoperative serum magnesium level and no history of atrial or ventricular arrhythmia were randomized into two groups of 25 patients. One group received magnesium sulfate (15 mmol/L) in the cardioplegic solution (group 1), the other (control) group did not receive magnesium sulfate in the cardioplegic solution (group 2). Intervention Coronary artery bypass grafting during which myocardial protection was provided by intermittent cold blood cardioplegia. Outcome Measures Postoperative serum magnesium levels, cardiac-related death, infarction and arrhythmias. Results All group 2 patients had a lower postoperative serum magnesium level than group 1 patients. There were no cardiac-related deaths in either group. More group 2 patients had ischemic electrocardiographic changes than group 1 patients (p < 0.03). Non-Q-wave myocardial infarction occurred in two patients (one in each group). Eight patients in group 2 had atrial fibrillation compared with five patients in group 1. Ventricular ectopia occurred significantly (p < 0.01) more frequently in group 2 than in group 1. Conclusion The addition of magnesium to the cardioplegic solution is beneficial in reducing the incidence of perioperative ischemia and ventricular arrhythmia in patients who undergo coronary bypass grafting. PMID:8857989

  19. Room temperature magnesium electrorefining by using non-aqueous electrolyte

    NASA Astrophysics Data System (ADS)

    Park, Jesik; Jung, Yeojin; Kusumah, Priyandi; Dilasari, Bonita; Ku, Heesuk; Kim, Hansu; Kwon, Kyungjung; Lee, Churl Kyoung

    2016-09-01

    The increasing usage of magnesium inevitably leads to a fast increase in magnesium scrap, and magnesium recycling appears extremely beneficial for cost reduction, preservation of natural resources and protection of the environment. Magnesium refining for the recovery of high purity magnesium from metal scrap alloy (AZ31B composed of magnesium, aluminum, zinc, manganese and copper) at room temperature is investigated with a non-aqueous electrolyte (tetrahydrofuran with ethyl magnesium bromide). A high purity (99.999%) of electrorefined magneisum with a smooth and dense surface is obtained after potentiostatic electrolysis with an applied voltage of 2 V. The selective dissolution of magnesium from magnesium alloy is possible by applying an adequate potential considering the tolerable impurity level in electrorefined magnesium and processing time. The purity estimation method suggested in this study can be useful in evaluating the maximum content of impurity elements.

  20. Magnesium in North America: A Changing Landscape

    NASA Astrophysics Data System (ADS)

    Slade, Susan

    The changing landscape of North American manufacturing in the context of global competition is impacting the market of all raw materials, including magnesium. Current automotive fuel economy legislation and pending legislation on the emissions of greenhouse gases are impacting magnesium's largest consuming industries, such as aluminum, automotive components, steel and transition metals. These industries are all considering innovative ways to efficiently incorporate the needed raw materials into their processes. The North American magnesium market differs from other regions based on maturity, supply streams, changing manufacturing capabilities and trade cases, combined with the transformation of North American manufacturing.

  1. Magnesium doping of boron nitride nanotubes

    DOEpatents

    Legg, Robert; Jordan, Kevin

    2015-06-16

    A method to fabricate boron nitride nanotubes incorporating magnesium diboride in their structure. In a first embodiment, magnesium wire is introduced into a reaction feed bundle during a BNNT fabrication process. In a second embodiment, magnesium in powder form is mixed into a nitrogen gas flow during the BNNT fabrication process. MgB.sub.2 yarn may be used for superconducting applications and, in that capacity, has considerably less susceptibility to stress and has considerably better thermal conductivity than these conventional materials when compared to both conventional low and high temperature superconducting materials.

  2. Boron Clusters as Highly Stable Magnesium-Battery Electrolytes**

    PubMed Central

    Carter, Tyler J; Mohtadi, Rana; Arthur, Timothy S; Mizuno, Fuminori; Zhang, Ruigang; Shirai, Soichi; Kampf, Jeff W

    2014-01-01

    Boron clusters are proposed as a new concept for the design of magnesium-battery electrolytes that are magnesium-battery-compatible, highly stable, and noncorrosive. A novel carborane-based electrolyte incorporating an unprecedented magnesium-centered complex anion is reported and shown to perform well as a magnesium-battery electrolyte. This finding opens a new approach towards the design of electrolytes whose likelihood of meeting the challenging design targets for magnesium-battery electrolytes is very high. PMID:24519845

  3. [Magnesium and the oxidative stress].

    PubMed

    Spasov, A A; Zheltova, A A; Kharitonov, M V

    2012-07-01

    Magnesium deficiency has been shown to result in alterations of cellular functions and biological activity of molecules. The review discusses possible relationship between Mg2+ deficiency and development of oxidative stress. Decrease of Mg2+ concentration in tissues and blood is accompanied with elevation of the oxidative stress markers, including products of the oxidative modification of lipids, proteins and DNA. The reduction in antioxidant defenses is synchronous with oxidative stress markers elevation. Different mechanisms including systemic reactions (hyperactivation of inflammation and endothelial dysfunction) and cellular changes (mitochondrial dysfunction and excessive production of fatty acids) are supposed to be involved in development and maintenance of the oxidative stress due to Mg2+ deficiency. Therefore the facts consolidated into the review evidence clear relation between Mg2+ deficiency and the oxidative stress development.

  4. Magnesium stearine production via direct reaction of palm stearine and magnesium hydroxide

    NASA Astrophysics Data System (ADS)

    Pratiwi, M.; Ylitervo, P.; Pettersson, A.; Prakoso, T.; Soerawidjaja, T. H.

    2017-06-01

    The fossil oil production could not compensate with the increase of its consumption, because of this reason the renewable alternative energy source is needed to meet this requirement of this fuel. One of the methods to produce hydrocarbon is by decarboxylation of fatty acids. Vegetable oil and fats are the greatest source of fatty acids, so these can be used as raw material for biohydrocarbon production. From other researchers on their past researchs, by heating base soap from divalent metal, those metal salts will decarboxylate and produce hydrocarbon. This study investigate the process and characterization of magnesium soaps from palm stearine by Blachford method. The metal soaps are synthesized by direct reaction of palm stearine and magnesium hydroxide to produce magnesium stearine and magnesium stearine base soaps at 140-180°C and 6-10 bar for 3-6 hours. The operation process which succeed to gain metal soaps is 180°C, 10 bar, for 3-6 hours. These metal soaps are then compared with commercial magnesium stearate. Based on Thermogravimetry Analysis (TGA) results, the decomposition temperature of all the metal soaps were 250°C. Scanning Electron Microscope with Energy Dispersive X-ray (SEM-EDX) analysis have shown the traces of sodium sulphate for magnesium stearate commercial and magnesium hydroxide for both type of magnesium stearine soaps. The analysis results from Microwave Plasma-Atomic Emission Spectrometry (MP-AES) have shown that the magnesium content of magnesium stearine approximate with magnesium stearate commercial and lower compare with magnesium stearine base soaps. These experiments suggest that the presented saponification process method could produced metal soaps comparable with the commercial metal soaps.

  5. Development and validation of simple titrimetric method for the determination of magnesium content in esomeprazole magnesium.

    PubMed

    Haddadin, R N; Issa, A Y

    2011-07-01

    A simple and inexpensive titrimetric method for the determination of magnesium ion in esomeprazole magnesium raw material was developed and validated according to International Conference on Harmonization guidelines and the United States Pharmacopoeia. The method depends on complex formation between EDTA and magnesium ion. The method was proven to be valid, equivalent and useful as an alternative method to the current pharmacopeial methods that are based on atomic absorption spectrometry.

  6. Development and Validation of Simple Titrimetric Method for the Determination of Magnesium Content in Esomeprazole Magnesium

    PubMed Central

    Haddadin, R. N.; Issa, A. Y.

    2011-01-01

    A simple and inexpensive titrimetric method for the determination of magnesium ion in esomeprazole magnesium raw material was developed and validated according to International Conference on Harmonization guidelines and the United States Pharmacopoeia. The method depends on complex formation between EDTA and magnesium ion. The method was proven to be valid, equivalent and useful as an alternative method to the current pharmacopeial methods that are based on atomic absorption spectrometry. PMID:22707837

  7. Magnesium Recycling of Partially Oxidized, Mixed Magnesium-Aluminum Scrap through Combined Refining and Solid Oxide Membrane Electrolysis Processes

    SciTech Connect

    Xiaofei Guan; Peter A. Zink; Uday B. Pal; Adam C. Powell

    2012-01-01

    Pure magnesium (Mg) is recycled from 19g of partially oxidized 50.5wt.% Mg-Aluminum (Al) alloy. During the refining process, potentiodynamic scans (PDS) were performed to determine the electrorefining potential for magnesium. The PDS show that the electrorefining potential increases over time as the magnesium content inside the Mg-Al scrap decreases. Up to 100% percent of magnesium is refined from the Mg-Al scrap by a novel refining process of dissolving magnesium and its oxide into a flux followed by vapor phase removal of dissolved magnesium and subsequently condensing the magnesium vapor. The solid oxide membrane (SOM) electrolysis process is employed in the refining system to enable additional recycling of magnesium from magnesium oxide (MgO) in the partially oxidized Mg-Al scrap. The combination of the refining and SOM processes yields 7.4g of pure magnesium.

  8. Magnesium Recycling of Partially Oxidized, Mixed Magnesium-Aluminum Scrap through Combined Refining and Solid Oxide Membrane (SOM) Electrolysis Processes

    NASA Astrophysics Data System (ADS)

    Guan, Xiaofei; Zink, Peter; Pal, Uday

    Pure magnesium (Mg) is recycled from 19g of partially oxidized 50.5 wt.%Mg-Aluminum (Al) alloy. During the refining process, potentiodynamic scans (PDS) were performed to determine the electrorefining potential for magnesium. The PDS show that the electrorefining potential increases over time as the Mg content inside the Mg-Al scrap decreases. Up to 100% percent of magnesium is refined from the Mg-Al scrap by a novel refining process of dissolving magnesium and its oxide into a flux followed by vapor phase removal of dissolved magnesium and subsequently condensing the magnesium vapors in a separate condenser. The solid oxide membrane (SOM) electrolysis process is employed in the refining system to enable additional recycling of magnesium from magnesium oxide (MgO) in the partially oxidized Mg-Al scrap. The combination of the refining and SOM processes yields 7.4g of pure magnesium; could not collect and weigh all of the magnesium recovered.

  9. Magnesium Recycling of Partially Oxidized, Mixed Magnesium-Aluminum Scrap Through Combined Refining and Solid Oxide Membrane (SOM) Electrolysis Processes

    SciTech Connect

    Guan, Xiaofei; Zink, Peter; Pal, Uday

    2012-03-11

    Pure magnesium (Mg) is recycled from 19g of partially oxidized 50.5wt.%Mg-Aluminum (Al) alloy. During the refining process, potentiodynamic scans (PDS) were performed to determine the electrorefining potential for magnesium. The PDS show that the electrorefining potential increases over time as the Mg content inside the Mg-Al scrap decreases. Up to 100% percent of magnesium is refined from the Mg-Al scrap by a novel refining process of dissolving magnesium and its oxide into a flux followed by vapor phase removal of dissolved magnesium and subsequently condensing the magnesium vapors in a separate condenser. The solid oxide membrane (SOM) electrolysis process is employed in the refining system to enable additional recycling of magnesium from magnesium oxide (MgO) in the partially oxidized Mg-Al scrap. The combination of the refining and SOM processes yields 7.4g of pure magnesium; could not collect and weigh all of the magnesium recovered.

  10. Magnesium levels in critically ill patients. What should we measure?

    PubMed

    Huijgen, H J; Soesan, M; Sanders, R; Mairuhu, W M; Kesecioglu, J; Sanders, G T

    2000-11-01

    We studied the relation between ionized magnesium, total magnesium, and albumin levels in serum of 115 critically ill patients and the role of extracellular and intracellular magnesium in outcome prediction. Levels of serum total and ionized magnesium, serum albumin, and magnesium in mononuclear blood cells and erythrocytes were measured and the APACHE II score and 1-month mortality recorded. Of all patients, 51.3% had a serum total magnesium concentration below the reference range. In 71% of these hypomagnesemic patients, a normal serum ionized magnesium concentration was measured. None of the patients had an intracellular magnesium concentration below the reference limit. Except for serum total and ionized magnesium, none of the magnesium parameters correlated significantly with each other. A significantly negative correlation was found between serum albumin and the fraction ionized magnesium. There was no association between low extracellular or intracellular magnesium and clinical outcome. The observation of hypomagnesemia in critically ill patients depends on which magnesium fraction is measured. The lack of correlation with clinical outcome suggests hypomagnesemia to be merely an epiphenomenon. Reliable concentrations of serum ionized magnesium can be obtained only by direct measurement and not by calculation from serum total magnesium and albumin.

  11. Nuclear reactor shield including magnesium oxide

    DOEpatents

    Rouse, Carl A.; Simnad, Massoud T.

    1981-01-01

    An improvement in nuclear reactor shielding of a type used in reactor applications involving significant amounts of fast neutron flux, the reactor shielding including means providing structural support, neutron moderator material, neutron absorber material and other components as described below, wherein at least a portion of the neutron moderator material is magnesium in the form of magnesium oxide either alone or in combination with other moderator materials such as graphite and iron.

  12. Cold Spray Aluminum for Magnesium Gearbox Repair

    DTIC Science & Technology

    2008-02-01

    Cold Spray Aluminum for Magnesium Gearbox Repair Phillip F Leyman . US Army Research Laboratory Weapons & Materials Research Directorate...AND SUBTITLE Cold Spray Aluminum for Magnesium Gearbox Repair 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d...tirogram ec ves • Develop the densest, thinnest, most corrosion resistant Aluminum -based Cold Spray coating ith th t t dh i b d t th tw e grea es

  13. Magnesium-titanium alloys for biomedical applications

    NASA Astrophysics Data System (ADS)

    Hoffmann, Ilona

    Magnesium has been identified as a promising biodegradable implant material because it does not cause systemic toxicity and can reduce stress shielding. However, it corrodes too quickly in the body. Titanium, which is already used ubiquitously for implants, was chosen as the alloying element because of its proven biocompatibility and corrosion resistance in physiological environments. Thus, alloying magnesium with titanium is expected to improve the corrosion resistance of magnesium. Mg-Ti alloys with a titanium content ranging from 5 to 35 at.-% were successfully synthesized by mechanical alloying. Spark plasma sintering was identified as a processing route to consolidate the alloy powders made by ball-milling into bulk material without destroying the alloy structure. This is an important finding as this metastable Mg-Ti alloy can only be heated up to max. 200C° for a limited time without reaching the stable state of separated magnesium and titanium. The superior corrosion behavior of Mg 80-Ti20 alloy in a simulated physiological environment was shown through hydrogen evolution tests, where the corrosion rate was drastically reduced compared to pure magnesium and electrochemical measurements revealed an increased potential and resistance compared to pure magnesium. Cytotoxicity tests on murine pre-osteoblastic cells in vitro confirmed that supernatants made from Mg-Ti alloy were no more cytotoxic than supernatants prepared with pure magnesium. Mg and Mg-Ti alloys can also be used to make novel polymer-metal composites, e.g., with poly(lactic-co-glycolic acid) (PLGA) to avoid the polymer's detrimental pH drop during degradation and alter its degradation pattern. Thus, Mg-Ti alloys can be fabricated and consolidated while achieving improved corrosion resistance and maintaining cytocompatibility. This work opens up the possibility of using Mg-Ti alloys for fracture fixation implants and other biomedical applications. KEYWORDS: Magnesium, titanium, corrosion

  14. Oxalate metabolism in magnesium-deficient rats.

    PubMed

    Rattan, V; Thind, S K; Jethi, R K; Sidhu, H; Nath, R

    1993-06-01

    Male weanling rats were maintained on magnesium-deficient diet for 30 d and compared with pair-fed control rats fed magnesium-supplemented diet. Magnesium deficiency led to slow growth and finally to a significant decrease in body weight (P < 0.001) accompanied by a significant hypomagnesaemia, hypomagnesuria and hyperoxaluria (P < 0.001 in each case) in experimental rats as compared to the control rats. Magnesium deficiency altered the glyoxylate metabolism in the liver and kidney mitochondria by significantly decreasing glyoxylate oxidation (by 26 per cent in liver and 17 per cent in kidney) and activity of alpha-ketoglutarate:glyoxylate carboligase enzyme (by 35 per cent in liver and 27 per cent in kidney) in the experimental animals. A significant increase in the specific activities of glycolic acid oxidase (P < 0.001) and glycolic acid dehydrogenase (P < 0.01) and a significant decrease in alanine transaminase (P < 0.01) was also observed in magnesium-deficient rats. No change in liver and kidney lactate dehydrogenase was observed. Thus magnesium deficiency in rats leads to accumulation of glyoxylate in the tissues, a part of which is converted into oxalate, thereby promoting hyperoxaluria.

  15. Immunological Response to Biodegradable Magnesium Implants

    NASA Astrophysics Data System (ADS)

    Pichler, Karin; Fischerauer, Stefan; Ferlic, Peter; Martinelli, Elisabeth; Brezinsek, Hans-Peter; Uggowitzer, Peter J.; Löffler, Jörg F.; Weinberg, Annelie-Martina

    2014-04-01

    The use of biodegradable magnesium implants in pediatric trauma surgery would render surgical interventions for implant removal after tissue healing unnecessary, thereby preventing stress to the children and reducing therapy costs. In this study, we report on the immunological response to biodegradable magnesium implants—as an important aspect in evaluating biocompatibility—tested in a growing rat model. The focus of this study was to investigate the response of the innate immune system to either fast or slow degrading magnesium pins, which were implanted into the femoral bones of 5-week-old rats. The main alloying element of the fast-degrading alloy (ZX50) was Zn, while it was Y in the slow-degrading implant (WZ21). Our results demonstrate that degrading magnesium implants beneficially influence the immune system, especially in the first postoperative weeks but also during tissue healing and early bone remodeling. However, rodents with WZ21 pins showed a slightly decreased phagocytic ability during bone remodeling when the degradation rate reached its maximum. This may be due to the high release rate of the rare earth-element yttrium, which is potentially toxic. From our results we conclude that magnesium implants have a beneficial effect on the innate immune system but that there are some concerns regarding the use of yttrium-alloyed magnesium implants, especially in pediatric patients.

  16. Magnesium-phosphate-glass cements with ceramic-type properties

    DOEpatents

    Sugama, T.; Kukacka, L.E.

    1982-09-23

    Rapid setting magnesium phosphate (Mg glass) cementitious materials consisting of magnesium phosphate cement paste, polyborax and water-saturated aggregate, exhibits rapid setting and high early strength characteristics. The magnesium glass cement is prepared from a cation-leachable powder and a bivalent metallic ion-accepting liquid such as an aqueous solution of diammonium phosphate and ammonium polyphosphate. The cation-leachable powder includes a mixture of two different magnesium oxide powders processed and sized differently which when mixed with the bivalent metallic ion-accepting liquid provides the magnesium glass cement consisting primarily of magnesium ortho phosphate tetrahydrate, with magnesium hydroxide and magnesium ammonium phosphate hexahydrate also present. The polyborax serves as a set-retarder. The resulting magnesium mono- and polyphosphate cements are particularly suitable for use as a cementing matrix in rapid repair systems for deteriorated concrete structures as well as construction materials and surface coatings for fireproof structures.

  17. Magnesium phosphate glass cements with ceramic-type properties

    SciTech Connect

    Sugama, T.; Kukacka, L.E.

    1984-03-13

    Rapid setting magnesium phosphate (Mg glass) cementitious materials consisting of magnesium phosphate cement paste, polyborax and water-saturated aggregate exhibiting rapid setting and high early strength characteristics. The magnesium glass cement is prepared from a cation-leachable powder and a bivalent metallic ion-accepting liquid such as an aqueous solution of diammonium phosphate and ammonium polyphosphate. The cation-leachable powder includes a mixture of two different magnesium oxide powders processed and sized differently which when mixed with the bivalent metallic ion-accepting liquid provides the magnesium glass cement consisting primarily of magnesium ortho phosphate tetrahydrate, with magnesium hydroxide and magnesium ammonium phosphate hexahydrate also present. The polyborax serves as a set-retarder. The resulting magnesium mono-and polyphosphate cements are particularly suitable for use as a cementing matrix in rapid repair systems for deteriorated concrete structures as well as construction materials and surface coatings for fireproof structures.

  18. Magnesium phosphate glass cements with ceramic-type properties

    DOEpatents

    Sugama, Toshifumi; Kukacka, Lawrence E.

    1984-03-13

    Rapid setting magnesium phosphate (Mg glass) cementitious materials consisting of magnesium phosphate cement paste, polyborax and water-saturated aggregate exhibiting rapid setting and high early strength characteristics. The magnesium glass cement is prepared from a cation-leachable powder and a bivalent metallic ion-accepting liquid such as an aqueous solution of diammonium phosphate and ammonium polyphosphate. The cation-leachable powder includes a mixture of two different magnesium oxide powders processed and sized differently which when mixed with the bivalent metallic ion-accepting liquid provides the magnesium glass cement consisting primarily of magnesium ortho phosphate tetrahydrate, with magnesium hydroxide and magnesium ammonium phosphate hexahydrate also present. The polyborax serves as a set-retarder. The resulting magnesium mono- and polyphosphate cements are particularly suitable for use as a cementing matrix in rapid repair systems for deteriorated concrete structures as well as construction materials and surface coatings for fireproof structures.

  19. Gestational magnesium deficiency is deleterious to fetal outcome.

    PubMed

    Almonte, R A; Heath, D L; Whitehall, J; Russell, M J; Patole, S; Vink, R

    1999-07-01

    A number of recent epidemiological findings have implicated magnesium as being essential to fetal well-being. Few studies, however, have examined the relationship between maternal requirements for dietary magnesium and subsequent mortality and morbidity in offspring. The present study uses a rodent model of dietary-induced hypomagnesemia to investigate the effects of magnesium deficiency prior to and during gestation on neonatal morbidity and mortality. Magnesium deficiency during gestation significantly increased neonatal mortality and morbidity. Such increases were associated with a reduced free magnesium concentration in both maternal and offspring blood and an increased incidence of periventricular hemorrhage and edema in newborn pups as observed by magnetic resonance imaging and histology. Animals fed a magnesium-deficient diet before mating but given magnesium supplementation during gestation did not demonstrate a significant change in neonatal mortality and morbidity when compared to control animals. The significant improvement in fetal outcome with dietary magnesium supports the concept of magnesium supplementation during pregnancy.

  20. Research of magnesium phosphosilicate cement

    NASA Astrophysics Data System (ADS)

    Ding, Zhu

    Magnesium phosphosilicate cement (MPSC) is a novel phosphate bonded cement, which consists mainly of magnesia, phosphate and silicate minerals. The traditional magnesium phosphate cements (MPCs) usually composed by ammonium phosphate, and gaseous ammonia will emit during mixing and in service. There is no noxious ammonia released from MPSC, furthermore, it can recycle a large volume of the non-hazardous waste. The goal of this research is to investigate the composition, reaction products, reaction mechanism, microstructure, properties, durability and applications of the MPSC. MPSC sets rapidly and has high early strength. It reacts better with solid industrial waste when compared to Portland cement. Many solid industrial wastes, such as fly ash, steel slag, coal gangue, red coal gangue, red mud, barium-bearing slag, copper slag, silica fume, and ground granulated blast furnace slag, have been used as the main component (40% by weight) in MPSC. The research has found that these aluminosilicate (or ironsilicate, or calciumsilicate) minerals with an amorphous or glass structure can enhance the performance of MPSC. The disorganized internal structure of amorphous materials may make it possess higher reactivity compared to the crystalline phases. Chemical reaction between phosphate and these minerals may form an amorphous gel, which is favorable to the cementing. Borax, boric acid and sodium tripolyphosphate have been used as retardants in the MPSC system. It is found that boric acid has a higher retarding effect on the setting of cement, than borax does. However, sodium polyphosphate accelerates the reaction of MPSC. The hydration of MPSC is exothermic reaction. The heat evolution may prompt hydrates formation, and shorten the setting process. Modern materials characterization techniques, XRD, DSC, TG-DTA FTIR, XPS, MAS-NMR, SEM, TEM, MIP, etc. were used to analyze the phase composition, micro morphology, and microstructure of hardened MPSC. The main hydration product

  1. Fast kinetics of magnesium monochloride cations in interlayer-expanded titanium disulfide for magnesium rechargeable batteries

    DOE PAGES

    Yoo, Hyun Deog; Liang, Yanliang; Dong, Hui; ...

    2017-08-24

    Magnesium rechargeable batteries potentially offer high-energy density, safety, and low cost due to the ability to employ divalent, dendrite-free, and earth-abundant magnesium metal anode. Despite recent progress, further development remains stagnated mainly due to the sluggish scission of magnesium-chloride bond and slow diffusion of divalent magnesium cations in cathodes. Here in this paper we report a battery chemistry that utilizes magnesium monochloride cations in expanded titanium disulfide. Combined theoretical modeling, spectroscopic analysis, and electrochemical study reveal fast diffusion kinetics of magnesium monochloride cations without scission of magnesium-chloride bond. The battery demonstrates the reversible intercalation of 1 and 1.7 magnesium monochloridemore » cations per titanium at 25 and 60 °C, respectively, corresponding to up to 400 mAh g-1 capacity based on the mass of titanium disulfide. The large capacity accompanies with excellent rate and cycling performances even at room temperature, opening up possibilities for a variety of effective intercalation hosts for multivalent-ion batteries.« less

  2. Isotopically pure magnesium isotope-24 is prepared from magnesium-24 oxide

    NASA Technical Reports Server (NTRS)

    Chellew, N. R.; Schilb, J. D.; Steunenberg, R. K.

    1968-01-01

    Apparatus is used to prepare isotopically pure magnesium isotope-24, suitable for use in neutron scattering and polarization experiments. The apparatus permits thermal reduction of magnesium-24 oxide with aluminum and calcium oxide, and subsequent vaporization of the product metal in vacuum. It uses a resistance-heated furnace tube and cap assembly.

  3. The efficacy of nebulized salbutamol, magnesium sulfate, and salbutamol/magnesium sulfate combination in moderate bronchiolitis.

    PubMed

    Kose, Mehmet; Ozturk, Mehmet Adnan; Poyrazoğlu, Hakan; Elmas, Tuba; Ekinci, Duygu; Tubas, Filiz; Kurt, Tuba; Goktas, Mehmet Akif

    2014-09-01

    The aim of this paper is to compare the effect of nebulized magnesium sulfate to nebulized salbutamol and salbutamol/magnesium sulfate on successful discharge from the emergency department. A total of 56 infants were included in this double-blinded, prospective study. Infants were grouped according to the nebulized treatment they received: group 1-salbutamol/normal saline, group 2-magnesium sulfate and normal saline, and group 3-salbutamol plus magnesium sulfate. Heart beat, bronchiolitis, clinical severity scores (CSS), and oxygen saturation of the patients were determined before and after nebulization (0, 1, 4 h). The patients were monitored for adverse reactions. Post-treatment mean CSS results were significantly lower than pre-treatment scores in all groups at 4 h with no significant difference within groups. CSS scores were lower in the salbutamol/magnesium sulfate group when compared with the magnesium sulfate and salbutamol groups (3.4 (2.4-4.3), 4.7 (3.8-5.7), 4.0 (3.2-4.3)). CSS were significantly lower than those from the magnesium sulfate group. Nebulized magnesium sulfate plus salbutamol may have additive effects for improving the short-term CSS.

  4. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies... treatment works from the manufacturing of magnesium anode batteries. ...

  5. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies... treatment works from the manufacturing of magnesium anode batteries. ...

  6. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies... treatment works from the manufacturing of magnesium anode batteries. ...

  7. The IMA Study on the Life Cycle Assessment (LCA) of Magnesium

    NASA Astrophysics Data System (ADS)

    Friedrich, Horst E.; Ehrenberger, Simone

    Magnesium shows considerable potentials as lightweight material for weight sensitive applications. To assess the potential environmental benefits of magnesium in transport applications, the International Magnesium Association (IMA) initiated a study on the life cycle assessment (LCA) of magnesium.

  8. Production of Magnesium by Vacuum Aluminothermic Reduction with Magnesium Aluminate Spinel as a By-Product

    NASA Astrophysics Data System (ADS)

    Wang, Yaowu; You, Jing; Peng, Jianping; Di, Yuezhong

    2016-06-01

    The Pidgeon process currently accounts for 85% of the world's magnesium production. Although the Pidgeon process has been greatly improved over the past 10 years, such production still consumes much energy and material and creates much pollution. The present study investigates the process of producing magnesium by employing vacuum aluminothermic reduction and by using magnesite as material and obtaining magnesium aluminate spinel as a by-product. The results show that compared with the Pidgeon process, producing magnesium by vacuum aluminothermic reduction can save materials by as much as 50%, increase productivity up to 100%, and save energy by more than 50%. It can also reduce CO2 emission by up to 60% and realize zero discharge of waste residue. Vacuum aluminothermic reduction is a highly efficient, low-energy-consumption, and environmentally friendly method of producing magnesium.

  9. Hydrogen Adsorption onto Magnesium Palladium and Magnesium Palladium Niobium Multilayer Thin Films

    NASA Astrophysics Data System (ADS)

    Steinmetz, Christian; Hettinger, Jeffrey; Dobbins, Tabbetha

    2013-03-01

    We report on the synthesis and characterization of magnesium palladium and magnesium niobium multilayer thin films as a possible reversible hydrogen storage material. The multilayer thin films are characterized by x-ray diffraction (XRD) and x-ray reflectivity (XRR) before and after hydrogen uptake. This study examines the optimal thickness of the magnesium film which would allow the diffusion of hydrogen to form magnesium hydride (MgH2). Thin barriers of palladium and niobium permit hydrogen to permeate while acting as a diffusion barrier to oxygen. Multilayer thin films are grown with various magnesium thicknesses via magnetron sputtering on a sapphire substrate. Thicknesses of Mg, MgH2, Pd, and Nb are reported. Likewise, interfacial roughness attributable to hydrogenation and dehydrogenation cycling measured using XRR are reported.

  10. Iatrogenic magnesium toxicity following intravenous infusion of magnesium sulfate: risks and strategies for prevention.

    PubMed

    Cavell, Gillian F; Bryant, Catherine; Jheeta, Seetal

    2015-07-31

    A 65-year-old man being treated with radiotherapy and chemotherapy for recurrent colonic adenocarcinoma was admitted for management of hypokalaemia and hypomagnesaemia secondary to diarrhoea. He was treated with intravenous infusions of potassium chloride and magnesium sulfate. Following an infusion of magnesium sulfate, he experienced a sudden neurological deterioration. A CT of the head revealed no haemorrhage or evidence of acute ischaemic injury. Results of serum biochemistry later that day revealed an elevated magnesium level. Iatrogenic magnesium toxicity was suspected. Further discussions between the pharmacist and ward staff confirmed that a medication error had been made in the preparation of the infusion resulting in an overdose of intravenous magnesium. 2015 BMJ Publishing Group Ltd.

  11. Laser-induced magnesium production from magnesium oxide using reducing agents

    NASA Astrophysics Data System (ADS)

    Mohamed, M. S.; Yabe, T.; Baasandash, C.; Sato, Y.; Mori, Y.; Shi-Hua, Liao; Sato, H.; Uchida, S.

    2008-12-01

    Experiments for laser induced production of magnesium (Mg) from magnesium oxide (MgO) using reducing agents (R) were conducted. In these experiments, continuous wave CO2 focused laser is focused on a mixture of magnesium oxide and reducing agent. High power density of focused laser leads to high temperature and the reduction reaction resulting in Mg production. The resultant vapor is collected on a copper plate and analyzed in terms of magnesium deposition efficiency. Deposition efficiencies with various reducing agents such as Zr, C, and Si have been measured to be 60, 9.2, and 12.1 mg/kJ respectively. An excess addition of reducing agent over their corresponding reaction stoichiometric amounts is found to be optimum condition for the most of performed laser induced reactions. In addition, utilizing solar-pumped laser in Mg production with reducing agent will reduce CO2 emission and produce magnesium with high-energy efficiency and large throughput.

  12. Leaf Senescence by Magnesium Deficiency

    PubMed Central

    Tanoi, Keitaro; Kobayashi, Natsuko I.

    2015-01-01

    Magnesium ions (Mg2+) are the second most abundant cations in living plant cells, and they are involved in various functions, including photosynthesis, enzyme catalysis, and nucleic acid synthesis. Low availability of Mg2+ in an agricultural field leads to a decrease in yield, which follows the appearance of Mg-deficient symptoms such as chlorosis, necrotic spots on the leaves, and droop. During the last decade, a variety of physiological and molecular responses to Mg2+ deficiency that potentially link to leaf senescence have been recognized, allowing us to reconsider the mechanisms of Mg2+ deficiency. This review focuses on the current knowledge about the physiological responses to Mg2+ deficiency including a decline in transpiration, accumulation of sugars and starch in source leaves, change in redox states, increased oxidative stress, metabolite alterations, and a decline in photosynthetic activity. In addition, we refer to the molecular responses that are thought to be related to leaf senescence. With these current data, we give an overview of leaf senescence induced by Mg deficiency. PMID:27135350

  13. Grosnaja ABCs: Magnesium isotope compositions

    NASA Technical Reports Server (NTRS)

    Goswami, J. N.; Srinivasan, G.; Ulyanov, A. A.

    1993-01-01

    Three CAI's from the Grosnaja CV3 chondrite were analyzed for their magnesium isotopic compositions by the ion microprobe. The selected CAI's represent three distinct types: GR4(compact Type A), GR7(Type B) and GR2(Type C). Petrographic studies indicate that all three Grosnaja inclusions were subjected to secondary alterations. The Type A CAI GR4 is primarily composed of melilite with spinel and pyroxene occurring as minor phases. The rim of the inclusion does not exhibit distinct layered structure and secondary alteration products (garnet, Fe-rich olivine and Na-rich plagioclase) are present in some localized areas near the rim region. The average major element compositions of different mineral phases in GR4 are given. Preliminary REE data suggest a depletion of HREE relative to LREE by about a factor of 3 without any clear indication of interelement fractionation. The CAI GR7 has textural and minerological characteristics similar to Type B inclusions. The REE data show a pattern that is similar to Group 6 with enrichment in Eu and Yb. In addition, a depletion of HREE compared to LREE is also evident in this object. Melilite composition shows a broad range of akermanite content (Ak(sub 15-55)). Detailed petrographic study is in progress. GR2 is a anorthite-rich Type C inclusion with large plagioclase laths intergrown with Ti-rich pyroxene. The average plagioclase composition is close to pure anorthite (An99).

  14. Blood compatibility of magnesium and its alloys.

    PubMed

    Feyerabend, Frank; Wendel, Hans-Peter; Mihailova, Boriana; Heidrich, Stefanie; Agha, Nezha Ahmad; Bismayer, Ulrich; Willumeit-Römer, Regine

    2015-10-01

    Blood compatibility analysis in the field of biomaterials is a highly controversial topic. Especially for degradable materials like magnesium and its alloys no established test methods are available. The purpose of this study was to apply advanced test methodology for the analysis of degrading materials to get a mechanistic insight into the corrosion process in contact with human blood and plasma. Pure magnesium and two magnesium alloys were analysed in a modified Chandler-Loop setup. Standard clinical parameters were determined, and a thorough analysis of the resulting implant surface chemistry was performed. The contact of the materials to blood evoked an accelerated inflammatory and cell-induced osteoconductive reaction. Corrosion products formed indicate a more realistic, in vivo like situation. The active regulation of corrosion mechanisms of magnesium alloys by different cell types should be more in the focus of research to bridge the gap between in vitro and in vivo observations and to understand the mechanism of action. This in turn could lead to a better acceptance of these materials for implant applications. The presented study deals with the first mechanistic insights during whole human blood contact and its influence on a degrading magnesium-based biomaterial. The combination of clinical parameters and corrosion layer analysis has been performed for the first time. It could be of interest due to the intended use of magnesium-based stents and for orthopaedic applications for clinical applications. An interest for the readers of Acta Biomaterialia may be given, as one of the first clinically approved magnesium-based devices is a wound-closure device, which is in direct contact with blood. Moreover, for orthopaedic applications also blood contact is of high interest. Although this is not the focus of the manuscript, it could help to rise awareness for potential future applications. Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All

  15. Effect of acute hyperinsulinemia on magnesium homeostasis in humans.

    PubMed

    Xu, Li Hao Richie; Maalouf, Naim M

    2017-02-01

    Insulin may influence magnesium homeostasis through multiple mechanisms. Acutely, it stimulates the shift of magnesium from plasma into red blood cells and platelets, and in vitro, it stimulates the activity of the TRPM6 channel, a key regulator of renal magnesium reabsorption. We investigated the impact of hyperinsulinemia on magnesium handling in participants with a wide range of insulin sensitivity. Forty-seven participants were recruited, including 34 nondiabetic controls and 13 with type 2 diabetes mellitus. After stabilization under fixed metabolic diet, participants underwent hyperinsulinemic-euglycemic clamp. Serum and urine samples were collected before and during hyperinsulinemia. Change in serum magnesium, urinary magnesium to creatinine (Mg(2)(+) :Cr) ratio, fractional excretion of urinary magnesium (FEMg(2)(+) ), and estimated transcellular shift of magnesium were compared before and during hyperinsulinemia. Hyperinsulinemia led to a small but statistically significant decrease in serum magnesium, and to a shift of magnesium into the intracellular compartment. Hyperinsulinemia did not significantly alter urinary magnesium to creatinine ratio or fractional excretion of urinary magnesium in the overall population, although a small but statistically significant decline in these parameters occurred in participants with diabetes. There was no significant correlation between change in fractional excretion of urinary magnesium and body mass index or insulin sensitivity measured as glucose disposal rate. In human participants, acute hyperinsulinemia stimulates the shift of magnesium into cells with minimal alteration in renal magnesium reabsorption, except in diabetic patients who experienced a small decline in fractional excretion of urinary magnesium. The magnitude of magnesium shift into the intracellular compartment in response to insulin does not correlate with that of insulin-stimulated glucose entry into cells. Copyright © 2016 John Wiley & Sons, Ltd.

  16. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia.

    PubMed

    Ryzen, E; Rude, R K

    1990-02-01

    To determine the role of magnesium deficiency in the pathogenesis of hypocalcemia in acute pancreatitis, we measured magnesium levels in serum and in peripheral blood mononuclear cells in 29 patients with acute pancreatitis, 14 of whom had hypocalcemia and 15 of whom had normal calcium levels. Only six patients had overt hypomagnesemia (serum magnesium less than 0.70 mmol per liter [1.7 mg per dl]). The mean serum magnesium concentration in hypocalcemic patients was not significantly lower than in normocalcemic patients, but the mononuclear cell magnesium content in hypocalcemic patients with pancreatitis was significantly lower than in normocalcemic patients with pancreatitis (P less than .01). The serum magnesium level did not correlate with that of serum calcium or the mononuclear cell magnesium content, but the latter did significantly correlate with the serum calcium concentration (r = .81, P less than .001). Most patients with hypocalcemia had a low intracellular magnesium content. Three normomagnesemic, hypocalcemic patients with alcoholic pancreatitis also underwent low-dose parenteral magnesium tolerance testing and showed increased retention of the magnesium load. We conclude that patients with acute pancreatitis and hypocalcemia commonly have magnesium deficiency despite normal serum magnesium concentrations. Magnesium deficiency may play a significant role in the pathogenesis of hypocalcemia in patients with acute pancreatitis.

  17. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia.

    PubMed Central

    Ryzen, E.; Rude, R. K.

    1990-01-01

    To determine the role of magnesium deficiency in the pathogenesis of hypocalcemia in acute pancreatitis, we measured magnesium levels in serum and in peripheral blood mononuclear cells in 29 patients with acute pancreatitis, 14 of whom had hypocalcemia and 15 of whom had normal calcium levels. Only six patients had overt hypomagnesemia (serum magnesium less than 0.70 mmol per liter [1.7 mg per dl]). The mean serum magnesium concentration in hypocalcemic patients was not significantly lower than in normocalcemic patients, but the mononuclear cell magnesium content in hypocalcemic patients with pancreatitis was significantly lower than in normocalcemic patients with pancreatitis (P less than .01). The serum magnesium level did not correlate with that of serum calcium or the mononuclear cell magnesium content, but the latter did significantly correlate with the serum calcium concentration (r = .81, P less than .001). Most patients with hypocalcemia had a low intracellular magnesium content. Three normomagnesemic, hypocalcemic patients with alcoholic pancreatitis also underwent low-dose parenteral magnesium tolerance testing and showed increased retention of the magnesium load. We conclude that patients with acute pancreatitis and hypocalcemia commonly have magnesium deficiency despite normal serum magnesium concentrations. Magnesium deficiency may play a significant role in the pathogenesis of hypocalcemia in patients with acute pancreatitis. PMID:2407029

  18. Magnesium sulphate versus phenytoin for eclampsia.

    PubMed

    Duley, Lelia; Henderson-Smart, David J; Chou, Doris

    2010-10-06

    Eclampsia, the occurrence of a seizure in association with pre-eclampsia, remains a rare but serious complication of pregnancy. A number of different anticonvulsants have been used to control eclamptic fits and to prevent further seizures. The objective of this review was to assess the effects of magnesium sulphate compared with phenytoin when used for the care of women with eclampsia. Magnesium sulphate is compared with diazepam and with lytic cocktail in other Cochrane reviews. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2010). Randomised trials comparing magnesium sulphate (intravenous or intramuscular administration) with phenytoin for women with a clinical diagnosis of eclampsia. Two review authors assessed trial quality and extracted data. We have included data from seven trials, involving 972 women. One large trial (775 women) was of good quality. Magnesium sulphate was associated with a substantial reduction in the recurrence of seizures, when compared to phenytoin (six trials, 972 women; risk ratio (RR) 0.34, 95% confidence interval (CI) 0.24 to 0.49). The trend in maternal mortality favours magnesium sulphate, but the difference does not reach statistical significance (three trials, 847 women; RR 0.50, 95% CI 0.24 to 1.05). There were reductions in the risk of pneumonia (one trial, RR 0.44, 95% CI 0.24 to 0.79), ventilation (one trial, RR 0.68, 95% CI 0.50 to 0.91) and admission to an intensive care unit (one trial, RR 0.67, 95% CI 0.50 to 0.89) associated with the use of magnesium sulphate rather than phenytoin.For the baby, magnesium sulphate was associated with fewer admissions to a special care baby unit (SCBU) (one trial, 518 babies; RR 0.73, 95% CI 0.58 to 0.91) and fewer babies who died or were in SCBU for more than seven days (one trial, 643 babies; RR 0.77, 95% CI 0.63 to 0.95) than phenytoin. There was no clear difference in perinatal deaths (two trials, 665 babies; (RR 0.85, 95% CI 0.67 to 1

  19. Magnesium inhibition of calcite dissolution kinetics

    SciTech Connect

    Arvidson, Rolf S.; Collier, Martin; Davis, Kevin J.; Vinson, Michael D.; Amonette, James E.; Luttge, Andreas

    2006-02-01

    We present evidence of inhibition of calcite dissolution by dissolved magnesium through direct observations of the (104) surface using atomic force microscopy (AFM) and vertical scanning interferometry (VSI). Far from equilibrium, the pattern of magnesium inhibition is dependent on solution composition and specific to surface step geometry. In CO2-free solutions (pH 8.8), dissolved magnesium brings about little inhibition even at concentrations of 0.8 x 10-3 molal. At the same pH, magnesium concentrations of less than 0.05 x 10-3 molal in carbonate-buffered solutions generate significant inhibition, although no changes in surface and etch pit morphology are observed. As concentrations exceed magnesite saturation, the dissolution rate shows little additional decrease; however, selective pinning of step edges results in unique etch-pit profiles, seen in both AFM and VSI datasets. Despite the decreases in step velocity, magnesium addition in carbonated solutions also appears to activate the surface by increasing the nucleation rate of new defects. These relationships suggest that the modest depression of the bulk rate measured by VSI reflects a balance between competing reaction mechanisms that simultaneously depress the rate through selective inhibition of step movement, but also enhance reactivity on terraces by lowering the energy barrier to new etch-pit formation.

  20. Alkalization is responsible for antibacterial effects of corroding magnesium.

    PubMed

    Rahim, Muhammad Imran; Eifler, Rainer; Rais, Bushra; Mueller, Peter P

    2015-11-01

    Magnesium alloys are presently investigated as potential medical implant materials for temporary applications. Magnesium has been reported to have antibacterial activities and could therefore be used to prevent antibiotic treatment-resistant bacterial implant infections. For characterizing the effects of magnesium on infectious bacteria, bioluminescent S. aureus or P. aeruginosa were employed. The proliferation of both types of bacteria was suppressed in the presence of metallic magnesium and also in aqueous magnesium corrosion extracts. Of the two soluble corrosion products, magnesium ions were well tolerated while antibacterial activities correlated with increased pH levels of the supernatants. The alkaline pH alone was sufficient for the antibacterial effects which were completely abolished when the pH of the corrosion supernatants was neutralized. These results demonstrate that pH increases are necessary and sufficient for the antibacterial activity of metallic magnesium. In an animal model magnesium implants showed an enhanced but variable resistance to bacterial colonization.

  1. Combustion Synthesis of Magnesium Aluminate

    SciTech Connect

    Kale, M. A.; Joshi, C. P.; Moharil, S. V.

    2011-10-20

    In the system MgO-Al{sub 2}O{sub 3}, three compounds MgAl{sub 2}O{sub 4}, MgAl{sub 6}O{sub 10}(also expressed as-Mg{sub 0.4}Al{sub 2.4}O{sub 4}) and MgAl{sub 26}O{sub 40} are well known. Importance of the first two is well established. Magnesium aluminate (MgAl{sub 2}O{sub 4}) spinel is a technologically important material due to its interesting thermal properties. The MgAl{sub 2}O{sub 4} ceramics also find application as humidity sensors. Apart from the luminescence studies, the interest in MgAl{sub 2}O{sub 4} is due to various applications such as humidity-sensing and PEM fuel cells, TL/OSL dosimetry of the ionizing radiations, white light source. Interest in the MgAl{sub 6}O{sub 10} has aroused due to possible use as a substrate for GaN growth. Attempt was made to synthesize these compounds by the combustion synthesis using metal nitrates as oxidizer and urea as a fuel. Compounds MgAl{sub 2}O{sub 4} and MgAl{sub 6}O{sub 10} were formed in a single step, while MgAl{sub 26}O{sub 40} was not formed by this procedure. Activation of MgAl{sub 6}O{sub 10} by rare earth ions like Ce{sup 3+}, Eu{sup 3+} and Tb{sup 3+} and ns{sup 2} ion Pb{sup 2+} could be achieved. Excitation bands for MgAl{sub 6}O{sub 10} are at slightly shorter wavelengths compared to those reported for MgAl{sub 2}O{sub 4}.

  2. Magnesium for treating sickle cell disease.

    PubMed

    Than, Nan Nitra; Soe, Htoo Htoo Kyaw; Palaniappan, Senthil K; Abas, Adinegara Bl; De Franceschi, Lucia

    2017-04-14

    Sickle cell disease is an autosomal recessive inherited haemoglobinopathy which causes painful vaso-occlusive crises due to sickle red blood cell dehydration. Vaso-occlusive crises are common painful events responsible for a variety of clinical complications; overall mortality is increased and life expectancy decreased compared to the general population. Experimental studies suggest that intravenous magnesium has proven to be well-tolerated in individuals hospitalised for the immediate relief of acute (sudden onset) painful crisis and has the potential to decrease the length of hospital stay. Some in vitro studies and open studies of long-term oral magnesium showed promising effect on pain relief but failed to show its efficacy. The studies show that oral magnesium therapy may prevent sickle red blood cell dehydration and prevent recurrent painful episodes. There is a need to access evidence for the impact of oral and intravenous magnesium effect on frequency of pain, length of hospital stay and quality of life. To evaluate the effects of short-term intravenous magnesium on the length of hospital stay and quality of life in children and adults with sickle cell disease. To determine the effects of long-term oral magnesium therapy on the frequency of painful crises and the quality of life in children and adults with sickle cell disease. We searched the Cochrane Haemoglobinopathies Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books.Date of last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register: 01 December 2016.Date of last search of other resources (clinical trials registries): 29 March 2017. We searched for published and unpublished randomized controlled studies of oral or intravenous magnesium compared to placebo or no magnesium. Authors independently assessed the study quality and extracted the data using standard Cochrane methodologies. We

  3. Magnesium for automotive applications: Primary production cost assessment

    NASA Astrophysics Data System (ADS)

    Das, Sujit

    2003-11-01

    Production technologies must be cost effective for primary magnesium to become an economically viable alternative material for wide spread automotive applications. In this article, the prices at which magnesium becomes competitive with aluminum and steel are examined, including magnesium production cost estimates for current and future scenarios using electrolytic and thermal processes. The economic viability of the industry for automotive applications is also examined in the context of magnesium market price, taking into consideration the dynamics of its supply and demand as well.

  4. Purification of Highly Contaminated Magnesium Melt

    NASA Astrophysics Data System (ADS)

    Moon, Byoung-Gi; You, Bong-Sun; Koh, Ki-Ho

    The steering wheel core is chosen as the first target for the development of a purification technology for highly contaminated magnesium melt, because it contains abundant foreign matter such as polyurethane, copper electrodes, and steel inserts, which have high potential to form non-metallic inclusions and to deteriorate the corrosion resistance of recycled alloys. Various melt treatment technologies have been investigated for refining AM50 magnesium alloy contaminated with polyurethane. The NMI content in magnesium alloy scrap contaminated with polyurethane was effectively reduced by a sequential refining process consisting of filtration, fluxing, and gas bubbling treatments. The filtration step reduced most large inclusions such as carbon residues from the decomposed polyurethane. The subsequent fluxing and gas bubbling treatments effectively removed the small inclusions such as carbonates and oxides.

  5. Controlled morphological structure of magnesium oxide particles

    NASA Astrophysics Data System (ADS)

    Pradita, T.; Aji, B. B.; Shih, S. J.; Sudibyo

    2017-03-01

    Magnesium Oxide (MgO) based material have been widely used as catalyst, paints, flame retardants, semiconductors, additives in refractory and solid adsorbent. Morphology of a particle has significant influence towards their application. MgO particles were prepared from Magnesium Acetate (MgAc) and Magnesium Nitrate (MgN) precursors using ultrasonic spray pyrolysis method (SP). The MgO particles were characterized by thermogravimetry analysis (TGA), X-Ray Diffraction Analysis (XRD), Field Emission-Secondary Electron Microscopy (FE-SEM) and Transmission Electron Microscopy (TEM). This experimental study results each precursor could have more than one morphologies. It also suggests that the morphology of the MgO particles were controlled by the selection of the precursor, each precursor possess different particle formation characteristic, including the different crystallization rate and also related from the different decomposition behavior during the heating process of SP.

  6. Solubility of magnesium carbonate in natural waters

    USGS Publications Warehouse

    Wells, R.C.

    1915-01-01

    (1) Under atmospheric conditions it appears possible to attain practically the same state in a solution saturated with MgCO33H2O, whether one starts with a solution containing an excess of magnesium bicarbonate or with the pure trihydrate and water, but the adjustment occurs very slowly. The solution finally contains 0.36 g. magnesium and 1.01 g. carbon dioxide per liter at 20??. (2) The solubility found for magnesite, however, is much smaller, viz., 0.02 g. magnesium and 0.07 g. carbon dioxide per liter. (3) Certain natural waters, freely exposed to the atmosphere, appear to be supersaturated with respect to magnesite but none approaches very closely to the point of saturation of the trihydrate MgCO3.3H2O.

  7. Simulating the dynamic response of magnesium alloys

    NASA Astrophysics Data System (ADS)

    Lloyd, Jeffrey; Becker, Richard

    Unlike several conventional metals, the mechanical response of magnesium is severely anisotropic for quasistatic and dynamic loading conditions. In this work we present a crystal-based strength model that is the same order of magnitude in computational cost as rate-dependent isotropic strength models, yet is able to capture essential features exhibited by textured magnesium polycrystals. The model demarcates plastic deformation into contributions from basal slip, extension twinning, and non-basal slip mechanisms. Comparisons are made between model predictions and experiments for two magnesium alloys with differing processing histories. The model is then used to explore and quantify the dependence of metallurgical and processing variations for several dynamic experiments that probe propensity for localization and failure under complex loading conditions.

  8. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 40 Protection of Environment 32 2012-07-01 2012-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as magnesium potassium...

  9. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as magnesium potassium...

  10. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 31 2011-07-01 2011-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as magnesium potassium...

  11. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as magnesium potassium...

  12. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as magnesium potassium...

  13. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  14. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  15. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 40 Protection of Environment 32 2012-07-01 2012-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  16. Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats

    PubMed Central

    Bujalska-Zadrożny, Magdalena; Kulik, Kamila; Ordak, Michał; Sasinowska-Motyl, Małgorzata; Gąsińska, Emilia; de Corde, Anna; Kowalczyk, Agnieszka; Sacharczuk, Mariusz; Naruszewicz, Marek

    2016-01-01

    Purpose As previously reported, magnesium sulphate administered parenterally significantly increased an opioid antinociception in different kinds of pain. Since the typical form of magnesium salts are poorly and slowly absorbed from the gastrointestinal tract we examined whether their micronized form could increase opioids induced antinociception. Methods In behavioural studies on rats morphine, tramadol and oxycodone together with magnesium (lactate dihydrate, hydroaspartate, chloride) in micronized (particles of size D90 < 50 μm) and conventional forms were used. Changes in pain thresholds were determined using mechanical stimuli. The intestinal absorption of two forms of magnesium lactate dihydrate (at the doses of 7.5 or 15 mg ions) in the porcine gut sac model were also compared. Results Micronized form of magnesium lactate dihydrate or hydroaspartate but not chloride (15 mg of magnesium ions kg-1) enhanced the analgesic activity of orally administered opioids, significantly faster and more effective in comparison to the conventional form of magnesium salts (about 40% for oxycodone administered together with a micronized form of magnesium hydroaspartate). Moreover, in vitro studies of transport across porcine intestines of magnesium ions showed that magnesium salts administered in micronized form were absorbed from the intestines to a greater extent than the normal form of magnesium salts. Conclusions The co-administration of micronized magnesium organic salts with opioids increased their synergetic analgesic effect. This may suggest an innovative approach to the treatment of pain in clinical practice. PMID:27792736

  17. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  18. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 31 2011-07-01 2011-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  19. 77 FR 59979 - Pure Magnesium (Granular) From China

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-01

    ... COMMISSION Pure Magnesium (Granular) From China Determination On the basis of the record \\1\\ developed in the... antidumping duty order on pure magnesium (granular) from China would be likely to lead to continuation or...), entitled Pure Magnesium (Granular) from China: Investigation No.731-TA- 895 (Second Review). Issued...

  20. 76 FR 11813 - Magnesium From China and Russia

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-03

    ... COMMISSION Magnesium From China and Russia Determinations On the basis of the record \\1\\ developed in the... antidumping duty order on magnesium from China would be likely to lead to continuation or recurrence of... revocation of the antidumping duty order on magnesium from Russia would not be likely to lead to continuation...

  1. 40 CFR 721.10504 - Surface modified magnesium hydroxide (generic).

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Surface modified magnesium hydroxide... Specific Chemical Substances § 721.10504 Surface modified magnesium hydroxide (generic). (a) Chemical... as surface modified magnesium hydroxide (PMN P-06-682) is subject to reporting under this section for...

  2. 75 FR 35086 - Magnesium From China and Russia

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-21

    ... COMMISSION Magnesium From China and Russia AGENCY: United States International Trade Commission. ACTION... orders on magnesium from China and Russia. SUMMARY: The Commission hereby gives notice that it will...)) to determine whether revocation of the antidumping duty orders on magnesium from China and Russia...

  3. 40 CFR 721.10504 - Surface modified magnesium hydroxide (generic).

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Surface modified magnesium hydroxide... Specific Chemical Substances § 721.10504 Surface modified magnesium hydroxide (generic). (a) Chemical... as surface modified magnesium hydroxide (PMN P-06-682) is subject to reporting under this section for...

  4. Preparation of petaloid microspheres of basic magnesium carbonate.

    PubMed

    Ohkubo, Takahiro; Suzuki, Sei; Mitsuhashi, Kohei; Ogura, Taku; Iwanaga, Shinichi; Sakai, Hideki; Koishi, Masumi; Abe, Masahiko

    2007-05-22

    The synthesis of basic magnesium carbonate was examined under ultrasonic irradiation and was performed by the soda ash method using magnesium sulfate and sodium carbonate as starting materials. The particulate product was evaluated using SEM observations. Ultrasonic irradiation in the preparation of basic magnesium carbonate was found to give fine petaloid microspheres of about 3 mum in primary particle size.

  5. 75 FR 48360 - Magnesium From China and Russia

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-08-10

    ...: Scheduling of full five-year reviews concerning the antidumping duty orders on alloy magnesium from China and pure and alloy magnesium from Russia. SUMMARY: The Commission hereby gives notice of the scheduling of...) to determine whether revocation of the antidumping duty orders on alloy magnesium from China and...

  6. SOLID STATE JOINING OF MAGNESIUM TO STEEL

    SciTech Connect

    Jana, Saumyadeep; Hovanski, Yuri; Pilli, Siva Prasad; Field, David P.; Yu, Hao; Pan, Tsung-Yu; Santella, M. L.

    2012-06-04

    Friction stir welding and ultrasonic welding techniques were applied to join automotive magnesium alloys to steel sheet. The effect of tooling and process parameters on the post-weld microstructure, texture and mechanical properties was investigated. Static and dynamic loading were utilized to investigate the joint strength of both cast and wrought magnesium alloys including their susceptibility and degradation under corrosive media. The conditions required to produce joint strengths in excess of 75% of the base metal strength were determined, and the effects of surface coatings, tooling and weld parameters on weld properties are presented.

  7. Chemically Prepared Lead Magnesium Niobate Dielectrics

    SciTech Connect

    Tuttle, B.A.; Voigt, J.A.; Sipola, D.L.; Olson, W.R.; Goy, D.M.

    1998-01-01

    A chemical solution powder synthesis technique has been developed that produces fine uniform powders of lead magnesium niobate (PMN) with 60 to 80 nm crystallite size. The synthesis technique was based on the dissolution of lead acetate and alkoxide precursors in acetic acid followed by precipitation with oxalic acid/propanol solutions. Lead magnesium niobate ceramics fabricated from these chemically derived powders had smaller, more uniform grain size and higher dielectric constants than ceramics fabricated from mixed oxide powders that were processed under similar thermal conditions.

  8. Solid State Joining of Magnesium to Steel

    NASA Astrophysics Data System (ADS)

    Jana, Saumyadeep; Hovanski, Yuri; Pilli, Siva P.; Field, David P.; Yu, Hao; Pan, Tsung-Yu; Santella, M. L.

    Friction stir welding and ultrasonic welding techniques were applied to join automotive magnesium alloys to steel sheet. The effect of tooling and process parameters on the post-weld microstructure, texture and mechanical properties was investigated. Static and dynamic loading were utilized to investigate the joint strength of both cast and wrought magnesium alloys including their susceptibility and degradation under corrosive media. The conditions required to produce joint strengths in excess of 75% of the base metal strength were determined, and the effects of surface coatings, tooling and weld parameters on weld properties are presented.

  9. Silicon and magnesium in planetary nebulae

    NASA Technical Reports Server (NTRS)

    Harrington, J. P.; Marionni, P. A.

    1981-01-01

    The IUE satellite spectra of some planetary nebulae show features due to silicon and magnesium: Si III wavelengths 1883, 1892; Si IV wavelengths 1394, 1403; Mg II wavelengths 2796, 2804 and Mg V wavelengths 2784, 2929. With the aid of modeling techniques, the corresponding elemental abundances are found. In addition to previous observations of NGC 7662 and IC 418, data were found for NGC 2440, Hu 1-2, IC 2003 and IC 2165. Silicon appears depleted by up to an order of magnitude relative to the sun. Large variations of magnesium abundance are found, which are likely to reflect differing degrees of depletion due to grain formation.

  10. Magnesium alloy ingots: Chemical and metallographic analyses

    NASA Astrophysics Data System (ADS)

    Tartaglia, John M.; Swartz, Robert E.; Bentz, Rodney L.; Howard, Jane H.

    2001-11-01

    The quality of a magnesium die casting is likely dependent on the quality of the feed stockingot material. Therefore, both Daimler-Chrysler and General Motors have established quality assurance measures that include analysis of magnesium ingots. These processes include chemical analysis, corrosion testing, fast neutron activation analysis, and metallography. Optical emission spectroscopy, inductively coupled plasma spectroscopy, and gravimetric analysis are several methods for determining the chemical composition of the material. Fast neutron activation analysis, image analysis and energy dispersive X-ray spectroscopy are used to quantify ingot cleanliness. These experimental techniques are described and discussed in this paper, and example case studies are presented for illustration.

  11. Free and total magnesium in lymphocytes of migraine patients - effect of magnesium-rich mineral water intake.

    PubMed

    Thomas, J; Millot, J M; Sebille, S; Delabroise, A M; Thomas, E; Manfait, M; Arnaud, M J

    2000-05-01

    Dietary surveys performed in Western countries show magnesium intakes lower than the recommended dietary allowances, suggesting a large prevalence of magnesium deficiency. Low brain magnesium as well as impaired magnesium metabolism have also been reported in various diseases such as migraine. To detect these deficiencies, a non-invasive and sensitive test assessing magnesium status is needed. Because magnesium is an intracellular cation, either total or ionized magnesium (Mg(2+)) of blood cells were suggested as the most adequate tests. Total magnesium levels in plasma, erythrocytes and lymphocytes and Mg(2+) in lymphocytes were analyzed in a group of 29 migraine patients and 18 control subjects. Results show significantly lower concentrations of total magnesium in erythrocytes (50.7+/-4.7 vs. 53.5+/-2.9 mg/l; P<0.01) and of Mg(2+) in lymphocytes (12.0+/-3.5 vs. 14.2+/-3.8 mg/l; P<0.05) in migraine patients as compared to controls. While a significant difference of mean values was noted between migraine patients and controls, an overlap of individual values was observed. These analyses were repeated on migraine patients before and after a 2-week intake of a mineral water containing 110 mg/l magnesium, and a significant increase in all intracellular magnesium concentrations with no effect on plasma magnesium was observed. These increased intracellular magnesium concentrations demonstrate the bioavailability of magnesium from this mineral water. Among the analyzed parameters, Mg(2+) in lymphocytes appears to be the most sensitive index of magnesium deficiency with a 15% decrease in migraine patients when compared to controls and a 16% increase after 2 weeks of a magnesium-rich mineral water intake.

  12. Magnesium for treatment-resistant depression: a review and hypothesis.

    PubMed

    Eby, George A; Eby, Karen L

    2010-04-01

    Sixty percent of cases of clinical depression are considered to be treatment-resistant depression (TRD). Magnesium-deficiency causes N-methyl-d-aspartate (NMDA) coupled calcium channels to be biased towards opening, causing neuronal injury and neurological dysfunction, which may appear to humans as major depression. Oral administration of magnesium to animals led to anti-depressant-like effects that were comparable to those of strong anti-depressant drugs. Cerebral spinal fluid (CSF) magnesium has been found low in treatment-resistant suicidal depression and in patients that have attempted suicide. Brain magnesium has been found low in TRD using phosphorous nuclear magnetic resonance spectroscopy, an accurate means for measuring brain magnesium. Blood and CSF magnesium do not appear well correlated with major depression. Although the first report of magnesium treatment for agitated depression was published in 1921 showing success in 220 out of 250 cases, and there are modern case reports showing rapid terminating of TRD, only a few modern clinical trials were found. A 2008 randomized clinical trial showed that magnesium was as effective as the tricyclic anti-depressant imipramine in treating depression in diabetics and without any of the side effects of imipramine. Intravenous and oral magnesium in specific protocols have been reported to rapidly terminate TRD safely and without side effects. Magnesium has been largely removed from processed foods, potentially harming the brain. Calcium, glutamate and aspartate are common food additives that may worsen affective disorders. We hypothesize that - when taken together - there is more than sufficient evidence to implicate inadequate dietary magnesium as the main cause of TRD, and that physicians should prescribe magnesium for TRD. Since inadequate brain magnesium appears to reduce serotonin levels, and since anti-depressants have been shown to have the action of raising brain magnesium, we further hypothesize that

  13. Magnesium status and association with diabetes in the Taiwanese elderly.

    PubMed

    Wang, Jui-Line; Shaw, Ning-Sing; Yeh, Hsiang-Yu; Kao, Mei-Ding

    2005-01-01

    The average dietary intake of magnesium is below recommended dietary allowances in many affluent Western countries. Prolonged low magnesium intake tends to result in hypomagnesaemia which might increase the risk of chronic diseases in elderly people. A national population-based cross-sectional nutrition survey, the Elderly Nutrition and Health Survey in Taiwan (1999-2000), was used to investigate the magnesium status and association with diabetes in the Taiwanese elderly. Dietary magnesium intake was based on 24-hour dietary recalls. Blood biochemical parameters including plasma magnesium and blood glucose were also measured. Average magnesium intake was 250 mg in men and 216 mg in women, which is equivalent to 68-70% of relevant Taiwanese Dietary Reference Intakes. The mean plasma magnesium concentration was 0.903 mmol/L in men and 0.906 mmol/L in women. The prevalence of a plasma magnesium level of <0.7 mmol/L was 0.7-0.9% in the elderly, and that of <0.8 mmol/L was 8.0-9.1%. Elderly vegans had a significantly lower magnesium intake than ovo-lacto vegetarians and non-vegetarians. Diabetic men and women had significantly higher blood glucose levels than non-diabetics. The risk of diabetes was elevated 3.25 times at plasma magnesium levels<0.863 mmol/L. There was an inverse association between plasma magnesium concentration and the prevalence of diabetes. However, no association was found between diabetes and low dietary magnesium. Taiwanese elderly persons had suboptimal levels of dietary magnesium intake, which although may be sufficient to avoid overt magnesium deficiency, may not be sufficient to reduce the risk of diabetes in the elderly. Further prospective study is required to help explain the differential results between dietary and plasma magnesium levels.

  14. Magnesium Ethylenediamine Borohydride as Solid-State Electrolyte for Magnesium Batteries.

    PubMed

    Roedern, Elsa; Kühnel, Ruben-Simon; Remhof, Arndt; Battaglia, Corsin

    2017-04-07

    Solid-state magnesium ion conductors with exceptionally high ionic conductivity at low temperatures, 5 × 10(-8) Scm(-1) at 30 °C and 6 × 10(-5) Scm(-1) at 70 °C, are prepared by mechanochemical reaction of magnesium borohydride and ethylenediamine. The coordination complexes are crystalline, support cycling in a potential window of 1.2 V, and allow magnesium plating/stripping. While the electrochemical stability, limited by the ethylenediamine ligand, must be improved to reach competitive energy densities, our results demonstrate that partially chelated Mg(2+) complexes represent a promising platform for the development of an all-solid-state magnesium battery.

  15. Magnesium Ethylenediamine Borohydride as Solid-State Electrolyte for Magnesium Batteries

    NASA Astrophysics Data System (ADS)

    Roedern, Elsa; Kühnel, Ruben-Simon; Remhof, Arndt; Battaglia, Corsin

    2017-04-01

    Solid-state magnesium ion conductors with exceptionally high ionic conductivity at low temperatures, 5 × 10-8 Scm-1 at 30 °C and 6 × 10-5 Scm-1 at 70 °C, are prepared by mechanochemical reaction of magnesium borohydride and ethylenediamine. The coordination complexes are crystalline, support cycling in a potential window of 1.2 V, and allow magnesium plating/stripping. While the electrochemical stability, limited by the ethylenediamine ligand, must be improved to reach competitive energy densities, our results demonstrate that partially chelated Mg2+ complexes represent a promising platform for the development of an all-solid-state magnesium battery.

  16. Magnesium Ethylenediamine Borohydride as Solid-State Electrolyte for Magnesium Batteries

    PubMed Central

    Roedern, Elsa; Kühnel, Ruben-Simon; Remhof, Arndt; Battaglia, Corsin

    2017-01-01

    Solid-state magnesium ion conductors with exceptionally high ionic conductivity at low temperatures, 5 × 10−8 Scm−1 at 30 °C and 6 × 10−5 Scm−1 at 70 °C, are prepared by mechanochemical reaction of magnesium borohydride and ethylenediamine. The coordination complexes are crystalline, support cycling in a potential window of 1.2 V, and allow magnesium plating/stripping. While the electrochemical stability, limited by the ethylenediamine ligand, must be improved to reach competitive energy densities, our results demonstrate that partially chelated Mg2+ complexes represent a promising platform for the development of an all-solid-state magnesium battery. PMID:28387305

  17. Magnesium substitution in the structure of orthopedic nanoparticles: A comparison between amorphous magnesium phosphates, calcium magnesium phosphates, and hydroxyapatites.

    PubMed

    Nabiyouni, Maryam; Ren, Yufu; Bhaduri, Sarit B

    2015-01-01

    As biocompatible materials, magnesium phosphates have received a lot of attention for orthopedic applications. During the last decade multiple studies have shown advantages for magnesium phosphate such as lack of cytotoxicity, biocompatibility, strong mechanical properties, and high biodegradability. The present study investigates the role of Mg(+2) and Ca(+2) ions in the structure of magnesium phosphate and calcium phosphate nanoparticles. To directly compare the effect of Mg(+2) and Ca(+2) ions on structure of nanoparticles and their biological behavior, three groups of nanoparticles including amorphous magnesium phosphates (AMPs) which release Mg(+2), calcium magnesium phosphates (CMPs) which release Mg(+2) and Ca(+2), and hydroxyapatites (HAs) which release Ca(+2) were studied. SEM, TEM, XRD, and FTIR were used to evaluate the morphology, crystallinity, and chemical properties of the particles. AMP particles were homogeneous nanospheres, whereas CMPs were combinations of heterogeneous nanorods and nanospheres, and HAs which contained heterogeneous nanosphere particles. Cell compatibility was monitored in all groups to determine the cytotoxicity effect of particles on studied MC3T3-E1 preosteoblasts. AMPs showed significantly higher attachment rate than the HAs after 1 day and both AMPs and CMPs showed significantly higher proliferation rate when compared to HAs after 7days. Gene expression level of osteoblastic markers ALP, COL I, OCN, OPN, RUNX2 were monitored and they were normalized to GAPDH housekeeping gene. Beta actin expression level was monitored as the second housekeeping gene to confirm the accuracy of results. In general, AMPs and CMPs showed higher expression level of osteoblastic genes after 7 days which can further confirm the stimulating role of Mg(+2) and Ca(+2) ions in increasing the proliferation rate, differentiation, and mineralization of MC3T3-E1 preosteoblasts. Copyright © 2015 Elsevier B.V. All rights reserved.

  18. Boron clusters as highly stable magnesium-battery electrolytes.

    PubMed

    Carter, Tyler J; Mohtadi, Rana; Arthur, Timothy S; Mizuno, Fuminori; Zhang, Ruigang; Shirai, Soichi; Kampf, Jeff W

    2014-03-17

    Boron clusters are proposed as a new concept for the design of magnesium-battery electrolytes that are magnesium-battery-compatible, highly stable, and noncorrosive. A novel carborane-based electrolyte incorporating an unprecedented magnesium-centered complex anion is reported and shown to perform well as a magnesium-battery electrolyte. This finding opens a new approach towards the design of electrolytes whose likelihood of meeting the challenging design targets for magnesium-battery electrolytes is very high. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  19. The Effect of Alloy Additions on Superplasticity in Thermomechanically Processed High Magnesium Aluminum-Magnesium Alloys.

    DTIC Science & Technology

    1984-12-01

    AD-Ri55 142 THE EFFECT OF ALLOY ADDITIONS ON SUPERPLASTICITY IN I/2 THERMOMECHANICALLY PR-.(U) NAVAL POSTGRADUATE SCHOOL UNCLSSIIED MONTEREY CA R J...Ln Monterey, California DTr J U N 1985 * THESIS THE EFFECT OF ALLOY ADDITIONS ON SUPERPLASTICITY IN THERMOMECHANICALLY PROCESSED HIGH MAGNESIUM *0...ALUMINUM-MAGNESIUM ALLOYS >by 0 (Richard J. Self December 1984 C-31 Thesis Advisor: Terry McNelley Approved for public release; distribution is unlimited

  20. Carbothermal Production of Magnesium: Csiro's Magsonic™ Process

    NASA Astrophysics Data System (ADS)

    Prentice, Leon H.; Nagle, Michael W.; Barton, Timothy R. D.; Tassios, Steven; Kuan, Benny T.; Witt, Peter J.; Constanti-Carey, Keri K.

    Carbothermal production has been recognized as conceptually the simplest and cleanest route to magnesium metal, but has suffered from technical challenges of development and scale-up. Work by CSIRO has now successfully demonstrated the technology using supersonic quenching of magnesium vapor (the MagSonic™ Process). Key barriers to process development have been overcome: the experimental program has achieved sustained operation, no nozzle blockage, minimal reversion, and safe handling of pyrophoric powders. The laboratory equipment has been operated at industrially relevant magnesium vapor concentrations (>25% Mg) for multiple runs with no blockage. Novel computational fluid dynamics (CFD) modeling of the shock quenching and metal vapor condensation has informed nozzle design and is supported by experimental data. Reversion below 10% has been demonstrated, and magnesium successfully purified (>99.9%) from the collected powder. Safe operating procedures have been developed and demonstrated, minimizing the risk of powder explosion. The MagSonic™ Process is now ready to progress to significantly larger scale and continuous operation.

  1. Friction Stir & Ultrasonic Solid State Joining Magnesium

    SciTech Connect

    Grant, Glenn J.; Hovanski, Yuri; Santella, M. L.

    2009-12-30

    Solid state joining between automotive sheet steel and magnesium alloys was investigated. Both friction stir welding and ultrasonic welding were utilized to study the potential for creating structural bonds between these dissimilar materials. A detailed investigation into the joint characteristics was undertaken including an evaluation of joint strength, microstructure, chemical structures, and alloy formation.

  2. Calcium, magnesium, and potassium in food

    USDA-ARS?s Scientific Manuscript database

    The biochemical and physiological functions and consequences of deficient intakes, which show the nutritional importance of calcium, magnesium and potassium for humans, are reviewed. The dietary recommendations and food sources for these essential mineral elements for humans are presented. Factors t...

  3. Design Considerations for Developing Biodegradable Magnesium Implants

    NASA Astrophysics Data System (ADS)

    Brar, Harpreet S.; Keselowsky, Benjamin G.; Sarntinoranont, Malisa; Manuel, Michele V.

    The integration of biodegradable and bioabsorbable magnesium implants into the human body is a complex undertaking that faces major challenges. The complexity arises from the fact that biomaterials must meet both engineering and physiological requirements to ensure the desired properties. Historically, efforts have been focused on the behavior of commercial magnesium alloys in biological environments and their resultant effect on cell-mediated processes. Developing causal relationships between alloy chemistry and micro structure, and its effect on cellular behavior can be a difficult and time intensive process. A systems design approach driven by thermodynamics has the power to provide significant contributions in developing the next generation of magnesium alloy implants with controlled degradability, biocompatibility, and optimized mechanical properties, at reduced time and cost. This approach couples experimental research with theory and mechanistic modeling for the accelerated development of materials. The aim of this article is to enumerate this strategy, design considerations and hurdles for developing new magnesium alloys for use as biodegradable implant materials [1].

  4. Constitutive Modeling of Magnesium Alloy Sheets

    SciTech Connect

    Lee, M. G.; Piao, K.; Wagoner, R. H.; Lee, J. K.; Chung, K.; Kim, H. Y.

    2007-05-17

    Magnesium alloy sheets have unique mechanical properties: high in-plane anisotropy/asymmetry of yield stress and hardening response, which have not been thoroughly studied. The unusual mechanical behavior of magnesium alloys has been understood by the limited symmetry crystal structure of h.c.p metals and thus by deformation twinning. In this paper, the phenomenological continuum plasticity models considering the unusual plastic behavior of magnesium alloy sheet were developed for a finite element analysis. A new hardening law based on two-surface model was developed to consider the general stress-strain response of metal sheets such as Bauschinger effect, transient behavior and the unusual asymmetry. Three deformation modes observed during the continuous tension/compression tests were mathematically formulated with simplified relations between the state of deformation and their histories. In terms of the anisotropy and asymmetry of the initial yield stress, the Drucker-Prager's pressure dependent yield surface was modified to include the anisotropy of magnesium alloys. Also, characterization procedures of material parameters for the constitutive equations were presented and finally the correlation of simulation with measurements was performed to validate the proposed theory.

  5. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing of Specific Substances Affirmed as...

  6. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium hydroxide. 184.1428 Section 184.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing of Specific Substances Affirmed as...

  7. Preparation of thorium magnesium-zinc reduction

    NASA Technical Reports Server (NTRS)

    Hariharan, A. V.; Knighton, J. B.; Steunenberg, R. K.

    1969-01-01

    Magnesium-zinc reduction of thorium dioxide is used for the preparation of thorium metal. Potential economic advantages of this technique include use of relatively inexpensive reagents for the metal and flux phases, and production of metal of acceptable quality in good yield.

  8. Magnesium gluconate offers no more protection than magnesium sulphate following diffuse traumatic brain injury in rats.

    PubMed

    Turner, Renee J; Dasilva, K W; O'Connor, C; van den Heuvel, Corinna; Vink, Robert

    2004-10-01

    Previous studies have demonstrated that magnesium salts, including the sulphate and chloride forms, are neuroprotective following traumatic brain injury (TBI). Recently, studies in cardiac ischaemia/reperfusion injury have demonstrated that the gluconate salt of magnesium may provide superior protection against oxidative damage and postischaemic dysfunction than MgSO(4). We have therefore compared the efficacy of both MgSO(4) and magnesium gluconate (MgGl(2)) on outcome following diffuse TBI in rats. Adult male Sprague-Dawley rats were injured using the 2-metre impact acceleration model of diffuse TBI. At 30 min after injury, animals were administered with either 250 micromoles/kg i.v. MgSO(4), MgGl(2), or equal volume saline vehicle. Thereafter, animals were assessed for motor and cognitive outcome using the rotarod and Barnes maze, respectively, or their brains removed at 3 days after TBI and used for histological examination. Treatment with either magnesium salt significantly improved functional outcome as compared to vehicle treated controls. Similarly, treatment with either magnesium salt attenuated the degree of histological dark cell change at 3 days after TBI relative to the vehicle treated animals. There were no significant differences between the magnesium treated groups. We conclude that MgSO(4) and MgGl(2) are equally neuroprotective following TBI. Our results suggest that MgGl(2) may only be more effective in conditions that produce ischaemia, where high concentrations of reactive oxygen species are generated.

  9. Magnesium physiology and clinical therapy in veterinary critical care.

    PubMed

    Humphrey, Sarah; Kirby, Rebecca; Rudloff, Elke

    2015-01-01

    To review magnesium physiology including absorption, excretion, and function within the body, causes of magnesium abnormalities, and the current applications of magnesium monitoring and therapy in people and animals. Magnesium plays a pivotal role in energy production and specific functions in every cell in the body. Disorders of magnesium can be correlated with severity of disease, length of hospital stay, and recovery of the septic patient. Hypermagnesemia is seen infrequently in people and animals with significant consequences reported. Hypomagnesemia is more common in critically ill people and animals, and can be associated with platelet, immune system, neurological, and cardiovascular dysfunction as well as alterations in insulin responsiveness and electrolyte imbalance. Measurement of serum ionized magnesium in critically or chronically ill veterinary patients is practical and provides information necessary for stabilization and treatment. Tissue magnesium concentrations may be assessed using nuclear magnetic resonance spectroscopy as well as through the application of fluorescent dye techniques. Magnesium infusions may play a therapeutic role in reperfusion injury, myocardial ischemia, cerebral infarcts, systemic inflammatory response syndromes, tetanus, digitalis toxicity, bronchospasms, hypercoagulable states, and as an adjunct to specific anesthetic or analgesic protocols. Further veterinary studies are needed to establish the frequency and importance of magnesium disorders in animals and the potential benefit of magnesium infusions as a therapeutic adjunct to specific diseases. The prognosis for most patients with magnesium disorders is variable and largely dependent on the underlying cause of the disorder. © Veterinary Emergency and Critical Care Society 2014.

  10. Nanostructured magnesium has fewer detrimental effects on osteoblast function

    PubMed Central

    Weng, Lucy; Webster, Thomas J

    2013-01-01

    Efforts have been made recently to implement nanoscale surface features on magnesium, a biodegradable metal, to increase bone formation. Compared with normal magnesium, nanostructured magnesium has unique characteristics, including increased grain boundary properties, surface to volume ratio, surface roughness, and surface energy, which may influence the initial adsorption of proteins known to promote the function of osteoblasts (bone-forming cells). Previous studies have shown that one way to increase nanosurface roughness on magnesium is to soak the metal in NaOH. However, it has not been determined if degradation of magnesium is altered by creating nanoscale features on its surface to influence osteoblast density. The aim of the present in vitro study was to determine the influence of degradation of nanostructured magnesium, created by soaking in NaOH, on osteoblast density. Our results showed a less detrimental effect of magnesium degradation on osteoblast density when magnesium was treated with NaOH to create nanoscale surface features. The detrimental degradation products of magnesium are of significant concern when considering use of magnesium as an orthopedic implant material, and this study identified a surface treatment, ie, soaking in NaOH to create nanoscale features for magnesium that can improve its use in numerous orthopedic applications. PMID:23674891

  11. Assessment of the magnesium primary production technology. Final report

    SciTech Connect

    Flemings, M.C.; Kenney, G.B.; Sadoway, D.R.; Clark, J.P.; Szekely, J.

    1981-02-01

    At current production levels, direct energy savings achievable in primary magnesium production are 1.2 milliquads of energy per annum. Were magnesium to penetrate the automotive market to an average level of 50 pounds per vehicle, the resultant energy savings at the production stage would be somewhat larger, but the resulting savings in gasoline would conserve an estimated 325 milliquads of energy per year. The principal barrier to more widespread use of magnesium in the immediate future is its price. A price reduction of magnesium of 10% would lead to widespread conversion of aluminum die and permanent mold castings to magnesium. This report addresses the technology of electrolytic and thermic magnesium production and the economics of expanded magnesium production and use.

  12. Fabrication and characterization of AZ91/CNT magnesium matrix composites

    NASA Astrophysics Data System (ADS)

    Park, Yong-Ha; Park, Yong-Ho; Park, Ik-Min; Oak, Jeong-jung; Kimura, Hisamichi; Cho, Kyung-Mox

    2008-12-01

    Carbon Nano Tube (CNT) reinforced AZ91 metal matrix composites (MMC) were fabricated by the squeeze infiltrated method. Properties of magnesium alloys have been improved by impurity reduction, surface treatment and alloy design, and thus the usage for the magnesium alloys has been extended recently. However there still remain barriers for the adaption of magnesium alloys for engineering materials. In this study, we report light-weight, high strength heat resistant magnesium matrix composites. Microstructural study and tensile test were performed for the squeeze infiltrated magnesium matrix composites. The wear properties were characterized and the possibility for the application to automotive power train and engine parts was investigated. It was found that the squeeze infiltration technique is a proper method to fabricate magnesium matrix composites reducing casting defects such as pores and matrix/reinforcement interface separation etc. Improved tensile and mechanical properties were obtained with CNT reinforcing magnesium alloys

  13. Magnesium Electrorefining in Non-Aqueous Electrolyte at Room Temperature

    NASA Astrophysics Data System (ADS)

    Kwon, Kyungjung; Park, Jesik; Kusumah, Priyandi; Dilasari, Bonita; Kim, Hansu; Lee, Churl Kyoung

    Magnesium, of which application is often limited by its poor corrosion resistance, is more vulnerable to corrosion with existence of metal impurities such as Fe. Therefore, for the refining and recycling of magnesium, high temperature electrolysis using molten salts has been frequently adopted. In this report, the purification of magnesium scrap by electrolysis at room temperature is investigated with non-aqueous electrolytes. An aprotic solvent of tetrahydrofuran (THF) was used as a solvent of the electrolyte. Magnesium scrap was used as anode materials and ethyl magnesium bromide (EtMgBr) was dissolved in THF for magnesium source. The purified magnesium can be uniformly electrodeposited on copper electrode under potentiostatic conditions. The deposits were confirmed by scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS) analysis.

  14. Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite.

    PubMed

    Elmore, Amy R

    2003-01-01

    This report reviews the safety of Aluminum, Calcium, Lithium Magnesium, Lithium Magnesium Sodium, Magnesium Aluminum, Magnesium, Sodium Magnesium, and Zirconium Silicates, Magnesium Trisilicate, Attapulgite, Bentonite, Fuller's Earth, Hectorite, Kaolin, Montmorillonite, Pyrophyllite, and Zeolite as used in cosmetic formulations. The common aspect of all these claylike ingredients is that they contain silicon, oxygen, and one or more metals. Many silicates occur naturally and are mined; yet others are produced synthetically. Typical cosmetic uses of silicates include abrasive, opacifying agent, viscosity-increasing agent, anticaking agent, emulsion stabilizer, binder, and suspending agent. Clay silicates (silicates containing water in their structure) primarily function as adsorbents, opacifiers, and viscosity-increasing agents. Pyrophyllite is also used as a colorant. The International Agency for Research on Cancer has ruled Attapulgite fibers >5 microm as possibly carcinogenic to humans, but fibers <5 microm were not classified as to their carcinogenicity to humans. Likewise, Clinoptilolite, Phillipsite, Mordenite, Nonfibrous Japanese Zeolite, and synthetic Zeolites were not classified as to their carcinogenicity to humans. These ingredients are not significantly toxic in oral acute or short-term oral or parenteral toxicity studies in animals. Inhalation toxicity, however, is readily demonstrated in animals. Particle size, fibrogenicity, concentration, and mineral composition had the greatest effect on toxicity. Larger particle size and longer and wider fibers cause more adverse effects. Magnesium Aluminum Silicate was a weak primary skin irritant in rabbits and had no cumulative skin irritation in guinea pigs. No gross effects were reported in any of these studies. Sodium Magnesium Silicate had no primary skin irritation in rabbits and had no cumulative skin irritation in guinea pigs. Hectorite was nonirritating to the skin of rabbits in a Draize primary skin

  15. Magnesium intake and depression: the SUN cohort.

    PubMed

    Martínez-González, Miguel Ángel; Sánchez-Villegas, Almudena

    2016-03-01

    A higher magnesium intake may reduce the risk of depression. We analyzed this association in the SUN Mediterranean cohort with an expanded sample size (n = 15,836) and a long follow-up (median = 10.2 y). We followed 9,289 women (age = 34.8, SD = 10.4) and 6,547 men (age = 42.8, SD = 13.1) initially free of any history of depression for a new-onset of medically diagnosed depression (maximum follow-up = 15.9 y). All participants in this cohort were university educated. We systematically reviewed previous studies relating magnesium to depression. We observed 837 incident cases of depression during 147,915 person-years of follow-up in the SUN cohort. No significant association of magnesium intake with the risk of depression was found, with a fully-adjusted hazard ratio = 0.85 (95% confidence interval = 0.60-1.22, for fifth versus first quintile). When we used a more restrictive definition for depression (both a medical diagnosis and habitual use of antidepressants), this HR was 0.63 (0.35-1.14). No significant association was found in our systematic review. No conclusive evidence for an association between magnesium dietary intake and depression incidence was found. Further longitudinal studies with a larger sample size and a better assessment of confounders and of depression cases are needed to try to identify potential protection against depression by magnesium.

  16. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women.

    PubMed

    Brookfield, Kathleen F; Su, Felice; Elkomy, Mohammed H; Drover, David R; Lyell, Deirdre J; Carvalho, Brendan

    2016-06-01

    Magnesium sulfate is one of the most commonly prescribed intravenous medications in obstetrics. Despite its widespread use, there are limited data about magnesium pharmacokinetics, and magnesium is prescribed empirically without dose adjustment for different indications. The aim of this study was to characterize the pharmacokinetics and placental transfer of magnesium sulfate in pregnant women and to determine key covariates that impact the pharmacokinetics. This is a prospective pharmacokinetic cohort study of pregnant women who were prescribed magnesium sulfate for preeclampsia, preterm labor, or extreme prematurity. Women received a 4-g loading dose and 2 g/h maintenance dose as clinically indicated. Maternal blood samples were obtained before and at multiple time points during and after magnesium administration. Cord blood also was sampled at delivery. A population pharmacokinetic approach that used a nonlinear mixed-effects modeling was used to characterize magnesium disposition. Pharmacokinetic profiles of 111 pregnant women were analyzed. Magnesium clearance was 3.98 L/h in preeclamptic women and 5.88 L/h non-preeclamptic women. Steady-state concentration of magnesium was 7.2 mg/dL in preeclamptic women compared with 5.1 mg/dL in non-preeclamptic women. Maternal weight significantly impacted time to steady state. The ratio of the mean umbilical vein magnesium level to the mean maternal serum magnesium level at the time of delivery was 0.94 ± 0.15. The study accurately characterizes the pharmacokinetics of magnesium administered to pregnant women. Preeclamptic status and maternal weight significantly impact serum magnesium levels. This pharmacokinetic model could be applied to larger cohorts to help tailor magnesium treatment and account for these covariates. Copyright © 2016 Elsevier Inc. All rights reserved.

  17. Ascorbic acid, calcium, phosphorus and magnesium intake variations: effects on calcium, phosphorus and magnesium utilization by human adults

    SciTech Connect

    Kies, C.; Brennan, M.A.; Parks, S.K.; Stauffer, D.J.; Wang, H.Y.; Young, S.F.; Fox, H.M.

    1986-03-01

    The objective of the study was to determine the effects of feeding two levels of ascorbic acid, calcium, phosphorus, magnesium and ascorbic acid on the apparent utilization of calcium, phosphorus and magnesium by healthy, human adult subjects. During 4 randomly-arranged experimental periods of 7 days each, a laboratory-controlled diet alone or with supplements of ascorbic acid, dicalcium phosphate or magnesium oxide was fed to the 18 subjects. Results indicated that ascorbic acid supplementation tended to reduce urinary phosphorus loss and to slightly increase fecal phosphorus loss so that overall phosphorus balances became more positive. Conversely, under these conditions, urinary calcium losses were little affected but fecal calcium losses were increased resulting in an overall decrease in calcium balance with ascorbic acid supplementation. Ascorbic acid supplementation resulted in decreased urine and fecal losses of magnesium and more positive magnesium balances. Magnesium supplementation resulted in more positive calcium and phosphorus balances as did calcium phosphate supplementation on magnesium balance.

  18. The Association Between Calcium, Magnesium, and Ratio of Calcium/Magnesium in Seminal Plasma and Sperm Quality.

    PubMed

    Liang, Hong; Miao, Maohua; Chen, Jianping; Chen, Kanglian; Wu, Bin; Dai, Qi; Wang, Jian; Sun, Fei; Shi, Huijuan; Yuan, Wei

    2016-11-01

    The study aimed to examine the relationships between calcium, magnesium, and calcium/magnesium ratio in semen plasma and sperm quality. It was a cross-sectional study based on a program aiming at promoting the reproductive health in less-developed areas. A total of 515 men aged between 18 and 55 years provided semen specimens at family planning clinics in Sandu County, Guizhou Province, China. Total calcium and magnesium concentrations in semen plasma were measured with flame atomic absorption spectrometry. Sperm quality, including sperm motility and concentration, was evaluated by using a computer-assisted sperm analysis method. The medians of seminal plasma calcium, magnesium, and zinc concentrations were 9.61, 4.41, and 2.23 mmol/l, respectively. Calcium concentration and calcium/magnesium ratio were negatively associated with sperm concentrations (β = -0.47, P = 0.0123 for calcium; β = -0.25, P = 0.0393 for calcium/magnesium ratio) after adjusting for zinc and other covariates. In stratified analyses, the association between calcium and sperm concentrations only persisted among subjects with a calcium/magnesium ratio of ≤2.5 (β = -0.71, P = 0.0268). In the same stratum, magnesium was associated with increased sperm concentration (β = 0.73, P = 0.0386). Among subjects with a calcium/magnesium ratio of >2.5, neither calcium nor magnesium was associated with sperm concentration. In conclusion, total calcium and magnesium concentrations were associated with sperm concentration among subjects with a lower calcium/magnesium ratio. The calcium and magnesium ratio had a modifying effect on the associations of calcium and magnesium with sperm concentration.

  19. Transport of Magnesium by a Bacterial Nramp-Related Gene

    PubMed Central

    Rodionov, Dmitry A.; Freedman, Benjamin G.; Senger, Ryan S.; Winkler, Wade C.

    2014-01-01

    Magnesium is an essential divalent metal that serves many cellular functions. While most divalent cations are maintained at relatively low intracellular concentrations, magnesium is maintained at a higher level (∼0.5–2.0 mM). Three families of transport proteins were previously identified for magnesium import: CorA, MgtE, and MgtA/MgtB P-type ATPases. In the current study, we find that expression of a bacterial protein unrelated to these transporters can fully restore growth to a bacterial mutant that lacks known magnesium transporters, suggesting it is a new importer for magnesium. We demonstrate that this transport activity is likely to be specific rather than resulting from substrate promiscuity because the proteins are incapable of manganese import. This magnesium transport protein is distantly related to the Nramp family of proteins, which have been shown to transport divalent cations but have never been shown to recognize magnesium. We also find gene expression of the new magnesium transporter to be controlled by a magnesium-sensing riboswitch. Importantly, we find additional examples of riboswitch-regulated homologues, suggesting that they are a frequent occurrence in bacteria. Therefore, our aggregate data discover a new and perhaps broadly important path for magnesium import and highlight how identification of riboswitch RNAs can help shed light on new, and sometimes unexpected, functions of their downstream genes. PMID:24968120

  20. Magnesium degradation products: effects on tissue and human metabolism.

    PubMed

    Seitz, J-M; Eifler, R; Bach, Fr-W; Maier, H J

    2014-10-01

    Owing to their mechanical properties, metallic materials present a promising solution in the field of resorbable implants. The magnesium metabolism in humans differs depending on its introduction. The natural, oral administration of magnesium via, for example, food, essentially leads to an intracellular enrichment of Mg(2+) . In contrast, introducing magnesium-rich substances or implants into the tissue results in a different decomposition behavior. Here, exposing magnesium to artificial body electrolytes resulted in the formation of the following products: magnesium hydroxide, magnesium oxide, and magnesium chloride, as well as calcium and magnesium apatites. Moreover, it can be assumed that Mg(2+) , OH(-) ions, and gaseous hydrogen are also present and result from the reaction for magnesium in an aqueous environment. With the aid of physiological metabolic processes, the organism succeeds in either excreting the above mentioned products or integrating them into the natural metabolic process. Only a burst release of these products is to be considered a problem. A multitude of general tissue effects and responses from the Mg's degradation products is considered within this review, which is not targeting specific implant classes. Furthermore, common alloying elements of magnesium and their hazardous potential in vivo are taken into account.

  1. Transport of magnesium by a bacterial Nramp-related gene.

    PubMed

    Shin, Jung-Ho; Wakeman, Catherine A; Goodson, Jonathan R; Rodionov, Dmitry A; Freedman, Benjamin G; Senger, Ryan S; Winkler, Wade C

    2014-06-01

    Magnesium is an essential divalent metal that serves many cellular functions. While most divalent cations are maintained at relatively low intracellular concentrations, magnesium is maintained at a higher level (∼0.5-2.0 mM). Three families of transport proteins were previously identified for magnesium import: CorA, MgtE, and MgtA/MgtB P-type ATPases. In the current study, we find that expression of a bacterial protein unrelated to these transporters can fully restore growth to a bacterial mutant that lacks known magnesium transporters, suggesting it is a new importer for magnesium. We demonstrate that this transport activity is likely to be specific rather than resulting from substrate promiscuity because the proteins are incapable of manganese import. This magnesium transport protein is distantly related to the Nramp family of proteins, which have been shown to transport divalent cations but have never been shown to recognize magnesium. We also find gene expression of the new magnesium transporter to be controlled by a magnesium-sensing riboswitch. Importantly, we find additional examples of riboswitch-regulated homologues, suggesting that they are a frequent occurrence in bacteria. Therefore, our aggregate data discover a new and perhaps broadly important path for magnesium import and highlight how identification of riboswitch RNAs can help shed light on new, and sometimes unexpected, functions of their downstream genes.

  2. Neonatal effects of magnesium sulfate given to the mother.

    PubMed

    Abbassi-Ghanavati, Mina; Alexander, James M; McIntire, Donald D; Savani, Rashmin C; Leveno, Kenneth J

    2012-11-01

    Magnesium historically has been used for treatment and/or prevention of eclampsia or preterm labor. More recently, antepartum magnesium sulfate has been suggested for prevention of cerebral palsy in preterm infants. Although adverse effects and toxicity of magnesium in pregnant women are well known, the fetal-neonatal effects of magnesium are less clear. The objective of this study was to evaluate the effects of magnesium on the newborn infant. This is a retrospective cohort analysis of women who received antepartum magnesium sulfate for prevention or treatment of eclampsia. Magnesium sulfate was given intravenously beginning with a 6-g dose, followed by 2- to 3-g/h infusion. Newborn hypotonia was diagnosed if an infant exhibited less than normal tone/activity upon admission to the nursery. Between January 2000 and February 2009, a total of 6654 women with preeclampsia were treated with intravenous magnesium sulfate as described; 88 (6%) of the infants were diagnosed with hypotonia. Lower 1-minute and 5-minute Apgar scores, intubation in the delivery room, admission to special care nursery, and hypotonia were all significantly increased as maternal serum magnesium concentrations increased before birth. Several neonatal complications are significantly related to increasing concentrations of magnesium in the maternal circulation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

  3. Struvite precipitation from urine with electrochemical magnesium dosage.

    PubMed

    Hug, Alexandra; Udert, Kai M

    2013-01-01

    When magnesium is added to source-separated urine, struvite (MgNH(4)PO(4)·6H(2)O) precipitates and phosphorus can be recovered. Up to now, magnesium salts have been used as the main source of magnesium. Struvite precipitation with these salts works well but is challenging in decentralized reactors, where high automation of the dosage and small reactor sizes are required. In this study, we investigated a novel approach for magnesium dosage: magnesium was electrochemically dissolved from a sacrificial magnesium electrode. We demonstrated that this process is technically simple and economically feasible and thus interesting for decentralized reactors. Linear voltammetry and batch experiments at different anode potentials revealed that the anode potential must be higher than -0.9 V vs. NHE (normal hydrogen electrode) to overcome the strong passivation of the anode. An anode potential of -0.6 V vs. NHE seemed to be suitable for active magnesium dissolution. For 13 subsequent cycles at this potential, we achieved an average phosphate removal rate of 3.7 mg P cm(-2) h(-1), a current density of 5.5 mA cm(-2) and a current efficiency of 118%. Some magnesium carbonate (nesquehonite) accumulated on the anode surface; as a consequence, the current density decreased slightly, but the current efficiency was not affected. The energy consumption for these experiments was 1.7 W h g P(-1). A cost comparison showed that sacrificial magnesium electrodes are competitive with easily soluble magnesium salts such as MgCl(2) and MgSO(4), but are more expensive than dosing with MgO. Energy costs for the electrochemical process were insignificant. Dosing magnesium electrochemically could thus be a worthwhile alternative to dosing magnesium salts. Due to the simple reactor and handling of magnesium, this may well be a particularly interesting approach for decentralized urine treatment.

  4. 76 FR 72172 - Continuation of Antidumping Duty Order: Pure Magnesium From the People's Republic of China

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-11-22

    ..., zirconium and rare earths. Excluded from the scope of the order are alloy primary magnesium (that meets... order. Pure magnesium is a metal or alloy containing by weight primarily the element magnesium and produced by decomposing raw materials into magnesium metal. Pure primary magnesium is used primarily as...

  5. Effects of magnesium salts in preventing experimental oxalate urolithiasis in rats.

    PubMed

    Ogawa, Y; Yamaguchi, K; Morozumi, M

    1990-08-01

    Magnesium oxide, magnesium hydroxide, magnesium sulfate, magnesium trisilicate, and magnesium citrate were added to a calcium-oxalate lithogenic diet in order to determine their effects in preventing lithogenesis. Male Wistar-strain rats which had been fed the glycolic-acid diet developed marked urinary calculi within four weeks. Rats in the magnesium-hydroxide, magnesium-citrate, and magnesium-trisilicate groups, however, had almost no stones in the urinary system. Rats in the magnesium-oxide and magnesium-sulfate groups showed significantly less effect than those in the former three groups. During the experimental period, the 24-hour urinary oxalate excretion and concentration were higher in the glycolic-acid group than in the other groups. The urinary citrate excretion and concentration were the highest in the magnesium-hydroxide and magnesium-citrate groups and higher in the magnesium-trisilicate and magnesium-oxide groups than in the magnesium-sulfate and glycolic-acid groups. Similar trends were observed in the urinary magnesium excretion and in its concentration. The urinary calcium excretion and concentration were higher in the experimental groups than in the glycolic-acid group. The urinary calcium/magnesium ratio remained mostly unchanged. Therefore, it can be concluded that alkaline magnesium salts increase the urinary calcium and magnesium concentrations, without changing the calcium/magnesium ratio, and inhibit urinary calculi formation, most likely by increasing the urinary citrate concentration.

  6. Effect of transdermal magnesium cream on serum and urinary magnesium levels in humans: A pilot study

    PubMed Central

    Tanner, Amy; Sullivan, Keith; McAuley, William; Plesset, Michael

    2017-01-01

    Background Oral magnesium supplementation is commonly used to support a low magnesium diet. This investigation set out to determine whether magnesium in a cream could be absorbed transdermally in humans to improve magnesium status. Methods and findings In this single blind, parallel designed pilot study, n = 25 participants (aged 34.3+/-14.8y, height 171.5+/-11cm, weight 75.9 +/-14 Kg) were randomly assigned to either a 56mg/day magnesium cream or placebo cream group for two weeks. Magnesium serum and 24hour urinary excretion were measured at baseline and at 14 days intervention. Food diaries were recorded for 8 days during this period. Mg test and placebo groups’ serum and urinary Mg did not differ at baseline. After the Mg2+ cream intervention there was a clinically relevant increase in serum magnesium (0.82 to 0.89 mmol/l,p = 0.29) that was not seen in the placebo group (0.77 to 0.79 mmol/L), but was only statistically significant (p = 0.02)) in a subgroup of non-athletes. Magnesium urinary excretion increased from baseline slightly in the Mg2+ group but with no statistical significance (p = 0.48). The Mg2+ group showed an 8.54% increase in serum Mg2+ and a 9.1% increase in urinary Mg2+ while these figures for the placebo group were smaller, i.e. +2.6% for serum Mg2+ and -32% for urinary Mg2+. In the placebo group, both serum and urine concentrations showed no statistically significant change after the application of the placebo cream. Conclusion No previous studies have looked at transdermal absorbency of Mg2+ in human subjects. In this pilot study, transdermal delivery of 56 mg Mg/day (a low dose compared with commercial transdermal Mg2+ products available) showed a larger percentage rise in both serum and urinary markers from pre to post intervention compared with subjects using the placebo cream, but statistical significance was achieved only for serum Mg2+ in a subgroup of non-athletes. Future studies should look at higher dosage of magnesium cream for

  7. Effect of transdermal magnesium cream on serum and urinary magnesium levels in humans: A pilot study.

    PubMed

    Kass, Lindsy; Rosanoff, Andrea; Tanner, Amy; Sullivan, Keith; McAuley, William; Plesset, Michael

    2017-01-01

    Oral magnesium supplementation is commonly used to support a low magnesium diet. This investigation set out to determine whether magnesium in a cream could be absorbed transdermally in humans to improve magnesium status. In this single blind, parallel designed pilot study, n = 25 participants (aged 34.3+/-14.8y, height 171.5+/-11cm, weight 75.9 +/-14 Kg) were randomly assigned to either a 56mg/day magnesium cream or placebo cream group for two weeks. Magnesium serum and 24hour urinary excretion were measured at baseline and at 14 days intervention. Food diaries were recorded for 8 days during this period. Mg test and placebo groups' serum and urinary Mg did not differ at baseline. After the Mg2+ cream intervention there was a clinically relevant increase in serum magnesium (0.82 to 0.89 mmol/l,p = 0.29) that was not seen in the placebo group (0.77 to 0.79 mmol/L), but was only statistically significant (p = 0.02)) in a subgroup of non-athletes. Magnesium urinary excretion increased from baseline slightly in the Mg2+ group but with no statistical significance (p = 0.48). The Mg2+ group showed an 8.54% increase in serum Mg2+ and a 9.1% increase in urinary Mg2+ while these figures for the placebo group were smaller, i.e. +2.6% for serum Mg2+ and -32% for urinary Mg2+. In the placebo group, both serum and urine concentrations showed no statistically significant change after the application of the placebo cream. No previous studies have looked at transdermal absorbency of Mg2+ in human subjects. In this pilot study, transdermal delivery of 56 mg Mg/day (a low dose compared with commercial transdermal Mg2+ products available) showed a larger percentage rise in both serum and urinary markers from pre to post intervention compared with subjects using the placebo cream, but statistical significance was achieved only for serum Mg2+ in a subgroup of non-athletes. Future studies should look at higher dosage of magnesium cream for longer durations. ISRCTN registry ID No. ISRTN

  8. Thermal conductivities of nanostructured magnesium oxide coatings deposited on magnesium alloys by plasma electrolytic oxidation.

    PubMed

    Shen, Xinwei; Nie, Xueyuan; Hu, Henry

    2014-10-01

    The resistances of magnesium alloys to wear, friction and corrosion can be effectively improved by depositing coatings on their surfaces. However, the coatings can also reduce the heat transfer from the coated components to the surroundings (e.g., coated cylinder bores for internal combustion of engine blocks). In this paper, nanostructured magnesium oxides were produced by plasma electrolytic oxidation (PEO) process on the magnesium alloy AJ62 under different current densities. The guarded comparative heat flow method was adopted to measure the thermal conductivities of such coatings which possess gradient nanoscale grain sizes. The aim of the paper is to explore how the current density in the PEO process affects the thermal conductivity of the nanostructured magnesium coatings. The experimental results show that, as the current density rises from 4 to 20 A/mm2, the thermal conductivity has a slight increase from 0.94 to 1.21 W/m x K, which is significantly smaller than that of the corresponding bulk magnesium oxide materials (29.4 W/m x K). This mostly attributed to the variation of the nanoscale grain sizes of the PEO coatings.

  9. Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates.

    PubMed

    Suzuki-Kakisaka, Haruka; Sugimoto, Jun; Tetarbe, Manas; Romani, Andrea M; Ramirez Kitchen, Christina M; Bernstein, Helene B

    2013-09-01

    Magnesium sulfate (MgSO4 ) exposure reduces the risk of cerebral palsy. As neonatal inflammatory cytokine levels strongly correlate with neurologic outcome, we hypothesize that MgSO4 decreases inflammatory cytokine production. We assessed the effect of MgSO4 on cellular magnesium levels, cytokine production, and release within THP-1 and cord blood mononuclear cells. MgSO4 exposure increased intracellular magnesium levels, reducing the frequency of THP-1 cells producing IL-1β, IL-8, and TNF-α following LPS stimulation. Significant reductions in the frequency of neonatal monocytes producing TNF-α (48%) and IL-6 (37%) were seen following LPS stimulation, and MgSO4 also significantly decreased the frequency of monocytes producing TNF-α (35%) under basal conditions. Decreased cytokine production was confirmed via ELISA, demonstrating a sustained effect and dose response. Magnesium also reduced cytokine production following stimulation with TLR ligands representing obstetrical infections (group B Streptococcus and Mycoplasma) and in preterm neonatal monocytes. MgSO4 increases intracellular magnesium, reducing inflammatory cytokine production and release, potentially elucidating the mechanism by which MgSO4 prevents cerebral palsy, eclampsia, and preterm birth. © 2013 John Wiley & Sons Ltd.

  10. The Corrosion of Magnesium and of the Magnesium Aluminum Alloys Containing Manganese

    NASA Technical Reports Server (NTRS)

    Boyer, J A

    1927-01-01

    The extensive use of magnesium and its alloys in aircraft has been seriously handicapped by the uncertainties surrounding their resistance to corrosion. This problem has been given intense study by the American Magnesium Corporation and at the request of the Subcommittee on Materials for Aircraft of the National Advisory Committee for Aeronautics this report was prepared on the corrosion of magnesium. The tentative conclusions drawn from the experimental facts of this investigation are as follows: the overvoltage of pure magnesium is quite high. On immersion in salt water the metal corrodes with the liberation of hydrogen until the film of corrosion product lowers the potential to a critical value. When the potential reaches this value it no longer exceeds the theoretical hydrogen potential plus the overvoltage of the metal. Rapid corrosion consequently ceases. When aluminum is added, especially when in large amounts, the overvoltage is decreased and hydrogen plates out at a much lower potential than with pure magnesium. The addition of small amount of manganese raises the overvoltage back to practically that of pure metal, and the film is again negative.

  11. Lead magnesium niobate actuator for micropositioning

    DOEpatents

    Swift, Charles D.; Bergum, John W.

    1994-01-01

    An improved lead magnesium niobate actuator is disclosed comprising a cylindrical lead magnesium niobate crystal stack mounted in a cylindrical casing wherein a bias means, such as one or more belleville washers, is located between one end of the crystal stack and a partially closed end of the casing; and adjustment means are provided which bear against the opposite end of the crystal stack, whereby an adjustable compressive force is constantly applied against the crystal stack, whether the crystal stack is actuated in an extended position, or is in an unactuated contracted position. In a preferred embodiment, cooling ports are provided for the circulation of coolant in the actuator to cool the crystal stack, and provision is made for removal and replacement of the crystal stack without disconnecting the actuator from the external device being actuated.

  12. Lead magnesium niobate actuator for micropositioning

    DOEpatents

    Swift, C.D.; Bergum, J.W.

    1994-10-25

    An improved lead magnesium niobate actuator is disclosed comprising a cylindrical lead magnesium niobate crystal stack mounted in a cylindrical casing wherein a bias means, such as one or more belleville washers, is located between one end of the crystal stack and a partially closed end of the casing; and adjustment means are provided which bear against the opposite end of the crystal stack, whereby an adjustable compressive force is constantly applied against the crystal stack, whether the crystal stack is actuated in an extended position, or is in an unactuated contracted position. In a preferred embodiment, cooling ports are provided for the circulation of coolant in the actuator to cool the crystal stack, and provision is made for removal and replacement of the crystal stack without disconnecting the actuator from the external device being actuated. 3 figs.

  13. Lithium-aluminum-magnesium electrode composition

    DOEpatents

    Melendres, Carlos A.; Siegel, Stanley

    1978-01-01

    A negative electrode composition is presented for use in a secondary, high-temperature electrochemical cell. The cell also includes a molten salt electrolyte of alkali metal halides or alkaline earth metal halides and a positive electrode including a chalcogen or a metal chalcogenide as the active electrode material. The negative electrode composition includes up to 50 atom percent lithium as the active electrode constituent and a magnesium-aluminum alloy as a structural matrix. Various binary and ternary intermetallic phases of lithium, magnesium, and aluminum are formed but the electrode composition in both its charged and discharged state remains substantially free of the alpha lithium-aluminum phase and exhibits good structural integrity.

  14. Non-aqueous magnesium batteries. Phase 1

    SciTech Connect

    Abraham, K.M.

    1990-09-06

    The Phase I research aimed at developing nonaqueous magnesium batteries has led to the identification of several electrolytic solutions. They include Mg(ClO4)2 in propylene carbonate (PC), LiAsF6 in PC, and LiAlCl4.2.6SO2, with conductivities of 0.0044/, 0.0051/, and 0.072/ohm.cm, respectively. Because Mg is more electronegative than Li, solutions of Li salts can be used in Mg primary batteries. The Mg/CuF2 cell, utilizing the LiAlCl4.2.6SO2 electrolyte, and the MgSO2,C cell have been identified as useful electrochemical power sources, as determined by the extent of their discharge capacities. Potential commercial applications of high energy density magnesium batteries include communication devices, hand-held tools, toys, military and space equipment, and biomedical devices.

  15. Enhancements in Magnesium Die Casting Impact Properties

    SciTech Connect

    David Schwam; John F. Wallace; Yulong Zhu; Srinath Viswanathan; Shafik Iskander

    2000-06-30

    The need to produce lighter components in transportation equipment is the main driver in the increasing demand for magnesium castings. In many automotive applications, components can be made of magnesium or aluminum. While being lighter, often times the magnesium parts have lower impact and fatigue properties than the aluminum. The main objective of this study was to identify potential improvements in the impact resistance of magnesium alloys. The most common magnesium alloys in automotive applications are AZ91D, AM50 and AM60. Accordingly, these alloys were selected as the main candidates for the study. Experimental quantities of these alloys were melted in an electrical furnace under a protective atmosphere comprising sulfur hexafluoride, carbon dioxide and dry air. The alloys were cast both in a permanent mold and in a UBE 315 Ton squeeze caster. Extensive evaluation of tensile, impact and fatigue properties was conducted at CWRU on permanent mold and squeeze cast test bars of AZ91, AM60 and AM50. Ultimate tensile strength values between 20ksi and 30ksi were obtained. The respective elongations varied between 25 and 115. the Charpy V-notch impact strength varied between 1.6 ft-lb and 5 ft-lb depending on the alloy and processing conditions. Preliminary bending fatigue evaluation indicates a fatigue limit of 11-12 ksi for AM50 and AM60. This is about 0.4 of the UTS, typical for these alloys. The microstructures of the cast specimens were investigated with optical and scanning electron microscopy. Concomitantly, a study of the fracture toughness in AM60 was conducted at ORNL as part of the study. The results are in line with values published in the literature and are representative of current state of the art in casting magnesium alloys. The experimental results confirm the strong relationship between aluminum content of the alloys and the mechanical properties, in particular the impact strength and the elongation. As the aluminum content increases from about 5

  16. PIGE analysis of magnesium and beryllium

    NASA Astrophysics Data System (ADS)

    Fonseca, M.; Jesus, A. P.; Luís, H.; Mateus, R.; Cruz, J.; Gasques, L.; Galaviz, D.; Ribeiro, J. P.

    2010-06-01

    In this work, we present an alternative method for PIGE analysis of magnesium and beryllium in thick samples. This method is based on the ERYA - Emitted Radiation Yield Analysis - code, which integrates the nuclear reaction excitation function along the depth of the sample. For this purpose, the excitations functions of the 25Mg(p,p'γ) 25Mg ( Eγ = 585 keV) and 9Be(p,γ) 10B ( Eγ = 718 keV) reactions were employed. Calculated gamma-ray yields were compared, at several proton energy values, with experimental yields for thick samples made of inorganic compounds containing magnesium or beryllium. The agreement is better than 5%. Taking into consideration the experimental uncertainty of the measured yields and the errors related to the stopping power values, this agreement shows that effects as the beam energy straggling, ignored in the calculation, seem to play a minor role.

  17. Chemically prepared lead magnesium niobate dielectrics

    SciTech Connect

    Tuttle, B.A.; Voigt, J.A.; Sipola, D.L.; Olson, W.R.; Goy, D.M.

    1998-11-01

    A chemical solution powder synthesis technique has been developed that produces first, uniform powders of lead magnesium niobate (PMN) with 60 to 80 nm crystallite size. The synthesis technique was based on the dissolution of lead acetate and alkoxide precursors in acetic acid followed by precipitation with oxalic acid/propanol solutions. Lead magnesium niobate ceramics fabricated from these chemically derived powders had smaller, more uniform grain size and higher dielectric constants than ceramics fabricated from mixed oxide powders that were processed under similar thermal conditions. Chem-prep PMN dielectrics with peak dielectric constants greater than 22,000 and polarizations in excess of 29 {micro}C/cm{sup 2} were obtained for 1,100 C firing treatments. Substantial decreases in dielectric constant and polarization were measured for chemically prepared PMN ceramics fired at lower temperatures, consistent with previous work on mixed oxide materials.

  18. Sodium-dependent magnesium uptake by ferret red cells.

    PubMed Central

    Flatman, P W; Smith, L M

    1991-01-01

    1. Magnesium uptake can be measured in ferret red cells incubated in media containing more than 1 mM-magnesium. Uptake is substantially increased if the sodium concentration in the medium is reduced. 2. Magnesium uptake is half-maximally activated by 0.37 mM-external magnesium when the external sodium concentration is 5 mM. Increasing the external sodium concentration increases the magnesium concentration needed to activate the system. 3. Magnesium uptake is increased by reducing the external sodium concentration. Uptake is half-maximum at sodium concentrations of 17, 22 and 62 nM when the external magnesium concentrations are 2, 5 and 10 mM respectively. 4. Replacement of external sodium with choline does not affect the membrane potential of ferret red cells over a 45 min period. 5. Magnesium uptake from media containing 5 mM-sodium is inhibited by amiloride, quinidine and imipramine. It is not affected by ouabain or bumetanide. Vanadate stimulates magnesium uptake but has no effect on magnesium efflux. 6. When cell ATP content is reduced to 19 mumol (1 cell)-1 by incubating cells for 3 h with 2-deoxyglucose, magnesium uptake falls by 50% in the presence of 5 mM-sodium and is completely abolished in the presence of 145 mM-sodium. Some of the inhibition may be due to the increase in intracellular ionized magnesium concentration ([Mg2+]i) from 0.7 to 1.0 mM which occurs under these conditions. 7. Magnesium uptake can be driven against a substantial electrochemical gradient if the external sodium concentration is reduced sufficiently. 8. These findings are discussed in terms of several possible models for magnesium transport. It is concluded that the majority of magnesium uptake observed in low-sodium media is via sodium-magnesium antiport. A small portion of uptake is through a parallel leak pathway. It is believed that the antiport is responsible for maintaining [Mg2+]i below electrochemical equilibrium in these cells at physiological external sodium concentration

  19. A study on factors affecting the degradation of magnesium and a magnesium-yttrium alloy for biomedical applications.

    PubMed

    Johnson, Ian; Liu, Huinan

    2013-01-01

    Controlling degradation of magnesium or its alloys in physiological saline solutions is essential for their potential applications in clinically viable implants. Rapid degradation of magnesium-based materials reduces the mechanical properties of implants prematurely and severely increases alkalinity of the local environment. Therefore, the objective of this study is to investigate the effects of three interactive factors on magnesium degradation, specifically, the addition of yttrium to form a magnesium-yttrium alloy versus pure magnesium, the metallic versus oxide surfaces, and the presence versus absence of physiological salt ions in the immersion solution. In the immersion solution of phosphate buffered saline (PBS), the magnesium-yttrium alloy with metallic surface degraded the slowest, followed by pure magnesium with metallic or oxide surfaces, and the magnesium-yttrium alloy with oxide surface degraded the fastest. However, in deionized (DI) water, the degradation rate showed a different trend. Specifically, pure magnesium with metallic or oxide surfaces degraded the slowest, followed by the magnesium-yttrium alloy with oxide surface, and the magnesium-yttrium alloy with metallic surface degraded the fastest. Interestingly, only magnesium-yttrium alloy with metallic surface degraded slower in PBS than in DI water, while all the other samples degraded faster in PBS than in DI water. Clearly, the results showed that the alloy composition, presence or absence of surface oxide layer, and presence or absence of physiological salt ions in the immersion solution all influenced the degradation rate and mode. Moreover, these three factors showed statistically significant interactions. This study revealed the complex interrelationships among these factors and their respective contributions to degradation for the first time. The results of this study not only improved our understanding of magnesium degradation in physiological environment, but also presented the key

  20. A Study on Factors Affecting the Degradation of Magnesium and a Magnesium-Yttrium Alloy for Biomedical Applications

    PubMed Central

    Johnson, Ian; Liu, Huinan

    2013-01-01

    Controlling degradation of magnesium or its alloys in physiological saline solutions is essential for their potential applications in clinically viable implants. Rapid degradation of magnesium-based materials reduces the mechanical properties of implants prematurely and severely increases alkalinity of the local environment. Therefore, the objective of this study is to investigate the effects of three interactive factors on magnesium degradation, specifically, the addition of yttrium to form a magnesium-yttrium alloy versus pure magnesium, the metallic versus oxide surfaces, and the presence versus absence of physiological salt ions in the immersion solution. In the immersion solution of phosphate buffered saline (PBS), the magnesium-yttrium alloy with metallic surface degraded the slowest, followed by pure magnesium with metallic or oxide surfaces, and the magnesium-yttrium alloy with oxide surface degraded the fastest. However, in deionized (DI) water, the degradation rate showed a different trend. Specifically, pure magnesium with metallic or oxide surfaces degraded the slowest, followed by the magnesium-yttrium alloy with oxide surface, and the magnesium-yttrium alloy with metallic surface degraded the fastest. Interestingly, only magnesium-yttrium alloy with metallic surface degraded slower in PBS than in DI water, while all the other samples degraded faster in PBS than in DI water. Clearly, the results showed that the alloy composition, presence or absence of surface oxide layer, and presence or absence of physiological salt ions in the immersion solution all influenced the degradation rate and mode. Moreover, these three factors showed statistically significant interactions. This study revealed the complex interrelationships among these factors and their respective contributions to degradation for the first time. The results of this study not only improved our understanding of magnesium degradation in physiological environment, but also presented the key

  1. Processing Aspects of Magnesium Alloy Stent Tube

    NASA Astrophysics Data System (ADS)

    Werkhoven, R. J.; Sillekens, W. H.; van Lieshout, J. B. J. M.

    Biomedical applications are an emerging field of interest for magnesium technology, envisioning biodegradable implants that resorb in the human body after having cured a particular medical condition (such as artery clogging or bone fractures). This challenges research in a sense that the materials to be used need to dissolve in vivo in a controlled fashion without leaving harmful remainders and while maintaining sufficient strength and other (mechanical) attributes as long as necessary.

  2. Gas phase antimony/magnesium/oxygen clusters

    SciTech Connect

    Deng, H.T.; Okada, Y.; Foltin, M.; Castleman, A.W. Jr. )

    1994-09-15

    Antimony/magnesium/oxygen clusters are produced by a gas aggregation source, in which a mixture of antimony and magnesium is vaporized and reacted with N[sub 2]O introduced in helium carrier gas. The resulting product distribution is detected by a time-of-flight mass spectrometer following ionization with a KrF excimer laser. Four types of cluster products are observed: Sb[sub x][sup +], Sb[sub x]Mg[sub y]O[sub z][sup +], Sb[sub x]Mg[sub y][sup +], and Mg[sub y]O[sub z][sup +]. The mass spectral intensity distributions display enhanced abundances for Mg[sub 2]O[sup +], Sb[sub 2[minus]4]Mg[sub 3]O[sup +], Sb[sub 1[minus]4]Mg[sub 2]O[sup +], Sb[sub 4]Mg[sup +], Sb[sub 5]Mg[sub 2][sup +], and Sb[sub 6]Mg[sub 2][sup +]. The experimental observation of Mg[sub 2]O[sup +] and Mg[sub 3]O[sup +] shows that the suboxides of group 2 are stable species, consistent with theoretical predictions. The binding abilities of antimony clusters to magnesium and magnesium oxides are found to be dependent on cluster size. When the number of antimony atoms in the clusters is smaller than 6, Sb[sub x]Mg[sub y]O[sub z][sup +] are the main products dominating the mass distribution the mass distribution. On the other hand, when the cluster size of Sb[sub x] is larger than 6, only Sb/Mg alloy clusters are observed. 52 refs., 3 figs., 1 tab.

  3. Magnesium Oxide Induced Metabolic Alkalosis in Cattle

    PubMed Central

    Ogilvie, T.H.; Butler, D.G.; Gartley, C.J.; Dohoo, I.R.

    1983-01-01

    A study was designed to compare the metabolic alkalosis produced in cattle from the use of an antacid (magnesium oxide) and a saline cathartic (magnesium sulphate). Six, mature, normal cattle were treated orally with a magnesium oxide (MgO) product and one week later given a comparable cathartic dose of magnesium sulphate (MgSO4). The mean percent dry matter content of the cattle feces changed significantly (P<0.001) following administration of both MgO (15.6-8.1) and MgSO4 (17.0-8.7) but there was no significant difference between treatments. The mean rumen pH values changed significantly (P<0.001) following administration of both MgO (7.-8.7) and MgSO4 (7.3-8.3) but there was no significant difference between treatments. However, use of the MgO product caused a more severe (P<0.001) metabolic alkalosis as determined by base excess values. The base excess values remained elevated for 24 hours in the MgO treated group compared to only 12 hours after MgSO4 administration. Following MgO administration, mean hydrogen ion concentration (pH), bicarbonate ion concentration ([HCO3-]) and base excess were 7.44, 33.3 mmol/L and +8.0 respectively compared to 7.38, 27 mmol/L and +3.0 after MgSO4. Since the oral use of MgO in normal cattle causes a greater and more prolonged metabolic alkalosis compared to MgSO4, MgO is contraindicated as a cathartic in normal cattle or in cattle with abomasal abnormalities characterized by pyloric obstruction and metabolic alkalosis. PMID:6883181

  4. Adsorption of β-carotene on modified magnesium silicate

    NASA Astrophysics Data System (ADS)

    Sun, Shanshan; Guo, Ning; Fu, Yongfeng

    2016-02-01

    Modified flocculation magnesium silicate is prepared by a hydrothermal process at 120°C for 18 h after adding Al2(SO4)3 into the magnesium silicate gel. Compared with standard magnesium silicate with 328.116 m2 g-1 surface area, this modified magnesium silicate has a bigger BET surface area of 536.803 m2 g-1 and a lower interlayer water content. Modified magnesium silicate exhibits high β-carotene adsorption with a maximum adsorption capacity of 364.96 mg g-1. It is shown that when suspended in organic solvent, this material can be used effectively for carotenoid separation. Furthermore, our results suggest that modified magnesium silicate may be a promising candidate as an absorbent in the decoloring of oil.

  5. Serum ionized magnesium in post-traumatic headaches.

    PubMed

    Marcus, J C; Altura, B T; Altura, B M

    2001-09-01

    The objective of this study was to determine the values of serum ionized magnesium, total magnesium, and ionized calcium/ionized magnesium ratios in children with headaches. One hundred thirty-five children with primary complaints of headaches were classified according to the criteria of the International Headache Society. Blood samples were obtained and tested for ionized magnesium (IMg(2+)), total magnesium, ionized calcium (ICa(2+)), and pH. The ICa(2+)/IMg(2+) ratio was calculated. Nine children were given a diagnosis of post-traumatic headache. Six of them had statistically significant (P <.05) lowered IMg(2+) levels and high ICa(2+)/IMg(2+) ratios. Abnormalities in serum IMg(2+) concentrations and ICa(2+)/IMg(2+) ratios were found in children with post-traumatic headaches, but total magnesium levels were normal.

  6. Magnesium in the gynecological practice: a literature review.

    PubMed

    Parazzini, Fabio; Di Martino, Mirella; Pellegrino, Paolo

    2017-02-01

    A growing amount of evidence suggests that magnesium deficiency may play an important role in several clinical conditions concerning women health such as premenstrual syndrome, dysmenorrhea, and postmenopausal symptoms. A number of studies highlighted a positive correlation between magnesium administration and relief or prevention of these symptoms, thus suggesting that magnesium supplementation may represent a viable treatment for these conditions. Despite this amount of evidence describing the efficacy of magnesium, few and un-systematize data are available about the pharmacological mechanism of this ion for these conditions. Herein, we review and systematize the available evidence about the use of oral magnesium supplementation in several gynecological conditions and discuss the pharmacological mechanisms that characterize these interventions. The picture that emerges indicates that magnesium supplementation is effective in the prevention of dysmenorrhea, premenstrual syndrome, and menstrual migraine and in the prevention of climacteric symptoms.

  7. Chromium, zinc and magnesium status in type 1 diabetes.

    PubMed

    Lin, Ching-Chiang; Huang, Yeou-Lih

    2015-11-01

    Chromium, zinc, and magnesium are involved in insulin signal transduction, glucose metabolism, and cellular antioxidative defense. This review details the statuses of chromium, zinc, and magnesium in type 1 diabetes patients. Blood levels of trace elements (especially magnesium and zinc) were lower in type 1 diabetes patients than in controls and were even lower in type 1 diabetes patients with poor glycemic control. Studies with mouse models have shown that chromium and magnesium supplementation alleviated diabetes-induced complications and improved glycemic control. Many studies indicated positive correlations between decreased levels of serum chromium, zinc, and magnesium and poor glycemic control. The supplementation of type 1 diabetes patients with zinc, magnesium, and chromium may help to control diabetes and prevent diabetes-related oxidative injuries, but require further study.

  8. Biodegradable magnesium-hydroxyapatite metal matrix composites.

    PubMed

    Witte, Frank; Feyerabend, Frank; Maier, Petra; Fischer, Jens; Störmer, Michael; Blawert, Carsten; Dietzel, Wolfgang; Hort, Norbert

    2007-04-01

    Recent studies indicate that there is a high demand to design magnesium alloys with adjustable corrosion rates and suitable mechanical properties. An approach to this challenge might be the application of metal matrix composite (MMC) based on magnesium alloys. In this study, a MMC made of magnesium alloy AZ91D as a matrix and hydroxyapatite (HA) particles as reinforcements have been investigated in vitro for mechanical, corrosive and cytocompatible properties. The mechanical properties of the MMC-HA were adjustable by the choice of HA particle size and distribution. Corrosion tests revealed that HA particles stabilised the corrosion rate and exhibited more uniform corrosion attack in artificial sea water and cell solutions. The phase identification showed that all samples contained hcp-Mg, Mg(17)Al(12), and HA before and after immersion. After immersion in artificial sea water CaCO3 was found on MMC-HA surfaces, while no formation of CaCO3 was found after immersion in cell solutions with and without proteins. Co-cultivation of MMC-HA with human bone derived cells (HBDC), cells of an osteoblasts lineage (MG-63) and cells of a macrophage lineage (RAW264.7) revealed that RAW264.7, MG-63 and HBDC adhere, proliferate and survive on the corroding surfaces of MMC-HA. In summary, biodegradable MMC-HA are cytocompatible biomaterials with adjustable mechanical and corrosive properties.

  9. Magnesium deficiency impairs fear conditioning in mice.

    PubMed

    Bardgett, Mark E; Schultheis, Patrick J; McGill, Diana L; Richmond, Raymond E; Wagge, Jordan R

    2005-03-15

    Magnesium (Mg2+) is one of the most abundant cations found in the body. In the central nervous system, Mg2+ plays an important role in the function of N-methyl-D-aspartate (NMDA)-type glutamate receptors, which are centrally involved in memory processing. Despite the relatively large concentration of Mg2+ in the CNS, little is known about the behavioral consequences of Mg2+ deficiency. The purpose of this study was to address this issue by assessing fear conditioning and related behaviors in mice maintained on normal or Mg(2+)-deficient diets. Young adult male C57Bl/6J mice were placed on a control or Mg(2+)-deficient diet, and testing was conducted between 10 and 21 days later. Magnesium-deficient mice exhibited impairments in contextual and cued fear conditioning. These impairments could not be attributed to changes in locomotor activity, exploration, or pain sensitivity. Furthermore, Mg(2+)-deficient mice were more sensitive to the convulsant effects of a peripheral injection of NMDA (100 mg/kg, IP). The results suggest that magnesium deficiency can lead to specific impairments in emotional memory. Such impairments may be related to hypersensitivity of NMDA-type glutamate receptors in Mg(2+)-deficient mice.

  10. Reversible Dehydrogenation of Magnesium Borohydride to Magnesium Triborane in the Solid State Under Moderate Conditions

    SciTech Connect

    Chong, Marina; Karkamkar, Abhijeet J.; Autrey, Thomas; Orimo, Shin-ichi; Jalisatgi, Satish; Jensen, Craig M.

    2011-02-17

    Thermal decomposition of magnesium borohydride, Mg(BH4)2, in the solid state was studied by a combination of PCT, TGA/MS and NMR spectroscopy. Dehydrogenation of Mg(BH4)2 at 200 °C, results in the highly selective formation of magnesium triborane, Mg(B3H8)2. This process is reversible at 250 °C under 120 atm H2. Dehydrogenation at higher temperature, > 300 °C, produces a complex mixture of polyborane species. Solution phase 11B NMR spectra of the hydrolyzed decomposition products reveals the formation of the B3H8 anion, boric acid from hydrolysis of the unstable polyboranes (BnHx) (n = 3-11, x >8), and the closoborane B12H12 dianion as a minor product. A BH condensation mechanism involving metal hydride formation is proposed to explain the limited reversible hydrogen storage in magnesium borohydride.

  11. Design Considerations of a Condensing System for Vaporized Magnesium

    NASA Technical Reports Server (NTRS)

    Witzke, Walter R; Prok, George M; Keller, Thomas A

    1955-01-01

    The effect of the design characteristics of various condensing chambers on magnesium build-up at the chamber inlet was investigated. The condensing chambers are used in the vapor-condensation process for making magnesium slurries. A complete description of the various chamber designs and the procedure used in testing the chambers is given. The results are evaluated on the basis of clogging and total magnesium distilled per run. Orifice design was also considered.

  12. Deep tendon reflexes, magnesium, and calcium: assessments and implications.

    PubMed

    Nick, Jan M

    2004-01-01

    The perinatal nurse, in collaboration with physicians, can use deep tendon reflexes as a powerful tool in determining the need to start, adjust, or stop magnesium infusion. Toxicity can be detected using physical manifestations as a guide. Clinical signs may be a better indicator than serum levels of tissue levels of magnesium. Whether magnesium is given to prevent seizures or for tocolysis, patients in both situations are at risk for developing toxicity and must be assessed regularly to ensure patient safety.

  13. Mechanical Properties of Several Magnesium and Aluminum Composites

    DTIC Science & Technology

    1992-12-01

    34AD-A262 481 ARMY RESEARCH LABORATORY Mechanical Properties of Several Magnesium and Aluminum Composites Nikos Tsangarakis and Barmac Taleghani ARL...ESJEI L .PwmOM N.ajmns Mechanical Properties of Several Magnesium and Aluminum Composites 2.AUIwORU Nikos Tsangarakis and Barmac Taleghani 7. PERONUMMN...Several composites of magnesiumn and aluminum alloys were tested In order to assess and evaluate their mechanical properties . The magnesium alloys were

  14. Materials Comparison and Potential Applications of Magnesium in Automobiles

    NASA Astrophysics Data System (ADS)

    Luo, Alan A.

    In this paper, the material properties, structural performance, mass saving potential, design and manufacturing characteristics of magnesium are compared with various competing materials such as cast iron, steel sheet, aluminum alloys and polymers. The current and potential automotive applications of magnesium are reviewed, and the technical challenges for these applications are also discussed. Recent alloy development for powertrain applications and the creep resistance of several experimental magnesium alloys are reviewed.

  15. Impurity control and corrosion resistance of magnesium-aluminum alloy

    SciTech Connect

    Liu, M.; Song, GuangLing

    2013-01-01

    The corrosion resistance of magnesium alloys is very sensitive to the contents of impurity elements such as iron. In this study, a series of diecast AXJ530 magnesium alloy samples were prepared with additions of Mn and Fe. Through a comprehensive phase diagram calculation and corrosion evaluation, the mechanisms for the tolerance limit of Fe in magnesium alloy are discussed. This adds a new dimension to control the alloying impurity in terms of alloying composition design and casting conditions.

  16. Ballistic Evaluation of Magnesium Alloy AZ31B

    DTIC Science & Technology

    2007-04-01

    References 7 Distribution List 8 iv List of Figures Figure 1. Specific strength of magnesium versus aluminum alloy armor plate (2...1 Figure 2. Specific stiffness of magnesium versus aluminum alloy armor plate (2). ..................... 2 Figure 3. 0.30-cal APM2 armor...magnesium is approximately 35% lower than aluminum and approximately 77% lower than steel (1). The moderate strength of commercially available wrought

  17. A New Coating Process for Production of Coated Magnesium Powders

    DTIC Science & Technology

    2008-04-16

    TGA data for magnesium hydroxide content. TGA analysis of the as-coated powders is a reproducible and accurate method for the determination of... TGA analysis of the as-coated powder, there is approximately 3wt% magnesium hydroxide present in the material due to the process variation compared...11: Magnesium hydroxide content as measured by TGA analysis for the 1-lb batches of as-coated ground powder Figure 12: Nitrometer analysis of

  18. Initial observations on using magnesium metal in peripheral nerve repair.

    PubMed

    Vennemeyer, J J; Hopkins, T; Hershcovitch, M; Little, K D; Hagen, M C; Minteer, D; Hom, D B; Marra, K; Pixley, S K

    2015-03-01

    Biodegradable magnesium metal filaments placed inside biodegradable nerve conduits might provide the physical guidance support needed to improve the rate and extent of regeneration of peripheral nerves across injury gaps. In this study, we examined basic issues of magnesium metal resorption and biocompatibility by repairing sub-critical size gap injuries (6 mm) in one sciatic nerve of 24 adult male Lewis rats. Separated nerve stumps were connected with poly(caprolactone) nerve conduits, with and without magnesium filaments (0.25 mm diameter, 10 mm length), with two different conduit filler substances (saline and keratin hydrogel). At 6 weeks after implantation, magnesium degradation was examined by micro-computed tomography and histological analyses. Magnesium degradation was significantly greater when the conduits were filled with an acidic keratin hydrogel than with saline (p < 0.05). But magnesium filaments in some animals remained intact for 6 weeks. Using histological and immunocytochemical analyses, good biocompatibility of the magnesium implants was observed at 6 weeks, as shown by good development of regenerating nerve mini-fascicles and only mild inflammation in tissues even after complete degradation of the magnesium. Nerve regeneration was not interrupted by complete magnesium degradation. An initial functional evaluation, determination of size recovery of the gastrocnemius muscle, showed a slight improvement due to magnesium with the saline but not the keratin filler, compared with respective control conduits without magnesium. These results suggest that magnesium filament implants have the potential to improve repair of injured peripheral nerve defects in this rodent model.

  19. Maternal obesity and neuroprotective magnesium sulfate.

    PubMed

    McPherson, Jessica; Smiley, Sarah; Stamilio, David

    2015-10-01

    Given the association between risk of cerebral palsy and children born to obese women, the study aim was to estimate whether maternal obesity is associated with reduced effectiveness of conventional antenatal magnesium sulfate dosing for the prevention of cerebral palsy and death. This is a secondary cohort analysis of a multicenter randomized clinical trial completed by the Maternal-Fetal Medicine Units Network. Women were included in the original trial if deemed high risk for preterm delivery in the subsequent 24 hours. The present study included singleton, nonanomalous fetuses that were randomized to and received magnesium sulfate with complete data available. Outcomes between obese (body mass index ≥30 kg/m(2)) and nonobese women were compared. A secondary analysis of outcomes between morbidly obese (body mass index ≥40 kg/m(2)) and nonmorbidly obese women was performed. The primary outcome was a composite of cerebral palsy or perinatal death before 15 months corrected age. Secondary outcomes included moderate to severe cerebral palsy or death, any cerebral palsy, moderate to severe cerebral palsy, and death. A logistic regression analysis was used to estimate the odds ratio of each outcome. Based on sample size, exposure rate (obesity) and an outcome rate of 10%, assuming an 80% power and a 0.05 alpha error, this study had sufficient power to detect a 2-fold increase in the primary outcome. Of 1188 women randomized to receive magnesium sulfate, 806 were included in this analysis. After adjusting for gestational age at delivery, maternal obesity was not associated with an increased risk of cerebral palsy or death in children born to women who received magnesium sulfate. Women with morbid obesity had higher rates of the primary outcome and cerebral palsy in an unadjusted analysis but did not have increased risks after adjusting for gestational age at delivery. In analyses stratified on gestational age, morbidly obese women who delivered after 28 weeks had

  20. Improved biological performance of magnesium by micro-arc oxidation

    PubMed Central

    Ma, W.H.; Liu, Y.J.; Wang, W.; Zhang, Y.Z.

    2014-01-01

    Magnesium and its alloys have recently been used in the development of lightweight, biodegradable implant materials. However, the corrosion properties of magnesium limit its clinical application. The purpose of this study was to comprehensively evaluate the degradation behavior and biomechanical properties of magnesium materials treated with micro-arc oxidation (MAO), which is a new promising surface treatment for developing corrosion resistance in magnesium, and to provide a theoretical basis for its further optimization and clinical application. The degradation behavior of MAO-treated magnesium was studied systematically by immersion and electrochemical tests, and its biomechanical performance when exposed to simulated body fluids was evaluated by tensile tests. In addition, the cell toxicity of MAO-treated magnesium samples during the corrosion process was evaluated, and its biocompatibility was investigated under in vivo conditions. The results of this study showed that the oxide coating layers could elevate the corrosion potential of magnesium and reduce its degradation rate. In addition, the MAO-coated sample showed no cytotoxicity and more new bone was formed around it during in vivo degradation. MAO treatment could effectively enhance the corrosion resistance of the magnesium specimen and help to keep its original mechanical properties. The MAO-coated magnesium material had good cytocompatibility and biocompatibility. This technique has an advantage for developing novel implant materials and may potentially be used for future clinical applications. PMID:25517917

  1. Magnesium, aluminum and lead in various brain areas

    SciTech Connect

    Zumkley, H.; Bertram, H.P.; Brandt, M.; Roedig, M.; Spieker, C.

    1986-01-01

    Whereas the lead concentrations were increased in brain tissue of patients with chronic alcoholism, the aluminum concentrations remained within the normal range. The magnesium concentrations were found decreased in patients with chronic alcoholism compared to normal controls. The sources for the elevated lead levels seem to be the increased intake of alcohol. The decreased magnesium levels are probably caused by an increased loss of magnesium with the urine, malnutrition, malabsorption, hormonal factors and drugs. Various neurological disorders which often accompanied chronic alcoholism may be caused or aggravated by lead encephalopathy and hypomagnesemia. Therapeutical implications may be the early substitution of magnesium deficiency in chronic alcoholism. 10 references, 5 figures.

  2. Assessment of the Requirements for Magnesium Transporters in Bacillus subtilis

    PubMed Central

    Wakeman, Catherine A.; Goodson, Jonathan R.; Zacharia, Vineetha M.

    2014-01-01

    Magnesium is the most abundant divalent metal in cells and is required for many structural and enzymatic functions. For bacteria, at least three families of proteins function as magnesium transporters. In recent years, it has been shown that a subset of these transport proteins is regulated by magnesium-responsive genetic control elements. In this study, we investigated the cellular requirements for magnesium homeostasis in the model microorganism Bacillus subtilis. Putative magnesium transporter genes were mutationally disrupted, singly and in combination, in order to assess their general importance. Mutation of only one of these genes resulted in strong dependency on supplemental extracellular magnesium. Notably, this transporter gene, mgtE, is known to be under magnesium-responsive genetic regulatory control. This suggests that the identification of magnesium-responsive genetic mechanisms may generally denote primary transport proteins for bacteria. To investigate whether B. subtilis encodes yet additional classes of transport mechanisms, suppressor strains that permitted the growth of a transporter-defective mutant were identified. Several of these strains were sequenced to determine the genetic basis of the suppressor phenotypes. None of these mutations occurred in transport protein homologues; instead, they affected housekeeping functions, such as signal recognition particle components and ATP synthase machinery. From these aggregate data, we speculate that the mgtE protein provides the primary route of magnesium import in B. subtilis and that the other putative transport proteins are likely to be utilized for more-specialized growth conditions. PMID:24415722

  3. Magnesium in the CNS: recent advances and developments.

    PubMed

    Vink, Robert

    2016-03-01

    A potential neuroprotective role for magnesium in neurological disease has been appreciated for almost three decades, yet translation to the clinical arena has proven elusive. Accumulating experimental evidence continues to suggest that magnesium plays a critical role in a number of neurological conditions including headache, stress, alcohol/drug intoxication, acute brain injury, seizures, Parkinson's disease and Alzheimer's disease. Simple administration of a magnesium salt in these conditions has not always been therapeutically successful, with a number of studies showing poor penetration of serum magnesium across the blood brain barrier. Several studies have since demonstrated that using a carrier such as polyethylene glycol can address this, simultaneously reducing the dose of magnesium required to achieve the desired central effects while at the same time attenuating deleterious peripheral effects. Alternatively, administering a more permeable magnesium salt, such as magnesium threonate, is seen as the preferred option in more chronic neurological conditions, with positive results having been achieved in experimental models of Alzheimer's disease. Irrespective of the approach, improved central penetration of a magnesium compound that avoids peripheral side effects of high magnesium dosages is clearly a desirable outcome, and should now be investigated in animal models that accurately mimic the complex human condition.

  4. Magnesium Modulates Doxorubicin Activity through Drug Lysosomal Sequestration and Trafficking.

    PubMed

    Trapani, Valentina; Luongo, Francesca; Arduini, Daniela; Wolf, Federica I

    2016-03-21

    Magnesium is directly involved in the control of cell growth and survival, but its role in cancer biology and therapy is multifaceted; in particular, it is highly controversial whether magnesium levels can affect therapy outcomes. Here we investigated whether magnesium availability can modulate cellular responses to the widely used chemotherapeutic doxorubicin. We used an in vitro model consisting of mammary epithelial HC11 cells and found that high magnesium availability was correlated with diminished sensitivity both in cells chronically adapted to high magnesium concentrations and in acutely magnesium-supplemented cells. This decrease in sensitivity resulted from reduced intracellular doxorubicin accumulation in the face of a similar drug uptake rate. We observed that high-magnesium conditions caused a decrease in intracellular drug retention by altering drug lysosomal sequestration and trafficking. In our model, magnesium supplementation correspondingly modulated expression of the TRPM7 channel, which is known to control cytoskeletal organization and dynamics and may be involved in the proposed mechanism. Our findings suggest that magnesium supplementation in hypomagnesemic cancer patients may hinder response to therapy.

  5. Hydrogen storage in magnesium clusters: quantum chemical study.

    PubMed

    Wagemans, Rudy W P; van Lenthe, Joop H; de Jongh, Petra E; van Dillen, A Jos; de Jong, Krijn P

    2005-11-30

    Magnesium hydride is cheap and contains 7.7 wt % hydrogen, making it one of the most attractive hydrogen storage materials. However, thermodynamics dictate that hydrogen desorption from bulk magnesium hydride only takes place at or above 300 degrees C, which is a major impediment for practical application. A few results in the literature, related to disordered materials and very thin layers, indicate that lower desorption temperatures are possible. We systematically investigated the effect of crystal grain size on the thermodynamic stability of magnesium and magnesium hydride, using ab initio Hartree-Fock and density functional theory calculations. Also, the stepwise desorption of hydrogen was followed in detail. As expected, both magnesium and magnesium hydride become less stable with decreasing cluster size, notably for clusters smaller than 20 magnesium atoms. However, magnesium hydride destabilizes more strongly than magnesium. As a result, the hydrogen desorption energy decreases significantly when the crystal grain size becomes smaller than approximately 1.3 nm. For instance, an MgH2 crystallite size of 0.9 nm corresponds to a desorption temperature of only 200 degrees C. This predicted decrease of the hydrogen desorption temperature is an important step toward the application of Mg as a hydrogen storage material.

  6. Magnesium Sulfate: Another Cause of a Solute Diuresis.

    PubMed

    Brown, Robert S

    2017-04-01

    In pregnant women, magnesium sulfate infusions are a treatment commonly used for preeclampsia and as a tocolytic agent. In this case report, a 33-year-old woman at 26 weeks of gestation received intravenous magnesium sulfate in Ringer's lactate solution and corticosteroids for preterm uterine contractions without preeclampsia. She developed polyuria of more than 18L in 48 hours, with urine chemistries documenting that magnesium sulfate contributed 30% of the solute in this massive isosthenuric diuresis. Therefore, magnesium sulfate should be added to the common solutes, glucose, sodium chloride, urea, and mannitol, as a cause of solute diureses. Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

  7. Measurement of serum ionized magnesium in CAPD patients.

    PubMed

    Saha, H H; Harmoinen, A P; Pasternack, A I

    1997-01-01

    To evaluate the magnesium status of continuous ambulatory peritoneal dialysis (CAPD) patients using a new method for assessing the level of the ionized fraction of serum magnesium. Serum ionized magnesium was measured in CAPD patients using the ion-selective electrode for Mg2+. The Dialysis Unit of Tampere University Hospital. Twenty-six patients on CAPD (age: 21-81 years, mean 54 +/- 16 years; duration of CAPD: 3-52 months, mean 13 months), and 26 sex- and age-matched healthy controls. Both serum ionized magnesium (0.73 +/- 0.11 mmol/L vs 0.56 +/- 0.07 mmol/L, p < 0.001) and total magnesium (1.11 +/- 0.22 vs 0.81 +/- 0.08 mmol/L, p < 0.01) were higher in CAPD patients than in sex- and age-matched controls. The ionized magnesium fraction of total magnesium was slightly lower in dialysis patients in spite of the fact that 16/26 patients had serum albumin less than 36 g/L. Hypermagnesemia (mean serum ionized magnesium 0.78 +/- 0.10 mmol/L) was observed in the 13 of 26 patients with 0.75 mmol/L Mg2+ dialysate; those with lower magnesium dialysate (Mg2+ 0.50 mmol/L in 10/26 and Mg2+ 0.25 mmol/L in 3/26) had mean serum ionized magnesium at the upper normal margin (0.69 +/- 0.10 mmol/L). In CAPD patients with Mg2+ 0.5-0.75 mmol/L in their dialysis fluid, both serum ionized and total magnesium concentrations were higher but the ionized/total magnesium ratio was lower than in healthy control subjects. Use of ion-selective electrodes to measure ionized magnesium may be a more useful methodology than measuring total magnesium in the evaluation of magnesium status of CAPD patients, because it is not influenced by hypoalbuminemia or increased complexed fraction of magnesium often present in dialysis patients.

  8. Role of magnesium on the biomimetic deposition of calcium phosphate

    NASA Astrophysics Data System (ADS)

    Sarma, Bimal K.; Sarma, Bikash

    2016-10-01

    Biomimetic depositions of calcium phosphate (CaP) are carried out using simulated body fluid (SBF), calcifying solution and newly developed magnesium containing calcifying solution. Calcium phosphate has a rich phase diagram and is well known for its excellent biocompatibility and bioactivity. The most common phase is hydroxyapatite (HAp), an integral component of human bone and tooth, widely used in orthopedic and dental applications. In addition, calcium phosphate nanoparticles show promise for the targeted drug delivery. The doping of calcium phosphate by magnesium, zinc, strontium etc. can change the protein uptake by CaP nanocrystals. This work describes the role of magnesium on the nucleation and growth of CaP on Ti and its oxide substrates. X-ray diffraction studies confirm formation of HAp nanocrystals which closely resemble the structure of bone apatite when grown using SBF and calcifying solution. It has been observed that magnesium plays crucial role in the nucleation and growth of calcium phosphate. A low magnesium level enhances the crystallinity of HAp while higher magnesium content leads to the formation of amorphous calcium phosphate (ACP) phase. Interestingly, the deposition of ACP phase is rapid when magnesium ion concentration in the solution is 40% of calcium plus magnesium ions concentration. Moreover, high magnesium content alters the morphology of CaP films.

  9. Recent advances in research on magnesium alloys and magnesium-calcium phosphate composites as biodegradable implant materials.

    PubMed

    Kuśnierczyk, Katarzyna; Basista, Michał

    2016-07-01

    Magnesium alloys are modern biocompatible materials suitable for orthopaedic implants due to their biodegradability in biological environment. Many studies indicate that there is a high demand to design magnesium alloys with controllable in vivo corrosion rates and required mechanical properties. A solution to this challenge can be sought in the development of metal matrix composites based on magnesium alloys with addition of relevant alloying elements and bioceramic particles. In this study, the corrosion mechanisms along with corrosion protection methods in magnesium alloys are discussed. The recently developed magnesium alloys for biomedical applications are reviewed. Special attention is given to the newest research results in metal matrix composites composed of magnesium alloy matrix and calcium phosphates, especially hydroxyapatite or tricalcium phosphate, as the second phase with emphasis on the biodegradation behavior, microstructure and mechanical properties in view of potential application of these materials in bone implants.

  10. [The role of alimentary magnesium deficiency in development of nephrolithiasis and its correction with magnesium salts in rats].

    PubMed

    Spasov, A A; Iezhitsa, I N; Kharitonova, M V; Kravchenko, M S; Snigur, G L

    2008-01-01

    Aims of our work were to appraise the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rats; and to find out whether the combination of pyridoxine with Mg L-aspartate or Mg chloride will reduce the length of the treatment needed to recover rats from magnesium deficient condition and urolithiasis state. To induce hypomagnesemia, fifty rats were placed on a magnesium-deficient diet (magnesium content < or = 15 mg/kg) and demineralized water for 10 weeks. On the forty-ninth day of magnesium-deficient diet, rats were treated one of the six supplementations: MgCl2, Mg-L-Asp or their combinations with pyridoxine hydrochloride, magnesium sulfate, magne B6.

  11. The unexpected discovery of the Mg(HMDS) 2 /MgCl 2 complex as a magnesium electrolyte for rechargeable magnesium batteries

    SciTech Connect

    Liao, Chen; Sa, Niya; Key, Baris; Burrell, Anthony K.; Cheng, Lei; Curtiss, Larry A.; Vaughey, John T.; Woo, Jung-Je; Hu, Libo; Pan, Baofei; Zhang, Zhengcheng

    2015-02-02

    We developed a unique class of non-Grignard, aluminum-free magnesium electrolytes based on a simple mixture of magnesium compounds: magnesium hexamethyldisilazide (Mg(HMDS)2) and magnesium chloride (MgCl2).

  12. Relationship between renal function and serum magnesium concentration in elderly outpatients treated with magnesium oxide.

    PubMed

    Horibata, Ken; Tanoue, Akiko; Ito, Masaaki; Takemura, Yousuke

    2016-05-01

    We investigated the relationship between renal function and serum magnesium concentration in elderly patients treated with magnesium oxide (MgO) in an outpatient setting of an urban hospital in Japan. In the present study, 44 elderly outpatients (23 patients with constipation treated with daily oral MgO and 21 untreated patients in the control group) who visited Kameyama municipal medical center were enrolled. Variables were age, sex, weight, height, serum magnesium concentration, serum blood urea nitrogen level, serum creatinine level, use of other magnesium-containing supplements and symptoms associated with hypermagnesemia. We calculated the estimated glomerular filtration rate (eGFR) and classified patients based on eGFR category. Compared with the control group, the MgO group showed a significantly higher concentration of serum magnesium (median 2.2 mg/dL [interquartile range 2.1-2.3] vs 2.4 mg/dL [2.2-2.6], P < 0.001). Hypermagnesemia (>2.6 mg/dL) was noted only in the MgO group. However, symptoms associated with hypermagnesemia occurred in patients from both groups, with no significant difference between groups. In the MgO group, significant difference was seen in the median serum magnesium concentration between eGFR categories (P < 0.05). The category G4 (eGFR 15-29 mL/min/1.73 m(2) ) group had the highest serum magnesium concentration in the MgO group (3.0 mg/L [2.9-3.1]). Elderly patients treated with MgO have higher serum magnesium levels compared with the control group. MgO should be prescribed with caution in patients with low renal function as shown by a GFR category G3b or less (eGFR < 30 mL/min/1.73 m(2) ). Geriatr Gerontol Int 2016; 16: 600-605. © 2015 Japan Geriatrics Society.

  13. Rechargeable Magnesium Batteries: Low-Cost Rechargeable Magnesium Batteries with High Energy Density

    SciTech Connect

    2010-10-01

    BEEST Project: Pellion Technologies is developing rechargeable magnesium batteries that would enable an EV to travel 3 times farther than it could using Li-ion batteries. Prototype magnesium batteries demonstrate excellent electrochemical behavior; delivering thousands of charge cycles with very little fade. Nevertheless, these prototypes have always stored too little energy to be commercially viable. Pellion Technologies is working to overcome this challenge by rapidly screening potential storage materials using proprietary, high-throughput computer models. To date, 12,000 materials have been identified and analyzed. The resulting best materials have been electrochemically tested, yielding several very promising candidates.

  14. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia.

    PubMed

    Taber, Evan B; Tan, Lily; Chao, Conrad R; Beall, Marie H; Ross, Michael G

    2002-05-01

    Intravenous magnesium sulfate is widely used in obstetrics for the treatment of both preterm labor and preeclampsia. Although therapeutic levels of total magnesium have been proposed, the levels remain controversial. Because the active form of magnesium is the free or ionized form, it is essential to determine whether ionized magnesium and total magnesium levels are highly correlated in vivo. We sought to examine the correlation between ionized magnesium and total magnesium under basal and therapeutic conditions and to define the initiation and elimination pharmacokinetics of both forms during intravenous magnesium sulfate infusion. Twenty-four singleton pregnant patients who were candidates for magnesium sulfate were studied (preterm labor, 15; preeclampsia, 9). Serial blood samples were taken before the magnesium sulfate infusion, during the first 4 hours after the initiation of magnesium sulfate infusion and for 4 hours after the discontinuation of the infusion. Baseline levels of total magnesium and ionized magnesium were not different between patients with preterm labor and with preeclampsia. Among patients with preeclampsia, although not patients with preterm labor, the initial apparent volume of distribution was significantly smaller for total magnesium than for ionized magnesium (16,397 +/- 1441 vs 23,856 +/- 2745 mL, respectively; P =.03), and the elimination half-life was greater for total magnesium as compared to ionized magnesium (707 +/- 160 vs 313 +/- 29 minutes;P <.05). Linear regression analysis demonstrated a lack of correlation between ionized magnesium and total magnesium during the pretreatment period and during the steady state infusion for both preterm labor and preeclampsia. The measurement of total magnesium may not be adequate for the titration of therapeutic magnesium infusions in patients with preeclampsia or preterm labor because of the lack of correlation between total magnesium and the physiologically active ionized magnesium. Further

  15. Performance characteristics of magnesium/para-nitrophenol cells in 2:1 magnesium electrolytes

    SciTech Connect

    Kumar, G.; Sivashanugam, A.; Sridharan, R. )

    1993-11-01

    1 V/1 Ah magnesium/para-nitrophenol (PNP) reserve cells were fabricated and their performance was evaluated in different electrolytes [2M aqueous solutions of Mg(C1O[sub 4])[sub 2], MgCl[sub 2], and MgBr[sub 2

  16. Magnesium and metabolic syndrome: The role of magnesium in health and disease

    USDA-ARS?s Scientific Manuscript database

    Metabolic syndrome is a constellation of conditions associated with elevated risk of diabetes and cardiovascular disease. Magnesium, the fourth most abundant cation in the human body and required in over 300 enzymatic reactions, has been shown in experimental, observational, and clinical studies to ...

  17. Cryogenic Thermoelectric Properties of the Bismuth-Magnesium and Bismuth-Antimony-Magnesium Systems

    NASA Astrophysics Data System (ADS)

    Orovets, Christine; Jin, Hyungyu; Wiendlocha, Bartlomiej; Heremans, Joseph P.

    2012-02-01

    There is a need to increase the Figure of Merit of thermoelectric materials used in low temperature cooling applications. Band structure calculations show that substitutional magnesium in bismuth can form sharp density of states peaks, suggesting the presence of a resonant level. Single crystal samples of (Bi1-xSbx)1-yMgy (0 <= x <= 12% and 0 <= y <= 0.7% nominally) were synthesized in evacuated ampoules. The composition of each ingot was analyzed using x-ray diffraction, and transport properties were measured using a Thermal Transport Option (TTO) in a Physical Properties Measurement System (PPMS) from 300K to 2K. It is apparent that the addition of magnesium strongly influences thermopower; the data for Bi90Sb10Mg0.7 shows a second minimum in thermopower at 20K, in addition to the expected minimum at approximately 50-60K. This could be due to the resonant scattering at the cryogenic temperatures which arises from the excess density of states. The addition of magnesium also appears to decrease thermal conductivity below 30K. We present systematic experimental approaches and the results to elucidate the role of magnesium in bismuth and bismuth-antimony systems.

  18. Magnesium Battery Electrolytes in Ionic Liquids

    NASA Astrophysics Data System (ADS)

    Watkins, Tylan Strike

    A lack of adequate energy storage technologies is arguably the greatest hindrance to a modern sustainable energy infrastructure. Chemical energy storage, in the form of batteries, is an obvious solution to the problem. Unfortunately, today's state of the art battery technologies fail to meet the desired metrics for full scale electric grid and/or electric vehicle role out. Considerable effort from scientists and engineers has gone into the pursuit of battery chemistries theoretically capable of far outperforming leading technologies like Li-ion cells. For instance, an anode of the relatively abundant and cheap metal, magnesium, would boost the specific energy by over 4.6 times that of the current Li-ion anode (LiC6). The work presented here explores the compatibility of magnesium electrolytes in TFSI---based ionic liquids with a Mg anode (TFSI = bis(trifluoromethylsulfonyl)imide). Correlations are made between the Mg2+ speciation conditions in bulk solutions (as determined via Raman spectroscopy) and the corresponding electrochemical behavior of the electrolytes. It was found that by creating specific chelating conditions, with an appropriate Mg salt, the desired electrochemical behavior could be obtained, i.e. reversible electrodeposition and dissolution. Removal of TFSI -- contact ion pairs from the Mg2+ solvation shell was found to be essential for reversible electrodeposition. Ionic liquids with polyethylene glycol chains pendent from a parent pyrrolidinium cation were synthesized and used to create the necessary complexes with Mg 2+, from Mg(BH4)2, so that reversible electrodeposition from a purely ionic liquid medium was achieved. The following document discusses findings from several electrochemical experiments on magnesium electrolytes in ionic liquids. Explanations for the failure of many of these systems to produce reversible Mg electrodeposition are provided. The key characteristics of ionic liquid systems that are capable of achieving reversible Mg

  19. Casting Porosity-Free Grain Refined Magnesium Alloys

    SciTech Connect

    Schwam, David

    2013-08-12

    The objective of this project was to identify the root causes for micro-porosity in magnesium alloy castings and recommend remedies that can be implemented in production. The findings confirm the key role played by utilizing optimal gating and risering practices in minimizing porosity in magnesium castings. 

  20. Adsorption of oxygen and 1-butene on magnesium ferrite

    SciTech Connect

    Samuilova, O.K.; Kozlova, M.M.; Yagodovskii, V.D.

    1986-08-01

    The kinetics of the adsorption of oxygen and 1-butene on magnesium ferrite was studied. Conductometry and thermal desorption methods were used to investigate the adsorption of oxygen on magnesium ferrite. Two forms of adsorbed oxygen were found. The formation of these forms affects the kinetics of the adsorption of 1-butene.

  1. Fogging technique used to coat magnesium with plastic

    NASA Technical Reports Server (NTRS)

    Mroz, T. S.

    1967-01-01

    Cleaning process and a fogging technique facilitate the application of a plastic coating to magnesium plates. The cleaning process removes general organic and inorganic surface impurities, oils and greases, and oxides and carbonates from the magnesium surfaces. The fogging technique produces a thin-filmlike coating in a clean room atmosphere.

  2. Absence of correlation between magnesium and riboflavin status.

    PubMed

    Eisinger, J; Clairet, D; Brue, F; Ayavou, T

    1993-06-01

    Erythrocyte magnesium and glutathione reductase activity coefficient (EGR-AC), reflecting vitamin B-2 status, were assessed in 11 athletes, 20 patients with fibromyalgia, 18 patients with hypothyroidism, and 13 controls. No correlation was demonstrated between erythrocyte magnesium and EGR-AC.

  3. Microtomography of magnesium implants in bone and their degradation

    NASA Astrophysics Data System (ADS)

    Witte, Frank; Fischer, Jens; Nellesen, Jens; Beckmann, Felix

    2006-08-01

    Biodegradable metal implants for musculoskeletal and intravascular applications made of magnesium alloys have been shown to degrade in-vivo by corrosion. The in vivo corrosion of magnesium alloys has the potential to provide a new mechanism which will allow metal implants to be applied in musculoskeletal surgery as biodegradable implants. This would particularly be true if magnesium alloys with predictable in vivo corrosion rates could be developed. Since the magnesium corrosion process depends on the corrosive environment, the corrosion rates of magnesium alloys under standard in-vitro environmental conditions are not directly comparable to results obtained from an animal model. Synchrotron-radiation based microtomography (SRμCT) enabled us to investigate non-destructively the in vivo corrosion as well as the osteointegration at the implant-bone interphase at a high spatial resolution. Corrosion morphology and its metallurgical quantification of pit formation could be obtained. Since the alloying elements of magnesium alloys have significant importance for the degradation process in biological environments the biocompatibility depending on their local concentration and distribution has to be investigated. For this purpose we used element-specific SRμCT to show the spatial distribution without destroying the bone-implant interphase. The SRμCT setup at HASYLAB at DESY will be an excellent tool in the future to develop suitable magnesium alloys and magnesium implants for special medical applications.

  4. Magnesium in cystic fibrosis--Systematic review of the literature.

    PubMed

    Santi, Maristella; Milani, Gregorio P; Simonetti, Giacomo D; Fossali, Emilio F; Bianchetti, Mario G; Lava, Sebastiano A G

    2016-02-01

    The metabolism of sodium, potassium, and chloride and the acid-base balance are sometimes altered in cystic fibrosis. Textbooks and reviews only marginally address the homeostasis of magnesium in cystic fibrosis. We performed a search of the Medical Subject Headings terms (cystic fibrosis OR mucoviscidosis) AND (magnesium OR hypomagnes[a]emia) in the US National Library of Medicine and Excerpta Medica databases. We identified 25 reports dealing with magnesium and cystic fibrosis. The results of the review may be summarized as follows. First, hypomagnesemia affects more than half of the cystic fibrosis patients with advanced disease; second, magnesemia, which is normally age-independent, relevantly decreases with age in cystic fibrosis; third, aminoglycoside antimicrobials frequently induce both acute and chronic renal magnesium-wasting; fourth, sweat magnesium concentration was normal in cystic fibrosis patients; fifth, limited data suggest the existence of an impaired intestinal magnesium balance. Finally, stimulating observations suggest that magnesium supplements might achieve an improvement in respiratory muscle strength and mucolytic activity of both recombinant and endogenous deoxyribonuclease. The first comprehensive review of the literature confirms that, despite being one of the most prevalent minerals in the body, the importance of magnesium in cystic fibrosis is largely overlooked. In these patients, hypomagnesemia should be sought once a year. Furthermore, the potential of supplementation with this cation deserves more attention. © 2015 Wiley Periodicals, Inc.

  5. The role of magnesium in hypertension and cardiovascular disease.

    PubMed

    Houston, Mark

    2011-11-01

    Magnesium intake of 500 mg/d to 1000 mg/d may reduce blood pressure (BP) as much as 5.6/2.8 mm Hg. However, clinical studies have a wide range of BP reduction, with some showing no change in BP. The combination of increased intake of magnesium and potassium coupled with reduced sodium intake is more effective in reducing BP than single mineral intake and is often as effective as one antihypertensive drug in treating hypertension. Reducing intracellular sodium and calcium while increasing intracellular magnesium and potassium improves BP response. Magnesium also increases the effectiveness of all antihypertensive drug classes. It remains to be conclusively proven that cardiovascular disease such as coronary heart disease, ischemic stroke, and cardiac arrhythmias can be prevented or treated with magnesium intake. Preliminary evidence suggests that insulin sensitivity, hyperglycemia, diabetes mellitus, left ventricular hypertrophy, and dyslipidemia may be improved with increased magnesium intake. Various genetic defects in magnesium transport are associated with hypertension and possibly with cardiovascular disease. Oral magnesium acts as a natural calcium channel blocker, increases nitric oxide, improves endothelial dysfunction, and induces direct and indirect vasodilation. © 2011 Wiley Periodicals, Inc.

  6. Ballistic Characterization of the Scalability of Magnesium Alloy AMX602

    DTIC Science & Technology

    2015-07-01

    Magnesium Alloy AMX602 by Tyrone L Jones Weapons and Materials Research Directorate, ARL Katsuyoshi Kondoh Joining and Welding Research...formed a collaborative partnership with Osaka University Joining and Welding Research Institute (JWRI), Taber Extrusions, Epson Atmix, Pacific Sowa...alloy are provided. 15. SUBJECT TERMS magnesium, AMX602, armor mechanisms, AZ31B, aluminum alloy 5083 16. SECURITY CLASSIFICATION OF: 17. LIMITATION

  7. Association of Cord Blood Magnesium Concentration and Neonatal Resuscitation

    PubMed Central

    Johnson, Lynn H.; Mapp, Delicia C.; Rouse, Dwight J.; Spong, Catherine Y.; Mercer, Brian M.; Leveno, Kenneth J.; Varner, Michael W.; Iams, Jay D.; Sorokin, Yoram; Ramin, Susan M.; Miodovnik, Menachem; O'Sullivan, Mary J.; Peaceman, Alan M.; Caritis, Steve N.

    2014-01-01

    Objective Assess the relationship between umbilical cord blood magnesium concentration and level of delivery room resuscitation received by neonates. Study design Secondary analysis of a controlled fetal neuroprotection trial that enrolled women at imminent risk for delivery between 24 and 31 weeks’ gestation and randomly allocated them to receive intravenous magnesium sulfate or placebo. The cohort included 1507 infants for whom total cord blood magnesium concentration and delivery room resuscitation information were available. Multivariable logistic regression was used to estimate the association between cord blood magnesium concentration and highest level of delivery room resuscitation, using the following hierarchy: none, oxygen only, bag-mask ventilation with oxygen, intubation or chest compressions. Results There was no relationship between cord blood magnesium and delivery room resuscitation (odds ratio [OR] 0.92 for each 1.0 mEq/L increase in magnesium; 95% confidence interval [CI]: 0.83-1.03). Maternal general anesthesia was associated with increased neonatal resuscitation (OR 2.51; 95% CI: 1.72-3.68). Each 1-week increase in gestational age at birth was associated with decreased neonatal resuscitation (OR 0.63; 95% CI: 0.60 – 0.66). Conclusion Cord blood magnesium concentration does not correlate with the level of delivery room resuscitation of infants exposed to magnesium sulfate for fetal neuroprotection. PMID:22056282

  8. Osteoblastic cell response on magnesium-incorporated apatite coatings

    NASA Astrophysics Data System (ADS)

    Qi, Guochao; Zhang, Sam; Khor, Khiam Aik; Lye, Sun Woh; Zeng, Xianting; Weng, Wenjian; Liu, Chunming; Venkatraman, Subbu S.; Ma, Lwin Lwin

    2008-11-01

    Magnesium is one of the most important bivalent ions associated with biological apatite. A series of magnesium-substituted calcium apatite coatings (Ca 10- xMg x)(PO 4) 6(OH) 2, where x = 0, 0.50, 1.00, 1.50 and 2.00, are synthesized onto Ti6Al4V substrate by sol-gel dip-coating method to determine how magnesium influences the synthesis and the resulting structural and biological properties. X-ray diffraction (XRD) analysis shows that the incorporation of magnesium helps formation of Mg-containing β-TCP (β-TCMP) phase. X-ray photoelectron spectroscopy (XPS) is used to study the chemical composition and the results show that the apatite structure can only host magnesium less than ˜2.4 wt.% beyond which magnesium aggregates on the surfaces. The incorporation of magnesium slows down the dissolution of Ca 2+ from the coating. The in vitro behavior of the coatings is evaluated with human osteosarcoma MG63 cells for cell morphology and proliferation. Similar cell morphologies are observed on all coatings. The cell proliferation results show that the incorporation of magnesium up to x = 2 has no adverse effect on cell growth.

  9. Recent data on the evaluation of magnesium bioavailability in humans.

    PubMed

    Benech, H; Grognet, J M

    1995-09-01

    Assessment of the bioavailability of exogenous ions present in a large amounts in the body, such as magnesium, cannot be performed by the conventional measurement of plasma levels after intravenous and/or oral administration. In the case of magnesium, this is emphasized by the fact that plasma levels are quickly regulated, mainly by the kidney and in storage compartments such as bone, after exogenous administration. Magnesium bioavailability and absorption are studied by indirect methods or by using radioactive or stable isotopes as tracers. Indirect methods are the metabolic balance method and comparison of urinary excretion between a treatment and a placebo period, often after magnesium load. However, the former only measures magnesium absorption and the latter is subject to the fragile balance of magnesium urinary excretion. Isotope studies, in particular with stable isotope probes, have benefited from the developments in mass spectrometry, such as inductively coupled plasma mass spectrometry (ICP-MS). It is possible to follow exogenous magnesium in plasma after oral and intravenous administrations using 25Mg and 26Mg as tracers, and to calculate the absolute bioavailability of magnesium.

  10. Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles.

    PubMed

    Murata, Takahiro; Dietrich, Hans H; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro; Dacey, Ralph G

    2016-06-01

    We investigated in cerebral penetrating arterioles the signaling mechanisms and dose-dependency of extracellular magnesium-induced vasodilation and also its vasodilatory effects in vessels preconstricted with agonists associated with delayed cerebral vasospasm following SAH. Male rat penetrating arterioles were cannulated. Their internal diameters were monitored. To investigate mechanisms of magnesium-induced vasodilation, inhibitors of endothelial function, potassium channels and endothelial impairment were tested. To simulate cerebral vasospasm we applied several spasmogenic agonists. Increased extracellular magnesium concentration produced concentration-dependent vasodilation, which was partially attenuated by non-specific calcium-sensitive potassium channel inhibitor tetraethylammonium, but not by other potassium channel inhibitors. Neither the nitric oxide synthase inhibitor L-NNA nor endothelial impairment induced by air embolism reduced the dilation. Although the magnesium-induced vasodilation was slightly attenuated by the spasmogen ET-1, neither application of PF2α nor TXA2 analog effect the vasodilation. Magnesium induced a concentration- and smooth muscle cell-dependent dilation in cerebral penetrating arterioles. Calcium-sensitive potassium channels of smooth muscle cells may play a key role in magnesium-induced vasodilation. Magnesium also dilated endothelium-impaired vessels as well as vessels preconstricted with spasmogenic agonists. These results provide a fundamental background for the clinical use of magnesium, especially in treatment against delayed cerebral ischemia or vasospasm following SAH. Copyright © 2015 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.

  11. Magnesium Finishing for OEM and Overhaul

    DTIC Science & Technology

    2011-02-01

    Corrosion Resistance TAGNITE® HAE DOW 17 Superior Corrosion Resistance  HAE AZ91E sand cast magnesium test plates assembled using cadmium plated...HAEl i   i  ‐ AZ91E Test Panel Coated with HAE Cadmium-Plated Steel Washer Cadmium-Plated Steel Bolt Galvanic Corrosion – Dow 17l i   i...Cadmium-Plated Steel Bolt Cadmium-Plated Steel Washer AZ91E Test Panel Coated with TAGNITE® Galvanic Corrosion – TAGNITEl i   i   I Cadmium-Plated

  12. Disorders Involving Calcium, Phosphorus, and Magnesium

    PubMed Central

    Moe, Sharon M.

    2008-01-01

    Abnormalities of calcium, phosphorus and magnesium homeostasis are common, and collectively are called disorders of mineral metabolism. Normal homeostatic regulation maintains serum levels, intracellular levels, and optimal mineral content in bone. This regulation occurs at three major target organs, the intestine, kidney and bone, principally via the complex integration of two hormones, parathyroid hormone and vitamin D. An understanding of normal physiology is necessary to accurately diagnose and treat disorders of mineral metabolism and will be briefly reviewed before discussing the differential diagnosis and treatment of specific disorders. PMID:18486714

  13. Product development of FGD recovered magnesium hydroxide

    SciTech Connect

    Beeghly, J.H.; Babu, M.; Smith, K.J.

    1999-07-01

    The ThioClear FGD processes developed by the Dravo Lime Company (DLC) produce a high brightness gypsum and magnesium hydroxide (Mg(OH){sub 2}) by-product. Both originate as white precipitates from a solution of magnesium sulfate. The use of magnesium-enhanced lime avoids the mineral impurities from direct neutralization when using pulverized limestone rock. White, pure FGD synthetic gypsum can be used to produce higher value products such as mineral fillers and industrial plasters. This paper focuses on the product development of the Mg(OH){sub 2} by-product. Commercial Mg(OH){sub 2} sells at over $200/Ton for a variety of uses, most of which is wastewater treatment and a feedstock to make magnesium chemicals and refractories. Beneficial uses in the power plant are pH control of acidic coal pile stormwater runoff and bottom ash quench water. A future use being explored is injection into coal fired boilers to neutralize sulfur trioxide (SO{sub 3}) to prevent stack gas opacity related emission problems and minimize air preheater corrosion and fouling. The objective of this project is to improve the purity and solids content of the by-product after it is separated from the gypsum. Several options were investigated to convert it into a more marketable or usable form. Test results and economic evaluations are reported during the different process steps needed to improve the product quality: (1) dissolving or washing out the gypsum impurity; (2) thickening the washed solids and using the overflow for makeup water within the FGD water balance; (3) finding the best means to dewater the washed, thickened slurry; and (4) repulp the dewatered cake into a stabilized slurry or dry it to powder. Flash drying the dewatered cake is compared to spray drying the thickened slurry. FGD Mg(OH){sub 2} is shown to have equal reactivity as an acid neutralization reagent on a Mg(OH){sub 2} molar basis to commercial Mg(OH){sub 2} products and other alkaline reagents. Its use for pH control

  14. Magnesium cluster film synthesis by helium nanodroplets.

    PubMed

    Emery, Samuel B; Rider, Keith B; Little, Brian K; Schrand, Amanda M; Lindsay, C Michael

    2013-08-07

    Atomic and molecular clusters are a unique class of substances with properties that differ greatly from those of the bulk or single atoms due to changes in surface to volume ratio and finite size effects. Here, we demonstrate the ability to create cluster matter films using helium droplet mediated cluster assembly and deposition, a recently developed methodology that condenses atoms or molecules within liquid helium droplets and then gently deposits them onto a surface. In this work, we examine magnesium nanocluster films, which exhibit growth behavior comparable to low-energy cluster beam methods, and demonstrate physical properties and morphology dependent on helium droplet size.

  15. Nanostructured Magnesium Hydride for Reversible Hydrogen Storage

    NASA Astrophysics Data System (ADS)

    de Rango, P.; Chaise, A.; Fruchart, D.; Miraglia, S.; Marty, Ph.

    2013-05-01

    The aim of this work was to develop suitable materials to store hydrogen in a solid state. A systematic investigation of the co-milling process of magnesium hydride with a transition metal was undertaken in order to produce nanostructured and highly reactive powders. The initiating role of the transition metal was evidenced by in situ neutron diffraction experiments. High performances in terms of thermal and mechanical behavior were achieved introducing expanded graphite and compacting the mixture to form composite materials. Absorption and desorption kinetics have been measured versus temperature and H2 pressure.

  16. Fabrication of faceted nanopores in magnesium

    SciTech Connect

    Wu, Shujing; Cao, Fan; Zheng, He; Sheng, Huaping; Liu, Chun; Liu, Yu; Zhao, Dongshan; Wang, Jianbo

    2013-12-09

    In this paper, using high resolution transmission electron microscopy, we showed the fabrication of faceted nanopores with various shapes in magnesium by focused electron beam (e-beam). The characteristics of nanopore shapes and the crystallographic planes corresponding to the edges of the nanopores were discussed in detail. Interestingly, by manipulating the e-beam (e.g., irradiation direction and duration), the nanopore shape and size could be effectively controlled along different directions. Our results provide important insight into the nanopore patterning in metallic materials and are of fundamental importance concerning the relevant applications, such as nanopore-based sensor, etc.

  17. Magnesium homeostasis in critically ill patients.

    PubMed

    Ryzen, E

    1989-01-01

    Magnesium (Mg) deficiency is a common finding in critically ill patients. Mg deficiency results primarily from gastrointestinal or urinary Mg losses, but malnutrition and decreased dietary Mg intake may hasten the development of Mg depletion. In our medical intensive-care unit, we have found hypomagnesemia in 65% of patients with normal serum creatinine concentrations. The prevalence of normomagnesemic Mg deficiency in critically ill patients may be even higher and may contribute to the pathogenesis of hypocalcemia, cardiac arrhythmias and other symptoms of Mg deficiency.

  18. MOVPE growth of zincblende magnesium sulphide

    NASA Astrophysics Data System (ADS)

    Konczewicz, L.; Bigenwald, P.; Cloitre, T.; Chibane, M.; Ricou, R.; Testud, P.; Briot, O.; Aulombard, R. L.

    1996-02-01

    The successful growth of MgS epitaxial layers with the MOVPE technique is reported. The samples were grown on GaAs substrates in a classical horizontal reactor, using bis(methylcyclopentadienyl) magnesium and H 2S as precursors. The zincblende structure of MgS layers is evidenced by careful X-ray diffraction analysis. The lattice constant is found to be about 5.66 Å. The influence of the growth temperature on the morphology and quality of the layers is studied in detail.

  19. Thermal Stability of Magnesium Silicide/Nickel Contacts

    NASA Astrophysics Data System (ADS)

    de Boor, J.; Droste, D.; Schneider, C.; Janek, J.; Mueller, E.

    2016-10-01

    Magnesium silicide-based materials are a very promising class of thermoelectric materials with excellent potential for thermoelectric waste heat recovery. For the successful application of magnesium silicide-based thermoelectric generators, the development of long-term stable contacts with low contact resistance is as important as material optimization. We have therefore studied the suitability of Ni as a contact material for magnesium silicide. Co-sintering of magnesium silicide and Ni leads to the formation of a stable reaction layer with low electrical resistance. In this paper we show that the contacts retain their low electrical contact resistance after annealing at temperatures up to 823 K for up to 168 h. By employing scanning electron microscope analysis and time-of-flight (ToF)-secondary ion mass spectrometry, we can further show that elemental diffusion is occurring to a very limited extent. This indicates long-term stability under practical operation conditions for magnesium silicide/nickel contacts.

  20. Security assessment of magnesium alloys used as biodegradable implant material.

    PubMed

    Sun, X; Cao, Z Y; Liu, J G; Feng, C

    2015-01-01

    The security risk of magnesium alloys used as biodegradable implant material was evaluated in this study. Dose-response assessment was conducted by using toxicological data from authoritative public health agencies (World Health Organization) and assuming 1~3 years of uniform corrosion. Through modification calculation, the tolerable corrosion rate of biodegradable magnesium alloys in vivo was proposed, which theoretically ensured the bio-safety of the degradation products. The tolerable limits corresponding to various component elements in magnesium alloys were considered separately, although there are deficits in the toxicological data of some component elements. The influence of corrosion on the strength of magnesium alloys was evaluated, which would contribute to the rationally utilization of magnesium alloys as degradable implant materials. This study illustrates that not only toxicological calculations but also mechanical performance should be taken into consideration when developing novel degradable metallic implant.

  1. Magnesium Castings in Aeronautics Applications — Special Requirements

    NASA Astrophysics Data System (ADS)

    Wendt, Achim; Weiss, Konra; Ben-Dov, Arye; Bamberger, Menachem; Bronfin, Boris

    Although weight reduction in aircrafts is a fundamental matter, use of magnesium alloys is not widespread in airplanes due to "traditional" problems with corrosion resistance. Though there is creation of new magnesium alloys with improved corrosion resistance, these alloys are mostly designed for automotive industry. Alloys for aerospace industry must combine high performance regarding mechanical properties and corrosion resistance. A review is given here on the use of magnesium in aircrafts in the past. The paper then presents requirements of modern aircraft industry from magnesium castings regarding mechanical properties as well as corrosion resistance. Today the drawback is a lack of sufficient number of available alloys fulfilling the needs of modern aerospace industry. The methodology used in an international research project (IDEA) to develop new magnesium alloys for special use in aircrafts is described here, as well as the experimental and virtual methods utilised in this development.

  2. Serum magnesium concentration in drug-addicted patients.

    PubMed

    Karakiewicz, Beata; Kozielec, Tadeusz; Brodowski, Jacek; Chlubek, Dariusz; Noceń, Iwona; Starczewski, Andrzej; Brodowska, Agnieszka; Laszczyńska, Maria

    2007-03-01

    Drug addiction is a complex problem which leads to many somatic, psychic and social diseases. It is accompanied by the disturbed metabolism of various macro and micronutrients. The aim of this study was to assess serum magnesium concentration in drug-addicted patients and analyze whether Human Immunodeficiency Virus (HIV) infection and methadone treatment affect the level of serum magnesium in these patients. The examination was conducted in a group of 83 people - patients of Szczecin-Zdroje Psychiatric Hospital (Poland). They were 21 to 49 years old, and the mean age was 32 +/- 7 years. The control group consisted of 81 healthy individuals. Flame atomic-absorption spectrometry method was used to determine the magnesium concentration. The total serum magnesium concentration was calculated for the whole patient group, subgroups of women and men, a subgroup of people infected with HIV, and a subgroup receiving methadone substitution treatment. How magnesium behaves depending on age and addiction period, was checked. The mean concentration of magnesium in blood serum of the patients examined was 0.57 mmol/L, which was significantly lower than in the control group. In the subgroup of men it was 0.57 mmol/L, and in the subgroup of women - 0.55 mmol/L; the differences were not statistically significant. In the patient group nobody had the appropriate magnesium concentration in blood serum. No significant correlation was found between the magnesium concentration, age of the patients and addiction period. In the subgroup of seropositive people the mean concentration of magnesium was 0.55 mmol/L, and in the subgroup of non-infected patients - 0.58 mmol/L; the difference was not statistically significant. The mean concentration of magnesium in the subgroup treated with methadone was 0.59 mmol/L, and in the subgroup not involved in this type of therapy - 0.55 mmol/L; it was not a statistically significant difference.

  3. Formation of Magnesium Silicates is Limited around Evolved Stars

    NASA Astrophysics Data System (ADS)

    Kimura, Yuki; Nuth, J. A., III

    2009-05-01

    Laboratory experiments suggest that magnesium silicide (Mg2Si) grains could be produced in the hydrogen dominant gas outflow from evolved stars in addition to amorphous oxide minerals. Astronomical observations have shown the existence of abundant silicate grains around evolved stars and we have long realized that most of the silicate grains are amorphous, based on the observed infrared features. Only high mass loss stars show the feature attributed to magnesium-rich crystalline silicate about 10-20 % respect to total silicates, so far. The lower degree of crystallinity observed in silicates formed in outflows of lower mass-loss-rate stars might be caused by the formation of magnesium silicide in this relatively hydrogen-rich environment. As a result of predominant distribution of magnesium into the silicide, the composition of interstellar amorphous silicates could be magnesium poor compared with silicon. Indeed, the chemical composition of isotopically anomalous GEMS (glass with embedded metal and sulfides) is magnesium poor with respect to a forsteritic composition (Floss et al. 2006; Keller & Messenger 2007). Infrared observations suggest that there is little or no crystalline forsterite in interstellar environments while there is an abundance of crystalline forsterite in our Solar System. If the forsterite is a result of the oxidation of interstellar magnesium silicide, then it is clear both why crystalline forsterite is stoichiometric olivine and why the chemical composition of isotopically anomalous GEMS is magnesium poor with respect to a forsteritic composition. In addition, it may also explain why the chemical composition of olivine is iron poor. Unfortunately, magnesium silicide has never been detected via astronomical observation or in the analysis of primitive meteorites. I would suggest that future analysis of meteorites and theoretical calculations could confirm the possibility of the formation of magnesium silicide grains around evolved stars.

  4. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study.

    PubMed

    Mauskop, A; Altura, B T; Cracco, R Q; Altura, B M

    1995-12-01

    1. We tested the hypothesis that patients with an acute attack of migraine headache and low serum levels (< 0.54 mmol/l) of ionized magnesium are more likely to respond to an intravenous infusion of magnesium sulphate (MgSO4) than patients with higher serum ionized magnesium levels. 2. Serum ionized magnesium levels were drawn immediately before infusion of 1 g of MgSO4 in 40 consecutive patients with an acute migraine headache. 3. Pain reduction of 50% or more as measured on a headache intensity verbal scale of 1 to 10, occurred within 15 min of infusion in 35 patients. In 21 patients, at least this degree of improvement or complete relief persisted for 24h or more. Pain relief lasted at least 24h in 18 of 21 patients (86%) with serum ionized magnesium levels below 0.54 mmol/l, and in 3 of 19 patients (16%) with ionized magnesium levels at or above 0.54 mmol/l (P < 0.001). Mean ionized magnesium levels in patients with relief lasting for at least 24h were significantly lower than in patients with no relief or brief relief (P < 0.01). 4. Measurement of serum ionized magnesium levels may be useful in identifying patients with migraine headaches who may respond to an intravenous infusion of MgSO4.

  5. Electrical characterization of magnesium implanted gallium nitride

    NASA Astrophysics Data System (ADS)

    Krtschil, A.; Kielburg, A.; Witte, H.; Christen, J.; Krost, A.; Wenzel, A.; Rauschenbach, B.

    2002-01-01

    Gallium nitride layers grown by molecular beam epitaxy on c axis oriented sapphire substrates were implanted with 180 keV magnesium ions with ion doses between 1×1014 and 1×1016cm-2. The implantation induced defect states were investigated by temperature dependent conductivity (TDC) as well as by thermal and optical admittance spectroscopy (TAS, OAS) measurements. Dominant carrier emissions having thermal activation energies between 360 and 800 meV were found in TAS and TDC. These states are assigned to implantation induced electron traps since they do not appear in the nonimplanted reference sample. Defect states with similar transition energies were also observed in OAS resulting in an enhancement of defect-to-band transitions in the near band-gap region around 3.45 eV, in the blue band around 3.0 eV, as well as in the midgap range for photon energies between 2.5 and 1.80 eV, respectively. In addition, new transitions were found at 2.1 and 1.95 eV. Furthermore, transitions from implantation induced shallow states were observed, i.e., the magnesium acceptor as well as a new donor level at about 70 meV, tentatively discussed as nitrogen vacancy. The critical ion dose for amorphization was determined to be between 5×1015 and 1×1016Mg+ cm-2 using x-ray diffraction.

  6. Synthesis of nanoscale magnesium diboride powder

    DOE PAGES

    Finnemore, D. K.; Marzik, J. V.

    2015-12-18

    A procedure has been developed for the preparation of small grained magnesium diboride (MgB2) powder by reacting nanometer size boron powder in a magnesium vapor. Plasma synthesized boron powder that had particle sizes ranging from 20 to 300nm was mixed with millimeter size chunks of Mg by rolling stoichiometric amounts of the powders in a sealed cylindrical container under nitrogen gas. This mixture then was placed in a niobium reaction vessel, evacuated, and sealed by e-beam welding. The vessel was typically heated to approximately 830°C for several hours. The resulting MgB2 particles have a grain size in the 200 nmmore » to 800 nm range. Agglomerates of loosely bound particles could be broken up by light grinding in a mortar and pestle. At 830°C, many particles are composed of several grains grown together so that the average particle size is about twice the average grain size. Furthermore, experiments were conducted primarily with undoped boron powder, but carbon-doped boron powder showed very similar results.« less

  7. Drug-eluting bioabsorbable magnesium stent.

    PubMed

    Di Mario, Carlo; Griffiths, Huw; Goktekin, Omer; Peeters, Nicolas; Verbist, Jan; Bosiers, Marc; Deloose, Koen; Heublein, Bernhard; Rohde, Roland; Kasese, Victor; Ilsley, Charles; Erbel, Raimund

    2004-12-01

    Current stent technology is based on the use of permanent implants that remain life long in the vessel wall, far beyond the time required for the prosthesis to accomplish its main goals of sealing dissection and preventing wall recoil. With the possibility to implant long vessel segments using antiproliferative drugs to prevent restenosis, the practice of transforming the coronary vessels into stiff tubes with a full metal jacket covering all side branches and being unable to adjust to the long-term wall changes, including wall remodeling with lumen ectasia becomes a serious concern. In this article, we describe the first biodegradable stent based on a magnesium alloy that allows controlled corrosion with release to the vessel wall and the blood stream of a natural body component such as magnesium with beneficial antithrombotic, antiarrhythmic, and antiproliferative properties. We also discuss the animal experiments and the initial clinical applications in 20 patients with implants below the knee, with final results soon to be released, and the plans for the first coronary study. The results of these last two studies will indicate whether the absence of a permanent implant and the antiproliferative properties shown in animals are sufficient to prevent the restenotic process in humans or whether the prosthesis must be modified by adding the biodegradable coating with conventional antiproliferative drugs.

  8. A Magnesium-Activated Carbon Hybrid Capacitor

    SciTech Connect

    Yoo, HD; Shterenberg, I; Gofer, Y; Doe, RE; Fischer, CC; Ceder, G; Aurbach, D

    2013-12-11

    Prototype cells of hybrid capacitor were developed, comprising activated carbon (AC) cloth and magnesium (Mg) foil as the positive and negative electrodes, respectively. The electrolyte solution included ether solvent (TBF) and a magnesium organo-halo-aluminate complex 0.25 M Mg2Cl3+-Ph2AlCl2-. In this solution Mg can be deposited/dissolved reversibly for thousands of cycles with high reversibility (100% cycling efficiency). The main barrier for integrating porous AC electrodes with this electrolyte solution was the saturation of the pores with the large ions in the AC prior to reaching the potential limit. This is due to the existence of bulky Mg and Al based ionic complexes consisting Cl, alkyl or aryl (R), and THF ligands. This problem was resolved by adding 0.5 M of lithium chloride (LiCl), thus introducing smaller ionic species to the solution. This Mg hybrid capacitor system demonstrated a stable cycle performance for many thousands of cycles with a specific capacitance of 90 Fg(-1) for the AC positive electrodes along a potential range of 2.4 V. (C) 2014 The Electrochemical Society. All rights reserved.

  9. Thermochemistry of dense hydrous magnesium silicates

    NASA Technical Reports Server (NTRS)

    Bose, Kunal; Burnley, Pamela; Navrotsky, Alexandra

    1994-01-01

    Recent experimental investigations under mantle conditions have identified a suite of dense hydrous magnesium silicate (DHMS) phases that could be conduits to transport water to at least the 660 km discontinuity via mature, relatively cold, subducting slabs. Water released from successive dehydration of these phases during subduction could be responsible for deep focus earthquakes, mantle metasomatism and a host of other physico-chemical processes central to our understanding of the earth's deep interior. In order to construct a thermodynamic data base that can delineate and predict the stability ranges for DHMS phases, reliable thermochemical and thermophysical data are required. One of the major obstacles in calorimetric studies of phases synthesized under high pressure conditions has been limitation due to the small (less than 5 mg) sample mass. Our refinement of calorimeter techniques now allow precise determination of enthalpies of solution of less than 5 mg samples of hydrous magnesium silicates. For example, high temperature solution calorimetry of natural talc (Mg(0.99) Fe(0.01)Si4O10(OH)2), periclase (MgO) and quartz (SiO2) yield enthalpies of drop solution at 1044 K to be 592.2 (2.2), 52.01 (0.12) and 45.76 (0.4) kJ/mol respectively. The corresponding enthalpy of formation from oxides at 298 K for talc is minus 5908.2 kJ/mol agreeing within 0.1 percent to literature values.

  10. Synthesis of nanoscale magnesium diboride powder

    SciTech Connect

    Finnemore, D. K.; Marzik, J. V.

    2015-12-18

    A procedure has been developed for the preparation of small grained magnesium diboride (MgB2) powder by reacting nanometer size boron powder in a magnesium vapor. Plasma synthesized boron powder that had particle sizes ranging from 20 to 300nm was mixed with millimeter size chunks of Mg by rolling stoichiometric amounts of the powders in a sealed cylindrical container under nitrogen gas. This mixture then was placed in a niobium reaction vessel, evacuated, and sealed by e-beam welding. The vessel was typically heated to approximately 830°C for several hours. The resulting MgB2 particles have a grain size in the 200 nm to 800 nm range. Agglomerates of loosely bound particles could be broken up by light grinding in a mortar and pestle. At 830°C, many particles are composed of several grains grown together so that the average particle size is about twice the average grain size. Furthermore, experiments were conducted primarily with undoped boron powder, but carbon-doped boron powder showed very similar results.

  11. [Mass transfer of magnesium in hemodialysis].

    PubMed

    Calzavara, P; Da Porto, A; Vianello, A; Gatti, P L; Maresca, M C; Caenaro, G

    1990-01-01

    The rate of mass-transfer (MT) of magnesium during hemodialysis was studied in thirty-five patients with hypermagnesemia (Mg = 3.75 +/- 0.72 mg/dl) undergoing chronic hemodialysis. The aim of the study was to verify which is the best dialytical approach to remove the excess of magnesium. The concentration of Mg in the dialysate was of 1.82 mg/dl for all patients. MT was -0.51 +/- 0.36 g and no statistical difference was found between patients treated with cuprophan hollow fibers dialyzers, PAN and cuprophan plates. Mg MT is not correlated with dialysis duration (r = -0.23; p:ns), urea clearance (r = -0.08; p:ns), KT/V index (r = -0.03; p:ns), blood flow (r = -0.15; p:ns). In conclusion from our data, in agreement with other Authors, reduction of serum Mg levels is more convenient by obtained by a decrease in Mg concentration in the dialysate under 1.82 mg/dl, in order to increase the blood-dialysate concentration gradient.

  12. Thermochemistry of dense hydrous magnesium silicates

    NASA Technical Reports Server (NTRS)

    Bose, Kunal; Burnley, Pamela; Navrotsky, Alexandra

    1994-01-01

    Recent experimental investigations under mantle conditions have identified a suite of dense hydrous magnesium silicate (DHMS) phases that could be conduits to transport water to at least the 660 km discontinuity via mature, relatively cold, subducting slabs. Water released from successive dehydration of these phases during subduction could be responsible for deep focus earthquakes, mantle metasomatism and a host of other physico-chemical processes central to our understanding of the earth's deep interior. In order to construct a thermodynamic data base that can delineate and predict the stability ranges for DHMS phases, reliable thermochemical and thermophysical data are required. One of the major obstacles in calorimetric studies of phases synthesized under high pressure conditions has been limitation due to the small (less than 5 mg) sample mass. Our refinement of calorimeter techniques now allow precise determination of enthalpies of solution of less than 5 mg samples of hydrous magnesium silicates. For example, high temperature solution calorimetry of natural talc (Mg(0.99) Fe(0.01)Si4O10(OH)2), periclase (MgO) and quartz (SiO2) yield enthalpies of drop solution at 1044 K to be 592.2 (2.2), 52.01 (0.12) and 45.76 (0.4) kJ/mol respectively. The corresponding enthalpy of formation from oxides at 298 K for talc is minus 5908.2 kJ/mol agreeing within 0.1 percent to literature values.

  13. [Connective tissue dysplasia, magnesium, and nucleotide polymorphisms].

    PubMed

    Torshin, I Iu; Gromova, O A

    2008-01-01

    Undifferentiated connective tissue dysplasia (UCTD) is one of most common diseases of the connective tissue. High frequency of UCTD in population along with the fact that it can provoke a number of other diseases make UCTD an important object of the modern biomedical research in the areas of cardiology, neurology, rheumatology and pulmonology. Modern diagnostics and determination of the predisposition to UCTD allow elaboration of personalized therapy. In particular, Mg-containing supplements and medications can be effectively used in the therapy of UCTD. In one of our previous works we have analyzed possible molecular mechanisms of UCTD etiology as well as therapeutic action of magnesium. The use of data on nucleotide polymorphisms as complementation of standard medical diagnostics is one of perspective trends of the post-genomic medical research. The present work suggest a number of nucleotide polymorphisms that can be used in genetic association analyses of the UCTD as of well as therapeutic efficiency of magnesium treatment. Selection and analysis of the polymorphisms was done on the base of molecular mechanisms we had proposed earlier, comprehensive analysis of published data and also with the use of an integral approach to analysis of the functional effects of the nucleotide polymorphisms and corresponding amino acid substitutions.

  14. Synthesis of nanoscale magnesium diboride powder

    NASA Astrophysics Data System (ADS)

    Finnemore, D. K.; Marzik, J. V.

    2015-12-01

    A procedure has been developed for the preparation of small grained magnesium diboride (MgB2) powder by reacting nanometer size boron powder in a magnesium vapor. Plasma synthesized boron powder that had particle sizes ranging from 20 to 300nm was mixed with millimeter size chunks of Mg by rolling stoichiometric amounts of the powders in a sealed cylindrical container under nitrogen gas. This mixture then was placed in a niobium reaction vessel, evacuated, and sealed by e-beam welding. The vessel was typically heated to approximately 830°C for several hours. The resulting MgB2 particles have a grain size in the 200 nm to 800 nm range. Agglomerates of loosely bound particles could be broken up by light grinding in a mortar and pestle. At 830°C, many particles are composed of several grains grown together so that the average particle size is about twice the average grain size. Experiments were conducted primarily with undoped boron powder, but carbon-doped boron powder showed very similar results.

  15. Preparation and hydriding behavior of magnesium metal clusters formed in low-temperature cocondensation: application of magnesium for hydrogen storage

    SciTech Connect

    Imamura, H.; Nobunaga, T.; Kawahigashi, M.; Tsuchiya, S.

    1984-08-01

    Magnesium metal clusters formed in low-temperature matrices were investigated with a view to forming the metal hydride. In practice, magnesium readily absorbed large amounts of hydrogen under more moderate conditions (P/sub H/sub 2// = 460 torr, T = 200-250/sup 0/C) when it had been transformed into tetrahydrofuran- (THF-) solvated small particles formed by the cocondensation reaction of magnesium atoms with THF molecules at -196/sup 0/C. To elucidate the characteristics of hydrogen sorption of Mg-THF, a comparative study with pure magnesium powder was carried out. It is believed from the H/sub 2/-D/sub 2/ isotope scrambling measurements that the high activity of the present Mg-THF system for hydrogen absorption is due to a rapid surface process in comparison with the case of the pure magnesium. This identification is reinforced by the employment of surface modification. 19 references, 2 figures, 1 table.

  16. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis.

    PubMed

    Tarighat Esfanjani, Ali; Mahdavi, Reza; Ebrahimi Mameghani, Mehrangiz; Talebi, Mahnaz; Nikniaz, Zeinab; Safaiyan, Abdolrasool

    2012-12-01

    Given the conflicting results about the positive effects of magnesium and L-carnitine and as there is no report concerning concurrent supplementation of magnesium and L-carnitine on migraine prophylaxis, the effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation on migraine indicators were assessed. In this clinical trial, 133 migrainous patients were randomly assigned into three intervention groups: magnesium oxide (500 mg/day), L-carnitine (500 mg/day), and Mg-L-carnitine (500 mg/day magnesium and 500 mg/day L-carnitine), and a control group. After 12 weeks of supplementation, the checklist of migraine indicators including migraine attacks/month, migraine days/month, and headache severity was completed, and serum concentrations of magnesium and L-carnitine were measured by atomic absorption spectrophotometry and enzymatic UV test, respectively. The results showed a significant reduction in all migraine indicators in all studied groups (p < 0.05). The ANOVA results showed a significant reduction in migraine frequency across various supplemented and control groups (p = 0.008). By separating the effects of magnesium supplementation from other confounding factors such as routine treatments using the repeated measures and nested model, it was clarified that magnesium supplementation had a significant effect on all migraine indicators. Oral supplementation with magnesium oxide and L-carnitine and concurrent supplementation of Mg-L-carnitine besides routine treatments could be effective in migraine prophylaxis; however, larger trials are needed to confirm these preliminary findings.

  17. 75 FR 56989 - Magnesium Metal From the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-09-17

    ...- magnesium granular materials to make magnesium-based reagent mixtures, including lime, calcium metal... International Trade Administration Magnesium Metal From the Russian Federation: Final Results of Antidumping... results of the administrative review of the antidumping duty order on magnesium metal from the Russian...

  18. [SIGNIFICANCE OF MAGNESIUM IN PHISIOLOGY AND PATHOLOGY OF THE DIGESTIVE SYSTEM].

    PubMed

    Grigus, Ya I; Mikhaylova, O D; Gorbunov A Yu; Vakhrushev, Ya M

    2015-01-01

    The article describes the physiological role of magnesium in the human body and its importance for metabolic processes. The reasons for the development of magnesium deficiency and hypermagnesaemia and its clinical symptoms are shown. The specialties of magnesium metabolism disturbances in gastroenterological pathology are described. Particular attention paid to the correction of magnesium levels with deviations of its content in the organism.

  19. 40 CFR 471.20 - Applicability; description of the magnesium forming subcategory.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... magnesium forming subcategory. 471.20 Section 471.20 Protection of Environment ENVIRONMENTAL PROTECTION... SOURCE CATEGORY Magnesium Forming Subcategory § 471.20 Applicability; description of the magnesium... introductions of pollutants into publicly owned treatment works from the process operations of the magnesium...

  20. 40 CFR 471.20 - Applicability; description of the magnesium forming subcategory.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... magnesium forming subcategory. 471.20 Section 471.20 Protection of Environment ENVIRONMENTAL PROTECTION... SOURCE CATEGORY Magnesium Forming Subcategory § 471.20 Applicability; description of the magnesium... introductions of pollutants into publicly owned treatment works from the process operations of the magnesium...

  1. 76 FR 61342 - Magnesium Metal from the Russian Federation: Amended Final Results of Antidumping Duty...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-04

    ... International Trade Administration Magnesium Metal from the Russian Federation: Amended Final Results of... magnesium metal from the Russian Federation. See Magnesium Metal from the Russian Federation: Preliminary... ``Administrative Review of the Antidumping Duty Order on Magnesium Metal from the Russian Federation--...

  2. Prevalence of Thrombocytopenia and Its Association with Serum Magnesium.

    PubMed

    Lu, Leihong; Zhan, Yiqiang; Yu, Jinming; Sui, Lihong

    2016-01-01

    The present study aimed to investigate the prevalence of thrombocytopenia and its association with serum magnesium in a nationally representative cohort. A total of 8478 participants aged 18 years and over were recruited in a cross-sectional survey. Thrombocytopenia was defined as platelet count less than 150 × 10(9)/L. Multivariable logistic regression models were applied to examine the association between serum magnesium and thrombocytopenia. The prevalence of thrombocytopenia in total was 16.5% with 18.8% for men and 14.4% for women (P < 0.0001), respectively. Compared with men in the first quartile of serum magnesium, the odds ratios (ORs) and 95% confidence intervals (CIs) for those in the second, third, and fourth quartiles of serum magnesium were 0.96 (0.75, 1.21), 0.78 (0.62, 0.98), and 0.82 (0.65, 1.04), respectively, after adjusting for multiple confounders. Likewise, the corresponding ORs (95% CIs) were 0.80 (0.63, 1.01), 0.79 (0.62, 0.99), and 0.65 (0.51, 0.84) in women. When serum magnesium was treated as a continuous variable, each one standard deviation increase of magnesium was associated with 12 and 8% lower risk of thrombocytopenia in men and women, respectively. Serum magnesium was inversely associated with thrombocytopenia, and the association was slightly different in men compared with that in women.

  3. Magnesium in human semen: possible role in premature ejaculation.

    PubMed

    Omu, A E; Al-Bader, A A; Dashti, H; Oriowo, M A

    2001-01-01

    Although magnesium is involved in many biological process and it is found higher levels in semen than serum, its role in human semen has not been elucidated. This investigation was conducted to evaluate the relationship between premature ejaculation and the levels of seminal magnesium. The levels of magnesium, zinc, copper, and selenium were evaluated with an atomic absorption spectrophotometer in serum and seminal plasma in 3 groups of men: (a) normal sperm parameters (15) (b) oligoasthenozoospermia (15), and genuine premature ejaculation (9). There were normal serum and semen levels of all the elements in the three groups, but significantly lower seminal plasma magnesium levels in men with premature ejaculation. The hormonal profile, body mass index (BMI) had no association with premature ejaculation. Decreased levels of magnesium gives rise to vasoconstriction from increased thromboxane level, increased endothelial intracellular Ca2+, and decreased nitric oxide. This may lead to premature emission and ejaculation processes. Magnesium is probably involved in semen transport. More research into the role of magnesium in the male physiology of reproductive tract, especially its association with premature ejaculation, is advocated.

  4. Reprint of: The history of biodegradable magnesium implants: A review.

    PubMed

    Witte, Frank

    2015-09-01

    Today, more than 200 years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals. Copyright © 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

  5. The history of biodegradable magnesium implants: a review.

    PubMed

    Witte, Frank

    2010-05-01

    Today, more than 200years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals. Copyright (c) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

  6. Magnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation?

    PubMed

    Ter Braake, Anique D; Shanahan, Catherine M; de Baaij, Jeroen H F

    2017-08-01

    Over the last decade, an increasing number of studies report a close relationship between serum magnesium concentration and cardiovascular disease risk in the general population. In end-stage renal disease, an association was found between serum magnesium and survival. Hypomagnesemia was identified as a strong predictor for cardiovascular disease in these patients. A substantial body of in vitro and in vivo studies has identified a protective role for magnesium in vascular calcification. However, the precise mechanisms and its contribution to cardiovascular protection remain unclear. There are currently 2 leading hypotheses: first, magnesium may bind phosphate and delay calcium phosphate crystal growth in the circulation, thereby passively interfering with calcium phosphate deposition in the vessel wall. Second, magnesium may regulate vascular smooth muscle cell transdifferentiation toward an osteogenic phenotype by active cellular modulation of factors associated with calcification. Here, the data supporting these major hypotheses are reviewed. The literature supports both a passive inorganic phosphate-buffering role reducing hydroxyapatite formation and an active cell-mediated role, directly targeting vascular smooth muscle transdifferentiation. However, current evidence relies on basic experimental designs that are often insufficient to delineate the underlying mechanisms. The field requires more advanced experimental design, including determination of intracellular magnesium concentrations and the identification of the molecular players that regulate magnesium concentrations in vascular smooth muscle cells. © 2017 American Heart Association, Inc.

  7. Antithrombotic effects of magnesium sulfate in in vivo experiments.

    PubMed

    Sheu, Joen R; Hsiao, George; Shen, Ming Y; Lee, Yen M; Yen, Mao H

    2003-05-01

    In this study, magnesium sulfate was effective in reducing the mortality of adenosine diphosphate-induced acute pulmonary thromboembolism in mice, when it was administered intravenously at doses of 100 and 200 microg/g body weight. In addition, intravenous injections of magnesium sulfate (100 and 200 microg/g) significantly prolonged bleeding time in the severed mesenteric arteries of rats by approximately 1.7- and 1.9-fold, respectively, compared with normal saline. Continuous infusion of magnesium sulfate (20 microg/g per minute) for 10 minutes also significantly increased the bleeding time by approximately 1.7-fold, and the bleeding time returned to baseline within 60 minutes of cessation of magnesium sulfate infusion. On the other hand, platelet thrombi formation was induced by irradiating mesenteric venules with filtered light in mice pretreated with intravenous fluorescein sodium. When magnesium sulfate was administered at 300 microg/g during induction of platelet plug formation with 10 microg/kg fluorescein sodium, occlusion time was not significantly prolonged, but a dose of 600 microg/g did significantly prolong the occlusion time. Furthermore, aspirin (250 microg/g) also showed a similar activity in this experiment in prolonging the occlusion time. In conclusion, these results suggest that magnesium sulfate has an effective antithrombotic activity in vivo, and treatment with magnesium sulfate may lower the risk of thromboembolic-related disorders.

  8. Effects of Maternal Magnesium Sulfate Treatment on Neonatal Feeding Tolerance.

    PubMed

    Belden, Meghan K; Gnadt, Sarah; Ebert, Ann

    2017-01-01

    To determine whether antenatal exposure to magnesium sulfate has an effect on neonatal enteral feeding tolerance. In this single-center, retrospective, observational study, charts of pregnant women who received intravenous magnesium sulfate infusions prior to delivery between July 1, 2012, and July 31, 2013, were reviewed. Neonates born at 24 weeks' gestational age or greater admitted to the neonatal intensive care unit (NICU) whose mothers received magnesium sulfate infusions prior to delivery were included. Neonates with independent factors that could lead to feeding intolerance were excluded. The primary outcome was incidence of neonatal enteral feeding intolerance measured by deviations from the NICU feeding protocol. Secondary outcomes included days on parenteral nutrition, incidence of necrotizing enterocolitis, time to first stool, and urine output in the first 72 hours of life. Cumulative maternal magnesium sulfate dose was significantly higher in the enteral feeding intolerance group than those infants who tolerated enteral feeds (70.4 ± 52.3 vs 47.4 ± 40.1 g; p = 0.04). Infants exposed to more than 80 g of maternal magnesium sulfate therapy were more likely to develop enteral feeding intolerance (44% vs 22%; p = 0.04). Multivariate logistic regression indicated that prematurity and cumulative maternal magnesium sulfate dose were the strongest predictors of neonatal enteral feeding intolerance. Infants of mothers who received more than 80 g of intravenous magnesium sulfate prior to delivery were more likely to develop feeding intolerance. Prematurity also was a significant predictor of intolerance.

  9. Magnesium sulfate for postoperative analgesia after surgery under spinal anesthesia.

    PubMed

    Shah, Prerana N; Dhengle, Yamini

    2016-06-01

    Magnesium has been proven to have antinociceptive effects in animal and human models of pain. Its effect is primarily based on the regulation of calcium influx into the cell, which is natural physiological calcium antagonism and N-methyl-d-aspartate (NMDA) receptor antagonism. One hundred and eight patients undergoing surgery with spinal anesthesia received either 250 mg of intravenous magnesium sulfate followed by an infusion of 500 mg magnesium sulfate (25 mg/mL) at the rate of 20 mL/hour; or the same volume of normal saline (control group) as bolus and infusion. The primary end-points in the study were to evaluate the analgesic effect and duration of sensory and motor blockade. The secondary end-points included assessment of hemodynamic effects of intravenous magnesium sulfate and rescue analgesia requirement. Sensory and motor blockade, respectively, were 25 minutes and 34 minutes shorter in the control group. Less patients in the magnesium group (33% vs. 53.7%) than in control group required rescue analgesia in the postoperative period. The control group required rescue analgesia nearly 3 hours earlier than the magnesium group. Only one patient in the control group experienced bradycardia. There was no event of intraoperative hypotension in either of the groups. Intravenous magnesium sulfate when given as a bolus, followed by an infusion, delayed and decreased the need of rescue analgesics after spinal anesthesia. Copyright © 2016. Published by Elsevier B.V.

  10. Sulfur dioxide removal process with gypsum and magnesium hydroxide production

    SciTech Connect

    College, J.W.; Benson, L.B.

    1992-01-28

    This patent describes improvement in a method for removing sulfur dioxide from flue gases wherein the flue gases are contacted in a wet scrubbing unit, in the absence of any substantial amount of calcium components, with an aqueous solution of magnesium components and magnesium sulfite produced, with aqueous solution, following the contact, collected and recycled to the wet scrubber for further contact with flue gases, and subjecting a portion of the aqueous discharge from the scrubbing unit, containing magnesium sulfite, to oxidation in an oxidation unit. The improvement comprises: adding calcium sulfate to the portion of aqueous discharge containing magnesium sulfite prior to oxidation in the oxidation unit to form an oxidized aqueous effluent containing calcium sulfate solids and dissolved magnesium sulfate; passing the oxidized aqueous effluent to a regeneration tank; adding lime to the regeneration tank to precipitate gypsum from and form an aqueous magnesium hydroxide suspension in the oxidized aqueous effluent; separating the precipitated gypsum from the aqueous magnesium hydroxide suspension; and returning at least a portion of the separated precipitated gypsum to the oxidizing unit as the added calcium sulfate.

  11. Association between Serum Magnesium Levels and Depression in Stroke Patients

    PubMed Central

    Gu, Yingying; Zhao, Kai; Luan, Xiaoqian; Liu, Zhihua; Cai, Yan; Wang, Qiongzhang; Zhu, Beilei; He, Jincai

    2016-01-01

    Post-stroke depression (PSD) is a common psychiatric complication of stroke that is associated with a poor outcome in stroke patients. Our aim was to assess the association between the serum magnesium levels and the presence of PSD in Chinese patients. Two hundred nine stroke patients were included in the study. Depressive symptoms were measured by the 17-Hamilton Rating Scale for Depression at 3 months after stroke. Based on the depressive symptoms, diagnoses of depression were made in line with the DSM-IV criteria for PSD. Serum magnesium levels were evaluated using the dimethyl aniline blue colorimetric method at admission. Multivariate analyses were conducted using logistic regression models. Further, 120 normal subjects were recruited, and their serum magnesium levels were also measured as control. At 3 months, fifty-nine patients (28.2%) were diagnosed as PSD. The serum magnesium levels were significantly lower in both PSD patients and non-PSD patients than in normal subjects (p < 0.001). Indeed, patients with PSD showed lower serum magnesium levels (p < 0.001) than did non-PSD patients at admission. In the multivariate analyses, after adjusting for potential variables, we found that an increased risk of PSD was associated with serum magnesium levels ≤ 0.84mmol/L (OR 2.614, 95% CI 1.178-5.798, p=0.018). Low serum magnesium levels at admission were found to be associated with the presence of PSD at 3 months after stroke. PMID:28053818

  12. Synthesis, Crystal Structure, and Electrochemical Properties of a Simple Magnesium Electrolyte for Magnesium/Sulfur Batteries.

    PubMed

    Li, Wanfei; Cheng, Shuang; Wang, Jian; Qiu, Yongcai; Zheng, Zhaozhao; Lin, Hongzhen; Nanda, Sanjay; Ma, Qian; Xu, Yan; Ye, Fangmin; Liu, Meinan; Zhou, Lisha; Zhang, Yuegang

    2016-05-23

    Most simple magnesium salts tend to passivate the Mg metal surface too quickly to function as electrolytes for Mg batteries. In the present work, an electroactive salt [Mg(THF)6 ][AlCl4 ]2 was synthesized and structurally characterized. The Mg electrolyte based on this simple mononuclear salt showed a high Mg cycling efficiency, good anodic stability (2.5 V vs. Mg), and high ionic conductivity (8.5 mS cm(-1) ). Magnesium/sulfur cells employing the as-prepared electrolyte exhibited good cycling performance over 20 cycles in the range of 0.3-2.6 V, thus indicating an electrochemically reversible conversion of S to MgS without severe passivation of the Mg metal electrode surface.

  13. Magnesium Based Materials and their Antimicrobial Activity

    NASA Astrophysics Data System (ADS)

    Robinson, Duane Allan

    The overall goals of this body of work were to characterize the antimicrobial properties of magnesium (Mg) metal and nano-magnesium oxide (nMgO) in vitro, to evaluate the in vitro cytotoxicity of Mg metal, and to incorporate MgO nanoparticles into a polymeric implant coating and evaluate its in vitro antimicrobial properties. In the course of this work it was found that Mg metal, Mg-mesh, and nMgO have in vitro antimicrobial properties that are similar to a bactericidal antibiotic. For Mg metal, the mechanism of this activity appears to be related to an increase in pH (i.e. a more alkaline environment) and not an increase in Mg2+. Given that Mg-mesh is a Mg metal powder, the assumption is that it has the same mechanism of activity as Mg metal. The mechanism of activity for nMgO remains to be elucidated and may be related to a combination of interaction of the nanoparticles with the bacteria and the alkaline pH. It was further demonstrated that supernatants from suspensions of Mg-mesh and nMgO had the same antimicrobial effect as was noted when the particles were used. The supernatant from Mg-mesh and nMgO was also noted to prevent biofilm formation for two Staphylococcus strains. Finally, poly-epsilon-caprolactone (PCL) composites of Mg-mesh (PCL+Mg-mesh) and nMgO (PCL+nMgO) were produced. Coatings applied to screws inhibited growth of Escherichia coli and Pseudomonas aeruginosa and in thin disc format inhibited the growth of Staphylococcus aureus in addition to the E. coli and P. aeruginosa. Pure Mg metal was noted to have some cytotoxic effect on murine fibroblast and osteoblast cell lines, although this effect needs to be characterized further. To address the need for an in vivo model for evaluating implant associated infections, a new closed fracture osteomyelitis model in the femur of the rat was developed. Magnesium, a readily available and inexpensive metal was shown to have antimicrobial properties that appear to be related to its corrosion products and

  14. Abdominal obesity and gestational diabetes: the interactive role of magnesium.

    PubMed

    Mostafavi, Ebrahim; Nargesi, Arash Aghajani; Asbagh, Firoozeh Akbari; Ghazizadeh, Zaniar; Heidari, Behnam; Mirmiranpoor, Hossein; Esteghamati, Alireza; Vigneron, Claude; Nakhjavani, Manouchehr

    2015-12-01

    Magnesium is a cofactor for numerous metabolic enzymatic reactions. It is required for glucose utilization and insulin signaling. We compared plasma magnesium concentrations in pregnant women with and without abdominal obesity, and investigated the interactive roles of magnesium and obesity in the development of gestational diabetes mellitus (GDM). Pregnant women with and without abdominal obesity (n = 40 in each group) were followed during gestation. Oral glucose tolerance tests (OGTT) were performed at 24-28 weeks of pregnancy to diagnose GDM. Plasma glucose, insulin, triglycerides, high-sensitive C-reactive protein (hs-CRP), and malondialdehyde (MDA) were measured. The obesity-GDM relationship was investigated prospectively, and the magnesium-GDM relationship was analyzed on a cross-sectional basis. Sixteen patients in the obese group and one in the control developed GDM. There were no differences in plasma magnesium levels between obese and control groups (p-value = 0.14), but significant differences between diabetic and non-diabetic patients (p-value = 0.05). Fourteen out of 17 diabetic patients had magnesium concentrations below the median. Increases in insulin, homeostatic model for insulin resistance, triglycerides, hs-CRP, MDA and second-hour blood glucose were more pronounced in those with both abdominal obesity and low-normal magnesium concentrations. In the Poisson regression model, obesity (relative risk = 20.6, p-value = 0.002), low-normal magnesium level (relative risk = 4.2, p-value = 0.009), and their interaction (p-value<0.001) were significant. Abdominally obese patients with lower plasma magnesium are more likely to show abnormal OGTT results. Insulin resistance, inflammatory response and oxidative stress are exaggerated in these patients.

  15. The bioavailability of magnesium in spinach and the effect of oxalic acid on magnesium utilization examined in diets of magnesium-deficient rats.

    PubMed

    Kikunaga, S; Ishii, H; Takahashi, M

    1995-12-01

    Spinach was evaluated for its bioavailability of magnesium in the experiment with magnesium-deficient rats. The effect of oxalic acid on absorption of dietary magnesium was also examined in the same experiment. After there were significant differences in the body weight of the rats between the control group and the magnesium-deficient group, and after the number of dead rats increased, the magnesium-deficient rats were divided into six groups. They were pair-fed for 8 days on the magnesium-deficient diet, magnesium-deficient diet supplemented with raw powdered spinach (R-sp), boiled powdered spinach (B-sp), or fried powdered spinach (F-sp), control diet supplemented with oxalic acid (Ox-C), and control diet (+Mg). On the 10th day, there was no significant difference in the food intake of the rats between the control group and magnesium-deficient group. However, the body weight, and body weight gain of the rats increased more significantly in the control group than in those of the magnesium-deficient group. Also, the contents of calcium and phosphorus in the liver and kidneys, and serum calcium content increased significantly in the magnesium-deficient rats compared with those of the control rats. However, the serum magnesium content decreased significantly in the magnesium-deficient rats. An especially large amount of calcium was accumulated in the kidneys of the magnesium-deficient rats. At the end of the experimental period, there were no significant differences in the food intake, body weight and body weight gain of the rats among the control group and each of the spinach-added groups. The body weight and body weight gain of the Ox-C rats decreased significantly in comparison with those of the control group and each of the spinach-added groups. Although, there were no significant differences in the concentrations of serum minerals (Mg, Ca and P) among each of the groups, kidney magnesium, calcium and phosphorus, and liver magnesium and phosphorus were

  16. Characteristics of tetrahydrofuran-based electrolytes with magnesium alkoxide additives for rechargeable magnesium batteries

    NASA Astrophysics Data System (ADS)

    Kim, In-Tae; Yamabuki, Kazuhiro; Sumimoto, Michinori; Tsutsumi, Hiromori; Morita, Masayuki; Yoshimoto, Nobuko

    2016-08-01

    The electrochemical behavior of magnesium (Mg) metal was investigated in tetrahydrofuran (THF)-based solutions containing magnesium bromide (MgBr2) and/or magnesium ethoxide (Mg(OEt)2). THF solutions containing a single solute, MgBr2 or Mg(OEt)2, show no visible faradaic current based on Mg deposition and/or dissolution. However, the electrolyte system containing both solutes, MgBr2 + Mg(OEt)2/THF, gives a reversible current response of Mg deposition and dissolution. The ionic structure of the electrolyte system containing the binary solute was examined by infrared (IR) spectroscopy and density functional theory (DFT) calculations. It was confirmed that MgBr2 and Mg(OEt)2 are coordinated (solvated) with THF molecules to form an EtOsbnd Mgsbnd Br·4THF complex. The DFT calculations also suggest the possible formation of μ-complexes for the MgBr2/Mg(OEt)2 binary system in THF. The voltammetric responses at the Pt electrode indicate low overpotential and high coulombic efficiency for Mg deposition and dissolution in THF-based solutions containing suitable molar ratios of MgBr2 and Mg(OEt)2. The constant-current charge-discharge cycling of Mg in MgBr2 + Mg(OEt)2/THF electrolyte also shows low overpotential and good cyclability over 300 cycles.

  17. Effect of magnesium sulfate concentration on serum ionized magnesium in vitro.

    PubMed

    Salamon, Mia; Mimouni, Francis B; Dollberg, Shaul; Mandel, Dror

    2010-08-01

    We undertook this in vitro study to quantify the effect that addition of magnesium (Mg) sulfate to neonatal serum, as compared with adult serum, might have on ionized Mg (Mg (2+)) concentration. We used one cord blood sample and one adult blood sample that we made hypermagnesemic by adding various amounts of magnesium sulfate to study five levels of serum Mg. Each sample was then studied at one of three levels of pH, from extreme alkalosis to extreme acidosis. We measured the changes in serum Mg (2+) and serum ionized calcium (Ca (2+)) in reaction to these changes in pH and Mg. At each pH level, there was an exponential increase in the serum Mg (2+) (and no significant change in serum Ca (2+)) with increasing serum Mg. Multiple regression analysis using Mg (2+) as the dependent variable and baseline Ca (2+), phosphorous, albumin, and blood type (adult versus cord blood) as well as blood pH and serum Mg as independent variables indicated that serum Mg and pH were the only variables significantly influencing serum Mg (2+). Within the range of serum Mg considered, the addition of magnesium sulfate in vitro causes an exponential increase in Mg (2+) and no significant change in serum Ca (2+). Copyright Thieme Medical Publishers.

  18. Functionalization of metallic magnesium with protein layers via linker molecules.

    PubMed

    Killian, Manuela S; Wagener, Victoria; Schmuki, Patrik; Virtanen, Sannakaisa

    2010-07-20

    We present an innovative method to cover pure magnesium with protein monolayers by utilizing the OH termination of the oxide surface and silane coupling chemistry. The protein of interest was albumin. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) and X-ray photoelectron spectroscopy (XPS) were used to monitor the success of the treatment. The attachment of proteins via linker groups yielded smoother and more homogeneous surfaces than coatings produced by steeping magnesium in protein solution. A positive effect on the corrosion behavior of pure magnesium was also observed.

  19. Process for converting magnesium fluoride to calcium fluoride

    DOEpatents

    Kreuzmann, A.B.; Palmer, D.A.

    1984-12-21

    This invention is a process for the conversion of magnesium fluoride to calcium fluoride whereby magnesium fluoride is decomposed by heating in the presence of calcium carbonate, calcium oxide or calcium hydroxide. Magnesium fluoride is a by-product of the reduction of uranium tetrafluoride to form uranium metal and has no known commercial use, thus its production creates a significant storage problem. The advantage of this invention is that the quality of calcium fluoride produced is sufficient to be used in the industrial manufacture of anhydrous hydrogen fluoride, steel mill flux or ceramic applications.

  20. Heated Hydro-Mechanical Deep Drawing of Magnesium Sheet Metal

    NASA Astrophysics Data System (ADS)

    Kurz, Gerrit

    In order to reduce fuel consumption efforts have been made to decrease the weight of automobile constructions by increasing the use of lightweight materials. In this field of application magnesium alloys are important because of their low density. A promising alternative to large surfaced and thin die casting parts has been found in construction parts that are manufactured by sheet metal forming of magnesium. Magnesium alloys show a limited formability at room temperature. A considerable improvement of formability can be achieved by heating the material. Formability increases above a temperature of approximately T = 225 °C.

  1. Strontium and Magnesium in Water and in Crassostrea Calcite.

    PubMed

    Lerman, A

    1965-11-05

    Distribution of magnesium and strontium was determined between waters and calcites secreted by the oyster species Crassostrea virginica and C. rhizophorae in natural habitats at eight localities, from Maine to Puerto Rico. The concentration of strontium in the calcite shells increases with increasing temperature in the range 13 degrees to 25 degrees C, and also with increasing Sr(++)/Ca(++) molal ratio in the water. The concentration of magnesium in the shells increases irregularly with temperature, and it is apparently independent of the Mg(++)/Ca(++) ratio in the water. The greater variation with temperature in the distribution factor for magnesium may be related to genetic differences between semi-isolated populations.

  2. Magnesium as a biodegradable and bioabsorbable material for medical implants

    NASA Astrophysics Data System (ADS)

    Brar, Harpreet S.; Platt, Manu O.; Sarntinoranont, Malisa; Martin, Peter I.; Manuel, Michele V.

    2009-09-01

    For many years, stainless steel, cobalt-chromium, and titanium alloys have been the primary biomaterials used for load-bearing applications. However, as the need for structural materials in temporary implant applications has grown, materials that provide short-term structural support and can be reabsorbed into the body after healing are being sought. Since traditional metallic biomaterials are typically biocompatible but not biodegradable, the potential for magnesium-based alloys in biomedical applications has gained more interest. This paper summarizes the history and current status of magnesium as a bioabsorbable implant material. Also discussed is the development of a magnesium-zinc-calcium alloy that demonstrates promising degradation behavior.

  3. Biodegradable Magnesium Alloys: A Review of Material Development and Applications

    PubMed Central

    Persaud-Sharma, Dharam; McGoron, Anthony

    2012-01-01

    Magnesium based alloys possess a natural ability to biodegrade due to corrosion when placed within aqueous substances, which is promising for cardiovascular and orthopedic medical device applications. These materials can serve as a temporary scaffold when placed in vivo, which is desirable for treatments when temporary supportive structures are required to assist in the wound healing process. The nature of these materials to degrade is attributed to the high oxidative corrosion rates of magnesium. In this review, a summary is presented for magnesium material development, biocorrosion characteristics, as well as a biological translation for these results. PMID:22408600

  4. The role of magnesium sulfate in the intensive care unit

    PubMed Central

    Panahi, Yunes; Mojtahedzadeh, Mojtaba; Najafi, Atabak; Ghaini, Mohammad Reza; Abdollahi, Mohammad; Sharifzadeh, Mohammad; Ahmadi, Arezoo; Rajaee, Seyyed Mahdi; Sahebkar, Amirhossein

    2017-01-01

    Magnesium (Mg) has been developed as a drug with various clinical uses. Mg is a key cation in physiological processes, and the homeostasis of this cation is crucial for the normal function of body organs. Magnesium sulfate (MgSO4) is a mineral pharmaceutical preparation of magnesium that is used as a neuroprotective agent. One rationale for the frequent use of MgSO4 in critical care is the high incidence of hypomagnesaemia in intensive care unit (ICU) patients. Correction of hypomagnesaemia along with the neuroprotective properties of MgSO4 has generated a wide application for MgSO4 in ICU. PMID:28694751

  5. Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.

    PubMed

    Bai, Jane P F; Hausman, Ethan; Lionberger, Robert; Zhang, Xinyuan

    2012-12-03

    Prolonged use of proton pump inhibitors has reportedly caused rare clinically symptomatic hypomagnesemia. A review of the literature suggests PPI drugs may impair intestinal magnesium absorption. With the goal of preventing PPI-induced hypomagnesemia, an oral absorption-centric model was developed by referencing literature data. Our modeling with human data reveals that magnesium absorption is substantial in the distal intestine. We then perform simulations by referring to the reported reduction in mid to distal intestinal pH caused by one week of oral esomeprazole, and to reported reduction of the divalent cation-sensitive current when the carboxyl side chains of glutamic and aspartic residues in the binding channels of TRPM6/TRPM7 were neutralized. Our simulations reveal that short-term PPI therapy may cause a very small reduction (5%) in the serum magnesium level, which is qualitatively consistent with the reported 1% reduction in magnesium absorption following 1 week of omeprazole in humans. Simulations provide insight into the benefit of frequent but small dose of magnesium supplementation in maintaining the serum magnesium level when magnesium deficiency occurs.

  6. Metallization of magnesium polyhydrides under pressure

    NASA Astrophysics Data System (ADS)

    Lonie, David C.; Hooper, James; Altintas, Bahadir; Zurek, Eva

    2013-02-01

    Evolutionary structure searches are used to predict stable phases with unique stoichiometries in the hydrogen-rich region of the magnesium/hydrogen phase diagram under pressure. MgH4, MgH12, and MgH16 are found to be thermodynamically stable with respect to decomposition into MgH2 and H2 near 100 GPa, and all lie on the convex hull by 200 GPa. MgH4 contains two H- anions and one H2 molecule per Mg2+ cation, whereas the hydrogenic sublattices of MgH12 and MgH16 are composed solely of H2δ- molecules. The high-hydrogen content stoichiometries have a large density of states at the Fermi level, and the Tc of MgH12 at 140 GPa is calculated to be nearly three times greater than that of the classic hydride, MgH2, at 180 GPa.

  7. Laser glazing of lanthanum magnesium hexaaluminate

    NASA Astrophysics Data System (ADS)

    Zhang, Yanfei; Wang, Yaomin; Jarligo, Maria Ophelia; Zhong, Xinghua; Li, Qin; Cao, Xueqiang

    2008-08-01

    Lanthanum magnesium hexaalumminate (LMA) is an important candidate for thermal barrier coatings due to its thermal stability and low thermal conductivity. On the other hand, laser glazing method can potentially make thermal barrier coatings impermeable, resistant to corrosion on the surface and porous at bulk. LMA powder was synthesized at 1600 °C by solid-state reaction, pressed into tablet and laser glazed with a 5-kW continuous wave CO2 laser. Dendritic structures were observed on the surface of the laser-glazed specimen. The thicker the tablet, the easier the sample cracks. Cracking during laser glazing is attributed to the low thermal expansion coefficient and large thickness of the sample.

  8. Scattering law of a magnesium hydride moderator

    NASA Astrophysics Data System (ADS)

    Muhrer, G.; Hartl, M.; Daemen, L.; Tovesson, F.; Schnegg, A.; Russina, M.; Schachinger, E.

    2011-02-01

    Metal hydrides have long been considered possible moderator and pre-moderator materials for neutron sources. These materials have hydrogen density comparable to liquid hydrogen or light water. They usually do not undergo phase transitions in the desired operating range of 0-300 K, and display reasonable resistance to radiation damage. Magnesium hydride is such a simple, robust hydride system. To assess its neutronic usefulness as a moderator material, we determined experimentally the total scattering cross-section of the material. We compared our theoretical results to the experimental total neutron cross-section and to the data from quasi-elastic neutron scattering experiments, and produced a scattering kernel suitable for neutron transport calculations.

  9. Magnesium sulphate as a new desensitizing agent.

    PubMed

    Liu, G H; Morimoto, M

    1991-07-01

    Various desensitizing agents have been used in clinics to solve the problem of dentinal hypersensitivity (DH), but none of them has been shown to be consistently effective. We here introduce a new type of desensitizing agent, i.e. 4% magnesium sulphate with iontophoresis at 2mA for 3 min. These optimal conditions were determined by animal experiments, while only a minor effect on dentinal issues was observed within 4 weeks after the treatment. When this desensitizing agent was used to treat DH, the cure rate of 62.4% remained steady within the 25-week observation period, while some effect was achieved in all the subjects who participated in the study.

  10. A lightweight shape-memory magnesium alloy.

    PubMed

    Ogawa, Yukiko; Ando, Daisuke; Sutou, Yuji; Koike, Junichi

    2016-07-22

    Shape-memory alloys (SMAs), which display shape recovery upon heating, as well as superelasticity, offer many technological advantages in various applications. Those distinctive behaviors have been observed in many polycrystalline alloy systems such as nickel titantium (TiNi)-, copper-, iron-, nickel-, cobalt-, and Ti-based alloys but not in lightweight alloys such as magnesium (Mg) and aluminum alloys. Here we present a Mg SMA showing superelasticity of 4.4% at -150°C and shape recovery upon heating. The shape-memory properties are caused by reversible martensitic transformation. This Mg alloy includes lightweight scandium, and its density is about 2 grams per cubic centimeter, which is one-third less than that of practical TiNi SMAs. This finding raises the potential for development and application of lightweight SMAs across a number of industries. Copyright © 2016, American Association for the Advancement of Science.

  11. Magnesium carbonate precipitate strengthened aerobic granules.

    PubMed

    Lee, Duu-Jong; Chen, Yu-You

    2015-05-01

    Aerobic granules were precipitated internally with magnesium carbonate to enhance their structural stability under shear. The strengthened granules were tested in continuous-flow reactors for 220 days at organic loadings of 6-39 kg/m(3)/day, hydraulic retention times of 0.44-19 h, and temperatures of 10 or 28°C. The carbonate salt had markedly improved the granule strength without significant changes in granule morphology or microbial communities (with persistent strains Streptomyces sp., Rhizobium sp., Brevundimonas sp., and Nitratireductor sp.), or sacrifice in biological activity for organic degradation. MgCO3 precipitated granules could be used in continuous-flow reactor for wastewater treatment at low cost and with easy processing efforts.

  12. A lightweight shape-memory magnesium alloy

    NASA Astrophysics Data System (ADS)

    Ogawa, Yukiko; Ando, Daisuke; Sutou, Yuji; Koike, Junichi

    2016-07-01

    Shape-memory alloys (SMAs), which display shape recovery upon heating, as well as superelasticity, offer many technological advantages in various applications. Those distinctive behaviors have been observed in many polycrystalline alloy systems such as nickel titantium (TiNi)-, copper-, iron-, nickel-, cobalt-, and Ti-based alloys but not in lightweight alloys such as magnesium (Mg) and aluminum alloys. Here we present a Mg SMA showing superelasticity of 4.4% at -150°C and shape recovery upon heating. The shape-memory properties are caused by reversible martensitic transformation. This Mg alloy includes lightweight scandium, and its density is about 2 grams per cubic centimeter, which is one-third less than that of practical TiNi SMAs. This finding raises the potential for development and application of lightweight SMAs across a number of industries.

  13. Nanocomposite polymer electrolyte for rechargeable magnesium batteries

    SciTech Connect

    Shao, Yuyan; Rajput, Nav Nidhi; Hu, Jian Z.; Hu, Mary Y.; Liu, Tianbiao L.; Wei, Zhehao; Gu, Meng; Deng, Xuchu; Xu, Suochang; Han, Kee Sung; Wang, Jiulin; Nie, Zimin; Li, Guosheng; Zavadil, K.; Xiao, Jie; Wang, Chong M.; Henderson, Wesley A.; Zhang, Jiguang; Wang, Yong; Mueller, Karl T.; Persson, Kristin A.; Liu, Jun

    2014-12-28

    Nanocomposite polymer electrolytes present new opportunities for rechargeable magnesium batteries. However, few polymer electrolytes have demonstrated reversible Mg deposition/dissolution and those that have still contain volatile liquids such as tetrahydrofuran (THF). In this work, we report a nanocomposite polymer electrolyte based on poly(ethylene oxide) (PEO), Mg(BH4)2 and MgO nanoparticles for rechargeable Mg batteries. Cells with this electrolyte have a high coulombic efficiency of 98% for Mg plating/stripping and a high cycling stability. Through combined experiment-modeling investigations, a correlation between improved solvation of the salt and solvent chain length, chelation and oxygen denticity is established. Following the same trend, the nanocomposite polymer electrolyte is inferred to enhance the dissociation of the salt Mg(BH4)2 and thus improve the electrochemical performance. The insights and design metrics thus obtained may be used in nanocomposite electrolytes for other multivalent systems.

  14. Bearing Tests of Magnesium-alloy Sheet

    NASA Technical Reports Server (NTRS)

    Sharp, W H; Moore, R L

    1943-01-01

    Bearing tests of AM-3S, AM-52S, and AM-C57S magnesium-alloy sheet in various thicknesses and tempers were made. Bearing yield and ultimate strengths were determined and compared for various edge distances and for various ratios of loading-pin diameter to sheet thickness. Tensile strengths were determined and ratios of average bearing yield and ultimate strength to tensile strength are given. The results of the tests indicated that ultimate bearing strengths increased with edge distances up to 1.5 to 2 times the diameter of the loading pin; that ultimate bearing strengths are a function of the ratio of pin diameter to sheet thickness; and that these properties are effected only slightly by increases in edge distance greater than 1.5 diameters.

  15. Magnesium sulphate for preventing preterm birth in threatened preterm labour.

    PubMed

    Crowther, Caroline A; Brown, Julie; McKinlay, Christopher J D; Middleton, Philippa

    2014-08-15

    Magnesium sulphate has been used in some settings as a tocolytic agent to inhibit uterine activity in women in preterm labour with the aim of preventing preterm birth. To assess the effects of magnesium sulphate therapy given to women in threatened preterm labour with the aim of preventing preterm birth and its sequelae. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (last searched 31 January 2014). Randomised controlled trials of magnesium sulphate as the only tocolytic, administered by any route, compared with either placebo, no treatment or alternative tocolytic therapy (not magnesium sulphate) to women considered to be in preterm labour. At least two review authors assessed trial eligibility and risk of bias and undertook data extraction independently. The 37 included trials (total of 3571 women and over 3600 babies) were generally of moderate to high risk of bias. Antenatal magnesium sulphate was compared with either placebo, no treatment, or a range of alternative tocolytic agents.For the primary outcome of giving birth within 48 hours after trial entry, no significant differences were seen between women who received magnesium sulphate and women who did not (whether placebo/no alternative tocolytic drug, betamimetics, calcium channel blockers, cox inhibitors, prostaglandin inhibitors, or human chorionic gonadotropin) (19 trials, 1913 women). Similarly for the primary outcome of serious infant outcome, there were no significant differences between the infants exposed to magnesium sulphate and those not (whether placebo/no alternative tocolytic drug, betamimetics, calcium channel blockers, cox inhibitors, prostaglandin inhibitors, human chorionic gonadotropin or various tocolytic drugs) (18 trials; 2187 babies). No trials reported the outcome of extremely preterm birth. In the seven trials that reported serious maternal outcomes, no events were recorded.In the group treated with magnesium sulphate compared with women receiving

  16. Early geodynamo powered by magnesium exsolution?

    NASA Astrophysics Data System (ADS)

    Du, Z.; Jackson, C.; Bennett, N.; Driscoll, P.; Fei, Y.; Lee, K. K. M.

    2016-12-01

    Earth's magnetic field is generated by a convective dynamo in the outer core. The power driving this convection is likely a mix of thermal and compositional sources that rely on the steady cooling of the core. As such, the overlying mantle also plays a major role in magnetic field generation as it modulates the core cooling rate, and the convective sources in the core. Therefore understanding the nature of the core is of primary importance to understand the history of Earth's dynamo and mantle dynamics. Magnesium, present at a value as small as 1-2 wt%, may provide sufficient energy to drive an early geodynamo (O'Rourke and Stevenson, 2016), in spite of newly proposed high thermal conductivity of core materials (e.g. Pozzo et al., 2012). Much is still unknown about the plausibility of Mg in Earth's core, while recent studies suggest appreciable amount of magnesium might be present in liquid iron above 4000K (Wahl and Militzer, 2013, Badro et al., 2016). In this study, we examine different potential energy sources for driving the geodynamo over geologic history and we present new experiments for light element (e.g., Mg, Si, and O) partitioning between liquid metal and molten silicate using the laser-heated diamond anvil cell. Recovered samples are processed with focused ion beam milling and analyzed by field-emission electron microscopy. Our partitioning data are in disagreement with previous reports (Wahl and Militzer, 2013, Badro et al., 2016) and we explore the implications of our new partitioning results on the thermal and magnetic history of the core.

  17. The magnesium chelation step in chlorophyll biosynthesis

    SciTech Connect

    Weinstein, J.

    1990-11-01

    In photosynthetic organisms, the biogenesis of energy transducing membranes requires the coordinate synthesis of prosthetic groups, proteins, and various lipids. Two of the major prosthetic groups, chlorophyll and heme, share a common biosynthetic pathway that diverges at the point of metal insertion into protoporphyrin IX (Proto). Insertion of iron leads to the formation of hemes, while insertion of magnesium is the first step unique to chlorophyll formation. This project is directed toward identifying the enzyme(s) responsible for magnesium chelation and elucidating the mechanism which regulates the flux of precursors through the branch point enzymes in isolated chloroplasts. Using intact chloroplasts from greening cucumber cotyledons, we have confirmed the ATP requirement for Mg-Proto formation. Use of non-hydrolyzable ATP analogs, uncouplers and ionophores has led to the conclusions that ATP hydrolysis is necessary, but that this hydrolysis is not linked to the requirement for membrane intactness by transmembrane ion gradients or electrical potentials. The enzyme(s) are flexible with respect to the porphyrin substrate specificity, accepting porphyrins with -vinyl, -ethyl, or -H substituents at the 2 and 4 positions. The activity increases approximately four-fold during greening. Possible physiological feedback inhibitors such as heme, protochlorophyllide, and chlorophyllide had no specific effect on the activity. The activity has now been assayed in barely, corn and peas, with the system from peas almost ten-fold more active than the cucumber system. Work is continuing in pea chloroplasts with the development of a continuous assay and investigation of the feasibility of characterizing an active, organelle-free preparation. 6 figs.

  18. Solid oxide membrane process for the direct reduction of magnesium from magnesium oxide

    NASA Astrophysics Data System (ADS)

    Krishnan, Ajay

    The Solid Oxide Membrane (SOM) process is an emerging generic technology for the environmentally friendly extraction of high-energy-content metals directly from their oxides. This process has the potential to offer a viable, cost effective and cleaner alternative to existing state of the art primary magnesium extraction processes. The SOM process in principle uses a tubular yttria stabilized-zirconia-based solid oxide fuel cell with liquid metal (copper or tin) as an anode in the temperature range of 1100--1300°C. Magnesium oxide is dissolved in a molten ionic flux and oxygen ions are pumped out of the flux through the zirconia membrane and are oxidized at, the liquid metal anode. Magnesium vapor evolves at the cathode and is condensed in a separate chamber (condenser). The proof of concept for the SOM process was initially demonstrated at 1300°C using a magnesium fluoride-based flux. Since the membrane is the most expensive part of the process, its long-term stability is critical to the scale up and eventual commercialization of the process. Temperature, flux chemistry and cell operating conditions have been identified as key process parameters for membrane stability. A new low temperature flux based on the eutectic: magnesium fluoride-calcium fluoride system, has been developed which has lowered the operating temperature of the SOM cell to 1150°C. Additionally, a minor addition of yttrium fluoride to the flux minimized yttria diffusion from the yttria-stabilized-zirconia membrane, thereby further enhancing membrane stability. Important thermo-physical properties of the selected flux compositions critical to the process such as viscosity, density, volatility, solubility and electrical conductivity have been measured. The SOM cell has been electrochemically characterized and concepts related to MgO dissociation voltage, observed leakage current and mass transfer in the SOM cell are explained. The viability of the SOM process has been demonstrated by the

  19. Lattice dynamics of fct indium and hcp magnesium

    SciTech Connect

    Chen, X.M.; Xuan, Y.; Overhauser, A.W. )

    1991-01-15

    Phonon spectra of fct indium and hcp magnesium are calculated using the dynamic pseudopotential theory developed by Wang and Overhauser. Good agreement with experimental data is achieved with two adjustable pseudopotential parameters.

  20. POURING IRON FROM ELECTRIC FURNACE INTO BULL LADLE AFTER MAGNESIUM ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    POURING IRON FROM ELECTRIC FURNACE INTO BULL LADLE AFTER MAGNESIUM HAD BEEN ADDED TO GENERATE DUCTILE IRON WHEN IT COOLS IN THE MOLD. - Southern Ductile Casting Company, Casting, 2217 Carolina Avenue, Bessemer, Jefferson County, AL

  1. Design considerations for developing biodegradable and bioabsorbable magnesium implants

    NASA Astrophysics Data System (ADS)

    Brar, Harpreet S.; Keselowsky, Benjamin G.; Sarntinoranont, Malisa; Manuel, Michele V.

    2011-04-01

    The integration of biodegradable and bioabsorbable magnesium implants into the human body is a complex undertaking that faces major challenges. Candidate biomaterials must meet both engineering and physiological requirements to ensure the desired properties. Historically, efforts have been focused on the behavior of commercial magnesium alloys in biological environments and their resultant effect on cell-mediated processes. Developing causal relationships between alloy chemistry and microstructure, and effects as a cellular behavior can be a difficult and time-intensive process. A systems design approach has the power to provide significant contributions in the development of the next generation of magnesium alloy implants with controlled degradability, biocompatibility, and optimized mechanical properties, at reduced time and cost. This approach couples experimental research with theory and mechanistic modeling for the accelerated development of materials. The aim of this article is to enumerate this strategy, design considerations, and hurdles for developing new cast magnesium alloys for use as biodegradable implant materials.

  2. Magnesium-zinc reduction is effective in preparation of metals

    NASA Technical Reports Server (NTRS)

    Knighton, J. B.; Steuneberg, R. K.

    1967-01-01

    Uranium, thorium, and plutonium are effectively prepared by magnesium-zinc reduction, using uranium oxides, thorium dioxide, and plutonium dioxide as starting materials. This technique is also useful in performing reduction of metals such as zirconium and titanium.

  3. Injectable bioactive calcium-magnesium phosphate cement for bone regeneration.

    PubMed

    Wu, Fan; Su, Jiacan; Wei, Jie; Guo, Han; Liu, Changsheng

    2008-12-01

    Novel injectable and degradable calcium-magnesium phosphate cement (CMPC) with rapid-setting characteristic was developed by the introduction of magnesium phosphate cement (MPC) into calcium phosphate cement (CPC). The calcium-magnesium phosphate cement prepared under the optimum P/L ratio exhibited good injectability and desired workability. It could set within 10 min at 37 degrees C in 100% relative humidity and the compressive strength could reach 47 MPa after setting for 48 h, indicating that the prepared cement has relatively high initial mechanical strength. The results of in vitro degradation experiments demonstrated the good degradability of the injectable CMPC, and its degradation rate occurred significantly faster than that of pure CPC in simulated body fluid (SBF) solution. It can be concluded that the novel injectable calcium-magnesium phosphate cement is highly promising for a wide variety of clinical applications, especially for the development of minimally invasive techniques.

  4. Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid

    MedlinePlus

    Sodium picosulfate, magnesium oxide, and anhydrous citric acid combination powder is used to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check ...

  5. Topologically ordered magnesium-biopolymer hybrid composite structures.

    PubMed

    Oosterbeek, Reece N; Seal, Christopher K; Staiger, Mark P; Hyland, Margaret M

    2015-01-01

    Magnesium and its alloys are intriguing as possible biodegradable biomaterials due to their unique combination of biodegradability and high specific mechanical properties. However, uncontrolled biodegradation of magnesium during implantation remains a major challenge in spite of the use of alloying and protective coatings. In this study, a hybrid composite structure of magnesium metal and a biopolymer was fabricated as an alternative approach to control the corrosion rate of magnesium. A multistep process that combines metal foam production and injection molding was developed to create a hybrid composite structure that is topologically ordered in all three dimensions. Preliminary investigations of the mechanical properties and corrosion behavior exhibited by the hybrid Mg-polymer composite structures suggest a new potential approach to the development of Mg-based biomedical devices. © 2014 Wiley Periodicals, Inc.

  6. EPA Response to Fruitland Magnesium Fire, Maywood, CA

    EPA Pesticide Factsheets

    The U.S. Environmental Protection Agency and its state and local partners continue the response operations and assessment of hazardous waste in the aftermath of the Fruitland Magnesium Fire Incident in Maywood, Los Angeles County, Calif.

  7. Magnesium hydroxide nanoparticles synthesized in water-in-oil microemulsions.

    PubMed

    Wu, Jianming; Yan, Hong; Zhang, Xuehu; Wei, Liqiao; Liu, Xuguang; Xu, Bingshe

    2008-08-01

    Well-dispersed magnesium hydroxide nanoplatelets were synthesized by a simple water-in-oil (w/o) microemulsion process, blowing gaseous ammonia (NH(3)) into microemulsion zones solubilized by magnesium chloride solution (MgCl(2)). Typical quaternary microemulsions of Triton X-100/cyclohexane/n-hexanol/water were used as space-confining microreactors for the nucleation, growth, and crystallization of magnesium hydroxide nanoparticles. The obtained magnesium hydroxide was characterized by field-emission scanning electron microscopy (FESEM), high-resolution transmission election microscopy (HRTEM), X-ray powder diffraction (XRD), laser light scattering, Fourier transform infrared spectroscopy (FT-IR), and thermogravimetric analysis-differential scanning calorimetry (TGA-DSC). The mole ratio of water to surfactant (omega(0)) played an important role in the sizes of micelles and nanoparticles, increasing with the increase of omega(0). The compatibility and dispersibility of nanoparticles obtained from reverse micelles were improved in the organic phase.

  8. The Magnesium Industry Today…The Global Perspective

    NASA Astrophysics Data System (ADS)

    Patzer, Greg

    World demand for magnesium will show a decline in 2009. The outlook for 2010, which is guardedly optimistic, will be for a resumption of slow growth. The industry has seen marked changes in the sources of supply for primary and alloyed magnesium in recent years. Technological advances in magnesium continue at a strong pace as does interest in the material as a substitute for other light metals. The automotive segment remains the end-use area with the largest growth potential, if for no other reason than the size and quantity of the potential materials substitution applications. However, the shrinkage of that market, particularly in North America will have a definite impact on expectations for magnesium. The 3C market (computers, communications & consumer electronics) will continue to show above average growth. Other niche markets related to medical and construction industries also offer potential.

  9. Alterations in magnesium and oxidative status during chronic emotional stress.

    PubMed

    Cernak, I; Savic, V; Kotur, J; Prokic, V; Kuljic, B; Grbovic, D; Veljovic, M

    2000-03-01

    Magnesium and oxidative status were investigated in young volunteers exposed to chronic stress (political intolerance, awareness of potential military attacks, permanent stand-by duty and reduced holidays more than 10 years) or subchronic stress consisting of everyday mortal danger in military actions lasting more than 3 months. Significant decreases in plasma ionized Mg2+, total Mg and ionized Ca2+ concentrations were found in both groups. Similarly, both study groups exhibited oxidative stress as assessed by increased plasma superoxide anions and malondialdehyde and modified antioxidant defense. There were no significant differences between the two stress groups. A negative correlation between magnesium balance and oxidative stress was observed suggesting that the same etiological factor (chronic stress) initiate decreases in both free and total magnesium concentrations and simultaneously increase oxidative stress intensity. These findings support the need for magnesium supplementation with antioxidant vitamins for people living in conditions of chronic stress.

  10. Ionized magnesium in the planetary nebula NGC 7027

    NASA Technical Reports Server (NTRS)

    Evans, N. J., II; Natta, A.; Russell, R. W.; Wyant, J.; Beckwith, S.

    1984-01-01

    Observations of NGC 7027 are presented for six ionic lines: Mg(+3) (4.48 microns), Mg(+4) (5.61 microns), H(0) (4.05 and 7.46 microns), Ne(+5) (7.64 microns), and Ar(+5) (4.53 microns). The magnesium lines are consistent with the measurements of Russell, Soifer, and Willner (1977), and the hydrogen lines are consistent with the line strengths predicted from the radio flux. Upper limits were obtained for the neon and argon lines. The abundance of magnesium in the central part of the nebula is highly uncertain because the fine-structure collision strengths are poorly known. The strong gradient of magnesium abundance from the inner to the outer portions of the nebula derived by Pequignot and Stasinska (1980) could be an artifact of this uncertainty. A brief analysis of the effective stellar temperature derived from the magnesium line ratios is given.

  11. Is magnesium sulfate by the intrathecal route efficient and safe?

    PubMed

    Mebazaa, M S; Ouerghi, S; Frikha, N; Moncer, K; Mestiri, T; James, M F; Ben Ammar, M S

    2011-01-01

    The polypharmacological approach to the treatment of postoperative pain has become routine in an attempt to minimize the adverse side effects of opioids. Magnesium sulphate is a noncompetitive antagonist of the N-methyl-d-aspartate (NMDA) receptor and thus can modify nociceptive modulation. Intravenous administration of magnesium sulphate can improve postoperative analgesia and decrease the requirement for postoperative opiates, but the effects are inconsistent and have not been reliably accompanied by a reduction in the incidence of morphine-related adverse events. Several studies have shown that the administration of magnesium by the intrathecal route is safe and, in combination with opiates, extends the effect of spinal anaesthesia in both animal and human studies. The analysis of these studies justifies further investigation of the use of magnesium sulphate by the intrathecal route. Copyright © 2010 Elsevier Masson SAS. All rights reserved.

  12. Electrodeposition of magnesium film from BMIMBF 4 ionic liquid

    NASA Astrophysics Data System (ADS)

    NuLi, Yanna; Yang, Jun; Wang, Pu

    2006-09-01

    In this paper, we reported for the first time magnesium electrodeposition and dissolution processes in the ionic liquid of BMIMBF 4 with 1 M Mg(CF 3SO 3) 2 at room temperature. Our study found that complete electrochemical reoxidation of the electrodeposited magnesium film was feasible only on Ag substrate, comparing with the Pt, Ni, and stainless-steel. Scanning electron microscope (SEM) and energy dispersive spectroscopy (EDS) results showed that magnesium was found in the deposited film and the deposits were dense. The electrodeposition of magnesium on Ag substrate in the ionic liquid was considered to be a reversible process by cyclic voltammetry. Plots of peak current versus the square root of the scan rate were found to be linear, which indicates that the mass-transport process of electroactive species was mainly diffusion controlled. The diffusion coefficient D values of electroactive species were calculated from cyclic voltammetry and chronoamperometry, respectively.

  13. Clumped-isotope thermometry of magnesium carbonates in ultramafic rocks

    NASA Astrophysics Data System (ADS)

    García del Real, Pablo; Maher, Kate; Kluge, Tobias; Bird, Dennis K.; Brown, Gordon E.; John, Cédric M.

    2016-11-01

    Magnesium carbonate minerals produced by reaction of H2O-CO2 with ultramafic rocks occur in a wide range of paragenetic and tectonic settings and can thus provide insights into a variety of geologic processes, including (1) deposition of ore-grade, massive-vein cryptocrystalline magnesite; (2) formation of hydrous magnesium carbonates in weathering environments; and (3) metamorphic carbonate alteration of ultramafic rocks. However, the application of traditional geochemical and isotopic methods to infer temperatures of mineralization, the nature of mineralizing fluids, and the mechanisms controlling the transformation of dissolved CO2 into magnesium carbonates in these settings is difficult because the fluids are usually not preserved. Clumped-isotope compositions of magnesium carbonates provide a means to determine primary mineralization or (re)equilibration temperature, which permits the reconstruction of geologic processes that govern magnesium carbonate formation. We first provide an evaluation of the acid fractionation correction for magnesium carbonates using synthetic magnesite and hydromagnesite, along with natural metamorphic magnesite and low-temperature hydromagnesite precipitated within a mine adit. We show that the acid fractionation correction for magnesium carbonates is virtually indistinguishable from other carbonate acid fractionation corrections given current mass spectrometer resolution and error. In addition, we employ carbonate clumped-isotope thermometry on natural magnesium carbonates from various geologic environments and tectonic settings. Cryptocrystalline magnesite vein deposits from California (Red Mountain magnesite mine), Austria (Kraubath locality), Turkey (Tutluca mine, Eskişehir district) and Iran (Derakht-Senjed deposit) exhibit broadly uniform Δ47 compositions that yield apparent clumped-isotope temperatures that average 23.7 ± 5.0 °C. Based on oxygen isotope thermometry, these clumped-isotope temperatures suggest

  14. Physicochemical action of potassium-magnesium citrate in nephrolithiasis

    NASA Technical Reports Server (NTRS)

    Pak, C. Y.; Koenig, K.; Khan, R.; Haynes, S.; Padalino, P.

    1992-01-01

    Effect of potassium-magnesium citrate on urinary biochemistry and crystallization of stone-forming salts was compared with that of potassium citrate at same dose of potassium in five normal subjects and five patients with calcium nephrolithiasis. Compared to the placebo phase, urinary pH rose significantly from 6.06 +/- 0.27 to 6.48 +/- 0.36 (mean +/- SD, p less than 0.0167) during treatment with potassium citrate (50 mEq/day for 7 days) and to 6.68 +/- 0.31 during therapy with potassium-magnesium citrate (containing 49 mEq K, 24.5 mEq Mg, and 73.5 mEq citrate per day). Urinary pH was significantly higher during potassium-magnesium citrate than during potassium citrate therapy. Thus, the amount of undissociated uric acid declined from 118 +/- 61 mg/day during the placebo phase to 68 +/- 54 mg/day during potassium citrate treatment and, more prominently, to 41 +/- 46 mg/day during potassium-magnesium citrate therapy. Urinary magnesium rose significantly from 102 +/- 25 to 146 +/- 37 mg/day during potassium-magnesium citrate therapy but not during potassium citrate therapy. Urinary citrate rose more prominently during potassium-magnesium citrate therapy (to 1027 +/- 478 mg/day from 638 +/- 252 mg/day) than during potassium citrate treatment (to 932 +/- 297 mg/day). Consequently, urinary saturation (activity product) of calcium oxalate declined significantly (from 1.49 x 10(-8) to 1.03 x 10(-8) M2) during potassium-magnesium citrate therapy and marginally (to 1.14 x 10(-8) M2) during potassium citrate therapy.(ABSTRACT TRUNCATED AT 250 WORDS).

  15. Al-TiH2 Composite Foams Magnesium Alloy

    NASA Astrophysics Data System (ADS)

    Prasada Rao, A. K.; Oh, Y. S.; Ain, W. Q.; A, Azhari; Basri, S. N.; Kim, N. J.

    2016-02-01

    The work presented here in describes the synthesis of aluminum based titanium-hydride particulate composite by casting method and its foaming behavior of magnesium alloy. Results obtained indicate that the Al-10TiH2 composite can be synthesized successfully by casting method. Further, results also reveal that closed-cell magnesium alloy foam can be synthesized by using Al-10TiH2 composite as a foaming agent.

  16. Formation of chemically bonded ceramics with magnesium dihydrogen phosphate binder

    DOEpatents

    Wagh, Arun S.; Jeong, Seung-Young

    2004-08-17

    A new method for combining magnesium oxide, MgO, and magnesium dihydrogen phosphate to form an inexpensive compactible ceramic to stabilize very low solubility metal oxides, ashes, swarfs, and other iron or metal-based additives, to create products and waste forms which can be poured or dye cast, and to reinforce and strengthen the ceramics formed by the addition of fibers to the initial ceramic mixture.

  17. Influence of magnesium on insulin resistance in obese women.

    PubMed

    Cruz, Kyria Jayanne Clímaco; de Oliveira, Ana Raquel Soares; Pinto, Denise Pereira; Morais, Jennifer Beatriz Silva; Lima, Fabiana da Silva; Colli, Célia; Torres-Leal, Francisco Leonardo; Marreiro, Dilina do Nascimento

    2014-09-01

    The present study evaluated the influence of magnesium on insulin resistance in obese women. A case-control study involving 114 women on the age between 20 and 50 years old, divided into two groups: control (eutrophic women, n = 59) and case (obese women, n = 55). The analysis of magnesium intake was carried out through the 3-day food record and also NutWin software version 1.5. The plasma, erythrocyte, and urinary magnesium concentrations were determined by flame atomic absorption spectrophotometry. The determinations of serum glucose and serum insulin were performed by enzymatic colorimetric method and chemiluminescence, respectively. The insulin resistance was assessed by homeostasis model assessment insulin resistance (HOMA-IR). The mean values of magnesium intake were lower than those recommended, without difference between groups (p > 0.05). All the patients who were evaluated showed adequate mean concentrations of magnesium in the plasma and erythrocyte. The urinary excretion of this mineral was lower than the reference values in both groups and did not show significant difference (p > 0.05). The values of serum glucose, serum insulin, and HOMA-IR were higher in obese women compared to the control group. A negative correlation was observed between erythrocyte magnesium and glycemic parameters (p < 0.05). Obese patients take in foods with low dietary magnesium content, and they show hypomagnesuria as a compensatory mechanism to keep the plasma concentration of this mineral in adequate levels. The correlation between the erythrocyte magnesium concentration and the parameters of glycemic control suggests the influence of this mineral on the index of insulin resistance in obese women.

  18. Activation of magnesium hydride by pressing with catalytic additives

    NASA Astrophysics Data System (ADS)

    Shikin, I. V.; Elets, D. I.; Voyt, A. P.; Gabis, I. E.

    2017-02-01

    We have studied the activation of magnesium hydride decomposition by means of its pressing with a catalyst. It is established that pressing leads to the formation of metal nuclei, which favor a decrease in the temperature threshold of magnesium hydride decomposition. The introduction of catalytic additives also reduces the temperature of dehydrogenation. The most effective in this respect was found to be the addition of nickel powder.

  19. Serum Magnesium and Mortality in Maintenance Hemodialysis Patients.

    PubMed

    Yu, Ling; Li, Han; Wang, Shi-Xiang

    2017-01-01

    The study aimed to investigate the potential contributing effect of serum magnesium on mortality in maintenance hemodialysis (MHD) patients. The patients receiving regular MHD in March 2013 were involved. Baseline data including clinical data, anthropometrics and biochemical measurement were collected. After being followed for 36 months, the time of death and reason were recorded. One hundred and thirty-five MHD patients were enrolled in the study and analyzed, with mean serum magnesium of 1.11 ± 0.15 mmol/l. The level of serum magnesium in 64 patients was normal (47.4%), and it was elevated in 71 of the 135 patients (52.6%). And none of MHD patients had hypomagnesemia. The levels of serum albumin (Alb), urea nitrogen, creatinine (Cr), uric acid and phosphorus were significantly higher, but high-sensitivity C-reactive protein (Hs-CRP) and lipoprotein A were significantly lower in hypermagnesemia group compared to the normal serum magnesium group (p < 0.05). Serum Alb, serum Cr, serum phosphorus and Hs-CRP were related factors of hypermagnesemia by multivariate logistic regression analysis (p < 0.05). During the 36 months of follow-up, 27 patients died (20.0%), of whom 55.6% died of cardiovascular (CV) events. Kaplan-Meier curves showed that cumulative incidence of CV mortality were significantly higher in the normal serum magnesium group than in the hypermagnesemia group (p = 0.027); however, there was no significant difference in all-cause mortality (p > 0.05). Serum magnesium was elevated, which was related with nutrition and inflammation markers including serum Alb, serum Cr, serum phosphorus and Hs-CRP. Lower serum magnesium is a risk factor of CV mortality in MHD patients. Intervention studies are needed to clarify whether magnesium supplementation is beneficial for improving patient prognosis, when MHD patients had inflammatory and malnutrition. © 2016 S. Karger AG, Basel.

  20. Tensile and Compressive Tests of Magnesium Alloy J-1 Sheet

    DTIC Science & Technology

    1943-12-01

    Tensile and compressive properties of longitudinal and transverse specimens of magnesium alloy J-1 sheets, 0.032 and 0.12 in. thick, were tested. It was found that he tensile properties were above the Navy specification 47M2a for magnesium-base-alloy 8H. Longitudinal and transverse specimens were in close agreement in the tensile test . In the compressive yield strengths, longitudinal direction was much less

  1. Physicochemical action of potassium-magnesium citrate in nephrolithiasis

    NASA Technical Reports Server (NTRS)

    Pak, C. Y.; Koenig, K.; Khan, R.; Haynes, S.; Padalino, P.

    1992-01-01

    Effect of potassium-magnesium citrate on urinary biochemistry and crystallization of stone-forming salts was compared with that of potassium citrate at same dose of potassium in five normal subjects and five patients with calcium nephrolithiasis. Compared to the placebo phase, urinary pH rose significantly from 6.06 +/- 0.27 to 6.48 +/- 0.36 (mean +/- SD, p less than 0.0167) during treatment with potassium citrate (50 mEq/day for 7 days) and to 6.68 +/- 0.31 during therapy with potassium-magnesium citrate (containing 49 mEq K, 24.5 mEq Mg, and 73.5 mEq citrate per day). Urinary pH was significantly higher during potassium-magnesium citrate than during potassium citrate therapy. Thus, the amount of undissociated uric acid declined from 118 +/- 61 mg/day during the placebo phase to 68 +/- 54 mg/day during potassium citrate treatment and, more prominently, to 41 +/- 46 mg/day during potassium-magnesium citrate therapy. Urinary magnesium rose significantly from 102 +/- 25 to 146 +/- 37 mg/day during potassium-magnesium citrate therapy but not during potassium citrate therapy. Urinary citrate rose more prominently during potassium-magnesium citrate therapy (to 1027 +/- 478 mg/day from 638 +/- 252 mg/day) than during potassium citrate treatment (to 932 +/- 297 mg/day). Consequently, urinary saturation (activity product) of calcium oxalate declined significantly (from 1.49 x 10(-8) to 1.03 x 10(-8) M2) during potassium-magnesium citrate therapy and marginally (to 1.14 x 10(-8) M2) during potassium citrate therapy.(ABSTRACT TRUNCATED AT 250 WORDS).

  2. Magnesium nitrate attenuates blood pressure rise in SHR rats.

    PubMed

    Vilskersts, Reinis; Kuka, Janis; Liepinsh, Edgars; Cirule, Helena; Gulbe, Anita; Kalvinsh, Ivars; Dambrova, Maija

    2014-01-01

    The administration of magnesium supplements and nitrates/nitrites decreases arterial blood pressure and attenuates the development of hypertension-induced complications. This study was performed to examine the effects of treatment with magnesium nitrate on the development of hypertension and its complications in spontaneously hypertensive (SHR) rats. Male SHR rats with persistent hypertension at the age of 12-13 weeks were allocated to two groups according to their arterial blood pressure. Rats from the control group received purified water, while the experimental animals from the second group received magnesium nitrate dissolved in purified water at a dose of 50 mg/kg. After four weeks of treatment, blood pressure was measured, the anatomical and functional parameters of the heart were recorded using an ultrasonograph, vascular reactivity was assayed in organ bath experiments and the cardioprotective effects of magnesium nitrate administration was assayed in an ex vivo experimental heart infarction model. Treatment with magnesium nitrate significantly increased the nitrate concentration in the plasma (from 62 ± 8 μmol/l to 111 ± 8 μmol/L), and attenuated the increase in the arterial blood pressure. In the control and magnesium nitrate groups, the blood pressure rose by 21 ± 3 mmHg and 6 ± 4 mmHg, respectively. The administration of magnesium nitrate had no effect on the altered vasoreactivity, heart function or the size of the heart infarction. In conclusion, our results demonstrate that magnesium nitrate effectively attenuates the rise in arterial blood pressure. However, a longer period of administration or earlier onset of treatment might be needed to delay the development of complications due to hypertension.

  3. In vitro decomposition study of coated magnesium alloys

    NASA Astrophysics Data System (ADS)

    Piersma, Tyler; White, Desiree; Cheng, Xinggou; Rabago-Smith, Montserrat; Lecronier, David

    2010-04-01

    In the last decade, magnesium has resurged as an important biomaterial. It's mechanical properties are very similar to natural bone, and it degrades in vivo to non toxic substances. Unfortunately, corrosion of pure magnesium in vivo is rapid, thus coated alloys that decrease it's corrosion could be used as implants in orthopedics. This presentation will describe the degradation results in a simulated body fluid (SBF).

  4. In vivo decomposition study of coated magnesium alloys

    NASA Astrophysics Data System (ADS)

    White, Desiree; Piersma, Tyler; Lecronier, David; Cheng, Xingguo; Rabago-Smith, Montserrat

    2010-04-01

    In the last decade, magnesium has resurged as an important biomaterial. Its mechanical properties are very similar to natural bone, and it degrades in vivo to non toxic substances. Unfortunately, corrosion of pure magnesium in vivo is rapid, thus coated alloys that decrease its corrosion could be used as implants in orthopedics. This presentation will describe the degradation results in cell cultures and in rats.

  5. Temperature dependent phase transformation in nano sized magnesium ferrite

    NASA Astrophysics Data System (ADS)

    Sumangala T., P.; Mahender, C.; Venkataramani, N.; Prasad, Shiva

    2015-06-01

    The phase transformation in nanosized stoichiometric magnesium ferrite is being discussed. It was shown by TGA/DSC that there exist two reactions (shown by exothermic peaks) in nano sized magnesium ferrite when synthesized by sol gel combustion synthesis. First one of these reactions resulted in the precipitation of α-Fe2O3 and a resultant spinel. The second reaction resulted in stoichiometric spinel from this two phase system.

  6. High power rechargeable magnesium/iodine battery chemistry

    PubMed Central

    Tian, Huajun; Gao, Tao; Li, Xiaogang; Wang, Xiwen; Luo, Chao; Fan, Xiulin; Yang, Chongyin; Suo, Liumin; Ma, Zhaohui; Han, Weiqiang; Wang, Chunsheng

    2017-01-01

    Rechargeable magnesium batteries have attracted considerable attention because of their potential high energy density and low cost. However, their development has been severely hindered because of the lack of appropriate cathode materials. Here we report a rechargeable magnesium/iodine battery, in which the soluble iodine reacts with Mg2+ to form a soluble intermediate and then an insoluble final product magnesium iodide. The liquid–solid two-phase reaction pathway circumvents solid-state Mg2+ diffusion and ensures a large interfacial reaction area, leading to fast reaction kinetics and high reaction reversibility. As a result, the rechargeable magnesium/iodine battery shows a better rate capability (180 mAh g−1 at 0.5 C and 140 mAh g−1 at 1 C) and a higher energy density (∼400 Wh kg−1) than all other reported rechargeable magnesium batteries using intercalation cathodes. This study demonstrates that the liquid–solid two-phase reaction mechanism is promising in addressing the kinetic limitation of rechargeable magnesium batteries. PMID:28071666

  7. Synthesis of magnesium aluminate spinel by periclase and alumina chlorination

    SciTech Connect

    Orosco, Pablo; Barbosa, Lucía; Ruiz, María del Carmen

    2014-11-15

    Highlights: • Use of chlorination for the synthesis of magnesium aluminate spinel. • The reagents used were alumina, periclase and chlorine. • Isothermal and non-isothermal assays were performed in air and Cl{sub 2}–N{sub 2} flows. • The chlorination produced magnesium aluminate spinel at 700 °C. • Selectivity of the chlorination reaction to obtain spinel is very high. - Abstract: A pyrometallurgical route for the synthesis of magnesium aluminate spinel by thermal treatment of a mechanical mixture containing 29 wt% MgO (periclase) and 71 wt% Al{sub 2}O{sub 3} (alumina) in chlorine atmosphere was developed and the results were compared with those obtained by calcining the same mixture of oxides in air atmosphere. Isothermal and non-isothermal assays were performed in an experimental piece of equipment adapted to work in corrosive atmospheres. Both reagents and products were analyzed by differential thermal analysis (DTA), X-ray diffraction (XRD) and X-ray fluorescence (XRF). Thermal treatment in Cl{sub 2} atmosphere of the MgO–Al{sub 2}O{sub 3} mixture produces magnesium aluminate spinel at 700 °C, while in air, magnesium spinel is generated at 930 °C. The synthesis reaction of magnesium aluminate spinel was complete at 800 °C.

  8. Sol - Gel synthesis and characterization of magnesium peroxide nanoparticles

    NASA Astrophysics Data System (ADS)

    Jaison, J.; Ashok raja, C.; Balakumar, S.; Chan, Y. S.

    2015-04-01

    Magnesium peroxide is an excellent source of oxygen in agriculture applications, for instance it is used in waste management as a material for soil bioremediation to remove contaminants from polluted underground water, biological wastes treatment to break down hydrocarbon, etc. In the present study, sol-gel synthesis of magnesium peroxide (MgO2) nanoparticles is reported. Magnesium peroxide is odourless; fine peroxide which releases oxygen when reacts with water. During the sol-gel synthesis, the magnesium malonate intermediate is formed which was then calcinated to obtain MgO2 nanoparticles. The synthesized nanoparticles were characterized using Thermo gravimetric -Differential Thermal Analysis (TG- DTA), X-Ray Diffraction studies (XRD) and High Resolution Transmission Electron Microscope (HRTEM). Our study provides a clear insight that the formation of magnesium malonate during the synthesis was due to the reaction between magnesium acetate, oxalic acid and ethanol. In our study, we can conclude that the calcination temperature has a strong influence on particle size, morphology, monodispersity and the chemistry of the particles.

  9. Multi-functional magnesium alloys containing interstitial oxygen atoms

    PubMed Central

    Kang, H.; Choi, H. J.; Kang, S. W.; Shin, S. E.; Choi, G. S.; Bae, D. H.

    2016-01-01

    A new class of magnesium alloys has been developed by dissolving large amounts of oxygen atoms into a magnesium lattice (Mg-O alloys). The oxygen atoms are supplied by decomposing titanium dioxide nanoparticles in a magnesium melt at 720 °C; the titanium is then completely separated out from the magnesium melt after solidification. The dissolved oxygen atoms are located at the octahedral sites of magnesium, which expand the magnesium lattice. These alloys possess ionic and metallic bonding characteristics, providing outstanding mechanical and functional properties. A Mg-O-Al casting alloy made in this fashion shows superior mechanical performance, chemical resistance to corrosion, and thermal conductivity. Furthermore, a similar Mg-O-Zn wrought alloy shows high elongation to failure (>50%) at room temperature, because the alloy plastically deforms with only multiple slips in the sub-micrometer grains (<300 nm) surrounding the larger grains (~15 μm). The metal/non-metal interstitial alloys are expected to open a new paradigm in commercial alloy design. PMID:26976372

  10. Multi-functional magnesium alloys containing interstitial oxygen atoms

    NASA Astrophysics Data System (ADS)

    Kang, H.; Choi, H. J.; Kang, S. W.; Shin, S. E.; Choi, G. S.; Bae, D. H.

    2016-03-01

    A new class of magnesium alloys has been developed by dissolving large amounts of oxygen atoms into a magnesium lattice (Mg-O alloys). The oxygen atoms are supplied by decomposing titanium dioxide nanoparticles in a magnesium melt at 720 °C the titanium is then completely separated out from the magnesium melt after solidification. The dissolved oxygen atoms are located at the octahedral sites of magnesium, which expand the magnesium lattice. These alloys possess ionic and metallic bonding characteristics, providing outstanding mechanical and functional properties. A Mg-O-Al casting alloy made in this fashion shows superior mechanical performance, chemical resistance to corrosion, and thermal conductivity. Furthermore, a similar Mg-O-Zn wrought alloy shows high elongation to failure (>50%) at room temperature, because the alloy plastically deforms with only multiple slips in the sub-micrometer grains (<300 nm) surrounding the larger grains (~15 μm). The metal/non-metal interstitial alloys are expected to open a new paradigm in commercial alloy design.

  11. High power rechargeable magnesium/iodine battery chemistry

    NASA Astrophysics Data System (ADS)

    Tian, Huajun; Gao, Tao; Li, Xiaogang; Wang, Xiwen; Luo, Chao; Fan, Xiulin; Yang, Chongyin; Suo, Liumin; Ma, Zhaohui; Han, Weiqiang; Wang, Chunsheng

    2017-01-01

    Rechargeable magnesium batteries have attracted considerable attention because of their potential high energy density and low cost. However, their development has been severely hindered because of the lack of appropriate cathode materials. Here we report a rechargeable magnesium/iodine battery, in which the soluble iodine reacts with Mg2+ to form a soluble intermediate and then an insoluble final product magnesium iodide. The liquid-solid two-phase reaction pathway circumvents solid-state Mg2+ diffusion and ensures a large interfacial reaction area, leading to fast reaction kinetics and high reaction reversibility. As a result, the rechargeable magnesium/iodine battery shows a better rate capability (180 mAh g-1 at 0.5 C and 140 mAh g-1 at 1 C) and a higher energy density (~400 Wh kg-1) than all other reported rechargeable magnesium batteries using intercalation cathodes. This study demonstrates that the liquid-solid two-phase reaction mechanism is promising in addressing the kinetic limitation of rechargeable magnesium batteries.

  12. Seawater desalination and serum magnesium concentrations in Israel.

    PubMed

    Koren, Gideon; Shlezinger, Meital; Katz, Rachel; Shalev, Varda; Amitai, Yona

    2017-04-01

    With increasing shortage of fresh water globally, more countries are consuming desalinated seawater (DSW). In Israel >50% of drinking water is now derived from DSW. Desalination removes magnesium, and hypomagnesaemia has been associated with increased cardiac morbidity and mortality. Presently the impact of consuming DSW on body magnesium status has not been established. We quantified changes in serum magnesium in a large population based study (n = 66,764), before and after desalination in regions consuming DSW and in regions where DSW has not been used. In the communities that switched to DSW in 2013, the mean serum magnesium was 2.065 ± 0.19 mg/dl before desalination and fell to 2.057 ± 0.19 mg/dl thereafter (p < 0.0001). In these communities 1.62% of subjects exhibited serum magnesium concentrations ≤1.6 mg/dl between 2010 and 2013. This proportion increased by 24% between 2010-2013 and 2015-2016 to 2.01% (p = 0.0019). In contrast, no such changes were recorded in the communities that did not consume DSW. Due to the emerging evidence of increased cardiac morbidity and mortality associated with hypomagnesaemia, it is vital to consider re-introduction of magnesium to DSW.

  13. Magnesium in Disease Prevention and Overall Health12

    PubMed Central

    Volpe, Stella Lucia

    2013-01-01

    Magnesium is the fourth most abundant mineral and the second most abundant intracellular divalent cation and has been recognized as a cofactor for >300 metabolic reactions in the body. Some of the processes in which magnesium is a cofactor include, but are not limited to, protein synthesis, cellular energy production and storage, reproduction, DNA and RNA synthesis, and stabilizing mitochondrial membranes. Magnesium also plays a critical role in nerve transmission, cardiac excitability, neuromuscular conduction, muscular contraction, vasomotor tone, blood pressure, and glucose and insulin metabolism. Because of magnesium’s many functions within the body, it plays a major role in disease prevention and overall health. Low levels of magnesium have been associated with a number of chronic diseases including migraine headaches, Alzheimer’s disease, cerebrovascular accident (stroke), hypertension, cardiovascular disease, and type 2 diabetes mellitus. Good food sources of magnesium include unrefined (whole) grains, spinach, nuts, legumes, and white potatoes (tubers). This review presents recent research in the areas of magnesium and chronic disease, with the goal of emphasizing magnesium’s role in disease prevention and overall health. PMID:23674807

  14. High power rechargeable magnesium/iodine battery chemistry

    DOE PAGES

    Tian, Huajun; Gao, Tao; Li, Xiaogang; ...

    2017-01-10

    Rechargeable magnesium batteries have attracted considerable attention because of their potential high energy density and low cost. However, their development has been severely hindered because of the lack of appropriate cathode materials. Here we report a rechargeable magnesium/iodine battery, in which the soluble iodine reacts with Mg2+ to form a soluble intermediate and then an insoluble final product magnesium iodide. The liquid–solid two-phase reaction pathway circumvents solid-state Mg2+ diffusion and ensures a large interfacial reaction area, leading to fast reaction kinetics and high reaction reversibility. As a result, the rechargeable magnesium/iodine battery shows a better rate capability (180 mAh g–1more » at 0.5 C and 140 mAh g–1 at 1 C) and a higher energy density (~400 Wh kg–1) than all other reported rechargeable magnesium batteries using intercalation cathodes. As a result, this study demonstrates that the liquid–solid two-phase reaction mechanism is promising in addressing the kinetic limitation of rechargeable magnesium batteries.« less

  15. Production and Refining of Magnesium Metal from Turkey Originating Dolomite

    NASA Astrophysics Data System (ADS)

    Demiray, Yeliz; Yücel, Onuralp

    2012-06-01

    In this study crown magnesium produced from Turkish calcined dolomite by the Pigeon Process was refined and corrosion tests were applied. By using factsage thermodynamic program metalothermic reduction behavior of magnesium oxide and silicate formation structure during this reaction were investigated. After thermodynamic studies were completed, calcination of dolomite and it's metalothermic reduction at temperatures of 1473 K, 1523 K and within a vacuum (varied from 20 to 200 Pa) and refining of crown magnesium was studied. Different flux compositions consisting of MgCl2, KCl, CaCl2, MgO, CaF2, NaCl, and SiO2 with and without B2O3 additions were selected for the refining process. These tests were carried out at 963 K for 15, 30 and 45 minutes setting time. Considerable amount of iron was transferred into the sludge phase and its amount decreased from 0.08% to 0.027%. This refined magnesium was suitable for the production of various magnesium alloys. As a result of decreasing iron content, minimum corrosion rate of refined magnesium was obtained 2.35 g/m2/day. The results are compared with previous studies.

  16. Magnesium Content of the Core: an Experimental Study

    NASA Astrophysics Data System (ADS)

    Fiquet, G.; Badro, J.; Auzende, A.; Siebert, J.; Gregoryanz, E.; Guignot, N.

    2006-12-01

    There is still a considerable debate about which light element among sulfur, silicon, oxygen, carbon or hydrogen should be in the core [Poirier, Phys. Earth Planet. Int., 85, 319, 1994]. The nature and distribution of these elements is a standing problem of prime importance, since it controls the freezing point depression at the inner core boundary. In addition to these candidates, new elements have been recently proposed as iron alloying constituants for the core, such as magnesium [Dubrovinskaia et al., Phys. Rev. Lett., 95, 245502, 2005]. We present series of experiments carried out on hot-pressed samples of iron and periclase in a laser-heated diamond-anvil cell, combined with in situ X-ray diffraction analysis and ATEM examination of recovered samples. We show that even at megabar pressures the amount of magnesium released in iron from the equilibrium with magnesium oxide is marginal. This finding is at odds with the 10 at% of magnesium found by Dubrovinskaia et al. [2005] in an iron alloy made from the reaction between iron and a metallic magnesium foil. Our observations suggest that magnesium is unlikely to be an important light element in the Earth's core. In addition, we provide structural data for iron to 130 GPa in excess of 3000 K with reliable pressure and temperature measurements, which enable us to propose a new thermal equation of state for iron at megabar pressures.

  17. Recycling of Magnesium Alloy Employing Refining and Solid Oxide Membrane (SOM) Electrolysis

    NASA Astrophysics Data System (ADS)

    Guan, Xiaofei; Zink, Peter A.; Pal, Uday B.; Powell, Adam C.

    2013-04-01

    Pure magnesium was recycled from partially oxidized 50.5 wt pct Mg-Al scrap alloy and AZ91 Mg alloy (9 wt pct Al, 1 wt pct Zn). Refining experiments were performed using a eutectic mixture of MgF2-CaF2 molten salt (flux). During the experiments, potentiodynamic scans were performed to determine the electrorefining potentials for magnesium dissolution and magnesium bubble nucleation in the flux. The measured electrorefining potential for magnesium bubble nucleation increased over time as the magnesium content inside the magnesium alloy decreased. Potentiostatic holds and electrochemical impedance spectroscopy were employed to measure the electronic and ionic resistances of the flux. The electronic resistivity of the flux varied inversely with the magnesium solubility. Up to 100 pct of the magnesium was refined from the Mg-Al scrap alloy by dissolving magnesium and its oxide into the flux followed by argon-assisted evaporation of dissolved magnesium and subsequently condensing the magnesium vapor. Solid oxide membrane electrolysis was also employed in the system to enable additional magnesium recovery from magnesium oxide in the partially oxidized Mg-Al scrap. In an experiment employing AZ91 Mg alloy, only the refining step was carried out. The calculated refining yield of magnesium from the AZ91 alloy was near 100 pct.

  18. Trends and nutritional status for magnesium in Taiwan from NAHSIT 1993 to 2008.

    PubMed

    Wang, Jui-Line; Weng, Yao-Lin; Pan, Wen-Harn; Kao, Mei-Ding

    2011-01-01

    Data from nationwide population-based nutrition surveys in Taiwan were used to investigate trends and nutritional status for magnesium from 1993 to 2008. Dietary magnesium intake was estimated from 24-hour dietary recalls. Serum and urinary magnesium were also measured. In Nutrition and Health Survey in Taiwan (NAHSIT) 2005-2008, average magnesium intake was 305 mg and 259 mg for adult males and females, respectively, which is equivalent to 82-85% of relevant Taiwanese Dietary Reference Intakes (DRIs). After correcting intra-individual variation, 74-81% of adult subjects' dietary magnesium was estimated as sub-optimal. Mean serum magnesium concentration was 0.866 mmol/L and 0.861 mmol/L for the males and females, respectively. The prevalence of low serum magnesium (<0.8 mmol/L) was 12.3% and 23.7% for the males and females, respectively. There was positive association among dietary magnesium, blood magnesium, and urinary magnesium/creatinine ratio. From NAHSIT 1993-1996 to NAHSIT 2005-2008, dietary magnesium significantly increased (p<0.05), the blood magnesium and urinary magnesium/creatinine ratio decreased (p<0.05). The findings suggest that the relationships between dietary magnesium and biochemical markers among different nutrition and health surveys are not straightforward and need to be further clarified.

  19. CO2 laser welding of magnesium alloys

    NASA Astrophysics Data System (ADS)

    Dhahri, Mohammed; Masse, Jean Eric; Mathieu, J. F.; Barreau, Gerard; Autric, Michel L.

    2000-02-01

    Metallic alloys with a low mass density can be considered to be basic materials in aeronautic and automotive industry. Magnesium alloys have better properties than aluminum alloys in respect of their low density and high resistance to traction. The main problems of magnesium alloy welding are the inflammability, the crack formation and the appearance of porosity during the solidification. The laser tool is efficient to overcome the difficulties of manufacturing by conventional processing. Besides, the laser processing mainly using shielding gases allows an effective protection of the metal against the action of oxygen and a small heat affected zone. In this paper, we present experimental results about 5 kW CO2 laser welding of 4 mm-thick magnesium alloy plates provided by Eurocopter France. The focused laser beam has about 0.15 mm of diameter. We have investigated the following sample: WE43, alloy recommended in aeronautic and space applications, is constituted with Mg, Y, Zr, rare earth. More ductile, it can be used at high temperatures until 250 degrees Celsius for times longer than 5000 hours without effects on its mechanical properties. A sample of RZ5 (French Norm: GZ4TR, United States Norm ZE41) is composed of Mg, Zn, Zr, La, rare earth. This alloy has excellent properties of foundry and it allows to the realization of components with complex form. Also, it has a good resistance and important properties of tightness. The parameters of the process were optimized in the following fields: laser power: 2 to 5 kW, welding speed: 1 to 4.5 m/min, focal position: -3 mm to +3 mm below or on the top of the metal surface, shielding gas: helium with a flow of 10 to 60 l/min at 4 bars. Metallurgical analyses and mechanical control are made (macroscopic structure, microscopic structure, interpretations of the structures and localization of possible defects, analyse phases, chemical composition, hardness, tensile test etc.) to understand the parameters influence of welding

  20. Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplant.

    PubMed

    Snyder, Matthew; Shillingburg, Alexandra; Newton, Michael; Hamadani, Mehdi; Kanate, Abraham S; Craig, Michael; Cumpston, Aaron

    2016-10-01

    For an outpatient cancer center to operate efficiently, optimizing the use of chair time is essential. Allogeneic hematopoietic cell transplant (allo-HCT) recipients are seen frequently in this setting after hospital discharge and regularly for several months thereafter. Aggressive electrolyte replacement is commonly required in these patients, primarily due to renal wasting with calcineurin inhibitor use. Frequent intravenous (IV) magnesium repletion, requiring several hours of infusion time, is often needed in these patients to adequately manage their magnesium deficiencies. The purpose of this study is to explore the impact of extending the infusion rate of intravenous magnesium sulfate on the frequency and degree of IV magnesium replacements required in allo-HCT recipients. We conducted a retrospective study to compare two cohorts of patients administered IV magnesium sulfate at a rate of 4 g/1 h versus 4 g/2 h. A total of 103 continuous patients were assessed in two groups as cohort 1 at the 4 g/1 h rate and cohort 2 at the 4 g/2 h rate. Cohort 1 required less IV magnesium per outpatient visit (median 2.2 vs. 2.9 g/visit, P = 0.0211) and less total IV magnesium replacement through day +100 (median 68 vs. 85 g, P = 0.0479) than cohort 2. These data suggest that there is no apparent benefit of prolonging magnesium infusion from 1 to 2 h in our outpatient allo-HCT population.